Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3051714	p-fidd	mg/l (mg/l)	57874	102716	0.69%
3051714	p-fidd	— (—)	28666	38117	100.00%	Distribution not available
3051714	p-fidd-o	mg/l (mg/l)	10037	12262	0.00%
3051714	p-fidd-o	— (—)	2479	2803	100.00%	Distribution not available
3051714	b-fidd	mg/l (mg/l)	1389	1790	0.00%
3051714	b-fiddp	mg/l (mg/l)	704	776	0.00%
3051714	b-fidd-o	mg/l (mg/l)	624	811	0.00%
3051714	p-fidd-lb	mg/l (mg/l)	612	805	0.00%
3051714	b-fidd	— (—)	333	396	100.00%	Distribution not available
3051714	oma-b-fidd	mg/l (mg/l)	323	365	0.00%
3051714	b-fidd-o	— (—)	277	315	100.00%	Distribution not available
3051714	p-fiddpik	mg/l (mg/l)	275	310	0.00%
3051714	p-tkfiddo	— (—)	158	180	100.00%	Distribution not available
3051714	p-tkfiddo	mg/l (mg/l)	146	192	0.00%
3051714	p-fiddpik	— (—)	122	130	100.00%	Distribution not available
3051714	b-fiddp	— (—)	110	121	100.00%	Distribution not available
3051714	b-fidd-pt	mg/l (mg/l)	69	74	0.00%
3051714	fibriinind-dimeerit,pikatesti(b-fidd-o)	mg/l (mg/l)	63	73	0.00%
3051714	p-fidd-lb	— (—)	54	60	100.00%	Distribution not available
3051714	fiddpika	— (—)	54	75	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti(fidd-o)	mg/l (mg/l)	40	42	0.00%
3051714	oma-b-fidd	— (—)	30	31	100.00%	Distribution not available
3051714	p-fidd-os	— (—)	25	28	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(23283b-fidd-pt)	mg/l (mg/l)	24	25	0.00%
3051714	b-fidd-p	mg/l (mg/l)	24	27	0.00%
3051714	b-fidd-pika	mg/l (mg/l)	24	26	0.00%
3051714	fibriinind-dimeerit,plasmasta(p-fidd)	mg/l (mg/l)	19	19	0.00%
3051714	p-fiddp	mg/l (mg/l)	19	32	0.00%
3051714	fibriinind-dimeerit,plasmasta(p-fidd)	— (—)	19	19	100.00%	Distribution not available
3051714	p-fiddhoi	— (—)	18	19	100.00%	Distribution not available
3051714	p-fiddhoi	mg/l (mg/l)	17	17	0.00%
3051714	fibriinind-dimeerit,pikatesti(3939b-fidd-o)	mg/l (mg/l)	16	16	0.00%
3051714	p-fidd-hoi	— (—)	15	17	100.00%	Distribution not available
3051714	b-fidd-pt	— (—)	14	15	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(4113p-fidd)	— (—)	12	14	100.00%	Distribution not available
3051714	p-fidd-poc	mg/l (mg/l)	11	13	0.00%
3051714	p-fidd-ospkl	mg/l (mg/l)	11	12	0.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(fidd)	mg/l (mg/l)	10	10	0.00%
3051714	fibriinind-dimeerit,plasmasta(fidd)	— (—)	10	10	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti(b-fidd-o)	— (—)	9	10	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(4113p-fidd)	mg/l (mg/l)	9	10	0.00%	Distribution not available
3051714	p-fidd-hoi	mg/l (mg/l)	8	8	0.00%
3051714	p-fidd-p	mg/l (mg/l)	7	7	0.00%	Distribution not available	Distribution not available
3051714	p-fidd-po	mg/l (mg/l)	7	7	0.00%	Distribution not available	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(3939b-fidd-pt)	mg/l (mg/l)	7	7	0.00%
3051714	p-fidd-poc	— (—)	5	5	100.00%	Distribution not available	Distribution not available
3051714	p-fidd-po	— (—)	5	6	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Behavioural syndromes associated with physiological disturbances and physical factors

13487

69043

1.51

321.26

1.8

0.89

1.18

mg/l

24.80

9893

52257

Allergic asthma (mode)

3444

17619

2.21

318.77

1.9

1.6

0.91

1.05

mg/l

1.66

2581

12908

Conduction disorders

3987

17637

2.12

316.96

2.2

1.6

1.41

1.40

mg/l

0.05

3079

13680

Transplanted organ and tissue status

1682

6822

3.47

315.34

6.0

1.7

2.17

1.18

mg/l

10.58

1496

5178

Hypertensive heart and/or renal disease

3477

13512

2.24

312.57

1.9

1.6

1.52

1.43

mg/l

0.64

2813

10311

Factors influencing health status and contact with health services

4265

11409

2.07

312.39

1.8

1.4

1.23

1.18

mg/l

0.32

3179

8646

Presence of cardiac and vascular implants and grafts

5968

27242

1.85

311.66

3.1

1.6

1.43

1.45

mg/l

0.13

4718

21186

Acute tubulo-interstitial nephritis

8849

51559

1.64

311.51

2.0

1.7

1.51

1.15

mg/l

11.20

6998

38920

Sleep disorders

12973

67631

1.51

311.42

1.7

1.8

0.86

1.17

mg/l

35.44

9494

51174

Functional dyspepsia

4080

23028

2.11

311.31

1.9

1.7

0.92

1.16

mg/l

7.96

3065

17573

Injuries to the head

16139

73691

1.45

311.21

1.9

1.8

1.18

mg/l

0.01

12202

55675

Hyperlipidaemia, other/unspecified

5272

29178

1.91

310.95

1.9

1.6

1.31

1.36

mg/l

0.44

4096

22495

Psychiatric diseases

14408

52249

1.48

310.00

1.9

1.7

1.10

1.23

mg/l

3.98

10784

39937

Irritable bowel syndrome

4222

24059

2.07

309.79

1.9

1.7

0.94

1.09

mg/l

1.84

3038

18102

Symptoms and signs involving the nervous and musculoskeletal systems

8258

55444

1.66

308.48

2.0

1.7

1.04

1.25

mg/l

7.26

6172

42427

Iron deficiency anaemia

6087

37648

1.82

308.43

2.5

1.7

1.39

1.27

mg/l

1.71

4771

28811

Selective serotonin reuptake inhibitors

14414

54612

1.48

307.87

1.8

1.08

1.24

mg/l

5.00

10687

41569

Dysphagia

3481

18643

2.21

307.81

2.0

1.6

1.19

1.33

mg/l

1.12

2628

14422

Finngen Rheumatological endpoints

15030

56726

1.66

307.65

1.9

1.7

1.11

1.15

mg/l

0.72

11635

42162

Disorders of lipoprotein metabolism and other lipidaemias

12191

48940

1.72

307.65

1.9

1.7

1.23

1.18

mg/l

0.77

9534

37374

Any reimbursement code in KELA

9086

27634

1.83

307.65

2.1

1.5

1.09

0.88

mg/l

5.68

6732

19892

Viral Sepsis

3538

15277

3.07

307.65

2.9

1.6

1.45

1.22

mg/l

2.78

2911

11530

Malaise and fatigue

9223

33277

2.77

307.65

2.2

1.6

1.31

1.26

mg/l

0.45

7169

25207

Exposure to unspecified factor

15332

75327

1.62

307.65

1.9

1.8

1.11

1.19

mg/l

2.37

11623

56847

Fall on same level

17388

67234

1.53

307.65

1.9

1.8

1.16

1.15

mg/l

0.12

13259

50423

Haemorrhage from respiratory passages

5236

20243

2.85

307.65

2.4

1.6

1.30

1.53

mg/l

3.71

4087

15715

Pain in throat and chest

18122

41569

3.39

307.65

2.0

1.6

0.88

1.27

mg/l

47.39

13382

31436

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6006

11562

3.03

307.65

2.0

1.5

1.00

1.09

mg/l

1.48

4392

8732

Other external causes of accidental injury

12218

42043

1.58

307.65

1.9

1.7

1.12

1.19

mg/l

1.21

9198

31689

Asthma-related pneumonia

6177

30083

2.55

307.65

2.3

1.7

1.20

1.35

mg/l

3.08

4968

22900

Headache

12685

46940

2.67

307.65

2.0

1.6

0.85

1.13

mg/l

20.34

9330

35084

Other dorsopathies, not elsewhere classified

16959

52962

1.90

307.65

1.8

1.7

1.00

1.26

mg/l

21.83

12662

39850

Disturbances of skin sensation

4593

24881

2.26

307.65

2.1

1.7

0.86

1.06

mg/l

3.17

3376

18738

Renal tubulo-interstitial diseases

13531

64971

1.74

307.65

2.3

1.7

1.66

1.11

mg/l

36.44

10930

48922

Nausea and vomiting

4224

20515

2.43

307.65

2.4

1.7

1.38

1.31

mg/l

0.52

3300

15588

Syncope and collapse

7159

30440

2.39

307.65

2.0

1.6

1.23

1.29

mg/l

0.75

5392

23073

Abnormal findings on diagnostic imaging of lung

6667

39956

1.82

307.65

2.0

1.7

1.39

1.35

mg/l

0.23

5405

30939

Cough

6351

27823

2.60

307.65

2.1

1.6

1.09

1.37

mg/l

6.18

4789

21281

All influenza

3789

19863

2.28

307.65

2.2

1.7

1.16

1.22

mg/l

0.45

2935

14732

Dizziness and giddiness

12115

58446

1.88

307.65

1.9

1.7

1.05

1.24

mg/l

8.54

9110

44772

Other functional intestinal disorders

6787

36950

1.96

307.65

2.0

1.7

1.17

1.28

mg/l

1.51

5268

28112

Abnormalities of breathing

20016

43055

3.55

307.65

2.1

1.6

1.06

1.27

mg/l

13.24

15353

32477

Oedema, not elsewhere classified

6965

23953

4.18

307.65

2.1

1.6

1.22

1.29

mg/l

1.22

5642

18225

Other diseases of urinary system

15201

58099

1.62

307.65

1.9

1.7

1.11

1.22

mg/l

3.19

11658

44065

Other joint disorders

13969

46496

1.76

307.65

1.8

0.97

1.22

mg/l

15.71

10375

34501

Acute upper respiratory infections

16511

66622

1.70

307.65

2.0

1.7

1.03

1.24

mg/l

11.55

12356

50678

Any mental disorder

16186

59117

1.47

307.65

1.9

1.7

1.12

1.20

mg/l

1.87

12122

45078

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9142

58160

1.76

307.65

2.1

1.7

1.40

1.20

mg/l

4.69

7309

44284

Non-ischemic cardiomyopathy

4428

17792

2.43

307.65

2.5

1.6

1.61

1.47

mg/l

1.20

3652

13614

Concussion

7684

35087

2.04

307.65

2.0

1.7

1.02

1.24

mg/l

8.49

5699

26397

Bronchitis

18075

70191

1.84

307.65

2.1

1.7

1.06

1.21

mg/l

7.52

13555

53141

Sleep apnoea, including avohilmo

15630

62418

1.75

307.65

1.8

1.7

0.93

1.23

mg/l

29.68

11826

47617

Oxycodone

5873

26492

2.41

307.65

2.1

1.6

1.67

1.33

mg/l

9.63

4823

20260

Tramadol

14356

44012

2.40

307.65

2.0

1.6

1.17

1.16

mg/l

0.03

11153

32965

Follow-up examination after treatment for conditions other than malignant neoplasms

6530

25925

1.87

307.65

1.8

1.6

1.14

1.25

mg/l

1.73

4963

19817

Septicaemia

6334

31923

2.20

307.65

2.6

1.6

1.99

1.25

mg/l

26.63

5269

24126

Parasetamol

12822

32883

2.27

307.65

1.9

1.7

1.06

1.22

mg/l

5.52

9608

24180

Phlebitis and thrombophlebitis (not including DVT)

4824

17804

4.11

307.65

2.3

1.7

1.62

1.10

mg/l

15.04

3889

13582

Undetermined asthma

2051

8672

3.01

307.65

2.0

1.5

0.94

1.14

mg/l

3.26

1580

6484

Acute bronchitis

6466

35381

2.11

307.65

2.2

1.8

1.11

1.28

mg/l

3.65

4894

26786

Other soft tissue disorders, not elsewhere classified

20081

50143

3.02

307.65

2.0

1.7

1.02

1.28

mg/l

23.06

15317

37586

Coronary revascularization (ANGIO or CABG)

12977

43467

2.17

307.65

2.4

1.6

1.14

1.24

mg/l

2.07

10055

33463

Spondylopathies

12040

44252

1.83

307.65

1.8

1.7

1.07

1.30

mg/l

13.07

9332

33961

Obesity

10267

60180

1.91

307.65

2.0

1.7

1.03

1.11

mg/l

1.91

8015

45233

Benzodiazepine use

14994

73818

1.52

307.65

1.9

1.7

1.16

1.19

mg/l

0.38

11197

56073

Other diseases of pleura

6249

32991

1.91

307.65

2.2

1.7

1.66

1.41

mg/l

4.77

5115

25457

Opioids

17495

49014

2.15

307.65

1.9

1.6

1.10

1.15

mg/l

1.03

13361

36247

Bleeding

11926

56836

1.65

307.65

2.3

1.7

1.37

1.24

mg/l

3.20

9362

43401

Venous thromboembolism

12150

44806

3.80

307.65

2.4

1.6

1.98

1.14

mg/l

75.92

9950

34270

Major coronary heart disease event

13508

46466

2.05

307.65

2.4

1.6

1.17

1.25

mg/l

1.38

10476

35763

All pneumoniae

17452

68005

1.99

307.65

2.3

1.7

1.36

1.10

mg/l

15.14

14049

50400

Abdominal and pelvic pain

16690

48788

1.95

307.65

2.0

1.7

1.12

1.24

mg/l

3.52

12466

37005

Osteopathies and chondropathies

8039

49333

1.71

307.65

2.1

1.7

1.21

1.22

mg/l

0.04

6323

37491

Examination and observation for other reasons

10462

30538

2.34

307.65

2.2

1.6

1.15

1.25

mg/l

1.52

7967

23326

Medical observation and evaluation for suspected diseases and conditions

11037

30772

2.10

307.65

2.1

1.6

1.11

1.25

mg/l

3.16

8171

23494

Cardiac arrhythmias

10487

33899

2.40

307.65

2.2

1.5

1.04

0.94

mg/l

2.01

7676

25141

Persons encountering health services for other counselling and medical advice, not elsewhere classified

17357

63531

1.64

307.65

2.0

1.7

1.19

mg/l

0.01

13182

48044

Other special examinations and investigations of persons without complaint or reported diagnosis

10151

30777

1.86

307.65

1.9

1.6

1.15

1.25

mg/l

1.67

7623

23497

Nerve, nerve root and plexus disorders

16230

68856

1.59

307.65

1.8

1.7

1.05

1.22

mg/l

8.00

12437

52311

Obesity related asthma

6092

29798

2.62

307.65

2.1

1.7

0.92

1.17

mg/l

12.53

4750

22708

Abnormalities of heart beat

6453

24726

3.30

307.65

2.1

1.5

0.95

1.38

mg/l

18.23

4665

18859

Implicit viral Sepsis

5066

23203

2.82

307.65

2.7

1.6

1.37

1.20

mg/l

2.55

4070

17536

Persons encountering health services for examination and investigation

9636

30777

1.72

307.65

1.9

1.6

1.14

1.25

mg/l

1.83

7218

23497

Certain infectious and parasitic diseases

11589

34953

1.85

307.65

1.9

1.6

1.15

1.14

mg/l

0.03

8816

26145

Other bacterial diseases

16261

61953

2.06

307.65

2.3

1.7

1.62

1.08

mg/l

47.29

13198

46355

Acetic acid derivatives and related substances

3887

9970

2.29

307.65

1.7

2.1

1.14

1.69

mg/l

9.77

2925

7638

Persons encountering health services for specific procedures and health care

17368

67296

1.73

307.65

2.2

1.7

1.41

1.08

mg/l

21.03

13699

50035

All anxiety disorders

9395

49406

1.67

307.65

2.0

1.7

0.94

1.04

mg/l

2.48

6721

36976

Oral corticosteroids

19308

63914

2.10

307.65

2.1

1.6

1.14

1.18

mg/l

1.00

15043

47950

Migraine

8482

37668

2.16

307.65

2.0

1.7

0.81

1.11

mg/l

16.60

6179

28084

Oxicams

3235

8871

2.38

307.65

1.7

2.0

1.13

1.73

mg/l

12.11

2435

6922

Chronic kidney disease

4227

23075

2.11

307.65

2.9

1.7

1.98

1.38

mg/l

11.35

3590

17707

Codeine

17070

48427

2.26

307.65

1.9

1.6

1.03

1.15

mg/l

4.52

13016

35892

Persons encountering health services in other circumstances, wide

18396

63783

1.63

307.65

2.1

1.7

1.18

1.19

mg/l

0.12

13914

48228

Coxibs

4099

10064

2.47

307.65

1.7

2.1

1.08

1.69

mg/l

18.04

3048

7694

Other pulmonary diagnosis

13258

36316

2.09

307.65

2.0

1.6

1.12

1.15

mg/l

0.40

10098

27130

Asthma, unspecified (mode), excluding more controls

9701

31122

2.91

307.65

2.0

1.5

1.03

1.13

mg/l

2.40

7441

23279

Mood disorders, excluding more controls

14317

58022

1.62

307.65

1.9

1.7

1.07

1.18

mg/l

2.75

10601

44179

Intestinal infectious diseases

14287

74735

1.59

307.65

2.1

1.7

1.17

1.19

mg/l

0.27

10886

56326

DVT of lower extremities

3920

14212

4.16

307.65

2.3

1.7

1.92

1.19

mg/l

19.08

3151

10909

Migraine with aura

3953

21007

2.26

307.65

2.0

1.7

0.80

1.06

mg/l

9.44

2873

15597

Pulmonary embolism

6378

23600

4.09

307.65

2.7

1.6

2.37

1.22

mg/l

62.35

5330

18108

Shoulder lesions

11407

41601

1.88

307.65

1.8

1.7

1.01

1.30

mg/l

17.49

8737

31775

Arthrosis

10513

37068

1.72

307.65

1.7

1.08

1.25

mg/l

4.94

8185

28112

Heart failure, strict

9058

33872

2.27

307.65

2.8

1.6

1.50

1.41

mg/l

1.29

7456

26125

Anxiety (asthma-related co-morbidities)

9238

46968

1.70

307.65

2.0

1.8

0.94

1.05

mg/l

2.76

6631

35213

Dyspnoea

20460

61381

3.35

307.65

2.2

1.6

1.13

1.23

mg/l

4.01

15954

46463

COPD

5920

29415

1.87

307.65

2.0

1.7

1.37

1.47

mg/l

1.22

4791

22789

Diseases of arteries, arterioles and capillaries

9084

44616

1.67

307.65

2.1

1.7

1.67

1.27

mg/l

15.23

7328

34317

Care involving use of rehabilitation procedures

9497

56870

1.72

307.65

2.1

1.7

1.23

1.11

mg/l

2.43

7516

42857

Bacterial Sepsis

7813

32937

2.50

307.65

2.5

1.6

1.85

1.25

mg/l

20.57

6428

25124

Heart failure and coronary heart disease

6307

22271

2.44

307.65

3.1

1.6

1.47

1.53

mg/l

0.57

5173

17280

Dorsalgia

17242

52855

2.01

307.65

1.9

1.7

1.00

1.27

mg/l

20.50

12886

39792

Other CVD (FINNGEN)

1742

4308

4.12

307.65

2.0

1.4

1.29

0.96

mg/l

4.11

1387

3174

Symptoms and signs involving the skin and subcutaneous tissue

10797

68725

1.74

307.65

2.0

1.7

1.09

1.21

mg/l

2.75

8137

52320

Myocardial infarction

6468

27167

1.91

307.65

2.3

1.6

1.45

1.42

mg/l

0.29

5150

21071

Disorders of synovium and tendon

7640

40644

1.86

307.65

1.8

1.7

0.95

1.26

mg/l

21.35

5916

30837

Other antidepressants

16038

54474

1.66

307.65

1.8

1.7

1.08

1.24

mg/l

6.92

11938

41472

Sleep apnoea

14747

60887

1.77

307.65

1.9

1.7

0.94

1.23

mg/l

26.99

11207

46552

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8353

55032

1.71

307.65

2.1

1.7

1.39

1.21

mg/l

3.56

6660

42001

Non-invasive ventilation

3290

14048

2.45

307.65

2.0

1.5

1.40

1.03

mg/l

5.22

2760

10601

Diarrhoea and gastroenteritis of presumed infectious origin

16324

69592

1.73

307.65

2.0

1.7

1.05

1.22

mg/l

8.58

12364

52560

Lower back pain or/and sciatica

18074

71345

1.90

307.65

1.9

1.7

0.99

1.22

mg/l

21.95

13662

53996

Fever of other and unknown origin

9649

41257

2.51

307.65

2.3

1.6

1.43

1.20

mg/l

5.91

7627

31031

General examination and investigation of persons without complaint and reported diagnosis

9729

30732

1.83

307.65

2.1

1.6

1.05

1.25

mg/l

8.33

7249

23469

Neurological diseases, wide definition

5039

10134

2.93

307.65

2.1

1.6

0.98

1.32

mg/l

6.90

3645

7348

Hypothyroidism and >3 levothyroxin purchases

3973

9317

2.82

307.65

2.1

1.4

1.01

0.79

mg/l

2.48

2920

6672

Asthma, hospital admission 2, infections

10583

53742

2.35

307.65

2.2

1.7

1.04

1.25

mg/l

9.97

8180

40568

Valvular heart disease excluding rheumatic fever

6526

26822

2.02

307.65

2.2

1.6

1.33

1.31

mg/l

0.14

5025

20785

Explicit Sepsis

6726

34467

2.15

307.65

2.5

1.6

1.94

1.22

mg/l

28.05

5559

26129

Other acute lower respiratory infections

8307

46826

1.95

307.65

2.2

1.8

1.11

1.26

mg/l

3.81

6327

35312

Hypertensive diseases

12320

42685

1.84

307.65

2.2

1.6

1.14

1.07

mg/l

1.28

9630

31799

Other and unspecified anaemias

5895

34422

1.87

307.65

2.3

1.7

1.68

1.37

mg/l

4.85

4771

26588

Obesity, other/unspecified

5408

31817

2.01

307.65

2.1

1.7

0.99

1.06

mg/l

0.79

4212

23875

Non-allergic asthma (mode), excluding more controls

2720

12618

2.55

307.65

2.0

1.5

1.08

1.18

mg/l

1.05

2086

9401

Metabolic disorders

14988

57835

1.78

307.65

2.1

1.7

1.29

1.14

mg/l

4.48

11681

43726

Pain, not elsewhere classified

5073

21739

3.01

307.65

2.3

1.6

1.06

1.18

mg/l

1.89

3894

16323

Diarrhoea and gastroenteritis of presumed infectious origin

10878

64026

1.71

307.65

2.2

1.7

1.17

1.18

mg/l

0.07

8348

48144

Episodal and paroxysmal disorders

18467

56365

1.88

307.65

1.9

1.7

0.99

1.28

mg/l

23.19

13747

42599

Asthma (only as main-diagnosis), excluding more controls

12701

33505

2.62

307.65

2.0

1.5

0.95

1.11

mg/l

7.39

9588

24925

Acute renal failure

3215

16345

2.43

307.65

3.3

1.7

2.39

1.33

mg/l

20.23

2756

12535

All-cause Heart Failure

8877

33306

2.26

307.65

2.6

1.6

1.49

1.41

mg/l

1.09

7311

25687

Diseases of the musculoskeletal system and connective tissue

8600

22970

2.11

307.65

2.0

1.8

1.06

1.36

mg/l

8.04

6314

16974

Pure hypercholesterolaemia

10496

45027

1.69

307.65

1.9

1.7

1.28

1.21

mg/l

1.19

8284

34591

Arthropathies

13890

46570

1.65

307.65

1.8

1.03

1.22

mg/l

8.77

10419

34561

First line medication for Crohn's disease

19600

60343

2.03

307.65

2.2

1.6

1.22

1.13

mg/l

2.63

15274

44768

Myalgia

4130

18378

2.88

307.65

2.0

1.6

0.85

1.19

mg/l

11.10

3027

13793

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

17027

60615

2.12

307.65

2.0

1.7

1.42

1.11

mg/l

18.56

13430

46021

Anaemias

4214

8740

4.06

307.65

2.9

1.4

1.40

0.81

mg/l

11.37

3303

6303

Intracranial trauma

8754

35689

1.94

307.65

1.9

1.7

1.10

1.24

mg/l

3.48

6512

26838

Disorders of thyroid, IBD co-morbidities

2780

7632

3.08

307.65

2.5

1.5

0.89

1.35

mg/l

11.64

2077

5674

Early onset COPD, excluding more controls

2801

13205

2.55

307.65

2.1

1.5

1.16

1.27

mg/l

1.14

2222

10072

Heart failure,strict

8435

28782

2.55

307.65

2.8

1.6

1.49

1.34

mg/l

3.13

6963

22044

Heart failure and bmi 25plus

5179

19195

2.19

307.65

2.6

1.6

1.44

1.37

mg/l

0.59

4218

14850

All chronic kidney diseases

7786

38942

1.86

307.65

2.4

1.7

1.85

1.21

mg/l

22.73

6418

29464

Provisional assignment of new diseases of uncertain etiology

11173

48834

3.09

307.65

2.5

1.7

1.26

1.19

mg/l

1.37

9224

36384

Polyarthropathies

10403

40612

1.89

307.65

1.9

1.8

1.27

1.25

mg/l

0.32

8202

30560

Recurrent or chronic depression

6057

25159

1.91

307.65

1.9

1.8

0.94

1.16

mg/l

4.61

4404

19181

Renal failure

6717

33564

2.08

307.65

2.8

1.7

2.13

1.33

mg/l

27.60

5701

25772

Complications of procedures, not elsewhere classified

12817

67520

1.78

307.65

2.0

1.7

1.31

1.16

mg/l

3.63

10044

51034

Viral pneumonia (unknown virus, not influenza)

1555

4874

5.67

307.65

3.6

1.8

1.38

1.12

mg/l

1.84

1388

3621

Codes for special purposes

11183

48894

3.09

307.65

2.5

1.7

1.26

1.19

mg/l

1.35

9231

36426

Dermatitis and eczema

16152

73847

1.46

307.65

1.9

1.8

1.09

1.20

mg/l

3.36

12161

55869

Accidents

12119

42043

1.56

307.65

1.9

1.7

1.12

1.19

mg/l

1.15

9115

31689

Diverticular disease of intestine

10547

42557

1.78

307.65

1.9

1.6

1.21

1.25

mg/l

0.57

8210

32906

Allergic asthma (mode), excluding more controls

3444

17247

2.27

307.65

1.9

1.5

0.91

1.04

mg/l

1.39

2581

12603

Other embolism and thrombosis

2456

9277

3.86

307.65

2.6

1.7

1.85

1.19

mg/l

10.41

1951

7103

Hypertension

12304

42653

1.84

307.65

2.2

1.6

1.14

1.07

mg/l

1.24

9619

31779

Rotator cuff syndrome

8635

37780

1.85

307.65

1.8

1.7

1.04

1.31

mg/l

11.16

6657

29088

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

16390

68536

1.89

307.65

2.4

1.6

1.50

1.11

mg/l

23.32

12887

51730

Cystitis

13266

51548

1.70

307.65

1.9

1.7

1.02

1.23

mg/l

11.40

10122

39065

COPD (mode)

4243

16725

2.35

307.65

2.0

1.5

1.41

1.37

mg/l

0.21

3440

12766

Spinal stenosis

7167

32182

1.93

307.65

1.8

1.7

1.16

1.44

mg/l

12.77

5705

25070

Depression medications

4635

9767

2.77

307.65

1.9

1.4

0.88

0.78

mg/l

1.59

3288

6910

Codeine or tramadol medication

20118

63639

2.00

307.65

1.9

1.7

1.06

1.22

mg/l

8.37

15372

47856

Hard cardiovascular diseases

13627

45777

2.08

307.65

2.4

1.6

1.17

1.19

mg/l

0.24

10540

34988

Implicit Sepsis

14013

56765

2.13

307.65

2.4

1.6

1.58

1.11

mg/l

25.97

11003

42907

Pain in limb

18383

48900

3.37

307.65

2.1

1.7

1.05

1.29

mg/l

16.63

14242

36802

Gonarthrosis

9614

33604

1.83

307.65

1.7

1.13

1.27

mg/l

3.70

7612

25742

Bacterial infection, other or unspecified

8666

39531

2.29

307.65

2.5

1.6

1.82

1.21

mg/l

29.46

7142

29927

COPD differential diagnosis

13023

36223

2.05

307.65

2.0

1.6

1.12

1.15

mg/l

0.33

9931

27076

15813

51020

2.21

307.65

2.2

1.6

1.35

1.15

mg/l

7.63

12708

38117

Spondylosis

7866

38459

1.90

307.65

1.8

1.7

1.03

1.33

mg/l

16.77

6074

29780

Complications of surgical and medical care, not elsewhere classified

16257

69946

1.81

307.65

2.1

1.7

1.31

1.16

mg/l

5.57

12833

52740

COPD/asthma related infections

17218

51033

1.92

307.65

2.0

1.6

1.16

1.15

mg/l

0.09

13207

38124

Gastro-oesophageal reflux disease

10485

56717

1.81

307.65

1.9

1.7

1.05

1.22

mg/l

6.33

7763

43469

Major coronary heart disease event excluding revascularizations

8529

33237

1.97

307.65

2.3

1.6

1.31

1.39

mg/l

1.04

6704

25747

7943

39979

2.43

307.65

2.2

1.8

0.94

1.19

mg/l

11.52

6037

29947

Soft tissue disorders related to use, overuse and pressure

3828

20609

2.19

307.65

2.0

1.6

1.05

1.30

mg/l

5.86

2975

15769

Other heart diseases

8521

23133

2.98

307.65

2.6

1.5

1.23

0.80

mg/l

19.19

6496

16741

Gonarthrosis,primary

12508

53988

1.57

307.65

1.7

1.20

1.25

mg/l

0.73

9875

41748

Symptoms and signs involving cognition, perception, emotional state and behaviour

15552

67661

1.76

307.65

1.9

1.7

1.09

1.20

mg/l

3.46

11746

51484

Depression

14414

68455

1.56

307.65

1.9

1.7

1.03

1.16

mg/l

4.74

10579

51809

COPD/asthma/ILD related infections

17218

51033

1.92

307.65

2.0

1.6

1.16

1.15

mg/l

0.09

13207

38124

Pain in joint

10100

29000

2.67

307.65

1.9

1.7

0.94

1.32

mg/l

28.60

7513

22119

Diseases of the skin and subcutaneous tissue

15106

53661

1.53

307.65

1.9

1.7

1.12

1.20

mg/l

2.02

11425

40397

Atrial fibrillation and flutter

4781

12777

2.95

307.65

2.3

1.4

1.36

0.81

mg/l

14.19

3645

9515

Cardiovascular diseases (excluding rheumatic etc)

12157

30487

2.81

307.65

2.3

1.5

1.11

0.82

mg/l

13.48

9263

21715

Gonarthrosis [arthrosis of knee](FG)

11210

42312

1.71

307.65

1.7

1.14

1.20

mg/l

1.17

8888

32286

Asthma

14341

35965

2.50

307.65

2.0

1.6

0.99

1.15

mg/l

6.74

10911

26875

Injuries to the knee and lower leg

17701

71455

1.49

307.65

1.8

1.09

1.20

mg/l

4.48

13605

53706

Asthma (only as main-diagnosis)

13002

35965

2.51

307.65

2.0

1.6

0.95

1.15

mg/l

9.57

9820

26875

Atrial fibrillation and flutter with reimbursement

3780

9286

3.18

307.65

2.3

1.4

1.34

0.86

mg/l

8.97

2829

7015

ILD differential diagnosis

13020

36211

2.05

307.65

2.0

1.6

1.12

1.15

mg/l

0.33

9929

27064

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

9032

21582

3.45

307.65

2.2

1.4

1.32

0.79

mg/l

29.56

7168

15842

Diseases of arteries, arterioles and capillaries (FINNGEN)

3905

9582

3.61

307.65

2.3

1.4

1.55

0.85

mg/l

23.42

3181

7151

Obesity due to excess calories

7468

44973

1.94

307.65

2.0

1.8

1.05

1.11

mg/l

0.85

5822

33823

Complications of medical and surgical care

11561

67111

1.81

307.65

2.1

1.7

1.37

1.18

mg/l

5.67

9175

50922

Influenza and pneumonia

18346

67695

2.00

307.65

2.3

1.7

1.33

1.10

mg/l

12.48

14635

50120

Dental caries

3928

19526

2.32

307.65

3.2

1.7

1.56

1.29

mg/l

2.81

3173

15116

Mood disorders

15429

70716

1.54

307.65

1.9

1.7

1.06

1.18

mg/l

3.94

11361

53618

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

9486

54783

1.75

307.65

2.0

1.7

1.32

1.27

mg/l

0.58

7571

42058

Other nutritional deficiencies

10917

61857

1.93

307.65

2.0

1.7

1.03

1.12

mg/l

2.44

8496

46481

Caries of dentine

3431

17207

2.33

307.65

3.1

1.7

1.53

1.30

mg/l

1.94

2769

13313

ILD medications: immunosuppressive drugs

9580

55262

1.82

307.65

2.6

1.6

1.41

1.15

mg/l

7.96

7625

41252

Pneumonia, organism unspecified

15358

62523

2.00

307.65

2.2

1.7

1.40

1.12

mg/l

14.29

12319

46512

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1808

3570

4.79

307.65

2.5

1.5

1.45

1.68

mg/l

1.09

1497

2749

ILD medications: prednisolone, methylprednisolone, prednisone

19811

61573

2.10

307.65

2.2

1.6

1.19

1.17

mg/l

0.28

15434

45957

Gastrointestinal diseases

9147

28101

1.80

307.65

2.0

1.5

1.16

1.08

mg/l

1.07

6744

20702

Disorders of gallbladder, biliary tract and pancreas

14439

65017

1.53

307.65

2.0

1.7

1.27

1.18

mg/l

2.25

11254

49571

Other disorders of fluid, electrolyte and acid-base balance

4552

23683

2.17

307.65

2.1

1.7

1.57

1.34

mg/l

2.74

3704

18118

Other specific joint derangements/joint disorders

12298

45415

2.02

307.65

1.9

1.8

0.91

1.21

mg/l

26.53

9178

33738

Asthma, including avohilmo

20307

68921

1.89

307.65

1.9

1.8

0.98

1.25

mg/l

24.54

15328

52047

General symptoms and signs

20089

50770

2.35

307.65

2.1

1.6

1.13

1.14

mg/l

0.16

15222

38032

Infections, IBD-co-morbidities

2561

6022

3.82

307.65

2.5

1.6

1.38

1.42

mg/l

0.15

2049

4511

Constipation

13017

61910

1.60

307.65

1.9

1.8

1.22

mg/l

0.03

9910

47454

Diseases of the respiratory system

9916

29206

1.90

307.65

1.9

1.6

1.13

1.22

mg/l

1.56

7555

21785

Other heart diseases, wide

15907

55072

2.05

307.65

2.3

1.6

1.16

1.09

mg/l

1.40

11950

41521

Pain (limb, back, neck, head abdominally)

11788

30095

2.24

307.65

2.0

1.7

1.14

1.35

mg/l

6.61

8823

22942

STROKE

8047

31923

1.96

307.65

2.4

1.5

1.25

1.15

mg/l

1.56

6250

24447

Inflammatory bowel disease treatment related agents

20271

65683

1.99

307.65

2.2

1.7

1.15

1.18

mg/l

0.69

15726

49098

ILD medications

20070

62344

2.01

307.65

2.2

1.6

1.18

1.17

mg/l

0.21

15575

46449

Myocardial infarction, without ST-elevation

5450

29451

1.94

307.65

1.9

1.7

1.42

1.48

mg/l

0.55

4377

22948

Hypothyroidism (congenital or acquired)

4006

9350

2.84

307.65

2.1

1.4

1.01

0.79

mg/l

2.52

2948

6693

Asthma (diagnoses ohter than nonallergic)

15170

72713

2.02

307.65

2.0

1.7

1.03

1.22

mg/l

11.93

11583

54840

Hypertensive diseases (excluding secondary)

8728

23161

2.63

307.65

2.3

1.4

1.08

0.78

mg/l

10.73

6796

16820

Excluding asthma or asthma-COPD overlap

13096

36316

2.06

307.65

2.0

1.6

1.12

1.15

mg/l

0.32

9989

27130

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

16541

67873

1.91

307.65

2.2

1.7

1.38

1.10

mg/l

15.58

13263

50495

Infections of the skin and subcutaneous tissue

8447

55595

1.68

307.65

2.1

1.8

1.17

mg/l

0.05

6496

41696

Lumbar disc prolapse

9442

45700

1.78

307.65

1.8

1.7

0.94

1.26

mg/l

22.73

7195

34881

Symptoms and signs involving the urinary system

10729

56585

1.59

307.65

1.9

1.7

1.29

1.25

mg/l

0.52

8214

43321

Asthma (mode)

13972

36211

2.47

307.65

2.0

1.6

0.98

1.15

mg/l

6.80

10597

27064

Non-rheumatic valve diseases

6454

26648

2.00

307.65

2.2

1.6

1.32

1.31

mg/l

0.09

4968

20664

Asthma-related pneumonia or sepsis

6187

30135

2.55

307.65

2.3

1.7

1.20

1.35

mg/l

3.05

4974

22941

Ischemic heart diseases

13453

45526

2.08

307.65

2.4

1.6

1.19

1.21

mg/l

0.32

10378

34955

Pulmonary heart disease, diseases of pulmonary circulation

6804

25788

3.91

307.65

2.8

1.7

2.32

1.23

mg/l

60.02

5675

19803

Certain infectious and parasitic diseases

15857

49779

1.78

307.65

2.0

1.6

1.22

1.07

mg/l

4.84

12157

37041

Bacterial infection, other or unspecified

9424

42282

2.26

307.65

2.4

1.6

1.79

1.18

mg/l

31.33

7739

31922

Implicit viral Sepsis

3537

15251

3.07

307.65

2.9

1.6

1.45

1.22

mg/l

2.80

2910

11508

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

14600

66003

1.58

307.65

2.6

1.6

1.31

1.13

mg/l

6.30

11410

49739

Paroxysmal tachycardia

3321

11755

2.87

307.65

3.1

1.5

1.05

0.84

mg/l

4.90

2510

8598

Undetermined asthma, excluding more controls

2051

8367

3.13

307.65

2.0

1.5

0.94

1.13

mg/l

3.03

1580

6231

Pneumonias (Asthma/COPD co-morbidities)

17341

67883

1.99

307.65

2.3

1.7

1.36

1.10

mg/l

15.32

13969

50298

Other anaemias

5948

34681

1.86

307.65

2.3

1.7

1.68

1.37

mg/l

4.92

4817

26791

Implicit bacterial Sepsis

6960

29321

2.64

307.65

2.6

1.6

1.88

1.27

mg/l

18.08

5755

22433

Heart failure and antihypertensive medication

4408

10227

3.74

307.65

3.7

1.6

1.52

1.20

mg/l

5.14

3672

7822

DVT of lower extremities and pulmonary embolism

9384

34555

4.05

307.65

2.5

1.6

2.19

1.19

mg/l

72.77

7726

26515

Asthma, hospital admissions , main diagnosis only

13605

73109

1.88

307.65

2.0

1.7

0.96

1.21

mg/l

19.84

10287

55116

Symptoms and signs involving the digestive system and abdomen

16471

48792

1.91

307.65

2.0

1.7

1.16

1.24

mg/l

1.73

12272

37009

Hypothyroidism, levothyroxine purchases

3973

9317

2.82

307.65

2.1

1.4

1.01

0.79

mg/l

2.48

2920

6672

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

15813

51020

2.21

307.65

2.2

1.6

1.35

1.15

mg/l

7.63

12708

38117

Emergency coronary revascularization (for ACS)

13997

47448

2.10

307.65

2.4

1.6

1.17

1.28

mg/l

2.54

10862

36571

Asthma, unspecified (mode)

9974

33389

2.79

307.65

2.0

1.5

1.03

1.16

mg/l

3.85

7660

25078

Anxiety disorders

13918

65569

1.64

307.65

2.0

1.7

1.03

1.12

mg/l

2.13

10191

49550

Heart failure, not strict

12906

43864

2.46

307.65

2.6

1.6

1.52

1.19

mg/l

15.67

10516

33475

Cardiovascular diseases

11461

26068

2.88

307.65

2.3

1.5

1.06

0.84

mg/l

7.08

8486

18548

19015

60271

1.84

307.65

2.0

1.6

1.07

1.24

mg/l

8.57

14339

45652

Artrosis, including avohilmo

12045

45667

1.57

307.65

1.7

1.8

1.05

1.23

mg/l

5.84

9297

34603

GASTRO-related operations

13399

38295

1.98

307.65

2.1

1.5

1.24

0.96

mg/l

11.67

10061

28101

Implicit bacterial Sepsis

7661

31582

2.62

307.65

2.5

1.6

1.84

1.26

mg/l

18.33

6290

24154

Condition for Implicit Sepsis (Organ dysfunction codes)

14869

60618

1.94

307.65

2.4

1.6

1.51

1.06

mg/l

26.42

11621

45533

Antihypertensive medication - note that there are other indications

9960

29111

2.07

307.65

2.2

1.6

0.96

1.02

mg/l

1.01

7357

20926

Symptoms and signs involving the circulatory and respiratory systems

20429

43147

2.94

307.65

2.0

1.6

0.99

1.26

mg/l

20.75

15190

32530

Other septicaemia

5652

28904

2.24

307.65

2.6

1.6

2.00

1.27

mg/l

24.02

4717

21857

Sleep disorders (combined)

18105

61688

1.72

307.65

1.8

1.7

0.95

1.28

mg/l

39.28

13550

46853

Asthma, hospital admissions 3, pneumonia

6187

30135

2.55

307.65

2.3

1.7

1.20

1.35

mg/l

3.05

4974

22941

Unstable angina pectoris

5010

21805

2.11

307.65

1.9

1.6

1.10

1.52

mg/l

19.87

3854

16911

Mood [affective] disorders

15394

70662

1.54

307.65

1.9

1.7

1.05

1.18

mg/l

3.95

11332

53571

Neurotic, stress-related and somatoform disorders

13791

65177

1.64

307.65

2.0

1.7

1.03

1.12

mg/l

1.91

10093

49236

Pulmonary heart disease

6378

23673

4.08

307.65

2.7

1.7

2.37

1.22

mg/l

62.51

5330

18172

Erysipelas

12121

50546

2.16

307.65

1.9

1.6

1.30

1.11

mg/l

8.62

9620

38015

Mycoses

12406

76693

1.54

307.65

1.9

1.8

1.04

1.19

mg/l

7.32

9257

58036

Cerebrovascular diseases (FINNGEN)

4762

14443

2.82

307.65

2.5

1.4

1.25

0.80

mg/l

18.77

3709

10744

Continuous positive airway pressure

2790

9569

3.02

307.65

2.5

1.6

1.32

1.10

mg/l

2.24

2120

7408

Asthma-related infections

10583

53742

2.35

307.65

2.2

1.7

1.04

1.25

mg/l

9.97

8180

40568

All kidney diseases

15538

69578

1.70

307.65

2.3

1.7

1.55

1.07

mg/l

34.72

12386

52046

Chronic lower respiratory diseases

20170

67170

1.80

307.65

1.9

1.7

1.03

1.22

mg/l

12.93

15399

50442

Covid-19 confirmed case

8188

30838

3.98

307.65

2.7

1.7

1.37

1.28

mg/l

1.49

6936

23146

Other diseases of intestines

17047

62456

1.73

307.65

2.0

1.7

1.15

1.16

mg/l

0.06

12942

46861

Implicit Sepsis

12944

52448

2.22

307.65

2.4

1.6

1.62

1.14

mg/l

23.79

10260

39660

Other bacterial diseases

17712

63577

2.06

307.65

2.2

1.7

1.50

1.06

mg/l

38.77

14215

47299

Soft tissue disorders

18201

50592

2.15

307.65

1.9

1.7

1.01

1.28

mg/l

21.93

13677

37856

Any gastric operation

13399

38295

1.98

307.65

2.1

1.5

1.24

0.96

mg/l

11.67

10061

28101

Coronary atherosclerosis

9139

34357

1.92

307.65

2.2

1.6

1.24

1.33

mg/l

1.25

7085

26597

Anxiety disorders, excluding more controls

13051

54935

1.73

307.65

2.0

1.7

1.05

1.15

mg/l

1.89

9619

41707

Asthma, excluding more controls

13908

33505

2.61

307.65

2.0

1.5

0.99

1.11

mg/l

4.63

10565

24925

Intestinal infectious diseases

18393

69112

1.69

307.65

2.0

1.7

1.08

1.22

mg/l

6.43

14034

52237

Neurological diseases

13913

41898

1.87

307.65

2.0

1.7

1.06

1.26

mg/l

7.50

10317

31568

Erysipelas

9003

43143

2.19

307.65

1.9

1.6

1.35

1.17

mg/l

6.69

7218

32669

Other headache syndromes

7373

37785

2.38

307.65

2.0

1.6

0.90

1.21

mg/l

12.44

5508

28624

Hernia of abdominal wall, postoperative

2779

12844

2.66

307.65

2.0

1.5

1.33

1.02

mg/l

4.59

2186

9751

Obesity and other hyperalimentation

10316

60363

1.91

307.65

2.0

1.7

1.03

1.11

mg/l

1.92

8047

45368

Coagulation defects, purpura and other haemorrhagic conditions

3155

15916

2.51

307.65

3.1

1.8

1.73

1.18

mg/l

7.91

2489

12074

Asthma/COPD (KELA code 203)

15284

67041

1.75

307.65

1.9

1.7

1.00

1.22

mg/l

17.23

11711

50350

Endocrine, nutritional and metabolic diseases

12320

40683

1.68

307.65

2.0

1.7

1.13

1.10

mg/l

0.34

9310

29848

Acute upper respiratory infections of multiple and unspecified sites

12399

55861

1.88

307.65

2.1

1.7

0.99

1.19

mg/l

8.79

9214

42204

Sciatica+with lumbago

8313

42547

2.12

307.65

1.9

1.7

0.94

1.26

mg/l

19.94

6353

32513

Other arrhythmias

10258

44386

2.02

307.65

2.1

1.6

1.00

1.13

mg/l

3.78

7523

33892

Falls/tendency to fall

16283

58619

1.50

307.65

1.9

1.8

1.11

1.15

mg/l

0.83

12319

43918

Other arthrosis

7473

31967

1.82

307.65

1.8

1.7

1.04

1.27

mg/l

10.37

5764

24526

Aplastic and other anaemias

6456

36816

1.87

307.65

2.3

1.7

1.70

1.36

mg/l

6.27

5222

28411

Other/unspecified dorsalgia

5976

31980

2.19

307.65

2.0

1.7

1.03

1.29

mg/l

7.68

4490

24319

Percutaneous Coronary Intervention

13074

43446

2.19

307.65

2.4

1.6

1.15

1.24

mg/l

1.95

10131

33451

Low back pain

13258

51683

2.17

307.65

1.9

1.7

0.99

1.26

mg/l

21.03

9977

39065

Viral pneumonia

2540

9212

4.05

307.65

3.1

1.7

1.34

1.19

mg/l

1.15

2173

6838

Other disorders of urethra and urinary system

10717

49164

1.77

307.65

1.9

1.7

1.15

1.23

mg/l

1.40

8290

37314

Other disorders of veins

6637

35046

2.31

307.65

1.9

1.6

1.11

1.07

mg/l

0.56

5124

26764

Diseases of oesophagus, stomach and duodenum

17331

65875

1.77

307.65

2.0

1.7

1.13

1.19

mg/l

1.38

13111

50000

Angina pectoris

8023

30831

2.00

307.65

2.0

1.6

1.09

1.38

mg/l

14.25

6281

23894

Acute sinusitis

7882

46066

1.79

307.65

1.9

1.7

0.97

1.12

mg/l

4.07

5870

34650

Condition for Implicit Sepsis (Organ dysfunction codes)

14143

58294

1.98

307.65

2.4

1.6

1.60

1.08

mg/l

29.70

11090

43985

Depression or dysthymia

10098

35115

1.76

307.65

1.8

1.04

1.31

mg/l

12.47

7482

27056

Ischaemic heart disease, wide definition

11500

43202

1.89

307.65

2.2

1.6

1.20

1.27

mg/l

1.20

8906

33391

Dorsopathies

16549

53110

1.76

307.65

1.9

1.7

0.99

1.27

mg/l

24.86

12357

39957

Hypertension, essential

12371

41570

1.92

307.65

1.9

1.6

1.10

1.06

mg/l

0.55

9680

31052

Other intervertebral disc disorders

12942

48508

1.80

307.65

1.8

1.7

0.98

1.28

mg/l

25.45

9865

36933

Gout

3915

16976

2.43

307.65

2.1

1.7

1.44

1.55

mg/l

1.00

3146

13229

Non-allergic asthma (mode)

2720

13187

2.42

305.75

2.0

1.6

1.08

1.21

mg/l

1.46

2086

9862

Other neurological diseases

9986

54393

1.59

304.49

2.0

1.7

1.23

1.28

mg/l

0.73

7706

41821

Genitourinary diseases

8180

26552

1.68

304.45

2.0

1.8

1.24

1.19

mg/l

0.55

6152

19707

Other chronic obstructive pulmonary disease

5620

28339

1.85

302.64

2.0

1.7

1.35

1.47

mg/l

1.52

4544

21947

Other anxiety disorders

6948

38905

1.74

301.74

2.0

1.7

0.91

1.03

mg/l

2.54

4954

28897

Autoimmune diseases related-to ILD

12178

75035

1.51

300.87

1.9

1.7

1.16

1.17

mg/l

0.14

9413

56459

Visual disturbances and blindness

7379

48713

1.70

299.44

2.1

1.7

1.09

1.26

mg/l

4.03

5514

37166

Diaphragmatic hernia

5097

30959

1.91

297.97

2.0

1.7

1.30

1.28

mg/l

0.16

3973

23885

Myocardial infarction, strict

5816

25460

1.83

297.74

2.3

1.6

1.44

1.43

mg/l

0.05

4641

19762

External causes of morbidity and mortality

9721

32971

1.60

296.87

1.8

1.7

1.09

1.16

mg/l

1.23

7319

24695

Hypertensive Heart Disease

3129

12586

2.28

295.29

1.9

1.5

1.47

1.44

mg/l

0.12

2510

9597

Visual disturbances

6906

45137

1.73

295.09

2.1

1.7

1.07

1.23

mg/l

3.79

5166

34400

Gout, FINNGEN

3915

22020

2.08

294.75

2.1

1.7

1.44

1.48

mg/l

0.24

3146

17165

Other diseases of upper respiratory tract

15885

61516

1.44

294.65

1.8

1.06

1.28

mg/l

10.35

11915

46818

Type 2 diabetes, wide definition

10952

49379

1.55

294.22

2.0

1.7

1.32

1.20

mg/l

2.75

8740

37679

Other disorders of skin and subcutaneous tissue

9663

59864

1.58

291.42

2.0

1.7

1.22

1.24

mg/l

0.30

7565

45733

Nutritional anaemias

6887

43442

1.71

288.28

2.4

1.7

1.43

1.29

mg/l

2.22

5401

33341

Insomnia

12632

67008

1.49

287.56

1.7

1.8

0.86

1.16

mg/l

33.57

9244

50592

Autoimmune diseases excluding thyroid diseases

15053

60844

1.45

286.96

1.9

1.8

1.26

1.17

mg/l

2.16

11633

45680

Used for control exclusion in common control thyroid runs

15232

57115

1.44

281.34

1.9

1.7

1.16

1.18

mg/l

0.28

11549

42823

Gout, idiopatic and unspecified

3387

18631

2.18

280.67

2.1

1.7

1.43

1.49

mg/l

0.46

2708

14535

Cholelithiasis, broad definition with cholecystitis

12332

60336

1.49

279.18

1.9

1.7

1.17

1.18

mg/l

0.16

9551

46072

Cholelithiasis

11908

59384

1.50

278.89

1.8

1.7

1.15

1.19

mg/l

0.54

9218

45356

Disorders of eyelid, lacrimal system and orbit

12078

66687

1.49

278.78

1.9

1.7

1.09

1.22

mg/l

3.73

9186

50920

Other enthesopathies

4096

23709

1.99

278.77

1.7

0.91

1.21

mg/l

6.80

3073

18062

Chronic sinusitis

6169

39717

1.75

278.24

1.8

1.7

0.99

1.20

mg/l

4.89

4590

30247

Persons encountering health services in other circumstances

5748

36181

1.78

278.11

2.0

1.7

1.11

1.19

mg/l

0.83

4207

27202

Autoimmune diseases excluding thyroid diseases, strict definition

14595

59254

1.44

276.51

1.8

1.7

1.26

1.17

mg/l

2.31

11286

44455

Later onset COPD, excluding more controls

2637

10074

2.39

276.34

1.9

1.5

1.54

1.58

mg/l

0.14

2175

7713

Paracetamol or NSAID medication

2232

4830

2.59

276.02

1.9

2.2

1.15

1.71

mg/l

6.95

1633

3592

Bacterial pneumoniae

5502

30274

1.80

274.69

2.2

1.6

1.45

1.24

mg/l

3.86

4540

22680

Dialysis, with operation codes

1971

9081

2.85

274.21

5.5

1.8

2.81

1.25

mg/l

21.91

1769

6894

Other reaction to severe stress, and adjustment disorders

5473

34510

1.80

271.93

2.2

1.7

1.16

1.02

mg/l

1.29

4041

25716

Liquid cancers, helper endpoint

5182

28052

1.84

268.92

2.3

1.7

1.74

1.19

mg/l

12.18

4252

21429

Other coagulation defects

1411

5746

3.64

268.75

3.8

1.7

1.37

1.06

mg/l

2.34

1078

4325

Exposure to other specified factors

10657

70443

1.51

267.59

1.9

1.8

1.09

1.16

mg/l

1.41

7899

53157

Hernia

13144

65104

1.46

266.56

1.9

1.7

1.28

1.17

mg/l

2.44

10129

49293

Other and unspecified iron deficiency

4787

29441

1.87

264.65

2.2

1.7

1.29

1.26

mg/l

0.31

3749

22458

Meniscus derangement

7490

33678

1.65

264.60

1.7

1.08

1.26

mg/l

3.95

5825

25685

Bacterial pneumonia, not elsewhere classified

5206

28495

1.81

264.32

2.2

1.6

1.44

1.26

mg/l

3.11

4302

21382

Migraine without aura

3102

16874

2.18

263.47

2.1

1.7

0.80

0.98

mg/l

2.67

2245

12469

Neoplasms

11149

42148

1.51

263.36

2.0

1.8

1.17

1.01

mg/l

4.62

8454

30950

Autoimmune diseases

15928

61193

1.41

262.40

1.9

1.8

1.18

1.17

mg/l

0.17

12113

45940

Intracranial injury

8087

52565

1.60

262.26

2.0

1.8

1.18

1.26

mg/l

1.15

6065

39795

Oter anti-inflammatory and antirheumatic agents, non-steroids

2858

7890

2.27

261.10

1.7

2.0

1.31

1.74

mg/l

6.07

2231

6221

Internal derangement of knee

5121

31771

1.80

260.69

1.8

0.97

1.26

mg/l

11.00

3812

24055

Varicose veins

8160

42226

1.60

260.10

1.7

1.6

1.26

1.15

mg/l

1.67

6361

32531

Diseases of the eye and adnexa

11828

42714

1.49

259.37

2.0

1.7

1.08

1.13

mg/l

0.63

8842

32014

Other and unspecified coagulation defects

1049

3800

4.64

257.20

3.9

1.7

1.32

0.98

mg/l

2.46

806

2838

Pain in thoracic spine

2349

11794

2.45

255.11

2.0

1.7

0.82

1.19

mg/l

12.70

1726

8912

Hypothyroidism, drug reimbursement

1900

5886

2.65

253.91

1.9

1.4

0.86

0.74

mg/l

1.30

1429

4322

Benign neoplasms

14079

58015

1.43

252.82

1.9

1.7

1.14

1.18

mg/l

0.67

10701

43526

Gout, unspecified

2788

14951

2.26

250.98

2.2

1.7

1.47

1.49

mg/l

0.11

2229

11657

Viral infections characterized by skin and mucous membrane lesions

12098

76659

1.46

250.85

1.9

1.8

1.11

1.18

mg/l

1.16

9143

57946

Use of hypnotics and sedatives

15102

65751

1.41

250.84

1.9

1.7

1.15

1.18

mg/l

0.44

11467

49990

Benign neoplasm of colon, rectum, anus and anal canal

8357

50670

1.58

249.81

2.0

1.7

1.25

1.32

mg/l

1.24

6525

39385

Vocal cord dysfunction

1979

8251

2.56

248.87

2.0

1.5

1.04

1.05

mg/l

0.08

1497

6221

Injury, poisoning and certain other consequences of external causes

7792

26211

1.61

246.89

1.9

1.7

1.11

1.19

mg/l

1.00

5843

19584

L04AD Calcineurin inhibitors

1763

8157

2.89

246.20

5.5

1.8

2.11

1.12

mg/l

11.56

1550

6127

Dermatitis

8504

59744

1.56

244.81

2.0

1.7

1.13

1.22

mg/l

1.31

6455

45547

Other respiratory disorders and diseases

2827

15306

2.20

244.71

2.4

1.8

1.52

1.43

mg/l

0.41

2324

11802

Other diseases of the respiratory system

2827

15306

2.20

244.71

2.4

1.8

1.52

1.43

mg/l

0.41

2324

11802

ILD, hospital admission 2, with pulmonary infections

1447

6071

3.10

244.26

2.6

1.6

1.64

1.40

mg/l

1.17

1219

4653

Diseases of the ear and mastoid process

16731

64547

1.38

244.08

1.9

1.8

1.05

1.18

mg/l

4.28

12465

48893

Other chronic obstructive pulmonary disease, including avohilmo

6861

38199

1.65

243.99

2.0

1.7

1.33

1.38

mg/l

0.61

5521

29635

Type 2 diabetes

13985

61572

1.42

243.43

1.9

1.7

1.18

1.15

mg/l

0.35

10962

46372

Cardiomyopathy

2301

11626

2.36

240.16

4.4

1.6

1.49

1.38

mg/l

0.68

1819

9048

Nephropathy related operations

1860

8861

2.73

239.03

5.5

1.8

2.74

1.27

mg/l

20.01

1679

6771

Heartburn

1708

7782

2.79

239.00

2.3

1.6

0.94

1.17

mg/l

2.22

1238

5923

Gonarthrosis, primary, with knee surgery

7386

40360

1.61

238.59

1.7

1.33

1.36

mg/l

0.28

5909

31405

Statin medication

9641

38482

1.52

238.40

2.2

1.6

1.05

1.12

mg/l

0.93

7288

28846

Other bursopathies

1884

8919

2.62

237.80

2.0

1.7

1.10

1.35

mg/l

3.45

1493

6783

Other medical care

6040

35893

1.68

237.30

2.1

1.6

2.12

1.24

mg/l

30.43

5018

27146

Chronic rhinitis, nasopharyngitis and pharyngitis

4545

28334

1.83

237.10

1.9

1.8

0.91

1.18

mg/l

5.69

3351

21511

Artificial joint operation, meniscal resection

12337

59716

1.44

236.48

1.7

1.8

1.21

1.23

mg/l

0.20

9740

45647

Excessive, frequent and irregular menstruation

5659

19830

1.75

236.15

1.8

1.7

0.86

1.17

mg/l

15.72

4222

14797

Cholecystectomy

9788

61218

1.50

235.42

1.8

1.7

1.16

1.21

mg/l

0.62

7607

46853

Triptan medication for migraine, single purchase ok

10875

53964

1.48

235.09

1.8

0.84

1.10

mg/l

19.35

8097

40273

Migraine, single triptan purchase ok & required. ICD-code if available is included

10875

53964

1.48

235.09

1.8

0.84

1.10

mg/l

19.35

8097

40273

Cervicobrachial syndrome

3174

18022

2.06

234.46

1.8

1.7

0.80

1.19

mg/l

18.46

2397

13729

Ulcer of lower limb, not elsewhere classified

2097

10488

2.51

233.67

2.2

1.7

1.53

1.41

mg/l

0.87

1743

8083

Covid-19 suspected case

3266

18772

2.05

233.59

2.1

1.7

0.98

1.04

mg/l

0.47

2564

13773

Diabetes mellitus

14478

64572

1.40

230.28

1.9

1.7

1.18

1.15

mg/l

0.55

11316

48383

Injuries to the ankle and foot

9892

64086

1.49

229.80

2.0

1.8

0.97

1.11

mg/l

5.77

7370

47996

Respiratory insufficiency

1162

4461

3.32

229.27

2.6

1.6

1.38

1.45

mg/l

0.20

963

3397

Diabetes, varying definitions

14400

64478

1.40

227.62

1.9

1.7

1.19

1.15

mg/l

0.67

11260

48311

Superficial injury of lower leg

3581

21249

1.95

226.96

1.9

1.8

1.05

1.17

mg/l

1.44

2736

15827

Secondary hypertension

1047

3761

3.45

226.20

2.1

1.5

1.62

0.90

mg/l

3.47

847

2730

Disorders of the thyroid gland

13295

65666

1.41

225.71

1.9

1.7

1.07

1.21

mg/l

4.17

10021

49930

COPD related to multimorbidity

4939

26634

1.76

225.50

2.0

1.7

1.38

1.46

mg/l

0.80

3995

20729

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7035

47224

1.59

223.75

1.9

1.8

0.98

1.23

mg/l

12.63

5237

36051

Other and unspecified dermatitis

7118

49442

1.59

223.34

1.9

1.7

1.13

1.21

mg/l

1.03

5399

37752

AV-block

2284

10223

2.29

222.91

2.2

1.6

1.54

1.56

mg/l

0.09

1805

7995

Other systemic involvement of connective tissue (FG)

3571

20960

1.94

222.73

1.9

1.6

1.15

1.21

mg/l

0.69

2804

15829

Ovarian cyst

5189

19100

1.76

222.06

1.9

1.7

0.98

1.17

mg/l

2.76

3884

14322

Diseases of pulp and periapical tissues, including avohilmo

14948

59429

1.38

221.59

1.8

1.7

1.12

1.24

mg/l

4.68

11152

45062

Other symptoms and signs involving the circulatory and respiratory systems

1003

3663

3.63

221.40

2.2

1.7

1.04

1.39

mg/l

2.18

777

2790

COPD, hospital admission 2, with asthma infections

4089

21522

1.85

219.72

2.1

1.7

1.34

1.48

mg/l

1.89

3331

16728

Synovial cyst of popliteal space [Baker]

1172

4716

3.36

219.14

2.1

1.6

1.11

1.40

mg/l

2.63

944

3575

Coxarthrosis

6358

28107

1.63

218.97

1.8

1.7

1.32

1.35

mg/l

0.26

5130

21753

Cerebrovascular diseases

9564

48835

1.49

218.90

2.2

1.7

1.39

1.29

mg/l

2.13

7484

37794

Candidiasis

4127

25738

1.85

218.67

2.1

1.7

1.01

1.15

mg/l

3.39

3061

19388

COPD, hospital admissions

5624

31457

1.68

218.63

2.0

1.7

1.33

1.43

mg/l

1.71

4541

24422

Trochanteric bursitis

2005

10052

2.44

218.03

1.9

1.6

0.94

1.24

mg/l

6.97

1557

7660

Bacterial pneumonia (organism specified)

5861

35515

1.65

217.78

2.2

1.7

1.46

1.31

mg/l

2.33

4838

26931

COPD, early/later onset

5667

31697

1.68

217.08

2.0

1.7

1.35

1.43

mg/l

0.85

4576

24610

Other disorders of lacrimal gland

4863

31543

1.75

217.02

2.0

1.7

0.98

1.20

mg/l

6.53

3711

24087

Diseases of the digestive system

6046

40655

1.64

216.80

2.4

1.7

1.37

1.32

mg/l

0.42

4737

31092

Injuries to the thorax

6011

40621

1.64

215.76

2.0

1.8

1.31

1.29

mg/l

0.19

4664

31035

Type 2 diabetes, definitions combined, including avohilmo

13294

58928

1.40

215.49

1.9

1.7

1.18

1.16

mg/l

0.35

10451

44496

Other specified/unspecified arthritis

3602

21639

1.89

214.21

1.9

1.7

1.18

1.23

mg/l

0.54

2855

16401

Type 2 diabetes, definitions combined

13214

59080

1.40

213.93

1.9

1.7

1.20

1.16

mg/l

0.73

10394

44688

Type 2 diabetes, strict (exclude DM1)

13250

59316

1.40

212.71

1.9

1.7

1.20

1.16

mg/l

0.65

10418

44889

Benign neoplasm: Colon

6936

46163

1.58

212.56

2.0

1.7

1.26

1.35

mg/l

1.53

5413

35946

Migraine with aura and triptan purchases

2460

13414

2.22

211.78

2.1

1.8

0.74

0.97

mg/l

4.88

1800

9847

Inflammatory diseases of female pelvic organs

8720

46340

1.52

211.59

1.8

1.7

0.86

1.07

mg/l

10.47

6467

34911

Primary gonarthrosis, bilateral

6490

38260

1.60

208.54

1.7

1.29

1.34

mg/l

0.78

5158

29677

Chronic apical periodontitis

15771

70273

1.36

207.30

1.9

1.7

1.14

1.18

mg/l

0.68

11844

53196

Transient ischemic attack

6627

37076

1.59

205.91

2.1

1.6

1.21

1.39

mg/l

3.73

5189

28735

Subjective visual disturbances

3568

21796

1.91

205.56

2.1

1.7

0.94

1.17

mg/l

7.24

2622

16556

Adjustment and management of implanted device

2448

13376

2.16

204.86

2.9

1.6

1.53

1.44

mg/l

0.46

1953

10224

Hypothyroidism, strict autoimmune

10310

50264

1.45

203.87

1.8

1.7

1.12

1.17

mg/l

0.57

7765

37998

Other symptoms and signs involving cognitive functions and awareness

5835

36010

1.63

202.60

1.9

1.7

1.33

1.37

mg/l

0.32

4498

27937

Other diseases of anus and rectum

3954

24618

1.81

202.55

2.1

1.7

1.30

1.31

mg/l

0.04

2989

18840

Systemic connective tissue disorders

4818

31665

1.72

202.02

2.0

1.7

1.24

1.22

mg/l

0.18

3801

24162

Disorders of lacrimal system

5799

39455

1.63

201.99

2.0

1.7

1.00

1.22

mg/l

7.58

4429

30141

Speech therapy

3658

22659

1.87

199.72

2.0

1.7

1.21

1.22

mg/l

0.09

3034

17309

Cervical disc disorders

4629

30056

1.71

199.37

1.8

1.7

1.01

1.32

mg/l

9.56

3515

23201

Disorders of conjunctiva

11463

69928

1.41

198.99

1.9

1.8

1.05

1.16

mg/l

2.00

8528

52663

Polyarthrosis

2648

13824

2.07

198.12

1.8

1.7

1.14

1.34

mg/l

3.04

2093

10675

Pain and other conditions associated with female genital organs and menstrual cycle

2935

15660

1.99

197.13

1.9

1.7

0.72

1.06

mg/l

13.65

2064

11559

Gout, strict definition

2354

12916

2.18

196.94

2.2

1.7

1.45

1.49

mg/l

0.24

1867

10092

Carpal tunnel syndrome

8326

53425

1.50

196.48

1.7

1.00

1.20

mg/l

8.77

6460

40936

Substance abuse, excluding more controls

7264

43838

1.53

195.79

1.8

1.7

1.27

1.20

mg/l

1.08

5570

33428

Fibromyalgia

1425

6567

2.78

195.59

2.0

1.6

0.74

1.00

mg/l

4.84

1038

4911

Other bacterial intestinal infections

3163

18899

1.93

195.23

2.3

1.7

1.27

1.24

mg/l

0.19

2477

14354

Cervicalgia

2822

16318

2.00

194.67

1.9

1.7

1.00

1.27

mg/l

3.66

2097

12452

Polycystic ovarian syndrome, consortium definition

10207

45133

1.45

194.28

1.8

1.7

0.91

1.07

mg/l

6.07

7573

33969

Other diseases of the digestive system

4138

26429

1.76

193.19

2.6

1.7

1.42

1.39

mg/l

0.17

3277

20353

Dental pulpitis, including avohilmo

12656

63269

1.38

192.62

1.8

0.86

1.13

mg/l

24.65

9206

47682

Hypothyroidism, other/unspecified

12305

62137

1.39

191.88

1.9

1.7

1.11

1.20

mg/l

1.68

9274

47245

Other arthritis (FG)

4108

26225

1.76

191.82

1.9

1.7

1.18

1.16

mg/l

0.16

3245

19762

Implicit fungal Sepsis

1104

4665

3.28

190.12

3.0

1.6

1.44

1.17

mg/l

1.22

873

3541

Coxarthrosis [arthrosis of hip](FG)

6856

33834

1.55

189.27

1.8

1.7

1.33

1.29

mg/l

0.31

5540

26067

Any operation in hilmo

565

641

5.11

188.80

1.9

1.2

1.09

0.51

mg/l

5.34

408

445

Rheumatism, unspecified

1885

9732

2.34

188.38

1.8

1.6

0.96

1.20

mg/l

3.93

1436

7431

Enlarged lymph nodes

2099

11178

2.20

187.32

2.2

1.6

1.37

1.21

mg/l

0.91

1686

8357

Fenamates

1952

6662

2.29

186.68

1.8

2.0

0.98

1.60

mg/l

14.38

1483

5146

Peripheral artery disease

5299

28396

1.64

186.62

1.9

1.7

1.62

1.38

mg/l

4.11

4341

21998

Asthma and allergy, excluding more controls

1812

9018

2.31

186.47

2.0

1.5

0.73

0.95

mg/l

4.96

1320

6516

ILD, hospital admissions 3, with pneumonia sepsis

1221

5393

2.92

184.81

2.7

1.7

1.72

1.42

mg/l

1.40

1051

4125

Other and unspecified effects of external causes

3868

24660

1.78

184.74

2.0

1.8

0.99

1.11

mg/l

1.17

2833

18329

Other CVD

2613

15057

2.04

184.59

2.0

1.7

1.43

1.47

mg/l

0.18

2077

11654

Dipeptidyl peptidase 4 (DPP-4) inhibitors

6981

39819

1.53

184.52

1.9

1.7

1.44

1.32

mg/l

1.57

5601

30808

Hernia of abdominal wall

5942

41402

1.58

184.05

1.9

1.7

1.28

1.24

mg/l

0.41

4659

31747

GI-bleeding

4104

26440

1.74

184.03

2.6

1.7

1.41

mg/l

0.06

3275

20367

Propionic acid derivatives

3505

10404

1.84

183.71

1.8

2.2

1.19

1.67

mg/l

10.46

2585

7924

Asthma and allergy

1812

9083

2.29

182.84

2.0

1.6

0.73

0.98

mg/l

5.45

1320

6582

Hypothyreosis and Thyroxine purchase for inclusion criteria

12714

64750

1.37

182.70

1.9

1.7

1.10

1.19

mg/l

1.60

9589

49253

Hypo-osmolality and hyponatraemia

2338

12998

2.11

182.14

2.0

1.6

1.64

1.34

mg/l

2.09

1908

9903

Unspecified fall

6618

46305

1.54

182.09

1.9

1.8

1.29

1.27

mg/l

0.17

5099

35082

Injuries to the abdomen, lower back, lumbar spine and pelvis

5249

35415

1.62

180.27

1.9

1.8

1.33

1.26

mg/l

0.77

4039

26756

Convulsions, not elsewhere classified

2894

16833

1.90

180.00

2.2

1.6

1.40

1.23

mg/l

1.36

2200

12468

Personality disorders, excluding more controls

3534

22094

1.80

179.59

1.9

1.7

0.97

1.02

mg/l

0.36

2533

16526

Paralytic ileus and intestinal obstruction

3285

20155

1.84

179.17

2.0

1.7

1.60

1.36

mg/l

3.05

2697

15519

Persons encountering health services for specific procedures, not carried out

1347

6313

2.76

179.13

2.2

1.7

1.16

1.03

mg/l

0.83

1017

4623

Irregular menses

6760

38094

1.54

178.62

1.9

1.7

0.79

1.00

mg/l

10.58

4986

28545

Enthesopathies of lower limb, excluding foot

2982

17931

1.90

178.19

1.9

1.7

1.00

1.20

mg/l

2.53

2267

13620

Polyneuropathies and other disorders of the peripheral nervous system

2845

17005

1.95

177.30

2.3

1.8

1.26

1.36

mg/l

0.77

2249

13168

Other respiratory diseases principally affecting the interstitium

2364

13407

2.09

177.19

2.5

1.7

1.55

1.42

mg/l

0.84

1955

10407

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

3810

24217

1.75

177.17

2.0

1.7

1.04

1.03

mg/l

0.08

2802

18149

Cellulitis

2989

18109

1.91

175.74

2.2

1.8

1.20

1.21

mg/l

0.06

2333

13696

Other diseases of hard tissues of teeth

7993

29858

1.49

175.71

1.9

1.6

1.16

1.36

mg/l

5.27

6017

23272

Non-selective monoamine reuptake inhibitors

4932

32155

1.63

174.95

1.8

1.7

1.08

1.25

mg/l

3.99

3785

24920

Injuries to the shoulder and upper arm

11118

68979

1.38

174.37

1.8

1.12

1.23

mg/l

3.54

8592

52263

Sequelae of external causes of morbidity and mortality

3445

21704

1.82

174.36

2.1

1.8

1.34

1.23

mg/l

1.41

2810

16552

Migraine without aura and triptan purchases

2456

14176

2.05

174.16

2.1

1.8

0.76

0.94

mg/l

2.46

1776

10390

Symptoms and signs involving speech and voice

4437

29584

1.69

174.02

2.1

1.7

1.04

1.21

mg/l

3.42

3408

22630

Transport accidents

6103

36766

1.54

173.93

1.9

1.7

1.05

1.18

mg/l

3.29

4571

27631

Other symptoms and signs involving the nervous and musculoskeletal systems

5577

38860

1.58

172.54

2.1

1.7

0.93

1.19

mg/l

10.49

4100

29567

Valvular operations

1742

8947

2.29

172.45

2.6

1.6

1.39

1.51

mg/l

0.86

1345

6985

Unspecified haematuria

5185

29301

1.61

172.20

1.9

1.7

1.49

1.36

mg/l

1.34

4027

22648

L04AA Selective immunosuppressants

3108

19191

1.88

172.05

3.5

1.8

1.65

1.08

mg/l

9.14

2597

14465

Other gastritis (incl. Duodenitis)

2941

17810

1.89

171.75

2.0

1.7

1.26

1.31

mg/l

0.37

2314

13766

Disorders of vestibular function (Vertigo)

6107

42625

1.55

171.60

1.9

1.7

1.07

1.27

mg/l

5.44

4608

32910

Panic disorder

2204

12340

2.11

171.57

2.1

1.7

0.97

0.99

mg/l

0.09

1542

9028

1987

10819

2.20

170.51

3.6

1.7

1.31

1.07

mg/l

2.23

1534

8091

Hypotension

2237

12630

2.09

169.52

1.9

1.7

1.45

1.52

mg/l

0.32

1786

9792

COPD, hospital admissions 1, only main diagnosis

4171

23408

1.70

169.06

2.0

1.7

1.35

1.48

mg/l

1.70

3367

18224

Urticaria and erythema

4958

33955

1.62

168.80

2.1

1.8

1.04

1.11

mg/l

0.83

3647

25579

COPD, hospital admissions 3, with asthma pneumonia sepsis

3305

17542

1.81

168.50

2.1

1.7

1.39

1.52

mg/l

1.27

2732

13669

Conjunctivitis

10273

65772

1.39

168.47

1.9

1.8

1.03

1.13

mg/l

1.72

7615

49361

Pacemaker

3983

24914

1.72

168.44

2.7

1.7

1.49

1.52

mg/l

0.18

3101

19483

Diseases of oral cavity, salivary glands and jaws

8053

30114

1.47

168.42

1.9

1.6

1.22

1.36

mg/l

2.88

6081

23453

Other bacterial intestinal infections

2451

14238

2.01

167.96

2.4

1.7

1.29

mg/l

0.04

1949

10861

ILD, hospital admissions

1997

10980

2.19

167.15

2.4

1.7

1.54

1.41

mg/l

0.62

1650

8513

Atherosclerosis, excluding cerebral and coronary sclerosis

4887

26223

1.62

166.17

1.9

1.6

1.66

1.41

mg/l

4.05

4029

20327

Adverse effects, not elsewhere classified

2802

16992

1.92

166.13

2.1

1.8

0.90

1.10

mg/l

3.90

2064

12684

Other and unspecified polyneuropathies, also in other diseases

2491

14630

2.00

166.01

2.3

1.7

1.27

1.38

mg/l

0.83

1968

11322

Other viral diseases

5086

34802

1.60

165.19

2.2

1.8

1.11

1.04

mg/l

0.48

3811

25747

Second line medication for Crohn's disease

7634

56499

1.46

164.76

2.2

1.7

1.32

1.13

mg/l

3.89

5992

42668

Interstitial lung disease

2015

11162

2.16

164.34

2.4

1.7

1.55

1.41

mg/l

0.71

1665

8660

Interstitial lung disease endpoints

2015

11162

2.16

164.34

2.4

1.7

1.55

1.41

mg/l

0.71

1665

8660

Somatoform disorder

2355

13668

2.04

164.30

2.1

1.7

0.92

1.08

mg/l

2.20

1724

10335

Other interstitial pulmonary diseases

2015

11164

2.16

164.25

2.4

1.7

1.55

1.41

mg/l

0.70

1665

8662

Diabetes medication

14179

66839

1.33

164.08

1.9

1.7

1.19

1.16

mg/l

0.51

11079

50209

Anti-inflammatory and antirheumatic products, non-steroids

3422

10405

1.78

163.97

1.8

2.2

1.17

1.67

mg/l

10.97

2528

7925

Primary_lymphoid and hematopoietic malignant neoplasms

3054

18994

1.84

161.88

2.6

1.7

1.86

1.36

mg/l

4.80

2518

14603

L04AX Other immunosuppressants

7406

54720

1.47

161.72

2.2

1.7

1.33

1.14

mg/l

3.86

5814

41401

Deforming dorsopathies

3576

22977

1.74

161.64

1.8

1.7

1.12

1.28

mg/l

2.35

2762

17404

Stroke, excluding SAH

7300

38960

1.48

161.47

2.2

1.7

1.44

1.38

mg/l

0.69

5750

30165

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

4573

19490

1.67

161.24

2.0

1.7

0.94

0.78

mg/l

3.25

3423

14024

Nonorganic sleeping disorders, excluding more controls

2654

15898

1.91

161.02

2.0

1.7

0.86

1.08

mg/l

5.16

1908

11933

Cutaneous abscess, furuncle and carbuncle

3463

22219

1.76

160.17

2.3

1.8

1.23

1.14

mg/l

1.01

2651

16598

Dislocation, sprain and strain of joints and ligaments of knee

7999

55011

1.44

159.97

1.8

0.92

1.11

mg/l

8.54

6030

41096

Noninfective enteritis and colitis

6113

43812

1.52

158.74

2.0

1.8

1.18

1.16

mg/l

0.22

4661

32923

Other diseases of blood and blood-forming organs, wide

2937

18239

1.86

158.52

2.5

1.8

1.61

1.20

mg/l

5.90

2327

13906

Temporomandibular joint disorders, including avohilmo

6041

42739

1.53

158.46

1.8

1.7

0.75

1.03

mg/l

17.12

4384

31825

Menorrhagia

4680

17424

1.65

158.27

1.8

1.7

0.90

1.20

mg/l

10.57

3490

13215

Other obstetric conditions, not elsewhere classified

4657

20054

1.65

157.50

1.9

1.7

0.92

0.78

mg/l

2.90

3488

14441

Cardiomyopathies, Primary/intrinsic

1511

7659

2.34

156.27

5.6

1.6

1.58

1.40

mg/l

0.94

1223

5990

Chronic gastritis

3412

21930

1.75

155.20

1.9

1.7

1.25

1.38

mg/l

1.94

2592

17042

Special screening examination for infectious and parasitic diseases

3362

15588

1.74

153.72

1.9

1.6

0.98

0.99

mg/l

0.08

2311

11504

Triptan medication for migraine, min. 3 purchases

7807

44495

1.45

153.51

1.8

1.7

0.79

0.99

mg/l

10.53

5795

33117

Stroke, including SAH

7677

41365

1.45

153.26

2.2

1.7

1.45

1.35

mg/l

1.51

6053

32022

ILD, hospital admissions 1, main diag only

1794

9820

2.21

152.95

2.4

1.7

1.52

1.43

mg/l

0.37

1496

7616

Myocarditis

658

2320

3.63

152.01

3.2

1.5

1.46

0.76

mg/l

2.06

507

1666

Other shoulder lesions

1329

6537

2.49

151.94

1.9

1.7

0.89

1.19

mg/l

3.61

994

4898

Other (not insulin) diabetes medications

13119

61897

1.33

151.86

1.9

1.7

1.21

1.17

mg/l

0.54

10286

46895

Early onset COPD

2801

17329

1.85

151.68

2.1

1.7

1.16

1.28

mg/l

1.45

2222

13366

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

12547

59838

1.33

150.64

1.9

1.7

1.21

1.16

mg/l

0.79

9759

45100

Fracture of rib(s), sternum and thoracic spine

3794

25180

1.68

150.04

2.0

1.7

1.42

1.30

mg/l

1.11

2982

19336

Diseases of inner ear

6916

49492

1.47

149.47

1.8

1.7

1.10

1.26

mg/l

2.99

5224

38157

COPD-related respiratory insufficiency

1508

7816

2.33

149.19

2.4

1.7

1.48

1.55

mg/l

0.24

1240

6084

Diseases of pulp and periapical tissues and dental caries

9031

34917

1.41

149.18

1.9

1.7

1.22

1.34

mg/l

2.37

6785

27093

Other viral diseases, not elsewhere classified

3560

23230

1.71

148.55

2.3

1.9

1.05

1.06

mg/l

0.10

2696

17214

Presence of other functional implants

7105

36289

1.46

147.78

1.8

1.6

1.29

1.33

mg/l

0.52

5500

28132

Mycoses

3474

22757

1.72

147.66

2.2

1.8

1.18

1.19

mg/l

0.09

2643

17271

Polyuria

2807

17485

1.83

147.19

1.9

1.7

1.10

1.36

mg/l

5.36

2105

13444

Other systemic involvement of connective tissue

3648

24191

1.70

146.99

1.9

1.7

1.15

1.21

mg/l

0.67

2866

18460

Injuries to the hip and thigh

5959

38982

1.50

146.01

1.9

1.7

1.41

1.31

mg/l

1.10

4747

29743

Radiculopathy

2068

11869

2.01

145.92

2.0

1.7

1.07

1.40

mg/l

5.25

1565

9107

Viral hepatitis, IBD co-morbidity

709

2643

3.27

145.18

2.0

1.5

1.37

1.18

mg/l

0.34

548

1875

Voice disturbances

3523

23313

1.71

144.11

1.9

1.7

0.95

1.17

mg/l

5.83

2688

17824

Spontaneous rupture of synovium and tendon

1124

5305

2.64

143.82

2.0

1.7

1.24

1.37

mg/l

0.80

893

4036

Diseases of liver

4369

30126

1.61

143.53

2.1

1.8

1.63

1.17

mg/l

11.97

3507

23085

Sequelae with surgical and medical care as external cause

2688

16753

1.86

143.52

2.1

1.7

1.38

1.25

mg/l

1.40

2217

12813

Missing teeth due to accident, extraction or parodontitis

7400

52419

1.44

143.40

1.9

1.7

1.20

1.27

mg/l

1.33

5584

40655

Dental caries, including avohilmo

10013

39459

1.37

143.34

1.8

1.7

1.23

1.32

mg/l

1.49

7532

30591

Rheumatoid arthritis

3927

23584

1.64

143.18

1.8

1.7

1.42

1.28

mg/l

1.65

3129

17998

Dermatophytosis

7874

59658

1.41

143.17

1.8

1.05

1.21

mg/l

5.01

5908

45265

Ischaemic Stroke, excluding all haemorrhages

6735

36913

1.46

142.68

2.2

1.7

1.41

1.40

mg/l

0.07

5304

28627

Endometriosis

4621

18582

1.60

141.56

1.8

1.7

0.93

1.18

mg/l

4.55

3443

13982

Glucagon-like peptide-1 (GLP-1) analogues

3744

25169

1.67

141.24

1.9

1.7

0.91

1.11

mg/l

5.39

2929

19219

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3744

25169

1.67

141.24

1.9

1.7

0.91

1.11

mg/l

5.39

2929

19219

Disorders of other endocrine glands

5719

40743

1.50

141.09

2.1

1.8

1.21

1.18

mg/l

0.16

4326

30728

Cardiomyopathy (excluding other)

1543

8163

2.22

141.09

5.5

1.6

1.59

1.37

mg/l

1.31

1249

6343

Other or unspecified ileus, impaction or obstruction

2294

13662

1.91

140.68

2.1

1.7

1.68

1.38

mg/l

3.16

1930

10507

Peripheral arterial reconstruction

2068

12023

2.00

140.68

2.1

1.7

1.72

1.55

mg/l

1.28

1730

9399

Impingement syndrome of shoulder

2826

17743

1.78

140.46

1.8

1.7

0.99

1.32

mg/l

7.54

2160

13684

Gingivitis and periodontal diseases

13898

57751

1.30

139.68

1.9

1.7

1.15

1.22

mg/l

1.32

10393

44182

Caries of dentine, including avohilmo

10688

42579

1.35

139.64

1.8

1.7

1.19

1.30

mg/l

2.45

8041

32888

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

4970

35028

1.54

139.42

2.0

1.8

0.90

1.05

mg/l

3.28

3640

25781

Hypokalaemia

1617

8814

2.19

137.99

2.0

1.7

1.43

1.25

mg/l

1.06

1288

6709

All influenza (not pneumonia)

1922

10971

2.02

137.88

2.2

1.7

1.08

1.15

mg/l

0.35

1452

8046

Retention of urine

4025

22371

1.62

137.35

1.8

1.7

1.52

1.43

mg/l

0.58

3214

17365

Bacterial intestinal infections, IBD co-morbidities

2413

14757

1.88

137.09

2.4

1.7

1.28

mg/l

0.01

1925

11288

Care involving dialysis

1113

5366

2.63

136.96

3.6

1.7

2.30

1.21

mg/l

7.47

987

4068

Insulin, intermediate and long-acting

6797

49378

1.44

135.75

1.9

1.8

1.29

1.28

mg/l

0.06

5413

37511

Other enthesopathy of foot (+metatarsalgia)

1375

7138

2.31

135.01

1.8

1.7

0.92

1.21

mg/l

3.33

1035

5379

Malignant neoplasm, wide definition for exclusion

11709

54651

1.33

134.49

1.9

1.8

1.47

1.00

mg/l

28.97

9236

41223

Urticaria

3990

27395

1.62

134.36

2.2

1.8

0.99

1.09

mg/l

1.04

2910

20514

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1309

6759

2.41

134.07

2.6

1.8

1.16

mg/l

0.03

1011

5063

Dental operations

8286

32226

1.40

134.05

1.8

1.7

1.23

1.34

mg/l

2.19

6269

25023

Zoster [herpes zoster]

6176

44985

1.46

133.54

1.9

1.7

1.19

1.28

mg/l

1.08

4757

34519

Injuries to the neck

3022

19655

1.73

132.17

1.9

1.8

0.94

1.11

mg/l

2.11

2229

14687

Insulin medication

7480

47708

1.41

131.68

2.0

1.8

1.29

1.25

mg/l

0.33

5969

36108

Diabetes, insulin treatment (Kela reimbursement)

13252

64782

1.30

131.48

1.9

1.7

1.22

1.18

mg/l

0.64

10345

49056

Symptoms and signs concerning food and fluid intake

1317

6761

2.29

130.63

1.9

1.6

1.33

1.34

mg/l

0.02

948

5080

Benign paroxysmal vertigo

3723

25413

1.64

130.54

1.9

1.7

1.06

1.25

mg/l

3.06

2843

19592

Mental and behavioural disorders due to psychoactive substance use

7496

52874

1.40

130.07

1.8

1.27

1.19

mg/l

1.34

5733

39921

Substance abuse

7264

51751

1.41

129.98

1.8

1.27

1.19

mg/l

1.22

5570

39082

Hypothyroidism, strict autoimmune, 3 medication purchases required

11273

60790

1.32

129.46

1.8

1.7

1.13

1.18

mg/l

0.61

8490

46224

Metatarsalgia

1275

6547

2.35

129.37

1.9

1.7

0.93

1.20

mg/l

2.92

964

4931

Chronic diseases of tonsils and adenoids

10348

51569

1.34

129.35

1.8

0.87

1.18

mg/l

20.82

7767

38901

Biguanides

12611

62012

1.30

129.28

1.8

1.7

1.21

1.18

mg/l

0.36

9883

47144

Viral infections characterized by skin and mucous membrane lesions

5353

38925

1.49

128.64

2.1

1.8

1.20

1.18

mg/l

0.09

4076

29509

Injuries to the wrist and hand

13291

74920

1.29

128.34

1.8

1.03

1.19

mg/l

6.55

9834

56766

Gastroduodenal ulcer

3051

19881

1.69

126.79

2.1

1.7

1.56

1.46

mg/l

0.71

2466

15461

Superficial injury of head

3038

19911

1.70

126.74

1.8

1.17

1.25

mg/l

0.69

2344

15013

Purpura and other haemorrhagic conditions

1795

10395

2.04

126.38

2.6

1.8

1.92

1.21

mg/l

6.53

1447

7914

Ventral hernia

3020

19824

1.71

126.37

2.0

1.7

1.32

1.23

mg/l

0.80

2388

15239

Noninflammatory disorders of female genital tract

5547

20009

1.50

126.05

1.9

1.7

0.97

1.17

mg/l

4.39

4104

14910

Other complications of surgical and medical care, not elsewhere classified

1383

7418

2.27

125.79

2.3

1.7

1.16

1.11

mg/l

0.24

1095

5572

Other noninfective gastroenteritis and colitis

3134

20726

1.69

125.39

2.1

1.9

1.23

1.21

mg/l

0.19

2406

15630

Disease of hard tissues of teeth, NOS

7322

28810

1.42

125.31

1.7

1.6

0.93

1.33

mg/l

30.70

5465

22464

Hallux valgus (acquired)

4144

20604

1.58

125.10

1.7

1.05

1.20

mg/l

2.63

3217

15711

Dislocation, sprain and strain of joints and ligaments at neck level

2077

12543

1.93

124.90

1.9

1.8

0.75

1.03

mg/l

8.49

1516

9255

Dentofacial anomalies [including malocclusion]

9197

58017

1.35

124.71

1.9

1.8

0.86

1.09

mg/l

10.71

6645

43547

Other pulmonary heart/vessel disease

682

2786

3.33

124.60

4.9

1.7

1.55

1.35

mg/l

0.57

561

2157

Intestinal stricture

3776

26013

1.60

124.22

2.1

1.7

1.70

1.30

mg/l

7.10

3102

19999

Osteoporosis

3228

20144

1.68

124.18

2.2

1.7

1.45

1.36

mg/l

0.82

2600

15497

Volume depletion

1227

6301

2.32

123.30

2.3

1.7

1.68

1.40

mg/l

1.09

1007

4791

Vasomotor and allergic rhinitis

4863

34397

1.50

121.91

1.9

1.8

0.88

1.14

mg/l

7.23

3549

25714

Complications of internal orthopaedic prosthetic devices, implants and grafts

2737

17776

1.73

120.20

1.8

1.7

1.48

1.34

mg/l

1.58

2264

13695

Pleural effusion

1870

11059

1.95

119.65

2.1

1.7

1.93

1.46

mg/l

6.00

1569

8543

Secondary right heart disease

626

2509

3.44

119.46

5.1

1.6

1.58

1.36

mg/l

0.58

515

1943

Inflammatory disease of uterus

2012

12238

1.93

119.34

2.0

1.7

0.75

0.97

mg/l

4.42

1511

9132

Malignant neoplasm

11167

53050

1.31

119.04

1.9

1.8

1.49

1.00

mg/l

29.84

8840

40123

Haemorrhage, not elsewhere classified

566

2139

3.56

118.92

3.5

1.6

2.39

1.47

mg/l

2.25

456

1648

Fibroblastic disorders

2610

16680

1.73

118.92

1.7

1.6

1.20

1.44

mg/l

2.61

2032

12859

Other viral diseases

3745

25883

1.59

118.46

2.3

1.9

1.23

1.07

mg/l

1.19

2810

19137

Viral and other specified intestinal infections

3532

23257

1.60

118.01

2.3

1.8

1.02

1.10

mg/l

0.77

2614

16729

ILD medications: azathioprine

1882

11208

1.92

116.50

2.9

1.7

1.60

1.07

mg/l

3.78

1486

8295

Poisoning by drugs, medicaments and biological substances

3128

21050

1.65

116.11

1.9

1.8

1.13

1.03

mg/l

0.73

2283

15589

Other disorders of bone

2596

16831

1.74

115.61

2.0

1.8

0.94

1.07

mg/l

1.38

1949

12660

Disorders of muscles

1294

6913

2.20

115.58

2.0

1.7

1.06

1.25

mg/l

1.72

1005

5187

Need for other prophylactic measures

874

4135

2.78

115.37

3.2

1.9

1.42

1.19

mg/l

0.82

716

3140

Congenital malformations, deformations and chromosomal abnormalities

8363

60500

1.35

115.29

2.0

1.8

1.10

1.08

mg/l

0.22

6305

45065

Other cataract

5196

28748

1.47

115.00

1.9

1.7

1.32

mg/l

0.04

4058

22268

Abnormal involuntary movements

1768

10470

1.98

114.87

2.1

1.7

1.05

1.25

mg/l

1.67

1345

7978

Other general symptoms and signs

733

3140

2.92

114.73

2.3

1.7

1.12

1.11

mg/l

0.01

534

2329

Other disorders of ear

11816

62859

1.29

114.64

1.8

1.21

mg/l

0.07

8909

48251

Misadventures to patients during surgical and medical care

1878

11305

1.94

114.62

2.1

1.7

1.47

1.20

mg/l

1.95

1491

8586

Fungal Sepsis

625

2576

3.35

113.23

3.5

1.6

1.77

1.21

mg/l

1.81

515

1954

Other and unspecified drugs and medicaments

1213

6486

2.32

113.07

2.5

1.8

1.17

1.16

mg/l

0.04

942

4889

Calcific aortic valvular stenosis

3351

22216

1.61

112.80

1.8

1.7

1.41

1.56

mg/l

1.84

2681

17363

Calcific aortic valvular stenosis, operated

3351

22216

1.61

112.80

1.8

1.7

1.41

1.56

mg/l

1.84

2681

17363

Epilepsy

3606

24874

1.57

112.24

2.0

1.8

1.27

1.36

mg/l

0.77

2806

18958

Streptococcal septicaemia

1129

5848

2.32

111.88

2.4

1.6

2.02

1.30

mg/l

4.42

934

4390

Other diseases of intestine

1763

10452

1.94

111.78

2.1

1.7

1.44

1.29

mg/l

0.94

1388

8031

Reimbursement for rheumatic diseases

7247

56007

1.38

111.75

1.9

1.7

1.31

1.17

mg/l

2.98

5713

42502

Calcific aortic valvular stenosis, diagnosis (helper)

3340

22176

1.61

111.54

1.7

1.41

1.56

mg/l

1.84

2673

17333

Operations 2 for CAVS

3340

22176

1.61

111.54

1.7

1.41

1.56

mg/l

1.84

2673

17333

Insulin, combination of fast acting with intermediate-acting or long-acting

7494

53241

1.37

111.13

2.0

1.7

1.29

1.28

mg/l

0.02

5980

40440

Gastric ulcer

2100

13006

1.82

110.81

2.2

1.7

1.61

1.44

mg/l

1.09

1701

10099

Umbilical hernia

3329

22886

1.61

110.80

1.9

1.8

1.27

1.19

mg/l

0.57

2600

17539

Aortic aneurysm

2557

16236

1.71

110.71

2.1

1.7

2.29

1.44

mg/l

13.50

2040

12587

Implicit fungal Sepsis

584

2359

3.47

110.69

3.6

1.6

1.73

1.17

mg/l

1.72

478

1797

Calcific aortic valvular stenosis, including rheumatic fever

3346

22255

1.60

110.15

1.7

1.41

1.56

mg/l

1.86

2677

17397

Disorders of lens

8088

39429

1.36

109.48

1.9

1.7

1.29

1.24

mg/l

0.62

6327

30634

Explicit bacterial Sepsis

1325

7264

2.14

109.40

2.4

1.6

1.94

1.24

mg/l

5.49

1090

5484

Hyperkalaemia

764

3444

2.79

109.35

2.7

1.6

1.62

1.44

mg/l

0.54

661

2627

Glomerular diseases

2233

14174

1.79

109.16

2.2

1.8

1.76

1.26

mg/l

5.70

1872

10803

Other disorders of patella

2212

13962

1.78

108.87

1.8

1.7

0.86

1.05

mg/l

2.74

1656

10454

Unspecified acute lower respiratory infection

1928

11798

1.87

108.78

2.4

1.8

1.13

1.20

mg/l

0.40

1572

8931

Personality disorders

3534

24668

1.58

108.74

1.9

1.8

0.97

1.00

mg/l

0.22

2533

18278

Cervicocranial syndrome

1406

7897

2.09

108.32

1.8

1.6

0.85

1.26

mg/l

6.81

1077

5979

Poisoning by medicine

2829

18925

1.67

108.31

1.9

1.8

1.08

1.02

mg/l

0.44

2067

14016

Any event in cancer register

12193

58790

1.28

108.27

1.9

1.8

1.42

1.02

mg/l

26.13

9564

44313

Abnormal findings on examination of blood, without diagnosis

5475

37605

1.44

108.20

2.0

1.8

1.48

1.31

mg/l

2.06

4369

28968

Substance use, excluding alcohol

2523

16461

1.72

108.07

2.0

1.8

1.14

1.07

mg/l

0.67

1884

12128

Enterocolitis due to Clostridium difficile

1393

7822

2.11

108.06

2.7

1.8

1.48

1.38

mg/l

0.52

1133

6017

Azathioprine

1882

11452

1.87

107.64

2.9

1.7

1.60

1.08

mg/l

3.69

1486

8485

Nonorganic sleeping disorders

2654

17574

1.70

107.22

2.0

1.8

0.86

1.07

mg/l

4.95

1908

13018

Congenital malformations, deformations and chromosomal abnormalities

7557

56343

1.36

107.03

2.0

1.8

1.10

1.07

mg/l

0.33

5694

41812

Open wound of lower leg

1892

11575

1.87

106.63

2.0

1.8

1.23

1.26

mg/l

0.16

1473

8653

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

5973

39532

1.42

106.39

2.0

1.7

1.15

0.94

mg/l

4.80

4653

29516

Appendectomy

8407

63856

1.33

106.06

1.8

1.09

1.10

mg/l

0.07

6356

48067

Other disorders of eye and adnexa

1879

11592

1.88

104.55

2.2

1.8

1.24

1.12

mg/l

0.38

1349

8722

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

3810

27161

1.54

104.02

2.0

1.8

1.04

1.01

mg/l

0.28

2802

20152

Emphysema

902

4423

2.47

103.43

2.2

1.7

1.37

1.56

mg/l

0.85

743

3444

Generalized anxiety disorder

2091

13188

1.79

103.32

1.9

1.7

1.02

0.99

mg/l

0.13

1432

9615

Thoracic aortic aneurysm

1657

9895

1.94

103.23

2.1

1.7

1.78

1.33

mg/l

2.94

1283

7629

Open wound of head

6434

47734

1.38

102.85

1.8

1.35

1.28

mg/l

0.74

4907

36250

Spondylolisthesis/Spondylolysis

2191

13997

1.76

102.51

1.8

1.7

1.12

1.27

mg/l

1.43

1713

10716

Other symptoms and signs involving the digestive system and abdomen

2022

12652

1.79

102.33

1.9

1.6

1.19

1.18

mg/l

0.01

1522

9719

Haemorrhoids and perianal venous thrombosis

3746

26532

1.53

102.29

1.8

1.6

1.09

1.32

mg/l

4.06

2873

20393

Disorders of adult personality and behaviour

3689

26228

1.54

102.22

1.9

1.8

0.97

1.00

mg/l

0.25

2632

19393

Mouth breathing

4784

35465

1.46

101.79

1.8

1.9

0.94

1.19

mg/l

8.47

3615

27152

Other diseases of pericardium

627

2691

3.03

101.68

2.3

1.6

1.81

1.32

mg/l

2.50

515

2100

Other diseases of liver

2289

14881

1.75

101.57

2.1

1.8

1.35

1.12

mg/l

1.89

1770

11314

Disorders of skin appendages

6049

46373

1.39

101.26

2.0

1.8

0.95

1.11

mg/l

5.64

4483

34758

Unspecified kidney failure

1241

6851

2.13

100.73

2.5

1.7

1.89

1.41

mg/l

4.42

1052

5275

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3612

25347

1.54

100.56

2.5

1.8

1.03

1.00

mg/l

0.16

2726

18637

Lateral epicondylitis

1614

9594

1.92

100.42

1.7

1.6

0.92

1.10

mg/l

0.97

1211

7306

Use of pramipexole

2706

18278

1.66

100.17

1.8

1.7

1.11

1.27

mg/l

2.46

2072

14084

Extrapyramidal and movement disorders

4492

33120

1.47

99.91

1.8

1.7

1.17

1.32

mg/l

2.30

3401

25556

Specific personality disorders

3062

21155

1.60

99.73

1.9

1.8

0.97

1.00

mg/l

0.19

2196

15700

Cardiomyopathy, other and unspecified

964

4911

2.36

99.68

4.8

1.6

1.49

1.31

mg/l

0.64

752

3806

Exclusions for E4_PCOS_CONSORTIUM

9611

48609

1.31

99.47

1.8

1.04

1.08

mg/l

0.55

7193

36502

Glomerular disorders in diseases classified elsewhere

1469

8608

2.01

99.17

2.3

1.8

1.79

1.27

mg/l

3.92

1258

6565

Senile cataract

7217

34479

1.36

98.46

1.9

1.7

1.33

1.30

mg/l

0.30

5645

26892

Striking against or struck by other objects

4020

29132

1.49

97.84

1.9

1.05

1.15

mg/l

1.05

2915

21635

Other/unspecified synovitis and tenosynovitis

1390

7988

2.00

97.47

1.9

1.7

1.04

1.25

mg/l

1.98

1072

6001

Abnormalities of gait and mobility

1470

8657

1.99

97.13

2.0

1.8

1.47

1.42

mg/l

0.14

1123

6693

Iron deficiency anaemia secondary to blood loss (chronic)

2003

12731

1.79

97.09

3.4

1.7

1.62

1.29

mg/l

2.58

1585

9830

Other viral diseases, not elsewhere classified

2326

15249

1.70

96.51

2.4

1.9

1.22

1.10

mg/l

0.65

1770

11388

Conjunctivitis (acute, non atopic)

3477

24624

1.54

96.33

2.0

1.9

1.02

1.12

mg/l

1.15

2586

18507

Unspecified privation

1427

8375

2.01

96.28

2.5

1.8

1.40

1.21

mg/l

1.14

1143

6300

Fall on same level involving ice and snow

7097

55973

1.35

96.17

1.8

1.14

1.20

mg/l

0.80

5423

42504

Kidney transplant status

755

3622

2.72

96.16

3.0

2.0

2.05

1.21

mg/l

3.22

684

2721

Other hammer toe(s) (acquired)

1986

11574

1.77

95.89

1.7

1.6

1.18

1.39

mg/l

2.76

1542

8909

Certain disorders involving the immune mechanism

2364

15695

1.70

95.10

2.6

1.8

1.31

1.18

mg/l

0.66

1880

11977

Candidiasis

1778

11087

1.86

95.05

2.4

1.7

1.08

1.16

mg/l

0.69

1337

8348

Pregnancy hypertension

5372

36709

1.41

94.70

2.0

1.7

1.17

0.92

mg/l

5.85

4173

27393

Nonischemic cardiomyopathy

1167

6433

2.12

94.63

4.2

1.7

1.74

1.42

mg/l

1.51

954

4934

Bipolar affective disorders

2419

16101

1.67

94.37

1.9

1.7

1.04

1.02

mg/l

0.08

1763

11995

Sulfasalazine

3447

24504

1.53

94.12

1.7

1.6

1.22

1.12

mg/l

1.03

2705

18427

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

7042

54038

1.34

94.09

1.7

1.03

1.09

mg/l

0.51

5208

40463

Stomatitis and related lesions

2449

16406

1.67

93.93

2.2

1.8

1.10

1.15

mg/l

0.45

1857

12286

Deviated nasal septum

3806

27519

1.49

93.44

1.8

1.12

1.28

mg/l

1.84

2833

21180

Coronary artery bypass grafting

2652

13227

1.63

93.20

2.0

1.5

1.53

1.64

mg/l

0.82

2145

10267

Problems related to lifestyle

1350

7816

2.00

93.15

2.0

1.7

1.02

1.10

mg/l

0.61

1014

5854

Other maternal disorders predominantly related to pregnancy

7293

36081

1.35

93.05

1.8

1.7

0.87

0.98

mg/l

2.98

5502

26913

Idiopathic gout

1127

6228

2.16

92.64

1.9

1.7

1.37

1.46

mg/l

0.51

907

4853

Other and unspecified tonsillitis

4129

25356

1.47

92.37

2.1

1.8

0.96

1.04

mg/l

0.83

2957

18649

Other retinal disorders

7476

46229

1.33

91.93

1.8

1.7

1.37

1.33

mg/l

0.43

5807

35529

Status post-ami

2689

13824

1.61

91.52

2.5

1.5

1.43

1.61

mg/l

1.77

2128

10736

Disorders of vitreous body and globe

5979

44639

1.38

91.35

1.8

1.7

1.11

1.29

mg/l

4.18

4582

34659

Other extrapyramidal and movement disorders in other diseases

2861

19880

1.60

91.24

1.8

1.7

1.10

1.26

mg/l

1.55

2140

15260

Disorders of vitreous body

5828

43636

1.38

91.17

1.8

1.7

1.10

1.29

mg/l

4.13

4469

33909

False labour

3980

18041

1.50

90.94

1.8

1.7

0.72

0.79

mg/l

1.55

2857

13223

Insulin, fast-acting

4302

31911

1.45

90.91

2.0

1.8

1.16

1.24

mg/l

1.22

3423

23985

Coxarthrosis, primary

6859

45843

1.34

90.08

1.7

1.35

mg/l

0.06

5534

35588

Disorder of lipoprotein metabolism, unspecified

1558

9465

1.88

89.91

1.9

1.7

1.48

1.37

mg/l

0.49

1225

7296

Adhesive capsulitis of shoulder

1870

11845

1.76

89.74

1.9

1.6

1.02

1.29

mg/l

3.39

1444

9073

Plantar fascial fibromatosis

1199

6787

2.06

89.46

1.7

1.6

1.04

1.15

mg/l

0.56

923

5150

Unspecified/other endometriosis

1252

7203

2.03

88.90

1.9

1.6

0.79

1.01

mg/l

2.58

907

5315

Other abnormal uterine and vaginal bleeding

2803

13783

1.60

88.79

1.8

1.6

1.10

1.26

mg/l

1.71

2114

10542

Cardiac arrest

649

2450

2.59

88.67

3.1

1.4

3.20

1.02

mg/l

6.45

543

1806

Disorders of choroid and retina

9727

56618

1.28

88.61

1.9

1.7

1.33

1.26

mg/l

0.88

7525

43523

Maternal care for other conditions predominantly related to pregnancy

2762

18787

1.60

88.59

1.9

1.7

0.76

0.85

mg/l

1.38

2081

13786

Other diseases of lip and oral mucosa

4854

36885

1.42

88.47

1.9

1.8

1.07

1.18

mg/l

1.59

3599

28091

Fissure and fistula of anal and rectal regions

2865

19927

1.57

88.46

1.8

1.7

1.07

1.17

mg/l

0.78

2104

15122

Disorders of sclera, cornea, iris and ciliary body

6754

53487

1.34

88.45

1.8

1.12

1.18

mg/l

0.85

5141

40558

Neuralgia and neuritis, unspecified

688

3250

2.64

88.33

1.9

1.7

0.96

1.26

mg/l

1.97

518

2428

Ganglion

2455

16559

1.62

87.98

1.7

1.6

0.86

1.15

mg/l

6.71

1841

12437

Ocular pain

1158

6598

2.12

87.91

2.2

1.8

0.91

1.06

mg/l

0.90

824

4932

Alcohol use disorder, Swedish definition

6479

46692

1.34

87.91

1.9

1.8

1.42

1.21

mg/l

4.30

5000

35465

Diseases of salivary glands

3945

29114

1.47

87.85

1.9

1.7

1.03

1.14

mg/l

1.96

2962

22058

Solid cancers, helper endpoint

10757

52453

1.27

87.73

1.8

1.48

1.00

mg/l

27.48

8470

39701

Allergic conjunctivitis

7319

57045

1.32

87.61

1.8

1.03

1.08

mg/l

0.54

5413

42678

Other local infections of skin and subcutaneous tissue

1311

7702

1.99

87.54

2.2

1.8

1.25

1.22

mg/l

0.09

1030

5823

Extreme obesity with alveolar hypoventilation

619

2866

2.92

87.43

2.0

1.8

1.11

1.14

mg/l

0.13

504

2184

Noninfectious colitis NAS

1730

10921

1.81

86.70

2.0

1.8

1.14

1.21

mg/l

0.45

1323

8195

Other disorders of eyelid

5150

37590

1.39

86.43

1.8

1.7

1.25

1.36

mg/l

1.06

3965

29208

Diagnoses used for exclusion with ILD

2987

21074

1.55

86.05

2.1

1.7

1.47

1.29

mg/l

1.13

2361

16226

Chondrocostal junction syndrome [Tietze]

599

2764

2.97

85.93

2.4

1.7

0.71

1.09

mg/l

6.71

447

2076

Lung cancer and mesothelioma

1911

10404

1.72

85.90

1.7

1.5

2.00

1.45

mg/l

3.58

1595

7939

Superficial injury of abdomen, lower back and pelvis

1902

12280

1.74

85.88

2.0

1.8

1.02

1.17

mg/l

1.23

1409

9147

Fracture of lower leg, including ankle

6643

52090

1.33

85.79

1.8

1.26

1.22

mg/l

0.45

5152

39295

Periodontitis

12279

68968

1.24

85.72

1.9

1.7

1.24

1.17

mg/l

1.24

9336

52661

Zoster [herpes zoster]

2196

14657

1.68

85.59

2.2

1.7

1.34

1.31

mg/l

0.10

1705

11267

Arterial embolism and thrombosis

739

3619

2.48

85.36

2.9

1.6

2.06

1.40

mg/l

5.04

622

2781

Diseases of external ear

4020

29859

1.45

85.16

1.9

1.8

1.08

1.23

mg/l

2.34

2984

22699

Post-traumatic stress disorder

1160

6616

2.05

85.11

2.1

1.7

0.74

0.95

mg/l

2.45

840

4774

Other skin changes

2196

14681

1.68

85.01

2.1

1.7

1.18

1.31

mg/l

0.96

1689

11271

Cardiodefibrillation

3912

28889

1.46

84.82

2.6

1.7

1.32

1.45

mg/l

1.30

2900

22679

7226

50870

1.32

84.55

1.9

1.8

1.39

1.20

mg/l

4.28

5564

38513

Other and unspecified local infections of skin and subcutaneous tissue

1239

7243

2.01

84.40

2.2

1.8

1.27

1.23

mg/l

0.14

978

5467

Benign neoplasm of other and ill-defined parts of digestive system

2162

14488

1.68

83.69

2.2

1.7

1.16

1.28

mg/l

1.16

1681

11164

Postmenopausal bleeding

3219

12129

1.55

83.65

1.9

1.7

1.16

1.30

mg/l

1.22

2405

9471

Atopic dermatitis

7435

48908

1.31

83.59

1.8

0.94

1.06

mg/l

2.18

5432

36421

Chronic periodontitis, including avohilmo

12223

68932

1.24

83.59

1.9

1.7

1.23

1.17

mg/l

1.10

9296

52631

Superficial injury of hip and thigh

1788

11437

1.76

83.49

1.9

1.7

1.32

1.29

mg/l

0.07

1390

8667

Trigger finger

1649

10331

1.79

83.23

1.9

1.6

0.82

1.21

mg/l

11.83

1280

7857

Childhood asthma (age<16), excluding more controls

1526

7248

1.81

82.79

2.1

1.6

0.97

mg/l

0.02

1040

4979

Thrombocytopenia, unspecified

925

4995

2.25

82.71

2.7

1.7

1.94

1.22

mg/l

7.21

768

3814

Fracture of foot, except ankle

2975

21142

1.54

82.59

2.0

1.8

1.01

1.09

mg/l

0.80

2283

15732

6839

49244

1.32

82.55

1.9

1.8

1.40

1.21

mg/l

4.28

5283

37284

Diseases of male genital organs

5620

21720

1.37

82.38

1.9

2.0

1.25

1.36

mg/l

1.31

4217

16497

Inflammatory bowel disease

3845

28505

1.46

82.22

2.0

1.8

1.14

1.11

mg/l

0.26

2935

21273

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2172

14613

1.67

82.05

1.9

1.7

0.74

1.01

mg/l

8.95

1562

10823

Female infertility

3691

16295

1.48

81.87

1.8

1.7

0.98

1.08

mg/l

1.53

2788

12145

Acute pancreatitis

2268

15332

1.64

81.81

2.0

1.7

1.61

1.25

mg/l

2.97

1781

11721

Endocarditis

480

2009

3.09

81.73

2.9

1.6

1.98

1.40

mg/l

2.41

412

1563

Mental and behavioural disorders due to alcohol

5999

45339

1.34

81.63

1.8

1.31

1.22

mg/l

1.47

4614

34288

Recurrent aphthous stomatitis , including avohilmo

1773

11435

1.76

81.62

2.3

1.8

1.10

1.19

mg/l

0.76

1328

8571

Fracture of lumbar spine and pelvis

2565

17766

1.59

81.36

1.9

1.7

1.52

1.37

mg/l

1.53

2053

13619

Idiopathic pulmonary fibrosis

931

5060

2.20

80.68

2.6

1.6

1.76

1.52

mg/l

0.69

767

3951

Herpesviral [herpes simplex] infections

3107

22392

1.52

80.36

1.9

1.7

0.94

1.06

mg/l

1.49

2285

16758

Vascular disorders of the intestines

815

4217

2.29

80.27

2.8

1.6

1.96

1.50

mg/l

2.04

687

3285

Localized swelling, mass and lump of skin and subcutaneous tissue

3749

27802

1.46

80.24

2.0

1.7

1.24

1.20

mg/l

0.22

2854

21231

Extracorporeal dialysis

797

4156

2.39

80.09

4.1

1.8

2.51

1.28

mg/l

5.94

709

3175

Childhood asthma (age<16)

1526

7319

1.79

79.98

2.1

1.7

0.97

mg/l

0.00

1040

5035

Intestinal adhesions without obstruction

1032

5790

2.09

79.88

2.0

1.7

1.54

1.33

mg/l

1.22

852

4429

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4114

31009

1.43

79.76

2.2

1.8

1.09

1.15

mg/l

0.61

3134

23518

Lung transplantation

189

504

10.17

79.27

6.1

1.9

1.54

1.20

mg/l

0.82

162

389

Superficial injury of wrist and hand

2481

17202

1.59

78.82

2.0

1.9

0.86

1.12

mg/l

7.66

1801

12778

Other and unspecified visual disturbances

1306

7915

1.93

78.53

2.3

1.7

1.13

1.17

mg/l

0.11

997

6016

Lung transplant status

187

498

10.12

78.49

5.8

1.9

1.51

1.20

mg/l

0.71

161

387

Cardiac murmurs and other cardiac sounds

991

5376

2.05

78.43

2.2

2.0

1.28

1.32

mg/l

0.12

760

4007

Chronic laryngitis and laryngotracheitis

1677

10747

1.76

78.41

1.9

1.7

0.92

1.27

mg/l

7.11

1230

8283

Other and unspecified urticaria

2439

16913

1.60

78.41

2.1

1.8

1.07

1.09

mg/l

0.10

1786

12647

Mental and behavioural disorders due to alcohol, excluding acute intoxication

5130

39636

1.37

77.94

1.8

1.35

1.22

mg/l

1.84

3954

30089

Hyperkinetic disorders, excluding more controls

1338

7691

1.85

77.52

2.1

1.8

0.80

0.96

mg/l

1.29

877

5376

Insulin, fast-acting or short human

4319

32840

1.41

77.01

2.0

1.8

1.16

1.25

mg/l

1.36

3438

24731

Ascites

885

4792

2.18

76.57

2.5

1.6

2.83

1.34

mg/l

13.81

778

3700

Emotionally unstable personality disorder

1637

10524

1.77

76.19

1.9

1.8

0.95

0.94

mg/l

0.03

1146

7642

Faecal incontinence

1096

6344

2.01

76.16

1.8

1.6

1.33

1.32

mg/l

0.02

823

4907

Congenital malformations of the circulatory system

1704

10718

1.74

75.36

2.9

2.0

1.21

1.17

mg/l

0.23

1274

7985

Injuries to unspecified part of trunk, limb or body region

1283

7811

1.90

75.12

2.3

1.8

1.28

1.21

mg/l

0.36

1028

5878

Injury of muscle and tendon at shoulder and upper arm level

3970

29991

1.42

75.09

1.7

1.8

1.04

1.31

mg/l

7.59

3082

23185

Other pleural conditions

1169

6910

1.94

74.94

2.1

1.7

1.77

1.54

mg/l

1.47

965

5352

Diplopia

1589

10194

1.77

74.76

2.1

1.7

1.10

1.23

mg/l

1.01

1215

7807

Benign neoplasm: Colon, unspecified

2817

20212

1.52

74.60

1.9

1.7

1.26

1.37

mg/l

1.05

2183

15731

Peripheral artery operations in Hilmo

1389

8554

1.82

74.57

2.0

1.7

1.62

1.43

mg/l

1.33

1156

6594

Pericarditis

477

2089

2.90

73.32

2.2

1.6

1.29

1.23

mg/l

0.16

393

1601

Cerebral palsy and other paralytic syndromes

1378

8574

1.84

73.31

2.5

1.8

1.26

1.20

mg/l

0.20

1078

6505

Appendicitis, broad definition

9243

69664

1.25

73.15

1.8

1.03

1.15

mg/l

2.88

6936

52692

Diseases of appendix

9311

69980

1.25

73.11

1.8

1.04

1.15

mg/l

2.34

6984

52930

Pain associated with micturition

1420

8928

1.82

72.56

2.2

1.8

1.03

1.19

mg/l

1.32

1056

6747

Other and unspecified disorders of vitreous body

4730

36291

1.38

72.54

1.8

1.7

1.09

1.29

mg/l

3.61

3604

28276

Other sleep disorders

1312

8052

1.84

72.54

1.8

1.7

0.88

1.27

mg/l

8.78

984

6134

Fentanyl

1120

6538

1.92

72.43

1.9

1.6

1.80

1.45

mg/l

1.56

940

4977

Sensorineural hearing loss

8916

50111

1.26

72.38

1.7

1.29

1.28

mg/l

0.14

6822

38939

Acute pharyngitis

1783

11635

1.67

72.10

2.2

1.8

0.89

1.09

mg/l

1.63

1260

8544

ILD-related respiratory insufficiency

458

2022

3.04

71.57

3.1

1.7

1.68

1.44

mg/l

0.42

400

1573

Fitting and adjustment of other devices

3928

26794

1.41

71.49

1.8

1.6

1.27

1.33

mg/l

0.61

3099

20444

Seropositive rheumatoid arthritis

2822

20261

1.50

71.18

1.8

1.6

1.47

1.23

mg/l

3.16

2276

15397

Allergic rhinitis

3783

28251

1.42

70.96

1.9

0.83

1.04

mg/l

3.90

2729

20895

Alcohol use disorder, ICD-based

4731

36816

1.36

70.85

1.8

1.34

1.21

mg/l

1.67

3641

27921

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1227

7516

1.90

70.83

2.3

1.8

1.58

1.25

mg/l

1.82

1021

5713

Later onset COPD

2900

16652

1.50

70.78

1.8

1.6

1.55

1.65

mg/l

0.65

2383

13038

Procreative management

3906

24624

1.41

70.70

2.2

1.8

1.23

1.01

mg/l

2.78

2954

17989

Dilated cardiomyopathy

1350

8445

1.83

70.53

6.0

1.7

1.57

1.39

mg/l

0.88

1089

6577

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3447

25727

1.44

70.53

1.8

0.83

1.11

mg/l

11.84

2497

19230

Endometriosis of pelvic peritoneum

1955

12583

1.64

70.46

1.8

1.7

0.81

1.08

mg/l

5.26

1433

9473

Otitis externa

2627

18806

1.53

70.43

1.9

1.8

0.98

1.16

mg/l

2.56

1950

14202

Suicide or other Intentional self-harm

2956

21564

1.49

70.37

1.9

1.8

1.09

1.05

mg/l

0.30

2158

16091

Familial hypercholesterolemia, with ischemic heart disease

1015

5873

1.99

70.09

1.8

1.6

1.37

1.69

mg/l

1.79

826

4597

Conductive and sensorineural hearing loss

9427

53094

1.25

70.09

1.8

1.7

1.29

1.25

mg/l

0.35

7214

41139

Chronic Coagulation defects

410

1766

3.34

69.88

3.7

1.9

0.75

0.93

mg/l

1.20

301

1314

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2059

14131

1.62

69.85

1.9

1.8

1.07

0.98

mg/l

0.57

1492

10417

Other and unspecified nerve root and plexus disorders, also in other diseases

2359

16613

1.56

69.46

1.8

1.7

0.94

1.15

mg/l

2.88

1817

12673

Female infertility, cervical, vaginal, other or unspecified origin

3317

15891

1.46

68.79

1.8

1.7

1.00

1.09

mg/l

0.62

2516

11870

Polyp of the female genital tract

3705

15916

1.44

68.67

1.7

1.09

1.20

mg/l

0.83

2809

12163

Left bundle-branch block

826

4519

2.13

68.45

2.1

1.6

1.30

1.38

mg/l

0.22

615

3533

Chronic ulcer of skin, not elsewhere classified

852

4749

2.14

68.40

2.1

1.7

1.45

1.38

mg/l

0.20

676

3657

Sequelae of cerebrovascular disease

3884

25452

1.40

68.15

2.3

1.7

1.43

1.44

mg/l

0.02

3074

19790

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1690

11200

1.69

68.13

1.9

1.7

1.25

1.27

mg/l

0.09

1273

8546

Viral and other specified intestinal infections

2448

16877

1.52

68.06

2.5

1.8

1.09

1.12

mg/l

0.17

1813

12040

Disorders of breast

6152

45130

1.31

67.98

1.7

0.94

1.07

mg/l

2.40

4647

34123

Abnormal blood-pressure reading, without diagnosis

529

2473

2.56

67.83

1.8

1.6

0.82

1.35

mg/l

4.10

401

1896

Other metabolic disorders

1647

10875

1.70

67.72

2.5

1.7

1.27

1.03

mg/l

0.92

1283

8172

Gestational [pregnancy-induced] hypertension

3238

24123

1.46

67.61

2.0

1.7

1.12

0.86

mg/l

6.66

2523

17734

Other/unspecified enthesopathies of lower limb, excluding foot

888

5011

2.07

67.49

2.0

1.7

0.87

1.13

mg/l

2.84

648

3775

Budesonide

1647

10846

1.69

67.49

1.8

1.7

1.16

1.08

mg/l

0.49

1271

8065

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3685

27961

1.41

67.43

2.0

1.8

1.24

1.17

mg/l

0.58

2858

21005

Exclusions for E4_PCOS_BROAD

2047

14118

1.60

67.43

2.1

1.9

1.11

1.15

mg/l

0.15

1568

10632

Other or ill-defined heart diseases

651

3307

2.32

67.04

3.0

1.6

1.14

1.17

mg/l

0.09

491

2480

Female genital prolapse

3470

14565

1.45

67.04

1.7

0.96

1.22

mg/l

6.59

2680

11233

Other necrotizing vasculopathies (FG)

722

3834

2.25

66.89

2.1

1.7

1.59

1.37

mg/l

0.82

584

2896

Artificial opening status

688

3615

2.33

66.88

2.6

1.7

2.44

1.35

mg/l

3.80

586

2790

Chondropathies

1850

12569

1.64

66.29

2.0

1.8

0.83

1.10

mg/l

6.13

1370

9481

Other and unspecified injuries of lower leg

962

5605

2.01

66.08

2.0

1.8

0.89

1.09

mg/l

2.05

747

4119

Flat foot [pes planus] (acquired)

1129

6843

1.88

66.08

1.8

1.7

0.95

1.18

mg/l

2.45

868

5152

Superficial injury of thorax

1762

11852

1.65

65.86

2.1

1.8

1.09

1.21

mg/l

0.74

1357

8980

Failure and rejection of transplanted organs and tissues

244

832

4.80

65.86

5.8

2.1

1.75

1.03

mg/l

2.34

217

629

Cluster headache, strict

514

2447

2.66

65.69

1.9

1.7

0.82

1.02

mg/l

1.16

370

1813

Bronchiectasis

906

5195

2.04

65.52

2.2

1.7

1.26

1.46

mg/l

0.83

710

4019

Acute appendicitis

8616

67382

1.25

65.50

1.8

1.03

1.14

mg/l

2.53

6458

50941

Alcohol abuse, main dg, excluding more controls

1689

11231

1.66

65.44

1.9

1.8

1.26

1.16

mg/l

0.50

1308

8519

Cluster headache, wide

541

2627

2.58

65.42

1.9

1.7

0.88

1.05

mg/l

0.80

392

1951

Necrosis of pulp, including avohilmo

7062

57925

1.28

65.41

1.8

1.04

1.09

mg/l

0.81

5186

43799

Sequelae of injuries, of poisoning and of other consequences of external causes

2756

20137

1.49

65.20

1.9

1.8

1.08

1.12

mg/l

0.27

2099

15239

Adenomyosis (Endometriosis of uterus)

1581

10430

1.70

64.93

1.8

1.6

0.80

1.23

mg/l

12.29

1203

8014

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

3343

25173

1.42

64.27

1.9

1.8

0.99

1.19

mg/l

5.79

2548

18948

Acute pancreatitis (for exclusion)

2268

16076

1.54

64.20

2.0

1.8

1.61

1.26

mg/l

2.82

1781

12346

Arterial embolism and thrombosis of lower extremity artery

450

2033

2.77

64.16

3.0

1.6

2.04

1.40

mg/l

3.12

384

1569

Degeneration of macula and posterior pole

5123

32347

1.33

63.70

1.7

1.46

1.47

mg/l

0.07

3984

25224

Acute appendicitis, no complications

6822

55811

1.28

63.39

1.8

0.92

1.09

mg/l

6.51

5082

42109

Non-Hodgkin lymphoma, all, including Hilmo

1465

9551

1.72

63.33

2.1

1.7

1.82

1.22

mg/l

4.23

1193

7310

Acute gastritis

910

5279

2.00

63.00

1.8

1.7

1.18

1.27

mg/l

0.34

705

4060

Ulcerative colitis

2886

21336

1.46

62.96

2.0

1.8

1.16

1.12

mg/l

0.37

2227

15955

Suggestive for eosinophilic asthma

1075

6534

1.89

62.93

1.8

1.7

0.96

1.28

mg/l

2.31

825

5024

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1980

13320

1.59

62.89

2.7

2.0

1.47

1.15

mg/l

1.60

1482

9929

Achilles tendinitis

1195

7437

1.82

62.84

1.9

1.7

1.12

1.23

mg/l

0.53

931

5701

Complications associated with artificial fertilization

313

1235

3.61

62.82

2.3

1.6

1.08

0.83

mg/l

2.14

260

882

Disorders of mineral metabolism

1002

5982

1.94

62.78

1.9

1.7

1.43

1.20

mg/l

1.52

771

4514

Familial hypercholesterolemia

1634

10902

1.65

62.54

1.8

1.6

1.31

1.40

mg/l

0.54

1302

8393

Restless leg syndrome

1614

10833

1.68

62.48

1.7

1.12

1.17

mg/l

0.16

1195

8259

Lesion of ulnar nerve

1626

10884

1.67

62.38

2.0

1.8

1.14

1.18

mg/l

0.20

1241

8339

Cramp and spasm

642

3400

2.35

62.13

2.1

1.8

0.86

1.12

mg/l

2.21

497

2576

Pregnancy examination and test

2044

8769

1.59

62.05

1.8

1.6

0.80

0.75

mg/l

0.45

1480

6241

Other noninfective disorders of lymphatic vessels and lymph nodes

500

2415

2.64

62.03

2.3

1.7

1.31

0.99

mg/l

1.39

387

1823

Type of accident

3391

25764

1.41

61.58

2.0

1.8

1.25

1.16

mg/l

0.78

2618

19413

Injury of unspecified body region

957

5694

1.97

61.51

2.4

1.8

1.27

1.22

mg/l

0.19

771

4287

Amiodarone users

1130

7011

1.86

61.51

4.9

1.7

1.52

1.47

mg/l

0.14

868

5505

Otalgia

988

5936

1.94

61.24

2.2

2.0

1.05

1.13

mg/l

0.15

716

4451

Other diseases of oesophagus

1089

6665

1.85

61.15

1.9

1.7

1.08

1.36

mg/l

3.53

844

5131

Hallux rigidus

1493

9819

1.68

61.14

1.7

1.12

1.34

mg/l

2.05

1125

7566

Excessive attrition of teeth

6798

56143

1.27

60.63

1.8

0.92

1.11

mg/l

6.78

4923

42396

Glucosamine medication

5274

33755

1.32

60.58

1.7

1.33

1.40

mg/l

0.95

4117

26296

5-aminosalicylic acid

2406

17356

1.49

60.23

1.9

1.7

1.13

1.10

mg/l

0.21

1846

12841

Nonalcoholic fatty liver disease

1200

7609

1.82

60.22

1.9

1.8

1.10

1.11

mg/l

0.04

912

5743

Haemorrhage in early pregnancy

3378

25107

1.41

59.81

1.8

1.7

0.81

0.94

mg/l

3.17

2488

18693

Other specified/unspecified soft tissue disorders

590

3029

2.32

59.75

2.0

1.6

1.11

1.34

mg/l

1.23

437

2275

Left ventricular outflow tract obstruction (LVOTO), broad definition

1192

7547

1.81

59.70

3.0

2.0

1.38

1.16

mg/l

1.20

895

5741

Other disorders of kidney and ureter

1478

9813

1.69

59.58

2.1

1.8

1.68

1.30

mg/l

2.16

1190

7572

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1848

12380

1.59

59.50

2.7

2.0

1.48

1.14

mg/l

1.69

1390

9221

Other inflammation of eyelid

1597

10776

1.66

59.46

1.8

1.7

0.96

1.22

mg/l

3.86

1163

8187

Osteoporosis with pathological fracture (FG)

823

4730

2.04

59.19

2.1

1.7

1.46

1.36

mg/l

0.35

658

3600

Postprocedural disorders of nervous system

969

5860

1.94

59.07

1.9

1.7

0.81

0.88

mg/l

0.42

698

4314

Pruritus

1335

8688

1.74

58.99

2.0

1.7

1.01

1.19

mg/l

1.43

1009

6612

Pneumonia due to other infectious organisms, not elsewhere classified

442

2070

2.71

58.80

2.4

1.6

1.64

1.19

mg/l

0.96

376

1535

Persistent mood disorders

2269

16322

1.51

58.75

1.9

1.7

1.11

1.15

mg/l

0.28

1660

12365

Cholecystitis

1548

10352

1.65

58.66

1.8

1.7

1.42

1.37

mg/l

0.20

1215

7931

Other problems related to primary support group, including family circumstances

1393

8890

1.71

58.58

3.5

1.9

1.17

0.95

mg/l

1.04

1053

6457

Urolithiasis

3504

26933

1.39

58.15

1.8

1.29

1.33

mg/l

0.20

2717

20772

Neuromuscular dysfunction of bladder

1054

6502

1.85

58.03

2.0

1.8

1.22

1.26

mg/l

0.16

808

4990

Asthma and opportunity respiratory infection

573

2977

2.38

57.96

2.1

1.7

1.24

1.34

mg/l

0.24

448

2319

Reactive arthropathies

1009

6137

1.86

57.94

1.8

1.17

1.21

mg/l

0.19

793

4617

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1664

11355

1.62

57.92

1.8

1.7

1.99

1.19

mg/l

7.48

1383

8636

Amputation

1088

6751

1.82

57.56

2.2

1.7

1.68

1.47

mg/l

1.30

909

5238

Injuries to the elbow and forearm

8575

63730

1.23

57.53

1.8

1.21

1.17

mg/l

0.66

6523

47974

Agranulocytosis

1315

8607

1.74

57.20

2.6

1.8

1.91

1.18

mg/l

5.45

1043

6557

Overexertion and strenuous or repetitive movements

1204

7736

1.77

56.67

2.0

1.8

1.02

1.11

mg/l

0.53

923

5783

Excessive vomiting in pregnancy

1055

6588

1.85

56.35

1.9

1.7

0.76

0.91

mg/l

1.12

780

4832

Rheumatoid arthritis, including avohilmo

4387

34893

1.33

56.08

1.8

1.7

1.37

1.21

mg/l

2.43

3482

26731

Myeloid leukaemia

380

1722

2.94

56.08

3.2

1.7

3.04

1.25

mg/l

3.90

332

1342

Invasive ventilation

855

5056

1.97

55.97

2.7

1.8

2.36

1.32

mg/l

6.31

699

3862

4315

31343

1.34

55.83

1.7

1.44

1.46

mg/l

0.08

3299

24503

Superficial injury of shoulder and upper arm

1336

8789

1.70

55.77

2.0

1.8

1.00

1.18

mg/l

1.79

1009

6591

Brachial plexus disorders

1188

7643

1.77

55.72

1.9

1.7

0.72

0.95

mg/l

3.89

859

5710

Pre-eclampsia or eclampsia

2622

19542

1.46

55.71

2.2

1.7

1.39

0.90

mg/l

7.29

2041

14616

Elevated blood glucose level

995

6129

1.87

55.70

2.5

1.8

1.25

mg/l

0.00

802

4603

Tonsillectomy and adenotomy

7030

40651

1.26

55.55

1.9

1.8

0.84

1.00

mg/l

3.45

5187

29797

Decubitus ulcer and pressure area

702

3914

2.10

55.53

2.9

1.7

1.69

1.49

mg/l

0.85

579

3033

Superficial injury of ankle and foot

1430

9544

1.67

55.51

2.0

1.9

0.98

1.03

mg/l

0.23

1025

6967

Tinnitus

2674

19965

1.45

55.44

1.7

1.8

1.15

1.20

mg/l

0.19

1950

15385

Diseases of the myoneural junction and muscle

1374

9124

1.69

55.07

1.9

1.8

1.58

1.29

mg/l

1.83

1056

7007

Multiple myeloma, including Hilmo

538

2774

2.36

54.98

2.4

1.6

1.49

1.34

mg/l

0.39

450

2174

Other and unspecified injuries of head

843

4986

1.97

54.95

2.1

1.9

1.20

1.17

mg/l

0.11

646

3750

Skin changes due to chronic exposure to nonionizing radiation

4041

29357

1.35

54.93

1.7

1.45

1.49

mg/l

0.19

3090

22995

Keratitis

4138

32761

1.34

54.68

1.9

1.8

1.12

1.15

mg/l

0.34

3117

24735

Speech and linguistic disorders, excluding more controls

883

4903

1.89

54.63

3.1

2.0

1.56

1.15

mg/l

1.11

641

3435

Persons with potential health hazards related to communicable diseases

4526

35864

1.32

54.60

2.2

1.8

1.09

1.02

mg/l

0.62

3234

26417

KRA_PSY_EATING, excluding more controls

1015

6231

1.82

54.60

2.3

1.7

0.84

0.95

mg/l

0.39

683

4509

Other disorders of the musculoskeletal system and connective tissue

1689

11727

1.60

54.53

1.9

1.7

1.25

1.23

mg/l

0.08

1382

9003

Disorders of parathyroid gland

2329

16857

1.48

54.31

2.1

1.7

1.39

1.32

mg/l

0.37

1804

12982

Calculus of kidney and ureter

3250

24973

1.39

54.25

1.8

1.29

1.32

mg/l

0.18

2521

19252

Other necrotizing vasculopathies

853

5097

1.96

54.21

2.4

1.8

1.61

1.33

mg/l

1.39

699

3937

Actinic keratosis

3920

28533

1.35

54.20

1.7

1.47

1.50

mg/l

0.15

2997

22383

Preparatory care for dialysis

554

2926

2.36

54.10

2.7

1.8

2.00

1.24

mg/l

3.01

500

2254

Assault

1557

10620

1.62

54.04

1.8

1.9

1.15

0.99

mg/l

0.56

1110

7688

Acute myeloid leukaemia and myelodysplastic syndromes

276

1086

3.38

54.01

2.9

1.7

3.29

1.26

mg/l

3.63

246

837

Polymyalgia rheumatica

1447

9755

1.65

53.81

1.8

1.7

1.39

1.44

mg/l

0.27

1160

7610

Psoriatic and enteropathic arthropathies

1338

8865

1.68

53.58

1.7

1.03

1.07

mg/l

0.24

1062

6645

Mental and behavioural disorders due to sedatives or hypnotics

852

5099

1.95

53.51

2.1

1.8

1.23

0.96

mg/l

1.87

643

3754

Infections with a predominantly sexual mode of transmission

4746

35589

1.31

53.37

1.9

1.8

0.83

0.98

mg/l

5.08

3400

25976

Pre-eclampsia

2442

18132

1.47

53.23

2.3

1.7

1.41

0.88

mg/l

7.67

1910

13518

Adrenocortical insufficiency

501

2577

2.47

53.23

2.7

1.8

1.15

mg/l

0.01

386

1976

Supervision of high-risk pregnancy

2565

11386

1.47

53.21

1.8

1.7

0.87

0.79

mg/l

0.71

1920

8360

Schizophrenia or delusion, excluding more controls

3361

25673

1.37

53.19

1.8

1.7

1.23

1.09

mg/l

1.32

2503

19248

Hydronephrosis

1266

8302

1.70

53.11

1.9

1.7

2.01

1.24

mg/l

5.30

1047

6294

Benign neoplasm: Sigmoid colon

2059

14867

1.51

52.95

1.9

1.8

1.20

1.34

mg/l

1.28

1601

11556

Traumatic subdural haemorrhage

1289

8072

1.67

52.90

1.9

1.6

1.74

1.68

mg/l

0.20

1022

6289

Medical abortion

7971

36434

1.24

52.88

1.7

0.96

1.09

mg/l

3.79

5958

27411

Fall on and from stairs and steps

2956

22531

1.41

52.87

1.8

1.18

mg/l

0.02

2289

17118

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1478

10065

1.63

52.44

2.5

1.7

1.15

1.02

mg/l

0.62

1145

7575

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2338

15234

1.46

52.42

2.3

2.0

0.98

0.96

mg/l

0.10

1564

10597

Inflammatory diseases of prostate (prostatitis)

1282

8427

1.68

52.40

1.8

1.04

1.51

mg/l

8.11

957

6592

Other disorders of adrenal gland

593

3232

2.24

52.25

2.6

1.9

1.13

1.16

mg/l

0.08

449

2453

Allergic urticaria

1020

6429

1.82

52.12

2.5

1.9

1.01

1.08

mg/l

0.28

736

4806

Parkinson's disease, excluding more controls

1290

7953

1.66

52.11

1.7

1.6

1.39

1.71

mg/l

2.56

1029

6274

Papulosquamous disorders

4461

35850

1.32

52.01

1.8

1.7

1.15

1.18

mg/l

0.22

3502

27352

Thyrotoxicosis, other and/or unspecified

2360

17476

1.46

51.70

2.7

1.7

1.04

1.12

mg/l

0.84

1785

13286

Other infectious diseases

1058

6744

1.78

51.17

2.2

1.8

1.28

1.27

mg/l

0.01

857

5118

3040

20249

1.39

51.09

1.7

1.6

1.50

1.57

mg/l

0.42

2378

15891

Pyogenic arthritis

737

4255

1.98

51.02

2.0

1.8

1.41

1.36

mg/l

0.16

613

3222

Aortic valve malfunction, age under 60 years

1094

7055

1.77

50.88

2.7

1.9

1.31

1.15

mg/l

0.71

827

5366

Other noninflammatory disorders of vulva and perineum

1097

7044

1.75

50.74

1.8

1.6

0.88

1.17

mg/l

4.48

816

5284

Other diseases of pancreas

924

5720

1.85

50.66

1.9

1.7

1.61

1.31

mg/l

0.88

747

4376

Viral pneumonia (known virus, not influenza)

360

1661

2.83

50.56

2.6

2.0

1.63

1.31

mg/l

0.58

302

1263

Cluster headache, strict, including avohilmo

667

3819

2.11

50.17

1.9

1.8

0.82

0.95

mg/l

0.65

489

2829

Other/unspecified enthesopathies, not elsewhere classified

917

5640

1.82

50.03

1.7

0.96

1.33

mg/l

3.33

697

4257

Other disorders of bladder

1264

8396

1.67

49.93

1.8

1.7

1.37

1.43

mg/l

0.17

931

6493

Coxarthrosis, primary, with hip surgery

5019

38350

1.29

49.75

1.7

1.40

1.39

mg/l

0.04

4073

29827

Unspecified misadventure during surgical and medical care

686

3967

2.07

49.72

2.2

1.7

1.47

1.16

mg/l

0.95

560

3030

Parkinson's disease, strict definition, excluding more controls

1203

7465

1.67

49.71

1.7

1.6

1.41

1.72

mg/l

2.32

960

5871

Congenital malformations of heart and great arteries

1422

9390

1.62

49.66

2.9

2.1

1.22

1.17

mg/l

0.27

1038

6992

Other postsurgical states

765

4538

1.96

49.45

2.5

1.7

1.28

1.26

mg/l

0.03

601

3481

Pneumocystosis

285

1219

3.36

49.45

2.4

1.6

2.00

1.36

mg/l

0.87

249

946

Bronchitis, not specified as acute or chronic

960

6005

1.79

49.17

1.9

1.8

1.12

1.26

mg/l

0.79

749

4548

Colonic or urogenital fistula

3019

23320

1.38

48.94

1.8

1.13

1.17

mg/l

0.22

2221

17802

Disorders of calcium metabolism

742

4378

1.97

48.80

1.9

1.7

1.46

1.25

mg/l

1.02

578

3322

Abnormal findings on diagnostic imaging of other body structures

1565

10939

1.58

48.78

1.9

1.7

1.23

1.22

mg/l

0.09

1253

8349

Collagenous colitis

1072

6956

1.76

48.61

2.3

1.8

1.21

mg/l

0.01

833

5270

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

830

5060

1.89

48.43

2.0

1.8

1.06

1.05

mg/l

0.05

617

3705

Caries of enamel

10932

68745

1.18

48.32

2.0

1.8

1.01

1.13

mg/l

3.91

7931

52060

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

562

3072

2.19

48.23

2.1

1.6

1.40

1.33

mg/l

0.21

469

2386

Cluster headache, wide,, including avohilmo

694

4064

2.04

48.17

1.9

1.8

0.87

0.96

mg/l

0.39

511

3016

Psoriatic arthropathies

1113

7245

1.71

48.12

1.7

1.06

1.17

mg/l

0.72

885

5457

Reactive arthropathies, FINNGEN

828

5041

1.88

48.00

1.9

1.8

1.13

1.10

mg/l

0.13

652

3740

Benign neoplasm: Ascending colon

1495

10401

1.59

47.84

2.0

1.7

1.24

1.38

mg/l

0.73

1149

8069

Spondyloarthritis

2024

14768

1.48

47.75

1.9

1.7

1.12

1.13

mg/l

0.04

1575

11131

Any event in hilmo or specialist outpatient

8.23

47.67

1.5

1.4

0.92

0.43

mg/l

0.90

Other disorders of nervous system

787

4763

1.92

47.62

2.0

1.7

1.07

1.21

mg/l

0.85

593

3677

Crohn disease

1507

10486

1.58

47.61

1.9

1.8

1.10

1.07

mg/l

0.18

1119

7777

Other hearing loss

2927

22040

1.38

47.58

1.8

1.7

1.35

1.44

mg/l

0.65

2192

17207

Ulcerative colitis, NAS

1599

11247

1.56

47.51

2.2

1.8

1.22

1.09

mg/l

0.80

1236

8389

Car occupant injured in other and unspecified transport accidents

2177

16117

1.46

47.45

2.0

1.8

1.00

1.08

mg/l

0.62

1639

11904

Postmenopausal atrophic vaginitis

2946

12425

1.40

47.02

1.6

1.7

0.83

1.26

mg/l

16.84

2253

9682

Diabetes mellitus in pregnancy

4018

20531

1.33

46.90

1.8

1.7

0.92

0.81

mg/l

1.57

3044

14924

Osteonecrosis

734

4394

1.96

46.63

2.4

1.8

1.23

1.30

mg/l

0.41

619

3384

Other degenerative diseases of the nervous system

2794

15864

1.39

46.62

1.6

1.43

1.47

mg/l

0.21

2111

12233

Hyperplasia of prostate

3601

16003

1.34

46.49

1.8

1.33

1.47

mg/l

1.59

2799

12731

Thyrotoxicosis

2927

22700

1.38

46.47

2.5

1.7

1.08

1.13

mg/l

0.46

2220

17282

Other specified and unspecified personality disorders

1104

7277

1.71

46.36

1.9

1.8

0.94

0.97

mg/l

0.15

802

5370

Other diseases of arteries and capillaries

997

6405

1.75

46.34

2.1

1.7

1.42

1.25

mg/l

0.60

787

4877

Infections with a predominantly sexual mode of transmission

3627

28815

1.33

46.21

1.8

0.83

0.99

mg/l

4.64

2613

21197

Pollen allergy

2155

15764

1.45

46.21

2.0

0.82

0.98

mg/l

1.59

1502

11357

Fibrosis and cirrhosis of liver

873

5463

1.84

46.19

2.3

1.8

2.25

1.25

mg/l

7.31

752

4248

Methotrexate

1577

11112

1.55

45.97

1.9

1.6

1.42

1.14

mg/l

2.42

1243

8389

Spondylopathies (FG)

1549

10878

1.55

45.91

1.8

1.7

0.96

1.04

mg/l

0.77

1174

8065

2179

15198

1.45

45.88

1.7

1.45

1.56

mg/l

0.59

1702

11923

Atypical facial pain

650

3784

2.04

45.84

2.0

1.8

0.92

1.09

mg/l

0.67

467

2843

Right bundle-branch block

421

2110

2.38

45.66

2.0

1.6

1.27

1.39

mg/l

0.36

324

1647

Disorders of continuity of bone

1156

7723

1.68

45.56

2.0

1.8

1.04

1.05

mg/l

0.07

922

5775

Unspecified urinary incontinence

1023

6659

1.74

45.51

1.9

1.8

1.16

1.23

mg/l

0.27

707

5061

Hyperparathyroidism

2014

14668

1.47

45.42

2.0

1.7

1.41

1.34

mg/l

0.32

1558

11271

Abnormal results of function studies

1018

6624

1.74

45.22

2.2

1.8

1.20

1.18

mg/l

0.07

757

4977

Secondary and unspecified malignant neoplasm of lymph nodes

899

5676

1.79

45.01

2.0

1.8

1.98

1.20

mg/l

3.03

739

4310

Unspecified mental disorder

4672

38281

1.28

44.87

1.9

1.8

1.09

1.10

mg/l

0.09

3492

28602

Radial styloid tenosynovitis [de Quervain]

656

3816

1.98

44.85

1.7

1.6

0.77

1.08

mg/l

3.20

507

2859

Hemiplegia

608

3476

2.05

44.70

2.6

1.7

0.88

1.21

mg/l

3.84

469

2639

Other noninflammatory disorders of uterus, except cervix

2381

12039

1.43

44.62

1.7

1.18

1.29

mg/l

1.11

1835

9330

Oesophageal varices

475

2522

2.26

44.51

2.9

1.7

3.18

1.20

mg/l

7.22

413

1950

Artificial joint re-operation

792

4897

1.88

44.50

1.9

1.8

1.51

1.36

mg/l

0.91

654

3818

Chronic pancreatitis

1298

8888

1.61

44.41

1.9

1.8

1.57

1.27

mg/l

2.45

1039

6825

Fracture at wrist and hand level

3829

30676

1.31

44.38

1.8

1.08

1.17

mg/l

1.17

2836

22935

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1540

10898

1.55

44.35

2.2

1.8

2.25

1.26

mg/l

12.18

1321

8494

Primary coxarthrosis, bilateral

2995

23405

1.36

44.34

1.7

1.36

1.40

mg/l

0.25

2415

18163

Benign neoplasm: Stomach

1101

7336

1.70

44.33

2.4

1.7

1.12

1.28

mg/l

1.13

848

5650

Mental and behavioural disorders due to opioids

491

2644

2.23

44.28

2.2

1.9

1.19

0.93

mg/l

1.33

371

1878

Morphin

245

993

3.11

44.21

2.1

1.6

1.14

1.40

mg/l

1.08

206

778

Other/unspecified soft tissue disorders related to use, overuse and pressure

370

1803

2.53

44.20

1.7

0.91

1.12

mg/l

0.92

267

1338

Dialysis

485

2612

2.25

44.04

2.9

1.9

2.32

1.28

mg/l

2.05

440

1973

Dissociative [conversion] disorders

515

2824

2.19

44.03

1.9

1.7

0.77

1.03

mg/l

1.88

362

2073

Immunodeficiency with predominantly antibody defects

373

1855

2.61

43.97

3.1

1.9

1.36

1.09

mg/l

0.58

309

1395

Open wound of wrist and hand

5033

40655

1.26

43.88

1.8

1.11

1.18

mg/l

0.67

3668

30561

Chronic periodontitis, complicated

6064

50617

1.24

43.84

2.0

1.7

1.29

1.23

mg/l

0.79

4646

39107

Arthropathies in other diseases classified elsewhere

446

2333

2.31

43.80

1.8

1.14

1.27

mg/l

0.47

349

1743

Cirrhosis of liver, NAS

620

3607

2.04

43.70

2.2

1.7

2.53

1.31

mg/l

6.59

546

2808

Dermatophytosis

1418

9928

1.57

43.55

1.9

1.8

1.28

1.29

mg/l

0.03

1095

7613

Pre-eclampsia or poor fetal growth

3658

29288

1.32

43.46

2.1

1.7

1.26

0.88

mg/l

6.99

2789

21740

Fracture of femur

2798

19614

1.37

43.42

1.9

1.7

1.75

1.46

mg/l

3.24

2269

15098

Immunodeficiencies

598

3458

2.07

43.41

2.8

1.8

1.24

1.14

mg/l

0.27

493

2605

Seronegative rheumatoid arthritis

1270

8694

1.61

43.37

1.8

1.6

1.33

1.19

mg/l

1.05

1010

6575

Multiple myeloma and malignant plasma cell neoplasms

547

3071

2.12

43.37

2.4

1.6

1.44

1.47

mg/l

0.06

453

2401

Sicca syndrome [Sjögren]

1017

6705

1.73

43.37

1.9

1.7

1.12

mg/l

0.01

797

5107

Scoliosis

932

5964

1.74

43.27

2.0

1.8

1.25

mg/l

0.02

716

4393

Disorders of ocular muscles, binocular movement, accommodation and refraction

5453

45132

1.25

43.20

2.0

1.8

1.04

1.11

mg/l

0.88

4066

33834

Benign neoplasm: Transverse colon

1158

7833

1.66

43.13

1.9

1.7

1.22

1.37

mg/l

0.94

933

6115

Colectomy operation

1798

13135

1.49

43.01

2.2

1.7

1.74

1.33

mg/l

4.45

1489

10110

Suppurative and unspecified otitis media

4155

29868

1.29

43.00

2.1

1.8

0.99

1.06

mg/l

0.55

2933

21708

Sarcoidosis

1501

10660

1.55

43.00

2.2

1.8

1.32

1.16

mg/l

0.52

1170

8108

Additional codes for the location of defect, injury or illness

704

4261

1.94

42.99

1.8

1.08

1.13

mg/l

0.16

547

3242

Hypoplasia of dental enamel

125

352

5.20

42.90

11.4

5.1

3.44

2.17

mg/l

0.51

112

243

Ovarian hyperstimulation (induction)

295

1365

3.01

42.88

2.4

1.7

1.08

0.68

mg/l

5.51

245

985

Myeloproliferative diseases

925

5969

1.76

42.84

2.0

1.7

1.19

1.36

mg/l

1.02

726

4600

Amenorrhoea

813

5056

1.81

42.81

2.1

1.7

0.85

1.02

mg/l

1.31

626

3652

Phobic anxiety disorders

1505

10616

1.53

42.79

2.0

1.8

1.09

0.97

mg/l

0.49

1070

7652

Muscle strain

402

2038

2.38

42.77

2.0

1.7

0.91

1.06

mg/l

0.61

306

1505

Otitis externa, unspecified

1281

8837

1.61

42.77

1.9

1.8

0.92

1.14

mg/l

2.14

964

6638

Anosmia

229

866

3.01

42.73

1.8

1.4

1.35

0.72

mg/l

1.59

169

629

Charcot foot

237

975

3.20

42.58

1.9

1.5

1.10

1.05

mg/l

0.18

197

738

Drug-induced adrenocortical insufficiency

278

1256

3.09

42.58

3.2

1.9

1.28

1.14

mg/l

0.26

223

973

Hypertrophy of breast in women and men

2301

17510

1.42

42.31

1.7

0.82

0.97

mg/l

3.11

1767

13205

Fracture of skull and facial bones

2331

17697

1.40

42.28

1.9

1.8

1.17

1.18

mg/l

0.07

1751

13311

Delirium, not induced by alcohol and other psychoactive substances

1243

8493

1.60

42.22

1.8

1.7

1.79

1.47

mg/l

1.25

1008

6599

Acute suppurative otitis media

2986

21821

1.35

42.20

2.1

1.8

0.94

1.00

mg/l

0.36

2087

15608

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

913

5915

1.76

41.94

2.2

1.7

1.46

1.22

mg/l

1.14

714

4515

Other and unspecified mood [affective] disorders

870

5543

1.77

41.83

2.1

1.8

1.12

0.92

mg/l

0.70

621

4012

Blepharochalasis

3126

24754

1.34

41.79

1.7

1.17

1.35

mg/l

1.52

2406

19237

Any death

6839

41730

1.22

41.65

2.4

1.7

2.62

1.12

mg/l

67.79

5776

32038

Viral warts

2377

18168

1.40

41.57

2.1

1.8

1.02

1.11

mg/l

0.45

1739

13508

Other female pelvic inflammatory diseases

1840

13596

1.48

41.54

1.8

1.7

1.02

1.08

mg/l

0.24

1369

10318

Molar incisor enamel hypoplasia, with caries

112

296

5.44

41.54

9.6

3.4

3.31

2.33

mg/l

0.30

200

Atopic dermatitis, strict definition with reimbursement

3499

27047

1.31

41.46

1.8

1.9

0.98

1.00

mg/l

0.10

2528

19914

Disorders resulting from impaired renal tubular function

455

2462

2.28

41.39

2.2

1.8

2.11

1.23

mg/l

1.89

393

1889

Diseases of tongue

707

4297

1.88

41.32

1.8

1.6

1.02

1.32

mg/l

2.18

517

3361

Superficial injury of forearm

1127

7625

1.64

41.24

1.9

1.8

1.04

1.08

mg/l

0.17

856

5584

Early lumbar disc prolapse, operated

1131

7632

1.63

41.20

1.8

1.7

0.69

0.90

mg/l

3.02

821

5599

Salpingitis and oophoritis

2014

15120

1.45

40.98

1.8

1.7

0.97

1.04

mg/l

0.60

1521

11606

Osteomyelitis

715

4375

1.87

40.98

2.1

1.8

1.35

1.34

mg/l

0.03

585

3365

Other and unspecified myopathies

942

6150

1.72

40.97

2.0

1.7

1.71

1.38

mg/l

1.40

737

4736

Other condition

1604

11597

1.51

40.94

2.1

1.8

1.24

1.13

mg/l

0.55

1249

8735

Sequelae of other external causes

659

3957

1.93

40.89

2.2

1.7

1.33

1.12

mg/l

1.56

539

3005

Diseases of middle ear and mastoid

6773

47240

1.22

40.69

2.0

1.8

1.05

1.11

mg/l

0.80

4903

35052

Olecranon bursitis

629

3705

1.92

40.59

1.8

1.36

1.39

mg/l

0.06

506

2830

Amputation of toe

752

4669

1.83

40.45

1.8

1.7

1.39

1.49

mg/l

0.41

621

3628

Other disorders of white blood cells

644

3866

1.95

40.44

2.4

1.8

1.18

mg/l

0.01

508

2949

Injury of muscle and tendon at hip and thigh level

1105

7497

1.65

40.41

2.0

1.8

0.96

1.10

mg/l

1.44

881

5693

Unknown and unspecified causes of morbidity

741

4548

1.81

40.38

1.7

1.5

0.91

1.25

mg/l

2.47

551

3410

Herpesviral [herpes simplex] infections

1335

9387

1.57

40.33

2.1

1.8

1.09

1.12

mg/l

0.13

1008

7081

Panniculitis affecting regions of neck and back

452

2436

2.21

40.31

2.1

1.7

1.00

1.14

mg/l

0.53

356

1842

Hypertensive Renal Disease

385

1947

2.30

40.07

1.7

1.6

1.88

1.47

mg/l

0.89

328

1503

Cholangitis (primary sclerosing, PSC)

690

4203

1.87

40.03

2.6

1.8

2.09

1.32

mg/l

2.61

566

3191

Acute laryngitis and tracheitis

1282

8733

1.56

39.95

2.3

1.8

1.07

1.03

mg/l

0.13

909

6188

Algoneurodystrophy

456

2506

2.26

39.92

1.9

1.7

1.01

0.93

mg/l

0.17

343

1868

IBD patients in KELA-register

2566

19916

1.37

39.84

1.9

1.8

1.13

1.07

mg/l

0.36

1935

14784

Other disorders of conjunctiva

1502

10792

1.52

39.78

2.2

1.7

1.30

mg/l

0.00

1144

8372

Lung diseases due to external agents

1408

9962

1.53

39.74

2.0

1.7

1.64

1.45

mg/l

0.88

1132

7711

Cytomegalovirus infection, IBD co-morbidity

314

1521

2.71

39.72

3.4

2.0

2.23

1.16

mg/l

1.31

276

1165

Venous complications and haemorrhoids in pregnancy

296

1411

2.84

39.63

2.2

1.8

0.79

0.69

mg/l

0.60

231

1023

Other disorders of glucose regulation and pancreatic internal secretion

939

6166

1.70

39.59

2.0

1.8

1.35

1.22

mg/l

0.39

718

4628

Periapical abscess

5112

42818

1.25

39.49

1.8

1.12

1.13

mg/l

0.08

3876

32590

Alcohol abuse, main dg

1689

12391

1.47

39.04

1.9

1.26

1.14

mg/l

0.65

1308

9318

Other dialysis

382

1988

2.40

39.04

2.7

2.0

2.16

1.23

mg/l

1.66

346

1524

Other symptoms and signs involving the urinary system

1092

7416

1.62

38.94

1.9

1.8

1.23

1.30

mg/l

0.29

863

5689

Vascular diseases of the intestine

436

2344

2.19

38.87

2.3

1.6

2.51

1.39

mg/l

3.72

376

1805

Injury of muscle and tendon at lower leg level

1588

11545

1.49

38.85

2.0

1.8

1.06

1.23

mg/l

1.87

1253

8792

Complications predominantly related to the puerperium

3058

24401

1.33

38.78

1.9

1.7

1.03

0.95

mg/l

0.71

2307

18227

Other/unspecified cytomegaloviral diseases

274

1274

2.89

38.64

3.6

2.0

2.28

1.18

mg/l

1.15

247

967

Other infectious diseases

858

5564

1.74

38.58

2.3

1.7

1.34

1.28

mg/l

0.21

688

4265

Other aneurysm

583

3426

1.95

38.49

3.0

1.6

2.01

1.38

mg/l

3.67

482

2631

Other diseases of blood and blood-forming organs

781

4976

1.79

38.41

2.2

1.8

1.20

mg/l

0.00

604

3791

Disturbance of activity and attention

1280

8774

1.55

38.28

2.1

2.0

0.79

0.96

mg/l

1.45

839

6016

Speech disturbances, not elsewhere classified

966

6443

1.67

38.08

2.8

1.7

1.34

1.35

mg/l

0.02

757

4933

Nontoxic multinodular goitre

2154

16478

1.41

38.06

1.7

1.05

1.25

mg/l

3.45

1664

12696

Diabetic nephropathy, excluding more controls

1583

9494

1.50

37.96

1.9

1.46

1.23

mg/l

1.75

1315

7355

Secondary uncertain malignant neoplasm

1319

9319

1.54

37.80

1.9

1.7

2.06

1.24

mg/l

5.35

1080

7111

Alcohol dependence

2802

22118

1.34

37.77

1.9

1.8

1.41

1.23

mg/l

1.56

2196

16943

Hyperkinetic disorders

1345

9319

1.53

37.73

2.1

0.80

1.01

mg/l

2.04

882

6395

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2439

18712

1.37

37.70

1.6

1.7

2.37

1.21

mg/l

22.52

2054

14437

Hepatic failure, not elsewhere classified

451

2497

2.17

37.69

2.7

1.8

2.62

1.18

mg/l

8.81

390

1923

Benign neoplasm: Rectum, anus and anal canal

2099

16009

1.41

37.69

1.9

1.7

1.22

1.34

mg/l

1.04

1656

12417

Diseases of peritoneum

1100

7553

1.61

37.52

2.3

1.8

1.73

1.24

mg/l

4.32

868

5788

conjunctival haemorrhage

832

5407

1.74

37.42

2.4

1.8

1.29

1.36

mg/l

0.20

617

4204

Calcific tendinitis of shoulder

623

3755

1.88

37.33

1.8

1.6

0.81

1.18

mg/l

4.58

464

2861

L01XX Other antineoplastic agents

634

3867

1.90

37.32

2.5

1.6

1.31

1.45

mg/l

0.55

503

3026

Medial epicondylitis

438

2392

2.15

37.31

1.7

0.93

1.12

mg/l

0.68

320

1801

Diseases of spleen

256

1172

2.92

37.30

2.6

1.7

1.66

1.20

mg/l

1.66

211

896

Female infertility, associated with anovulation

934

6189

1.67

37.30

1.9

1.6

0.87

0.95

mg/l

0.59

730

4475

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

881

5766

1.69

37.23

1.9

1.8

1.01

1.03

mg/l

0.08

657

4226

Hypertension, Pulmonary Arterial

139

470

4.41

37.13

8.4

1.7

1.59

1.44

mg/l

0.16

107

354

Psoriasis

3111

24956

1.32

37.09

1.8

1.14

1.15

mg/l

0.09

2461

19001

Convalescence

637

3894

1.89

37.07

2.0

1.6

1.03

1.01

mg/l

0.05

482

2932

Cytomegaloviral disease

321

1610

2.57

36.99

3.3

1.9

2.20

1.13

mg/l

1.33

281

1234

Myeloproliferative diseases (CML excluded)

826

5377

1.74

36.89

2.0

1.7

1.15

1.34

mg/l

1.22

645

4161

Other peripheral vertigo

1017

6920

1.64

36.87

1.8

1.7

0.95

1.26

mg/l

3.96

760

5304

Endometriosis of rectovaginal septum and vagina

870

5716

1.70

36.78

1.7

1.6

0.93

1.22

mg/l

2.52

658

4332

Presbycusis

1364

9634

1.51

36.50

1.6

1.7

1.48

1.64

mg/l

0.71

1012

7571

Pneumothorax

735

4645

1.78

36.48

2.0

1.7

1.68

1.37

mg/l

1.23

586

3527

Dysplasia of cervi uteri

2720

15479

1.34

36.23

1.7

0.99

1.09

mg/l

0.84

2008

11600

Hypertrophy of breast

2029

15531

1.41

36.12

1.7

0.75

0.92

mg/l

4.38

1550

11704

Hereditary deficiency of other clotting factors

162

617

4.06

36.08

4.3

1.8

0.89

0.88

mg/l

0.02

116

472

Sequelae of injuries of lower limb

1059

7291

1.61

35.90

1.9

1.8

1.03

1.12

mg/l

0.44

827

5502

Ptosis of eyelid

1179

8282

1.57

35.90

1.8

1.7

1.24

1.38

mg/l

0.56

901

6426

Paralytic ileus

418

2273

2.15

35.80

2.1

1.7

1.55

1.36

mg/l

0.56

347

1757

Oligomenorrhoea

445

2482

2.11

35.72

1.9

1.7

0.75

1.07

mg/l

2.16

320

1812

Inflammatory bowel disease, strict (require KELA)

2566

20202

1.35

35.72

1.9

1.8

1.13

1.06

mg/l

0.49

1935

14994

Oesophagitis

605

3677

1.88

35.58

1.9

1.8

0.91

1.25

mg/l

4.93

491

2837

Weight loss

1068

7376

1.60

35.52

1.9

1.8

1.31

1.30

mg/l

0.04

771

5625

Benign neoplasm: Rectum

1859

14074

1.42

35.38

1.9

1.7

1.23

1.34

mg/l

0.83

1467

10932

Bicipital tendinitis

510

2957

1.98

35.32

2.0

1.7

0.91

1.26

mg/l

3.13

374

2254

Nasal polyp

1973

15025

1.40

35.22

1.7

1.8

1.08

1.29

mg/l

2.17

1519

11588

Open wound of ankle and foot

1126

7852

1.57

35.18

2.0

1.8

1.12

1.20

mg/l

0.53

865

5821

Trigeminal neuralgia

681

4287

1.81

35.14

1.9

1.8

0.79

1.12

mg/l

3.50

490

3246

Other arterial embolism and thrombosis

318

1587

2.40

35.13

2.8

1.6

2.09

1.41

mg/l

2.32

266

1225

Palmar fascial fibromatosis [Dupuytren]

1358

9721

1.49

35.06

1.7

1.34

1.64

mg/l

1.67

1071

7552

Suppurative and necrotic conditions of lower respiratory tract

597

3632

1.88

35.04

2.2

1.7

1.64

1.34

mg/l

1.28

514

2805

Benign neoplasm of other and unspecified endocrine glands

1444

10558

1.50

34.96

1.8

1.06

1.21

mg/l

1.34

1111

8057

Protozoal diseases

372

1997

2.31

34.90

2.3

1.7

1.78

1.24

mg/l

0.96

317

1539

Gestational diabetes (for exclusion)

4470

25943

1.26

34.90

1.8

1.7

0.92

0.82

mg/l

1.60

3387

19020

Non-follicular lymphoma

987

6736

1.63

34.88

2.2

1.7

1.98

1.40

mg/l

2.23

798

5248

Acute myeloid leukaemia

157

590

3.81

34.75

3.4

1.7

4.07

1.15

mg/l

2.87

142

444

Acute myeloid leukaemia, including Hilmo

157

590

3.81

34.75

3.4

1.7

4.07

1.15

mg/l

2.87

142

444

Acute myeloid leukaemia, helper endpoint

157

590

3.81

34.75

3.4

1.7

4.07

1.15

mg/l

2.87

142

444

Congenital malformations of cardiac septa

734

4546

1.76

34.75

3.1

2.3

1.19

1.18

mg/l

0.05

551

3378

Benign neoplasm: Caecum

1114

7802

1.58

34.71

2.0

1.7

1.36

1.40

mg/l

0.12

885

6050

Rare circulating lymphoid malignancy, including Hilmo

332

1696

2.35

34.61

5.9

1.9

1.96

1.32

mg/l

1.02

281

1289

Other abnormal products of conception

3902

21268

1.28

34.56

1.7

0.80

0.87

mg/l

1.23

2885

15829

Congenital malformations of cardiac chambers and connections

102

297

5.41

34.51

5.7

4.6

1.89

1.23

mg/l

0.94

216

Pregnancy with abortive outcome

8090

36820

1.19

34.43

1.7

0.98

1.10

mg/l

3.23

6074

27673

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

5135

29379

1.23

34.42

1.7

1.42

1.18

mg/l

4.12

3938

22611

Mental and behavioural disorders due to tobacco

981

6722

1.63

34.39

1.9

1.8

1.07

1.13

mg/l

0.32

760

5117

Smoking dependency

981

6725

1.63

34.31

1.9

1.8

1.07

1.13

mg/l

0.33

760

5123

Other menopausal disorders

3009

13537

1.32

34.20

1.6

1.7

0.83

1.17

mg/l

11.14

2278

10451

Other eating disorders

607

3728

1.85

33.99

2.4

1.9

0.79

0.93

mg/l

0.81

402

2644

Anaemia in chronic diseases classified elsewhere

294

1460

2.51

33.99

3.3

1.8

2.74

1.35

mg/l

1.96

257

1135

Maternal care for other known or suspected fetal problems

2833

14283

1.33

33.89

1.9

1.7

0.89

0.76

mg/l

2.14

2122

10301

Thyroiditis, ILD-related definition

1317

9533

1.51

33.76

1.9

1.8

1.03

mg/l

0.01

980

7148

Excessive earwax

5958

49950

1.21

33.72

1.8

1.13

1.30

mg/l

4.03

4542

38314

Focal epilepsy

2241

17465

1.36

33.72

2.0

1.9

1.19

1.22

mg/l

0.13

1729

13239

Progressive vascular leukoencephalopathy

423

2373

2.12

33.68

1.6

1.40

1.56

mg/l

0.53

312

1844

Benign lipomatous neoplasm

3171

25775

1.30

33.66

1.7

1.08

1.21

mg/l

1.66

2430

19822

Other (seronegative) rheumatoid arthritis, wide

2053

15877

1.39

33.52

1.8

1.7

1.36

1.23

mg/l

1.23

1635

12184

Abnormal weight loss

974

6691

1.62

33.42

1.8

1.24

1.32

mg/l

0.31

711

5113

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

839

5586

1.68

33.41

2.0

1.6

1.65

1.39

mg/l

0.72

685

4282

Other benign neoplasms of skin

4021

33468

1.26

33.40

1.7

1.17

1.25

mg/l

0.84

3032

25670

Other puerperal infections

961

6603

1.63

33.33

2.0

1.7

0.88

0.81

mg/l

0.46

720

4752

Personal history of other diseases and conditions

1263

9032

1.51

33.31

2.7

1.7

1.07

0.99

mg/l

0.44

945

6573

Mixed connective tissue disease

745

4872

1.75

33.19

2.0

1.8

1.11

1.07

mg/l

0.15

599

3710

Fracture of shoulder and upper arm

3836

31734

1.26

33.12

1.8

1.31

1.28

mg/l

0.27

3006

24018

Recurrent dislocation of patella

617

3835

1.82

32.99

1.8

1.7

0.81

0.92

mg/l

0.89

446

2740

Assault by bodily force

875

5889

1.65

32.89

1.9

1.8

0.87

0.91

mg/l

0.25

624

4213

Ulcer of oesophagus

710

4566

1.74

32.84

1.9

1.6

1.19

1.40

mg/l

1.37

576

3563

SLE (Finngen)

438

2512

2.09

32.81

2.5

1.8

1.53

1.03

mg/l

2.80

352

1906

Benign neoplasm: Adrenal gland

842

5661

1.68

32.71

1.7

1.8

1.07

1.24

mg/l

1.39

659

4393

Von Willebrand disease

208

931

3.13

32.69

3.3

1.8

0.60

0.82

mg/l

2.02

158

703

Meralgia paraesthetica

420

2385

2.11

32.58

2.0

1.7

1.18

1.10

mg/l

0.20

329

1796

Monoamine oxidase A inhibitors

1236

8878

1.51

32.53

1.9

1.7

1.03

1.22

mg/l

1.84

926

6861

Other diseases of biliary tract

904

6140

1.63

32.46

2.4

1.7

2.31

1.33

mg/l

3.86

734

4664

Abscess of anal and rectal regions

912

6196

1.62

32.36

1.9

1.7

1.37

1.10

mg/l

1.38

683

4616

Rash and other nonspecific skin eruption

1052

7380

1.57

32.21

1.9

1.8

1.13

1.19

mg/l

0.27

811

5595

Hyperhidrosis

363

1954

2.18

32.21

2.3

1.5

0.77

1.01

mg/l

1.72

268

1446

Redundant prepuce, phimosis and paraphimosis

1926

14593

1.38

32.17

1.8

1.9

1.16

1.32

mg/l

1.32

1448

10847

Acute posthaemorrhagic anaemia

392

2168

2.12

32.12

2.5

1.6

1.55

1.29

mg/l

0.67

305

1666

Ankylosing spondylitis

914

6217

1.61

32.09

1.8

1.7

1.00

1.24

mg/l

2.07

692

4679

Disorders of psychological development

1216

8049

1.50

32.03

3.0

2.1

1.30

1.07

mg/l

0.92

881

5531

Kela-code for severe mental illness

4046

33805

1.25

32.01

1.8

1.14

1.10

mg/l

0.31

3023

25252

Nontoxic goitre/thyroid nodule

3212

26310

1.29

32.00

1.8

1.7

1.03

1.22

mg/l

4.79

2498

20213

Other bursitis of hip

256

1231

2.58

31.92

2.6

1.6

1.02

1.17

mg/l

0.51

193

922

Myelodysplastic syndrome, including Hilmo

318

1647

2.29

31.75

2.2

1.6

1.75

1.31

mg/l

1.79

273

1281

Haemolytic anaemias

414

2355

2.09

31.69

4.6

1.8

2.44

1.31

mg/l

1.74

336

1803

Other and unspecified disorders of white blood cells

473

2797

1.99

31.66

2.2

1.8

1.11

1.22

mg/l

0.57

373

2130

Cerebral cysts

656

4199

1.77

31.48

2.2

1.8

1.36

1.08

mg/l

0.97

486

3135

Nonpyogenic thrombosis of intracranial venous system

157

630

3.70

31.44

3.8

1.8

2.27

1.19

mg/l

1.01

121

470

Other congenital malformations

1391

10261

1.47

31.32

2.0

1.27

1.06

mg/l

1.05

1065

7591

Any prescribed medicine buy

8.10

31.30

1.7

1.8

1.19

1.09

mg/l

0.07

Glomerulonephritis

1041

7327

1.56

31.21

2.2

1.8

1.74

1.26

mg/l

3.34

862

5563

Polycythaemia vera

378

2096

2.13

31.10

2.1

1.6

1.18

1.35

mg/l

0.59

295

1619

Multiple myeloma

294

1498

2.37

31.07

2.8

1.6

1.38

1.42

mg/l

0.06

245

1165

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

294

1498

2.37

31.07

2.8

1.6

1.38

1.42

mg/l

0.06

245

1165

Iridocyclitis

2428

19328

1.33

31.07

1.9

1.8

1.19

1.17

mg/l

0.13

1888

14694

Orchitis and epididymitis

863

5824

1.61

31.02

2.5

1.9

1.45

1.47

mg/l

0.05

664

4480

Speech and linguistic disorders

898

5863

1.60

31.00

3.2

2.3

1.55

1.13

mg/l

1.22

654

4082

Disorders of tooth development and eruption

1770

10883

1.39

30.74

2.0

1.7

1.03

1.20

mg/l

1.43

1285

8234

Maternal care for known or suspected abnormality of pelvic organs

2957

16324

1.30

30.67

1.9

1.7

1.01

0.81

mg/l

2.90

2239

12012

Tubulo-interstitial nephritis, not specified as acute or chronic

740

4873

1.68

30.66

2.0

1.7

1.21

1.19

mg/l

0.06

579

3671

Dermatitis due to substances taken internally

620

3940

1.78

30.66

2.0

1.8

1.11

1.19

mg/l

0.34

490

2980

Special screening examination for other diseases and disorders

1067

7493

1.52

30.65

2.2

1.6

1.04

1.26

mg/l

2.32

797

5674

Injury of eye and orbit

1495

11164

1.43

30.61

1.8

1.10

1.13

mg/l

0.10

1077

8346

Hypermobility syndrome

666

4333

1.76

30.45

1.9

1.7

0.66

0.83

mg/l

1.96

497

3175

ILD medications: pirfenidone

143

549

3.70

30.43

2.5

1.6

1.64

1.28

mg/l

0.31

118

435

Anogenital herpesviral [herpes simplex] infection

1242

9060

1.49

30.28

1.9

1.7

0.73

0.93

mg/l

3.44

860

6550

Ethmoidectomy

1404

10446

1.46

30.26

1.7

0.93

1.11

mg/l

1.25

1020

7934

Small fibre neuropathy

351

1936

2.22

30.22

2.3

1.7

1.48

1.27

mg/l

0.26

283

1492

Hypopituitarism

753

5003

1.68

30.21

2.0

2.1

1.06

1.12

mg/l

0.20

575

3729

Hypoglycaemia, other or unspecified

744

4935

1.68

30.18

2.1

1.9

1.41

1.17

mg/l

0.67

570

3713

Other fall from one level to another

2330

18508

1.33

29.98

2.0

1.9

1.19

1.20

mg/l

0.07

1742

13856

Type 1 diabetes, wide definition, subgroup 1

2200

17333

1.34

29.86

1.8

1.03

1.10

mg/l

0.69

1672

12669

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

337

1847

2.25

29.84

1.7

1.8

2.33

1.21

mg/l

6.77

300

1419

Follicular cysts of skin and subcutaneous tissue

1936

15072

1.37

29.83

1.8

0.99

1.17

mg/l

2.31

1465

11492

Biological medication for rheuma

1870

14496

1.38

29.81

1.9

1.8

1.10

0.99

mg/l

1.06

1423

10765

Complications following infusion, transfusion and therapeutic injection

212

985

2.83

29.77

3.5

1.7

1.45

1.16

mg/l

0.73

174

752

Retinal detachments and breaks

3660

30523

1.25

29.73

1.9

1.7

1.25

1.34

mg/l

0.82

2828

23679

Primary hyperparathyroidism

1165

8460

1.51

29.70

1.9

1.7

1.37

1.24

mg/l

0.47

875

6511

Diffuse large B-cell lymphoma, helper endpoint

477

2863

1.92

29.69

2.0

1.8

1.81

1.28

mg/l

1.40

387

2214

Diffuse large B-cell lymphoma, including Hilmo

477

2863

1.92

29.69

2.0

1.8

1.81

1.28

mg/l

1.40

387

2214

Diffuse large B-cell lymphoma

477

2863

1.92

29.69

2.0

1.8

1.81

1.28

mg/l

1.40

387

2214

Essential (haemorrhagic) thrombocythaemia

422

2457

2.02

29.65

2.0

1.7

1.09

1.20

mg/l

0.30

330

1872

Recurrent dislocation and subluxation of joint

751

4993

1.66

29.63

1.9

1.8

0.98

0.99

mg/l

0.03

554

3638

Other specified/unspecified bacterial intestinal infections

721

4784

1.69

29.55

2.0

1.8

1.05

1.21

mg/l

0.77

559

3647

Corneal ulcer

1981

15483

1.36

29.50

1.9

1.8

1.02

1.11

mg/l

0.95

1503

11658

Biomechanical lesions, not elsewhere classified

561

3530

1.83

29.45

1.9

1.7

1.32

1.24

mg/l

0.19

442

2723

Duodenal ulcer

1032

7284

1.53

29.42

2.0

1.7

1.48

1.49

mg/l

0.05

827

5704

Psychotic depression

629

4016

1.73

29.42

1.7

0.96

1.14

mg/l

1.18

453

3064

Lymphoid leukaemia

574

3617

1.80

29.37

4.2

1.8

1.41

1.44

mg/l

0.07

464

2805

Asthma mixed form (mode), excluding more controls

505

3042

1.83

29.36

1.9

1.5

0.94

1.16

mg/l

1.46

384

2243

Crohn's disease of small intestine

783

5291

1.65

29.35

2.0

1.8

1.05

1.02

mg/l

0.14

567

3904

Somnolence, stupor and coma

474

2841

1.90

29.30

2.1

1.7

1.24

1.16

mg/l

0.25

389

2170

Left ventricular outflow tract obstruction, narrow definition

530

3285

1.84

29.10

3.4

2.1

1.39

1.19

mg/l

0.73

378

2457

Portal vein thrombosis

207

956

2.79

29.08

4.3

1.8

2.56

1.13

mg/l

5.20

174

742

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1140

8189

1.49

29.07

1.6

1.7

1.87

1.46

mg/l

1.27

879

6395

Other specified/unspecified spondylopathies

282

1449

2.33

29.03

1.9

1.6

1.26

1.45

mg/l

0.42

228

1127

Endometriosis of ovary

1803

13593

1.38

28.98

1.8

1.7

1.13

1.15

mg/l

0.06

1329

10348

Other specified/unspecified systemic involvement of connective tissue

667

4386

1.73

28.95

2.0

1.8

1.08

1.07

mg/l

0.03

524

3335

Acute alcohol intoxication, ICD10

2094

16505

1.34

28.92

1.9

1.8

1.26

1.15

mg/l

0.66

1607

12465

Nail disorders

899

6253

1.59

28.91

2.1

1.9

1.14

1.10

mg/l

0.15

683

4684

Other noninflammatory disorders of vagina

847

5816

1.60

28.74

1.7

1.6

0.82

1.18

mg/l

6.66

635

4402

Type 1 diabetes

2639

21308

1.30

28.71

1.9

1.8

1.16

1.15

mg/l

0.05

2012

15659

Other specified disorders of muscle

324

1749

2.18

28.67

2.3

1.7

0.98

1.22

mg/l

1.02

255

1313

Mixed and other personality disorders

922

6464

1.58

28.63

1.9

1.8

0.93

0.92

mg/l

0.02

640

4762

Obsessive-compulsive disorder

734

4893

1.65

28.55

1.9

1.8

0.89

0.97

mg/l

0.39

494

3471

Disorders of oesophagus in diseases classified elsewhere

257

1297

2.46

28.53

2.3

1.6

1.20

1.24

mg/l

0.12

197

1014

Other malignant neoplasms of skin (=non-melanoma skin cancer)

4711

27491

1.22

28.52

1.7

1.46

1.20

mg/l

3.74

3637

21153

Crohn's disease NAS

723

4839

1.67

28.32

1.9

1.8

1.15

1.02

mg/l

0.64

543

3556

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

497

3038

1.84

28.29

1.9

1.7

0.85

1.11

mg/l

1.59

395

2238

Congenital malformations and deformations of the musculoskeletal system

1164

8431

1.48

28.24

2.2

2.1

1.32

1.08

mg/l

0.75

872

6116

Sacrococcygeal disorders, not elsewhere classified

368

2086

2.08

28.24

1.9

1.6

0.79

1.04

mg/l

2.25

276

1553

In situ neoplasms

4103

34753

1.23

28.21

1.8

1.7

1.43

1.27

mg/l

1.20

3145

26656

Other disorders of penis

886

6135

1.56

28.13

2.0

2.1

1.20

1.42

mg/l

0.95

668

4709

Abnormal findings on antenatal screening of mother

965

6829

1.55

28.06

1.9

1.7

0.99

0.78

mg/l

2.52

732

4861

Atopic dermatitis, strict definition

3305

26874

1.26

28.02

1.8

1.9

1.01

0.99

mg/l

0.12

2384

19730

Other disorders of breast

1445

10950

1.43

27.92

1.8

1.7

1.00

1.01

mg/l

0.01

1062

8236

Combinations of oral blood glucose lowering drugs

2820

23081

1.28

27.90

1.8

1.7

1.24

1.30

mg/l

0.30

2261

17827

Acute alcohol intoxication

2611

21166

1.29

27.86

1.8

1.26

1.24

mg/l

0.11

2008

16079

Other crystal arthropathies

219

1044

2.59

27.82

1.8

1.6

1.23

1.46

mg/l

0.95

170

809

Other specified/unspecified dorsopathies

392

2267

2.00

27.77

1.9

1.7

1.13

1.25

mg/l

0.18

305

1710

Eating disorders

1212

8913

1.47

27.72

2.2

1.8

0.91

0.99

mg/l

0.32

832

6416

FESS (DNB20)

1343

10061

1.44

27.71

1.7

0.90

1.11

mg/l

1.60

974

7635

Acquired haemolytic anaemia

293

1566

2.29

27.64

3.8

1.7

2.94

1.32

mg/l

1.94

247

1223

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

753

5090

1.63

27.61

2.1

1.9

1.20

0.96

mg/l

1.51

551

3603

Other congenital malformations

933

6582

1.55

27.58

2.2

1.40

1.08

mg/l

1.21

720

4841

1140

8351

1.49

27.51

1.8

1.7

0.85

0.77

mg/l

0.30

835

6052

Other peripheral vascular diseases

854

5941

1.58

27.31

1.8

1.7

1.14

1.12

mg/l

0.05

643

4489

Mixed hyperlipidaemia

430

2563

1.92

27.31

1.8

1.6

1.12

1.33

mg/l

1.02

325

1961

Barrett oesophagus

517

3239

1.82

27.27

1.8

1.7

1.23

1.29

mg/l

0.17

406

2528

Residual foreign body in soft tissue

521

3247

1.79

27.26

1.6

1.7

0.90

1.22

mg/l

2.62

394

2407

Crystal arthropathies, rheuma endpoint

219

1053

2.56

27.24

1.8

1.6

1.23

1.37

mg/l

0.48

170

820

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

446

2709

1.93

27.22

2.0

1.8

1.02

0.98

mg/l

0.16

330

2016

Tobacco use

609

3987

1.74

26.96

1.9

1.7

1.08

1.07

mg/l

0.01

468

3002

Other and unspecified diseases of blood and blood-forming organs

317

1754

2.19

26.94

2.5

1.6

1.41

1.15

mg/l

0.85

264

1345

Dissection of aorta

332

1840

2.09

26.91

2.8

1.6

3.32

1.44

mg/l

3.61

284

1418

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2752

22582

1.28

26.89

1.8

1.7

1.46

1.19

mg/l

3.90

2223

17338

Other viral hepatitis

703

4732

1.66

26.85

2.1

1.8

1.42

0.94

mg/l

1.26

538

3440

Carbimazole or st.post thyroidectomy, condition for graves disease

2304

18579

1.31

26.79

2.6

1.7

1.00

1.08

mg/l

0.81

1762

14079

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1800

14070

1.36

26.76

1.7

2.41

1.22

mg/l

17.01

1510

10819

Strabismus

2808

23013

1.28

26.72

2.0

1.9

1.13

1.14

mg/l

0.08

2122

17255

Right ventricular outflow tract obstruction

116

424

3.80

26.71

4.5

4.3

1.69

1.92

mg/l

0.16

306

Conotruncal defects

171

753

2.93

26.68

4.0

1.54

1.46

mg/l

0.09

123

541

Seborrhoeic keratosis

2259

18159

1.31

26.67

1.8

1.7

1.10

1.32

mg/l

3.64

1781

14006

Basal cell carcinoma, including avohilmo

4711

27785

1.21

26.61

1.7

1.48

1.19

mg/l

3.39

3612

21398

Other/unspecified seropositive rheumatoid arthritis

2791

22956

1.28

26.60

1.8

1.7

1.48

1.20

mg/l

3.91

2250

17630

Dislocation, sprain and strain of joints and ligaments of thorax

402

2385

1.97

26.58

2.1

1.8

0.97

1.15

mg/l

0.97

297

1791

Seropositive rheumatoid arthritis, wide

2821

23232

1.28

26.55

1.8

1.7

1.48

1.20

mg/l

3.90

2275

17836

Contraceptive management

4613

27671

1.21

26.53

1.9

1.8

0.86

0.97

mg/l

1.77

3443

20708

Focal epilepsy, strict definition

2015

15976

1.33

26.52

2.1

1.9

1.22

1.24

mg/l

0.12

1557

12139

Asthma mixed form (mode)

505

3129

1.77

26.42

1.9

1.6

0.94

1.21

mg/l

1.76

384

2326

Acute and subacute iridocyclitis

2021

16059

1.33

26.42

1.9

1.8

1.11

1.14

mg/l

0.15

1581

12213

Maternal care related to the fetus and amniotic cavity and possible delivery problems

5127

25928

1.20

26.40

1.7

0.87

0.88

mg/l

0.08

3840

19300

Other/unspecified reactive arthropathies

729

4970

1.64

26.40

1.9

1.7

1.18

1.08

mg/l

0.51

576

3723

Memory loss

911

6460

1.55

26.37

1.9

1.7

1.38

1.40

mg/l

0.05

676

5018

Allergic contact dermatitis

1504

11527

1.40

26.34

1.9

1.7

0.91

1.04

mg/l

1.22

1134

8732

Exposure to other and unspecified inanimate mechanical forces

792

5481

1.60

26.20

2.1

1.8

1.04

1.14

mg/l

0.54

568

4064

malignant neoplasm of female genital organs

1563

11991

1.39

26.15

1.6

1.7

2.01

1.13

mg/l

10.44

1272

9085

Other epidermal thickening

482

3003

1.84

26.13

2.2

1.8

1.04

1.22

mg/l

0.97

379

2280

Maternal care for known or suspected fetal abnormality and damage

1813

12225

1.36

26.11

1.8

1.7

0.96

0.78

mg/l

1.61

1354

8906

Idiopathic thrombocytopenic purpura

351

2017

2.06

26.05

2.4

1.8

1.83

1.21

mg/l

1.04

276

1537

Basal cell carcinoma

4485

26517

1.21

25.99

1.7

1.50

1.20

mg/l

3.38

3446

20399

Malignant neoplasm of skin

5227

30970

1.19

25.96

1.7

1.45

1.16

mg/l

4.39

4033

23825

Drug-induced cataract

296

1630

2.24

25.90

2.6

1.8

1.48

1.16

mg/l

0.90

233

1250

Systemic lupus erythematosus

438

2691

1.92

25.85

2.5

1.7

1.53

1.01

mg/l

2.99

352

2041

Complications of cardiac and vascular prosthetic devices, implants and grafts

236

1191

2.41

25.82

4.7

1.7

2.04

1.46

mg/l

1.25

204

929

Leisure time condition

1883

14871

1.34

25.82

1.9

1.8

1.27

1.21

mg/l

0.29

1433

11199

Inflammatory diseases of the central nervous system

890

6313

1.55

25.78

1.8

1.19

1.09

mg/l

0.48

693

4745

Infective dermatitis

1173

8698

1.45

25.66

2.0

1.7

1.20

1.23

mg/l

0.13

921

6652

Open wound of forearm

996

7192

1.50

25.65

2.1

1.7

1.14

1.17

mg/l

0.11

757

5355

Spontaneous abortion

5284

30892

1.19

25.63

1.7

0.90

1.02

mg/l

3.46

4023

23194

Disorders of refraction and accommodation

2883

23757

1.27

25.60

2.0

1.9

0.97

1.08

mg/l

1.27

2109

17678

Alzheimer disease, excluding more controls

1554

7789

1.38

25.57

1.6

1.72

1.75

mg/l

0.07

1195

6131

Other follicular disorders

809

5655

1.58

25.54

2.1

1.7

0.85

0.98

mg/l

1.08

611

4188

Retinal vascular occlusion

1156

8552

1.46

25.53

1.8

1.7

1.44

1.50

mg/l

0.18

909

6666

Postprocedural musculoskeletal disorders, not elsewhere classified

745

5139

1.61

25.43

1.9

1.8

1.37

1.28

mg/l

0.34

643

3968

Vitreous haemorrhage

1021

7426

1.49

25.37

1.7

1.24

1.32

mg/l

0.25

821

5680

Melanocytic naevi

3186

26647

1.25

25.37

2.0

1.7

1.17

1.12

mg/l

0.27

2407

20068

Discitis, unspecified

194

917

2.63

25.31

3.1

1.6

1.33

1.45

mg/l

0.35

165

724

Heart failure and hypertrophic cardiomyopathy

223

1123

2.51

25.27

8.8

1.7

1.63

1.31

mg/l

0.63

179

878

Other and unspecified immunodeficiencies with predominantly antibody defects

177

822

2.88

25.24

3.6

1.9

1.57

1.08

mg/l

0.53

147

630

Eating disorder

1015

7372

1.49

25.16

2.3

1.8

0.84

0.95

mg/l

0.36

683

5260

Thyroiditis

803

5635

1.58

25.14

1.8

1.7

0.87

1.07

mg/l

1.91

603

4254

Postprocedural disorders of digestive system, not elsewhere classified

374

2209

1.99

25.14

2.4

1.8

1.71

1.19

mg/l

0.92

300

1679

Hypocalcemia

285

1567

2.25

25.11

1.8

1.34

1.14

mg/l

0.56

224

1209

Toxic effects of substances chiefly nonmedicinal as to source

1201

8973

1.44

25.05

1.9

1.8

1.14

1.13

mg/l

0.02

879

6671

Gluteal tendinitis

424

2580

1.88

25.04

1.6

1.7

0.82

1.10

mg/l

2.46

317

1971

Crushed, pushed or stepped on by crowd or human stampede

786

5466

1.57

25.02

2.1

2.0

1.31

0.97

mg/l

0.76

557

3901

Wet age-related macular degeneration

1663

12579

1.36

24.95

1.7

1.60

1.59

mg/l

0.03

1300

9836

Diabetic retinopathy, excluding more controls

2719

12500

1.29

24.91

1.9

1.31

1.17

mg/l

1.01

2147

9680

Dermatographic urticaria

763

5310

1.60

24.90

2.1

1.7

0.69

0.96

mg/l

5.45

539

3955

Drug-induced neutropenia

757

5264

1.60

24.87

2.2

1.8

2.08

1.18

mg/l

4.88

599

4056

Congenital malformations of aortic and mitral valves

444

2747

1.85

24.68

3.3

2.1

1.25

1.17

mg/l

0.21

311

2056

Focal epilepsy, mode (most common among epilepsy diagnosis)

1910

15181

1.33

24.68

1.9

1.23

1.24

mg/l

0.07

1484

11515

Giant cell arteritis

441

2731

1.86

24.67

2.0

1.6

1.35

1.46

mg/l

0.27

351

2136

Emotional disorders starting during childhood or adolecense, excluding more controls

434

2564

1.81

24.63

2.5

2.0

1.53

1.15

mg/l

0.44

266

1745

Endometriosis ASRM stages 1,2

2001

16057

1.33

24.55

1.8

1.7

0.81

0.91

mg/l

1.25

1465

12006

Other blood glucose lowering drugs, excl. Insulins

1599

12457

1.36

24.49

1.7

1.34

1.35

mg/l

0.02

1264

9575

Non-Hodgkin lymphoma, all

419

2545

1.86

24.49

2.4

1.6

2.01

1.46

mg/l

1.73

359

1971

Retinal vascular disorders

1166

8693

1.44

24.43

1.8

1.7

1.43

1.50

mg/l

0.21

916

6774

Non-allergic asthma

883

6298

1.53

24.41

2.0

1.00

1.26

mg/l

2.59

691

4827

Pyothorax

445

2761

1.84

24.40

2.0

1.7

1.64

1.34

mg/l

1.44

380

2146

Abdominal aortic aneurysm (AAA)

851

5929

1.52

24.40

1.8

1.6

3.67

1.61

mg/l

21.14

725

4640

Atrial septal defect

419

2551

1.88

24.27

3.1

2.5

1.21

1.25

mg/l

0.11

306

1910

Persons encountering health services in circumstances related to reproduction

6346

37622

1.17

24.21

2.0

1.9

1.07

1.05

mg/l

0.17

4742

28029

Diabetic maculopathy, excluding more controls

1091

8066

1.45

24.12

1.9

1.7

1.27

1.23

mg/l

0.15

865

6036

Other diseases of stomach and duodenum

650

4391

1.63

24.10

1.9

1.7

1.42

1.33

mg/l

0.26

503

3405

Viral hepatitis

792

5572

1.56

24.07

2.1

1.8

1.42

0.96

mg/l

1.33

609

4088

Tumor necrosis factor alpha inhibitors

1652

12969

1.35

23.97

1.8

1.08

0.98

mg/l

0.89

1257

9593

Arthropod-borne viral fevers and viral haemorrhagic fevers

1839

14625

1.33

23.90

1.8

1.9

1.13

1.23

mg/l

0.71

1441

11133

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1889

15063

1.33

23.89

1.9

1.8

1.17

1.06

mg/l

0.70

1462

11225

Septal defects

656

4357

1.63

23.89

2.7

2.4

1.20

mg/l

0.01

491

3243

Other congenital malformations of heart

103

378

3.89

23.85

6.4

3.4

1.64

1.15

mg/l

0.73

297

Other specified/unspecified inflammatory spondylopathies

518

3341

1.73

23.84

1.8

1.6

0.92

1.01

mg/l

0.33

393

2453

Vitamin deficiency, wide

513

3312

1.74

23.75

2.2

1.7

1.26

1.17

mg/l

0.31

398

2513

Vitamin deficiency

513

3312

1.74

23.75

2.2

1.7

1.26

1.17

mg/l

0.31

398

2513

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1700

13401

1.34

23.72

1.9

1.8

1.14

1.06

mg/l

0.51

1316

9974

Total colectomy operation

466

2956

1.80

23.68

2.7

1.8

1.66

1.11

mg/l

1.70

396

2197

Total colectomy

466

2956

1.80

23.68

2.7

1.8

1.66

1.11

mg/l

1.70

396

2197

Arthropathic psoriasis

1185

8927

1.43

23.66

1.7

1.8

1.10

1.14

mg/l

0.15

945

6789

Peritonsillar abscess

2200

17830

1.29

23.65

1.8

1.04

1.12

mg/l

0.48

1643

13332

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

955

6940

1.48

23.51

1.7

1.55

1.28

mg/l

1.64

781

5344

Ulcerative colitis (strict definition, require KELA)

1757

13922

1.34

23.49

1.9

1.8

1.14

1.06

mg/l

0.52

1357

10360

Antenatal screening

2601

11969

1.28

23.46

1.7

0.82

0.79

mg/l

0.25

1947

8769

Anterior Iridocyclitis

2116

17139

1.30

23.42

1.8

1.20

1.15

mg/l

0.23

1646

13019

Drug-induced osteoporosis with pathological fracture

213

1093

2.51

23.39

2.7

1.7

1.71

1.17

mg/l

0.88

176

861

Chronic viral hepatitis

579

3854

1.68

23.39

2.1

1.8

1.46

0.94

mg/l

1.12

445

2781

Other disorders starting during childhood or adolecense, excluding more controls

444

2625

1.77

23.31

3.1

2.2

1.82

1.13

mg/l

0.92

306

1791

SLE, ICD10

416

2594

1.88

23.26

2.4

1.7

1.53

1.02

mg/l

2.84

334

1971

SLE, strict definition

416

2594

1.88

23.26

2.4

1.7

1.53

1.02

mg/l

2.84

334

1971

Visual field defects

854

6119

1.52

23.26

2.1

1.7

1.23

1.30

mg/l

0.23

651

4709

Burns and corrosions

1415

10929

1.38

23.19

1.9

1.11

1.14

mg/l

0.08

1055

8162

Acute generalized exanthematous pustulosis

496

3208

1.76

23.19

2.1

1.8

1.29

1.14

mg/l

0.60

398

2438

Bursitis of shoulder

277

1528

2.13

23.16

1.9

1.6

0.91

1.12

mg/l

0.96

216

1158

Lesion of lateral popliteal nerve

522

3406

1.72

23.14

2.1

1.7

1.22

1.19

mg/l

0.12

414

2573

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1633

12871

1.35

22.95

1.8

1.9

1.14

1.23

mg/l

0.53

1280

9798

Systemic lupus erythematosus, unspecified

367

2227

1.96

22.93

2.5

1.7

1.41

0.98

mg/l

2.50

295

1684

Atrophic disorders of skin

1555

12204

1.36

22.90

1.9

1.7

1.07

1.11

mg/l

0.29

1183

9230

257

1393

2.19

22.80

2.1

1.6

1.56

1.49

mg/l

0.07

212

1075

358

5875

0.57

22.78

1.6

1.7

2.50

1.36

mg/l

2.75

298

4615

Vulvovaginal ulceration/inflammation in other diseases

692

4809

1.60

22.77

1.9

1.8

0.62

0.88

mg/l

6.80

491

3540

Complex cardiac defects

358

4.06

22.72

6.3

3.5

1.81

0.98

mg/l

1.58

271

Other and unspecified aplastic anaemias

153

694

2.88

22.71

2.8

1.7

1.34

1.18

mg/l

0.42

117

526

Hepatomegaly and splenomegaly, not elsewhere classified

129

539

3.14

22.70

3.4

1.6

1.92

1.11

mg/l

0.97

110

407

Inguinal hernia

6248

36848

1.16

22.70

1.9

1.8

1.31

1.25

mg/l

0.52

4791

27937

Failed induction of labour

697

4852

1.59

22.68

1.9

1.7

1.27

0.72

mg/l

6.37

554

3421

Iron deficiency

338

2001

1.98

22.68

2.5

1.9

1.02

0.95

mg/l

0.22

248

1450

Schizophrenia or delusion

3361

28498

1.23

22.65

1.8

1.23

1.07

mg/l

1.65

2503

21159

Viral infections of the central nervous system

831

5967

1.52

22.57

1.9

1.8

0.85

1.09

mg/l

2.32

597

4460

Myocardial infarction, with ST-elevation

1615

12699

1.34

22.57

2.1

1.7

1.59

1.51

mg/l

0.36

1317

9933

Eosinophilic disease (BM)

171

801

2.59

22.52

1.9

1.6

1.36

1.17

mg/l

0.33

135

615

Contusion of other and unspecified parts of foot

559

3720

1.67

22.52

2.0

1.9

1.00

0.98

mg/l

0.04

401

2694

Single ventricle heart

14.36

22.49

5.6

5.8

2.06

2.12

mg/l

0.02

!Aliquae complicationes praecoces traumatis

473

3042

1.76

22.48

2.2

1.8

1.49

1.17

mg/l

0.77

366

2294

Early complications of trauma

473

3042

1.76

22.48

2.2

1.8

1.49

1.17

mg/l

0.77

366

2294

Vasculitis limited to skin, not elsewhere classified

306

1772

2.05

22.29

1.9

1.7

1.18

1.23

mg/l

0.19

257

1345

Gangrene, not elsewhere classified

334

3.70

22.26

2.3

1.6

1.34

1.38

mg/l

0.08

271

Effects of foreign body entering through natural orifice

2461

20323

1.27

22.26

1.8

1.9

1.13

1.18

mg/l

0.32

1806

15266

Congenital malformations and deformations of the musculoskeletal system

907

6569

1.48

22.20

2.3

2.2

1.33

1.07

mg/l

0.72

668

4762

Seborrhoeic dermatitis

956

7031

1.47

22.12

2.0

1.7

1.12

1.26

mg/l

0.61

729

5351

Mental and behavioural disorders due to use of other stimulants, including caffeine

329

1938

1.96

22.08

1.9

2.0

1.11

0.89

mg/l

1.03

240

1333

Causalgia

219

1152

2.37

22.07

2.0

1.7

0.85

1.03

mg/l

0.63

170

875

Prepatellar bursitis

437

2754

1.77

22.01

2.1

1.7

0.99

1.27

mg/l

2.21

344

2087

Other symptoms and signs involving general sensations and perceptions

430

2715

1.79

21.93

1.8

1.08

1.24

mg/l

0.59

335

2027

Pleural plaque

838

6022

1.50

21.92

1.6

1.29

1.69

mg/l

3.84

667

4732

Tongue abnormality

640

4419

1.62

21.90

1.8

1.02

1.26

mg/l

1.48

466

3404

Abnormal serum enzyme levels

2839

23182

1.24

21.86

1.8

1.54

1.42

mg/l

0.61

2259

18039

Viral warts

1026

7649

1.45

21.85

2.1

1.9

1.03

1.09

mg/l

0.36

755

5695

Schizophrenia, schizotypal and delusional disorders

3367

28643

1.22

21.83

1.8

1.22

1.07

mg/l

1.42

2504

21277

Pure hyperglyceridaemia

253

1386

2.16

21.77

2.0

1.7

1.10

1.28

mg/l

0.69

203

1054

Diabetic nephropathy

1597

12515

1.35

21.76

1.9

1.48

1.35

mg/l

0.77

1325

9823

Nonspecific lymphadenitis

634

4358

1.60

21.74

1.8

0.97

0.90

mg/l

0.28

476

3242

Other secondary gonarthrosis

536

3566

1.68

21.71

1.8

1.37

1.29

mg/l

0.24

442

2730

Acute peritonitis

640

4410

1.60

21.65

2.4

1.7

2.06

1.25

mg/l

5.79

541

3389

Other specified and unspecified disorders of eye and adnexa

428

2721

1.80

21.63

2.4

1.7

1.76

1.07

mg/l

0.79

318

2066

Malignant neoplasm of urinary organs

883

6423

1.48

21.59

1.7

1.56

1.30

mg/l

1.45

722

4979

Other Crohn's disease

751

5343

1.54

21.49

1.9

1.8

1.21

0.95

mg/l

1.52

542

3913

Nephrotic syndrome

344

2074

1.93

21.47

2.4

2.1

1.73

1.30

mg/l

1.46

297

1592

Leukaemia of unspecified cell type

129

559

3.11

21.45

6.0

1.7

3.52

1.38

mg/l

1.46

114

438

Other and unspecified abdominal hernia

429

2729

1.78

21.37

1.9

1.7

1.12

1.25

mg/l

0.59

334

2120

Type 1 diabetes, wide definition

2252

18469

1.27

21.37

1.8

1.03

1.12

mg/l

0.98

1713

13536

Nonsuppurative otitis media

2386

17021

1.26

21.22

2.2

1.9

1.15

1.14

mg/l

0.05

1737

12152

Acidosis

228

1219

2.23

21.19

2.1

1.7

1.81

1.32

mg/l

1.15

195

934

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

326

1940

1.94

21.18

1.9

1.7

0.92

1.05

mg/l

0.35

250

1456

Amyloidosis, other/unspecified

204

1054

2.35

21.11

2.1

1.6

1.77

1.37

mg/l

0.36

159

801

Other inflammatory liver diseases

682

4788

1.57

21.07

2.1

1.8

1.66

1.10

mg/l

3.94

551

3651

Female infertility, tubal origin

537

3595

1.65

20.95

1.9

1.6

1.23

0.99

mg/l

0.33

400

2704

Use of disulfiram, acamprosate or naltrexone

909

6704

1.47

20.94

1.8

1.7

1.26

1.08

mg/l

0.51

685

5037

Diabetic neuropathy

1122

8519

1.42

20.89

1.8

1.9

1.07

1.37

mg/l

5.27

892

6723

Peroneal tendinitis

209

1098

2.33

20.88

2.0

1.7

0.99

mg/l

0.01

165

824

Other predominantly sexually transmitted diseases, not elsewhere classified

2232

18388

1.27

20.84

1.8

0.82

0.94

mg/l

1.69

1610

13309

Congenital malformation of biliary tract

165

6.95

20.79

13.9

4.5

1.88

2.11

mg/l

0.07

133

Other mental disorders due to brain damage and dysfunction and to physical disease

1127

8581

1.41

20.73

1.7

1.23

1.40

mg/l

1.12

873

6650

Squamous cell neoplasms and carcinomas of the skin

736

5217

1.52

20.69

1.6

2.11

1.50

mg/l

1.38

572

4082

Amyloidosis

234

1269

2.17

20.68

2.1

1.6

1.87

1.37

mg/l

0.56

180

980

Otitis media, unspecified

1112

7743

1.40

20.66

2.6

1.9

1.18

1.07

mg/l

0.36

792

5507

Myositis

269

1523

2.04

20.55

2.0

1.7

1.34

mg/l

0.01

207

1158

Other abnormalities of plasma proteins

195

1010

2.41

20.54

3.6

1.7

1.45

1.16

mg/l

0.94

160

785

Intestinal malabsorption

501

3334

1.69

20.53

2.0

1.7

1.21

1.09

mg/l

0.39

382

2513

Urethritis and urethral syndrome

262

1482

2.09

20.50

2.0

1.7

0.82

1.16

mg/l

2.87

201

1103

L04AC Interleukin inhibitors

635

4431

1.59

20.42

2.0

1.8

1.04

0.98

mg/l

0.25

494

3267

Other infective otitis externa

628

4371

1.59

20.41

1.8

1.12

1.13

mg/l

0.03

475

3305

Hydrocele

999

7442

1.42

20.40

2.0

1.9

1.49

1.61

mg/l

0.37

759

5808

Sacroiliitis, not elsewhere classified

508

3377

1.66

20.36

1.8

1.7

1.00

0.95

mg/l

0.15

370

2451

Mental disorders, not otherwise specified

902

6675

1.46

20.35

2.0

1.8

0.82

0.95

mg/l

1.65

686

4881

Sleep disorders, other/unspecified

394

2485

1.80

20.33

1.9

0.81

1.01

mg/l

1.22

275

1819

Presence of other devices

2290

18849

1.26

20.32

1.7

1.6

1.24

1.44

mg/l

2.64

1778

14586

Psoriatic arthropathies, ICD10

1087

8275

1.42

20.32

1.7

1.06

1.12

mg/l

0.38

860

6306

Event of undetermined intent

672

4734

1.56

20.28

2.1

1.8

1.05

1.03

mg/l

0.08

484

3474

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

867

6397

1.48

20.26

2.2

1.7

0.81

0.72

mg/l

0.80

676

4715

Other strabismus

2272

18735

1.26

20.25

2.0

1.9

1.06

1.11

mg/l

0.30

1697

13946

Acute lymphadenitis

627

4364

1.58

20.21

1.9

1.8

0.90

0.99

mg/l

0.55

479

3236

Other predominantly sexually transmitted diseases, not elsewhere classified

1865

15151

1.30

20.17

1.8

0.79

0.92

mg/l

2.10

1356

11079

Anogenital herpesviral [herpes simplex] infection

715

5113

1.54

20.13

1.9

1.7

0.73

0.87

mg/l

1.13

495

3724

Benign neoplasm: Descending colon

690

4903

1.55

20.06

2.0

1.8

1.22

1.38

mg/l

0.56

563

3831

Specific development disorders of scholastic skills

428

2701

1.72

20.05

3.6

2.3

1.53

0.98

mg/l

0.66

287

1845

Generalized skin eruption due to drugs and medicaments

431

2796

1.75

19.99

2.0

1.8

1.20

1.16

mg/l

0.15

351

2119

Preterm labour and delivery

2749

23223

1.24

19.94

1.8

1.7

0.97

0.93

mg/l

0.32

2105

17476

Benign neoplasm: Small intestine

417

2689

1.77

19.91

2.2

1.6

1.15

1.33

mg/l

0.95

337

2088

Pneumonia due to Streptococcus pneumoniae

419

2681

1.74

19.90

2.1

1.7

1.55

1.19

mg/l

1.22

341

1980

Benign neoplasm of mouth and pharynx

1091

8327

1.41

19.90

1.7

1.8

1.17

1.23

mg/l

0.26

835

6353

Malignant neoplasm of kidney, except renal pelvis

809

5885

1.48

19.88

1.7

1.57

1.31

mg/l

1.31

661

4564

Mixed disorders of conduct and emotions, excluding more controls

224

1198

2.11

19.81

2.0

2.1

0.91

1.00

mg/l

0.32

155

790

Other other unspecified disorders of the circulatory system

394

2511

1.79

19.68

2.1

1.8

1.26

1.19

mg/l

0.16

303

1946

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

6764

48049

1.14

19.66

1.7

0.92

1.07

mg/l

4.96

5072

36403

Lichen simplex chronicus and prurigo

642

4516

1.56

19.63

1.8

1.29

1.23

mg/l

0.14

508

3462

Thyrotoxicosis with diffuse goitre

1515

12078

1.33

19.59

2.1

1.7

0.95

1.05

mg/l

0.98

1139

9125

Lesion of radial nerve

402

2576

1.77

19.48

2.0

1.7

1.46

1.11

mg/l

0.74

299

1934

Other psoriatic arthropathies

1055

8047

1.41

19.47

1.7

1.07

1.13

mg/l

0.34

836

6119

Spinal instabilities

307

1838

1.92

19.47

1.7

1.6

0.98

1.06

mg/l

0.24

235

1374

Cerebral aneurysm, nonruptured

891

6632

1.46

19.46

1.9

1.7

1.09

1.20

mg/l

0.57

710

5088

Other and unspecified injuries of shoulder and upper arm

350

2175

1.85

19.44

1.9

1.8

1.09

1.11

mg/l

0.04

268

1637

Ectopic pregnancy

1845

15051

1.29

19.39

1.7

0.97

0.96

mg/l

0.02

1383

11371

Malignant neoplasm of colon, including Hilmo

1738

14033

1.30

19.37

1.8

1.7

1.82

1.28

mg/l

6.81

1419

10817

Viral infections of the central nervous system

762

5538

1.50

19.34

1.9

1.8

0.85

1.09

mg/l

2.06

549

4135

Other/unspecified disorders of vestibular function

434

2842

1.73

19.31

1.9

1.7

1.09

1.21

mg/l

0.57

324

2194

Agoraphobia

364

2280

1.80

19.20

2.0

1.7

0.95

0.91

mg/l

0.12

245

1650

Mucosal proctocolitis

1314

10315

1.35

19.12

2.1

1.8

1.28

1.04

mg/l

1.74

1005

7665

Other disorders involving the immune mechanism, not elsewhere classified

337

2087

1.86

18.98

4.1

2.0

1.52

1.10

mg/l

1.65

281

1577

Psoriasis vulgaris

1876

15350

1.28

18.94

1.8

1.14

1.19

mg/l

0.28

1462

11695

Lack of expected normal physiological development

177

762

2.26

18.93

4.0

2.6

2.36

1.63

mg/l

0.52

137

492

Visual impairment including blindness (binocular or monocular)

666

4733

1.53

18.92

1.9

1.7

1.26

1.37

mg/l

0.43

484

3634

Other superficial mycoses

1069

8185

1.40

18.92

1.9

1.8

0.80

1.05

mg/l

2.73

765

5986

Other and unspecified nonorganic psychotic disorders

1992

16378

1.27

18.92

1.9

1.8

1.15

1.00

mg/l

1.85

1450

11951

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

939

7090

1.44

18.87

1.9

1.7

0.96

0.93

mg/l

0.22

752

5316

Hypertrophic cardiomyopathy

427

2797

1.72

18.86

5.4

1.8

1.35

1.32

mg/l

0.06

320

2145

Nonhereditary hypogammaglobulinemia

147

713

2.69

18.85

3.0

1.7

1.41

1.10

mg/l

0.27

125

551

Monoarthritis, not elsewhere classified

431

2815

1.70

18.82

2.1

1.8

1.05

1.19

mg/l

0.52

328

2084

Malignant neoplasm of colon

1360

10730

1.34

18.73

1.7

1.83

1.29

mg/l

5.70

1114

8282

Cyst of kidney

696

5014

1.52

18.68

1.9

1.7

1.31

1.41

mg/l

0.35

549

3912

Polycystic ovarian syndrome, broad definition

1257

9866

1.36

18.64

1.9

1.7

0.80

0.85

mg/l

0.43

957

7088

Infection of intervertebral disc (pyogenic)

147

704

2.57

18.64

1.9

1.7

1.91

1.49

mg/l

0.49

129

556

Chronic lymphocytic leukaemia

272

1591

1.96

18.59

1.8

1.6

1.82

1.33

mg/l

0.82

227

1236

Chronic lymphocytic leukaemia, helper endpoint

272

1591

1.96

18.59

1.8

1.6

1.82

1.33

mg/l

0.82

227

1236

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

272

1591

1.96

18.59

1.8

1.6

1.82

1.33

mg/l

0.82

227

1236

Temporal arteritis

376

2405

1.78

18.56

1.9

1.6

1.38

1.41

mg/l

0.06

296

1885

Bacterial, viral and other infectious agents

946

7149

1.42

18.53

2.3

1.8

1.04

1.02

mg/l

0.09

720

5368

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

637

4492

1.53

18.51

2.0

1.6

1.54

1.49

mg/l

0.11

491

3468

Congenital varicose veins

294

4.12

18.50

2.7

2.0

1.12

0.81

mg/l

0.72

222

Other congenital malformations of peripheral vascular system

175

905

2.40

18.50

3.0

2.0

1.11

0.99

mg/l

0.26

133

690

Disorders of optic nerve and visual pathways

982

7467

1.41

18.50

2.0

1.9

1.33

1.13

mg/l

0.47

744

5595

Single delivery by caesarean section

2080

9826

1.28

18.46

2.0

1.8

1.07

0.86

mg/l

2.70

1618

7049

ILD medications: nintedanib

297

3.88

18.37

2.5

1.5

1.54

1.17

mg/l

0.53

235

Other erythematous conditions

383

2469

1.77

18.35

2.3

1.8

1.39

1.15

mg/l

0.58

289

1884

Early lumbar disc prolapse operation

1159

9017

1.37

18.34

1.8

0.70

0.83

mg/l

1.50

843

6619

Pneumonitis due to solids and liquids

757

5515

1.47

18.32

2.0

1.7

1.89

1.42

mg/l

1.72

627

4249

Simple and mucopurulent chronic bronchitis

381

2422

1.73

18.30

2.1

1.9

1.21

1.46

mg/l

0.66

288

1875

Infarction of spleen

409

3.48

18.30

2.5

1.8

2.12

1.45

mg/l

1.18

330

Cystic fibrosis with intestinal manifestations

11.27

18.25

4.9

1.5

1.29

0.74

mg/l

0.40

Special screening examination for neoplasms

527

3594

1.59

18.24

1.7

1.91

1.32

mg/l

1.19

408

2802

Malignant neoplasm of ovary, including Hilmo

667

4804

1.53

18.16

1.7

2.09

1.05

mg/l

8.91

569

3642

Leiomyoma of uterus

7276

37239

1.14

18.13

1.7

1.01

1.04

mg/l

0.41

5487

28431

Intracerebral haemorrhage

1157

8980

1.36

18.04

2.4

1.6

1.62

1.56

mg/l

0.22

944

6950

Congenital malformations of pulmonary and tricuspid valves

409

3.20

18.02

5.5

3.7

1.45

1.13

mg/l

0.50

301

Disorders of speech understanding and production

405

2578

1.70

17.99

3.1

2.6

1.67

1.34

mg/l

0.70

313

1838

Polyarthritis, unspecified

365

2322

1.76

17.98

2.0

1.9

1.37

1.22

mg/l

0.42

304

1754

Symptoms and signs involving emotional state

332

2071

1.82

17.98

3.1

1.9

1.00

1.06

mg/l

0.11

250

1563

Nummular dermatitis

795

5883

1.46

17.90

1.9

1.8

1.15

1.28

mg/l

0.53

588

4515

Corns and callosities

679

4909

1.51

17.84

1.9

1.8

1.26

1.24

mg/l

0.04

506

3758

Other and specified injuries of hip and thigh

251

1462

2.01

17.82

2.0

1.7

1.59

1.21

mg/l

0.50

198

1105

Other specified congenital malformation syndromes affecting multiple systems

187

993

2.25

17.82

3.1

3.4

2.26

1.04

mg/l

2.00

143

741

Other surgical follow-up care

366

2345

1.76

17.73

2.1

1.8

1.34

0.99

mg/l

0.72

285

1740

Cardiomyopathy in other diseases

284

3.78

17.66

2.1

1.9

0.83

1.51

mg/l

3.04

229

Follow-up examination after treatment for malignant neoplasms

890

6670

1.41

17.64

1.7

1.6

1.62

1.48

mg/l

0.38

718

5190

Other and unspecified erythematous conditions

345

2192

1.80

17.64

2.4

1.8

1.47

1.16

mg/l

0.70

260

1673

Poisoning by narcotics and psychodysleptics [hallucinogens]

194

1049

2.21

17.59

1.9

1.8

1.48

0.91

mg/l

1.04

136

739

Other/unspecified rheumatoid arthritis

1216

9567

1.35

17.58

1.8

1.7

1.44

1.28

mg/l

1.13

972

7360

Dronedarone medication

276

1648

1.91

17.58

1.9

1.6

0.93

1.46

mg/l

2.94

173

1314

Hordeolum and other deep inflammation of eyelid

610

4341

1.54

17.58

2.0

1.8

0.94

1.13

mg/l

1.27

448

3227

Fracture of forearm

6089

50102

1.14

17.48

1.8

1.27

1.18

mg/l

1.20

4653

37800

Exclusion endpoint for clefts

219

1228

2.08

17.44

2.8

3.2

2.11

1.03

mg/l

2.08

167

902

Pediculosis, acariasis and other infestations

1667

13587

1.29

17.42

1.9

0.91

1.07

mg/l

1.86

1222

10012

Malignant neoplasm of mesothelium and soft tissue

378

2444

1.73

17.41

2.0

1.6

2.07

1.32

mg/l

1.58

314

1885

Subacute thyroiditis

407

2693

1.71

17.39

1.6

1.7

0.77

1.02

mg/l

1.89

306

2052

Other specified/unspecified necrotizing vasculopathies

169

883

2.37

17.38

2.0

1.7

1.50

1.18

mg/l

0.61

137

688

Scleritis and episcleritis

658

4763

1.52

17.37

2.0

1.7

0.85

0.98

mg/l

1.17

521

3567

Unspecified chronic bronchitis

327

2028

1.77

17.37

2.5

1.6

1.01

1.33

mg/l

1.71

244

1564

Gingival hyperplasia

370

2394

1.75

17.36

4.1

2.0

1.48

1.24

mg/l

0.80

285

1823

Bell's palsy

1164

9116

1.36

17.33

2.0

1.7

1.30

1.21

mg/l

0.18

887

6902

Giant cell arteritis with polymyalgia rheumatica

376

2448

1.74

17.25

1.9

1.6

1.38

1.36

mg/l

0.04

296

1913

Other disorders of optic [2nd] nerve and visual pathways

642

4625

1.52

17.25

2.1

1.9

1.62

1.25

mg/l

0.59

496

3471

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

188

1013

2.21

17.21

2.7

2.3

2.21

1.04

mg/l

0.77

134

759

Postmenopausal osteoporosis with pathological fracture

639

4615

1.52

17.21

2.0

1.7

1.36

mg/l

0.00

506

3540

Unspecified lump in breast

1634

13349

1.29

17.18

1.8

1.7

1.01

1.07

mg/l

0.48

1246

10139

Bulimia nervosa (incl. atypical)

392

2570

1.71

17.18

1.9

1.7

1.01

0.84

mg/l

0.22

267

1861

Attention to artificial openings

381

2471

1.71

17.18

2.8

1.8

1.87

1.31

mg/l

2.00

315

1896

Congenital malformations of trachea and bronchus

128

611

2.74

17.11

3.5

2.2

1.22

1.21

mg/l

0.01

100

482

Other congenital malformations of the digestive system

431

2856

1.66

17.11

4.5

2.4

1.76

1.25

mg/l

1.09

315

2120

Other and unspecified injuries of ankle and foot

448

3019

1.64

17.11

1.8

0.72

1.00

mg/l

5.09

321

2187

Non-small cell lung cancer, including Hilmo

1352

10130

1.32

17.09

1.7

1.81

1.31

mg/l

3.65

1135

7865

Congenital malformations of the respiratory system

218

1238

2.10

17.06

2.9

2.5

1.20

1.24

mg/l

0.06

160

958

Other and unspecified vasculitis limited to skin

266

1599

1.94

17.01

1.9

1.7

1.21

1.23

mg/l

0.06

224

1212

Deep endometriosis

1033

8023

1.39

17.01

1.8

1.7

0.97

1.02

mg/l

0.21

768

5968

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1368

10970

1.32

17.00

1.7

1.00

1.15

mg/l

1.06

1054

8393

Other and unspecified trigeminal disorders

192

1053

2.21

16.98

2.1

1.6

0.69

1.14

mg/l

4.54

140

806

Non-small cell lung cancer, adenocarcinoma

542

3784

1.56

16.96

1.7

2.26

1.38

mg/l

2.41

456

2947

Other congenital malformations of the digestive system

498

3406

1.59

16.86

4.1

2.3

1.66

1.25

mg/l

0.98

366

2537

Post-traumatic wound infection, not elsewhere classified

294

1815

1.86

16.84

1.9

1.8

1.03

1.16

mg/l

0.65

225

1374

Sequelae of injuries of upper limb

977

7520

1.39

16.82

1.8

0.97

1.12

mg/l

1.07

748

5687

Secondary thrombocytopenia

155

797

2.44

16.80

4.2

1.7

4.10

1.19

mg/l

2.44

136

620

Ingrowing nail

558

3942

1.55

16.79

2.0

1.8

1.16

1.11

mg/l

0.15

423

2924

Postzoster neuralgia

181

977

2.24

16.75

2.1

1.7

1.14

1.32

mg/l

0.59

146

760

Erosion of teeth , including avohilmo

2594

22120

1.22

16.67

2.1

1.8

1.00

1.05

mg/l

0.42

1869

16436

Acute nasopharyngitis (common cold)

1147

8935

1.35

16.61

1.8

0.94

1.10

mg/l

1.31

874

6736

D07AA Corticosteroids, weak (group I)

1587

12913

1.29

16.61

1.9

2.0

1.19

1.08

mg/l

0.43

1185

9546

Ovarian dysfunction

846

6405

1.42

16.58

2.0

1.7

0.74

0.86

mg/l

1.34

621

4628

Impotence

486

3342

1.59

16.55

2.2

1.8

1.58

1.49

mg/l

0.18

380

2614

Other keratitis

1150

9056

1.35

16.50

2.1

1.8

1.05

1.09

mg/l

0.20

842

6784

Specific development disorders of speech and language

544

3667

1.54

16.48

3.0

2.4

1.48

1.25

mg/l

0.64

417

2577

Complications of other internal prosthetic devices, implants and grafts

411

2745

1.67

16.47

2.2

1.7

1.18

1.24

mg/l

0.24

324

2069

Vitamin D deficiency

217

1244

2.06

16.46

2.2

1.7

1.24

0.99

mg/l

0.61

167

915

Enteropathic arthropathies

257

1539

1.93

16.46

1.8

1.7

0.87

1.08

mg/l

1.07

207

1119

Other and/or unspecified nontoxic goitre

831

6285

1.43

16.42

1.9

1.7

1.05

1.15

mg/l

0.47

652

4827

Organic, including symptomatic, mental disorders

4982

31549

1.15

16.40

1.7

1.54

1.44

mg/l

0.93

3913

24504

Foreign body in alimentary tract

541

3814

1.55

16.39

1.8

1.9

1.26

1.29

mg/l

0.06

398

2869

Carcinoma in situ of skin of other and unspecified parts of face

769

5740

1.44

16.38

1.7

1.87

1.55

mg/l

0.66

588

4491

Rosacea

1187

9407

1.34

16.36

1.8

1.7

0.95

1.09

mg/l

1.45

875

7170

Spirochaetal infections, other/unspecified

854

6491

1.42

16.33

1.7

1.8

1.09

1.22

mg/l

0.57

620

4985

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

308

1938

1.82

16.33

4.3

1.9

1.53

1.08

mg/l

1.63

257

1462

Cholangitis (primary sclerosing, PSC), with reimbursement 202

212

1211

2.08

16.30

3.6

2.1

1.79

1.16

mg/l

1.29

175

916

Malignant neoplasm of other and unspecified female genital organs

180

986

2.25

16.24

1.6

1.5

2.32

1.18

mg/l

3.91

158

753

Aneurysms, operations, SAH

1590

12998

1.28

16.24

1.8

1.7

1.32

1.25

mg/l

0.38

1268

10029

Respiratory conditions due to other external agents

227

1325

2.02

16.20

2.6

1.6

1.57

1.26

mg/l

0.73

183

1034

Coeliac disease

1225

9743

1.33

16.20

1.8

1.13

1.11

mg/l

0.05

934

7311

Other otitis externa (chronic)

665

4872

1.49

16.19

2.0

1.8

1.09

1.18

mg/l

0.27

469

3701

Kela reimbursement Agammaglobulinemia (D80-84)

120

573

2.78

16.19

2.9

1.8

1.05

0.98

mg/l

0.17

105

422

Intentional self-harm by unspecified means

162

853

2.31

16.12

2.2

1.9

0.69

0.89

mg/l

1.22

117

603

Heterophoria

819

6190

1.42

16.11

2.2

2.0

0.90

1.10

mg/l

1.71

600

4598

Other and unspecified vascular occlusions

860

6533

1.41

16.11

1.8

1.7

1.51

1.44

mg/l

0.15

673

5069

Acute lymphocytic leukaemia, including Hilmo

376

3.19

16.10

13.4

2.5

1.71

0.92

mg/l

1.31

274

Acute lymphocytic leukaemia, helper endpoint

376

3.19

16.10

13.4

2.5

1.71

0.92

mg/l

1.31

274

Acute lymphocytic leukaemia

376

3.19

16.10

13.4

2.5

1.71

0.92

mg/l

1.31

274

Congenital malformations of the musculoskeletal system, not elsewhere classified

221

1289

2.05

16.07

2.7

2.0

1.20

0.78

mg/l

0.53

165

935

Hodgkin lymphoma, hilmo

312

1982

1.80

15.99

1.9

1.8

2.02

1.11

mg/l

1.29

255

1481

194

1071

2.07

15.96

2.3

2.2

1.22

1.04

mg/l

0.24

142

696

Contusion of ankle

411

2764

1.65

15.95

2.2

1.8

1.03

0.99

mg/l

0.12

300

2016

Clear cell adenocarcinoma of kidney

426

2889

1.63

15.88

1.7

1.6

1.79

1.27

mg/l

1.72

358

2228

Congenital malformations of great arteries

212

1187

2.02

15.86

4.6

3.4

1.92

1.53

mg/l

0.51

148

891

Erythema nodosum

331

2139

1.77

15.85

2.1

1.6

1.10

1.04

mg/l

0.14

258

1630

Adalimumab

992

7719

1.37

15.80

1.9

1.8

1.07

0.96

mg/l

0.84

762

5688

Hidradenitis suppurativa

413

2798

1.65

15.76

1.8

1.7

0.76

0.92

mg/l

0.94

313

2080

Biological medicines for asthma

234

1395

1.99

15.76

1.9

1.7

0.72

0.99

mg/l

1.24

180

1036

Alcohol-induced chronic pancreatitis

617

4484

1.50

15.73

1.7

1.8

1.45

1.24

mg/l

0.83

485

3468

Maltreatment syndromes

547

3891

1.53

15.71

1.8

1.9

1.19

0.92

mg/l

0.37

394

2787

Polyarteritis nodosa and related conditions

166

890

2.26

15.68

1.8

1.21

1.26

mg/l

0.08

134

694

Ménière disease

914

7046

1.39

15.65

1.9

1.7

1.18

1.26

mg/l

0.23

691

5430

Other and unspecified injuries of wrist and hand

413

2797

1.64

15.60

1.8

0.76

1.07

mg/l

3.96

289

2088

Erythema intertrigo

259

1583

1.90

15.60

2.1

1.7

1.04

1.14

mg/l

0.36

201

1226

severe traumatic brain injury, does not include concussion

2081

17500

1.24

15.57

1.8

1.7

1.67

1.41

mg/l

1.96

1587

13484

Other diseases of peritoneum

466

3239

1.60

15.55

2.1

1.7

1.18

1.11

mg/l

0.21

331

2481

Disorders of synovium and tendon in diseases classified elsewhere

220

1281

1.98

15.50

1.9

1.7

1.05

1.23

mg/l

0.53

166

966

Bitten or struck by other mammals

1181

9413

1.33

15.46

1.9

1.8

0.98

0.99

mg/l

0.06

846

6959

Varicose veins of other sites

593

4277

1.49

15.45

1.9

1.8

1.21

1.15

mg/l

0.19

429

3181

Emotional disorders and disorders of social functioning with onset specific to childhood

479

3258

1.56

15.43

2.6

2.4

1.29

1.08

mg/l

0.27

298

2207

Bicuspidal aortic valve syndrome

372

2472

1.68

15.42

2.9

1.9

1.20

1.10

mg/l

0.29

261

1863

Other inflammation of vagina/vulva

422

2891

1.64

15.41

1.8

1.7

0.85

0.87

mg/l

0.04

306

2149

L01XE Protein kinase inhibitors

527

3753

1.55

15.40

2.2

1.8

2.31

1.31

mg/l

3.23

456

2906

Behavioural disorders, excluding more controls

214

1227

1.96

15.36

2.4

1.8

0.84

0.89

mg/l

0.13

156

863

Other diseases of gallbladder

445

3063

1.60

15.35

2.2

1.7

1.13

1.25

mg/l

0.46

349

2342

Myelodysplastic syndrome

120

573

2.55

15.35

2.2

1.6

2.22

1.25

mg/l

2.11

105

451

Cauda equina syndrome

166

903

2.27

15.35

2.0

1.6

0.89

1.13

mg/l

0.47

130

699

Other and unspecified rosacea

877

6749

1.40

15.35

1.8

1.7

0.94

1.10

mg/l

1.44

655

5146

Congenital malformations of the respiratory system

197

1122

2.09

15.34

3.0

2.6

1.24

mg/l

0.00

149

877

Lesion of plantar nerve

610

4451

1.50

15.34

1.7

0.92

1.17

mg/l

2.34

463

3419

Cystic fibrosis with pulmonary manifestations

10.41

15.34

5.5

1.3

0.67

0.77

mg/l

0.26

Personal history of malignant neoplasm

686

5094

1.46

15.33

1.9

1.6

1.06

1.07

mg/l

0.05

537

3852

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

329

2137

1.75

15.33

1.9

1.7

0.83

1.01

mg/l

1.15

245

1594

Acute bronchiolitis

502

3144

1.53

15.30

3.1

2.8

1.41

1.28

mg/l

0.17

349

2162

Malignant neoplasm of testis

166

887

2.18

15.30

1.7

1.9

1.34

0.98

mg/l

0.96

126

626

Examination and encounter for administrative purposes

429

2916

1.60

15.29

1.6

1.17

1.45

mg/l

1.34

330

2249

Outcome of delivery

1810

9266

1.26

15.27

1.6

1.7

0.92

0.77

mg/l

1.15

1328

6696

Dislocation, sprain and strain of joint and ligaments of hip

366

2427

1.68

15.27

1.9

1.7

1.39

1.21

mg/l

0.75

308

1856

Postviral fatigue syndrome

120

585

2.66

15.26

2.2

1.8

0.32

0.63

mg/l

10.61

427

Campylobacter enteritis

297

1888

1.80

15.20

1.9

1.7

0.93

1.10

mg/l

0.86

236

1421

Lactose intolerance

331

2149

1.73

15.19

1.9

1.8

1.75

1.04

mg/l

1.07

240

1590

Traumatic subarachnoid haemorrhage

333

2149

1.70

15.18

1.6

1.70

1.46

mg/l

0.52

252

1642

Vasomotor rhinitis (mode)

727

5459

1.44

15.15

1.6

1.8

0.95

1.14

mg/l

1.05

533

4157

Other ulcerative colitis

597

4345

1.50

15.14

1.8

1.13

1.01

mg/l

0.56

465

3211

Other maltreatment syndromes

332

2160

1.73

15.13

1.9

1.7

1.03

0.95

mg/l

0.28

239

1579

Cardiomyopathy, Hypertrophic obstructive

185

1029

2.08

15.10

6.9

1.6

1.44

1.33

mg/l

0.13

143

815

Shock, not elsewhere classified

108

497

2.66

15.07

7.9

1.6

2.97

1.30

mg/l

1.76

381

Bacterial, viral and other infectious agents

864

6645

1.39

15.03

2.3

1.9

1.05

1.02

mg/l

0.14

661

4996

Malignant neoplasm of testis, including Hilmo

181

998

2.08

15.03

1.8

1.31

0.99

mg/l

0.92

139

705

Nontraumatic intracranial haemmorrhage

1852

15454

1.25

15.03

2.2

1.7

1.61

1.44

mg/l

1.23

1504

11952

Bruxism

233

1407

1.96

15.01

2.2

1.8

0.68

0.91

mg/l

1.35

160

1065

Hereditary factor VIII deficiency

145

5.23

15.00

8.0

2.5

0.78

0.84

mg/l

0.14

117

Other and unspecified epidermal thickening

284

1792

1.81

14.92

2.1

1.7

1.07

1.14

mg/l

0.21

216

1355

Other disorders of the genitourinary system

1243

10016

1.32

14.91

1.8

1.7

1.11

1.26

mg/l

1.25

978

7679

Vestibular neuronitis

864

6658

1.39

14.89

1.8

1.7

0.93

1.24

mg/l

2.90

631

5112

Colorectal cancer

2111

17446

1.23

14.87

1.7

1.93

1.28

mg/l

9.29

1727

13475

Testicular dysfunction

363

2416

1.67

14.87

2.0

1.8

0.93

1.16

mg/l

0.84

272

1779

Tibial collateral bursitis [Pellegrini-Stieda]

133

673

2.43

14.86

1.7

1.6

1.57

1.20

mg/l

0.20

102

525

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

156

842

2.31

14.86

2.6

1.7

0.78

1.02

mg/l

1.39

128

645

Supervision of normal pregnancy

2397

11638

1.22

14.82

1.6

1.7

0.74

0.78

mg/l

0.43

1788

8506

Autoimmune hyperthyroidism

662

4921

1.46

14.73

1.9

1.7

0.90

0.99

mg/l

0.58

480

3717

Injuries involving multiple body regions

401

2733

1.63

14.73

1.9

1.7

1.07

1.05

mg/l

0.05

312

2040

Haemophagocytic lymphohistiocytosis

9.97

14.72

9.6

1.8

4.92

1.25

mg/l

1.79

Viral meningitis

396

2698

1.64

14.71

2.1

1.8

0.80

1.02

mg/l

0.85

276

2001

Lichen ruber planus, wide definition including periferal and oral lichen planus

2185

18593

1.23

14.69

1.7

1.06

1.19

mg/l

1.49

1667

14298

Other overlap syndromes

212

1254

2.01

14.67

1.9

1.6

1.13

1.06

mg/l

0.17

187

966

Selective deficiency of immunoglobulin G [IgG] subclasses

102

477

2.89

14.63

3.0

1.9

1.35

1.07

mg/l

0.38

364

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

189

1080

2.08

14.62

1.9

1.6

2.22

1.15

mg/l

3.01

166

841

Gout due to impairment of renal function

127

639

2.49

14.59

2.8

1.7

1.42

mg/l

0.00

107

497

Abnormal findings in secretions and smears from cervix uteri vagina vulva

5686

38841

1.13

14.58

1.7

0.84

0.97

mg/l

3.85

4232

29185

Polycystic ovarian syndrome

626

4627

1.47

14.52

2.0

1.7

0.67

0.83

mg/l

2.62

458

3313

Glaucoma

5720

44495

1.13

14.52

1.7

1.36

1.34

mg/l

0.09

4395

34571

Dislocation, sprain and strain of joints and ligaments of head

431

2983

1.59

14.50

1.9

0.84

0.97

mg/l

0.72

320

2211

Abnormal findings on examination of urine, without diagnosis

431

2988

1.59

14.41

1.9

1.8

1.66

1.24

mg/l

1.34

352

2252

Fluid overload

188

4.59

14.38

2.4

1.5

1.22

1.43

mg/l

0.37

146

Benign intracranial hypertension

136

707

2.40

14.37

2.2

1.7

0.70

0.78

mg/l

0.28

498

Cystic fibrosis, other manifestations/unspecified

104

7.86

14.35

4.9

1.6

1.43

0.91

mg/l

0.32

Other encephalitis

303

1964

1.76

14.33

2.0

1.8

1.00

1.15

mg/l

0.40

236

1468

Endometriosis of intestine

196

1135

2.02

14.32

1.9

1.6

1.00

0.82

mg/l

0.44

145

810

Habitual aborter

236

1433

1.88

14.30

2.0

1.6

0.69

0.81

mg/l

0.73

189

1033

Abnormal findings on diagnostic imaging of central nervous system

494

3521

1.54

14.28

2.1

1.8

1.10

1.05

mg/l

0.11

372

2636

Non-small cell lung cancer

853

6505

1.37

14.28

1.6

1.7

1.95

1.38

mg/l

2.41

719

5025

Uterine polyps

937

7324

1.36

14.27

1.7

1.6

1.03

1.15

mg/l

0.70

721

5631

Other and unspecified mononeuropathies, also in other diseases

305

1975

1.74

14.27

1.7

0.86

1.23

mg/l

4.28

224

1510

Other and unspecified paralytic syndromes

170

950

2.15

14.24

2.6

1.8

1.02

1.17

mg/l

0.35

141

715

Focal brain injury

559

4032

1.47

14.19

1.6

1.61

1.41

mg/l

0.54

413

3063

Sequelae of injuries of neck and trunk

312

2035

1.73

14.18

2.0

1.8

1.22

1.09

mg/l

0.42

238

1540

Postpartum care and examination

1514

7863

1.28

14.08

2.1

1.6

1.01

0.74

mg/l

2.44

1137

5566

Lichen planus, including avohilmo

1853

15610

1.24

14.07

1.7

1.09

1.22

mg/l

1.25

1418

11984

Ankle and foot

115

568

2.59

14.07

1.5

1.7

0.89

1.05

mg/l

0.43

439

Astigmatism

596

4375

1.47

14.06

2.3

2.1

1.03

1.22

mg/l

0.62

431

3243

Right hemicolectomy

540

3910

1.50

14.04

2.4

1.7

2.17

1.37

mg/l

2.94

452

3035

Raynaud syndrome

889

6941

1.37

14.02

1.8

0.91

1.05

mg/l

0.62

649

5214

Osteonecrosis due to drugs

165

922

2.18

14.02

2.8

1.7

1.23

1.24

mg/l

0.03

135

727

Torsion of ovary, ovarian pedicle and fallopian tube

254

1581

1.82

14.01

1.8

1.6

0.94

0.98

mg/l

0.13

198

1151

Episcleritis

557

4071

1.50

14.01

2.0

1.7

0.85

0.95

mg/l

0.69

442

3037

therapeutic use

315

2067

1.72

14.01

2.9

1.6

1.60

1.25

mg/l

0.75

245

1585

Melanocytic naevi of trunk

1191

9612

1.31

14.00

2.1

1.8

1.12

1.15

mg/l

0.14

880

7246

Congenital malformations of the musculoskeletal system, not elsewhere classified

183

1054

2.08

13.97

2.9

2.0

1.39

0.75

mg/l

0.71

134

782

Other abnormal findings of blood chemistry

464

3287

1.55

13.95

2.0

1.7

1.51

1.14

mg/l

1.08

360

2496

Endometriosis diagnosis and infertility diagnosis occurring together

1152

9285

1.32

13.94

1.8

1.7

0.85

0.83

mg/l

0.07

866

6867

Need for immunization against other single viral diseases

219

1324

1.94

13.92

2.4

1.8

1.33

1.13

mg/l

0.54

166

1018

Thrombotic microangiopathy

394

3.03

13.91

4.5

1.6

1.96

0.93

mg/l

3.65

315

Ankylosing spondylitis, ICD10

886

6915

1.37

13.89

1.9

1.7

0.99

1.07

mg/l

0.46

666

5173

Other bursitis, not elsewhere classified

112

543

2.51

13.84

1.8

1.6

1.13

1.25

mg/l

0.13

420

Hirsutism in women

235

1452

1.89

13.82

1.8

1.7

0.64

0.75

mg/l

0.56

167

1061

Hypercalcemia

426

2980

1.58

13.81

2.1

1.7

1.53

1.26

mg/l

1.14

338

2293

Abnormal findings in nipple discharge synovial fluid wound secretions

185

1074

2.07

13.81

2.2

1.7

1.27

1.09

mg/l

0.27

147

823

Testicular hypofunction

322

2124

1.69

13.81

2.1

1.8

0.91

1.12

mg/l

0.68

240

1565

6-mercaptopurine

344

2294

1.65

13.81

4.3

1.8

1.12

0.93

mg/l

0.50

263

1655

Encephalitis

318

2101

1.71

13.78

2.0

1.8

1.03

1.14

mg/l

0.27

244

1564

Allergic bronchopulmonary aspergillosis (ABPA)

164

4.07

13.72

2.6

1.4

1.71

0.92

mg/l

0.63

125

Lichen planus

1237

10051

1.30

13.71

1.7

1.17

1.26

mg/l

0.53

950

7730

Hypertrophic disorders of skin

596

4411

1.46

13.69

1.9

1.7

0.90

0.99

mg/l

0.32

443

3258

Burns and corrosions of external body surface, specified by site

1049

8356

1.33

13.68

1.9

1.23

1.14

mg/l

0.23

782

6233

Abscess of lung

169

950

2.10

13.66

2.3

1.8

1.63

1.25

mg/l

0.52

146

742

Benign neoplasm: Skin of other and unspecified parts of face

1025

8154

1.33

13.63

1.7

1.8

1.16

1.27

mg/l

0.65

761

6264

Whooping cough

162

902

2.14

13.62

2.1

1.7

0.87

0.93

mg/l

0.13

121

646

Other and unspecified haemorrhagic conditions

186

1083

2.03

13.55

2.6

1.7

1.15

1.13

mg/l

0.04

153

825

Disorder of external ear, unspecified

344

2319

1.66

13.54

1.6

1.7

1.00

1.14

mg/l

0.62

265

1743

Other articular cartilage disorders

244

1516

1.82

13.53

1.7

0.93

1.25

mg/l

2.09

196

1158

Hypertrichosis

262

1671

1.81

13.50

1.8

0.66

0.78

mg/l

0.67

186

1223

Cystic fibrosis

158

5.08

13.50

4.3

1.6

1.26

1.01

mg/l

0.17

112

Benign neoplasm: Liver

269

1727

1.80

13.48

2.2

1.7

0.99

1.02

mg/l

0.07

210

1294

Schizoaffective disorder

778

5994

1.39

13.48

1.9

1.08

0.96

mg/l

0.70

567

4426

Other spirochaetal diseases

3100

27240

1.18

13.44

1.7

1.8

1.00

1.16

mg/l

2.01

2265

20816

Unspecified jaundice

430

2999

1.54

13.43

2.4

1.7

1.85

1.30

mg/l

1.29

341

2309

Benign neoplasm: Duodenum

268

1718

1.79

13.42

1.9

1.6

1.24

1.28

mg/l

0.09

212

1340

Scabies

1382

11362

1.27

13.40

1.9

0.87

1.03

mg/l

1.70

995

8289

Other deformities of toe(s)

337

2254

1.65

13.38

1.6

1.8

1.02

1.20

mg/l

0.72

242

1692

Patent foramen ovale

239

1489

1.85

13.38

3.0

2.6

1.11

1.37

mg/l

0.49

174

1142

Somnolence

152

837

2.19

13.35

2.1

1.9

1.08

1.07

mg/l

0.01

114

626

Etanercept

670

5071

1.43

13.32

1.9

1.8

1.15

0.97

mg/l

1.02

517

3764

Antepartum haemorrhage, not elsewhere classified

919

7247

1.35

13.31

1.8

1.7

0.91

0.74

mg/l

1.11

680

5361

Pleural plaque with presence of asbestos

608

4515

1.44

13.31

1.6

1.7

1.28

1.71

mg/l

3.40

472

3592

Hypotension due to drugs

155

857

2.15

13.27

1.9

1.7

1.28

1.47

mg/l

0.34

125

690

Amputation of foot

243

1516

1.81

13.27

2.0

1.8

1.80

1.51

mg/l

0.53

214

1206

Spermatocele

638

4764

1.42

13.27

1.8

1.01

1.56

mg/l

6.27

474

3728

Other and unspecified disorders of skin and subcutaneous tissue

613

4576

1.44

13.24

1.7

1.8

1.00

1.20

mg/l

1.68

428

3499

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

694

5181

1.41

13.23

2.1

2.3

1.30

1.00

mg/l

0.49

512

3757

Benign neoplasm: Liver/bile ducts

292

1917

1.74

13.21

2.2

1.7

1.02

1.03

mg/l

0.03

228

1445

Viral agents as the cause of diseases classified to other chapters

279

1811

1.76

13.21

2.3

1.9

1.01

1.12

mg/l

0.35

227

1373

Other congenital malformations of skin

801

6218

1.38

13.12

1.9

1.06

1.11

mg/l

0.12

615

4613

Other disorders of amniotic fluid and membranes

1439

11634

1.27

13.07

1.7

0.81

0.80

mg/l

0.06

1083

8475

Contusion of toe(s) without damage to nail

272

1754

1.75

13.07

2.0

1.9

0.81

0.98

mg/l

0.90

202

1278

Exposure to other and unspecified animate mechanical forces

331

2229

1.66

13.07

1.8

1.18

0.98

mg/l

0.28

246

1632

Malignant neoplasm of bladder, including Hilmo

976

7671

1.32

13.06

1.8

1.7

1.81

1.42

mg/l

1.92

804

6001

Disorders of plasma-protein metabolism, not elsewhere classified

428

2.78

13.05

2.5

1.7

1.45

1.11

mg/l

0.45

322

Inflammatory disorders of breast

698

5334

1.41

13.05

1.7

1.8

1.14

0.99

mg/l

0.62

516

3928

Other immunodeficiencies

136

731

2.28

13.02

2.7

2.1

0.85

1.10

mg/l

0.82

120

552

Dystonia

555

4100

1.47

13.02

2.0

1.8

1.02

1.13

mg/l

0.49

401

3121

Degenerative macular diseases

1096

8827

1.31

13.01

1.8

1.7

1.49

1.43

mg/l

0.20

851

6865

Ulcer of vagina/vulva

290

1908

1.73

12.98

1.9

1.8

0.75

1.00

mg/l

2.67

219

1424

Wegener granulomatosis

174

1007

2.05

12.96

2.6

1.7

2.02

1.25

mg/l

1.70

149

785

Other and unspecified mononeuropathies of upper limb

317

2121

1.67

12.90

1.8

1.7

1.44

1.06

mg/l

0.44

240

1580

Macular pucker

1379

11396

1.27

12.90

1.6

1.7

1.57

1.45

mg/l

0.28

1066

8907

Entropion and trichiasis of eyelid

739

5675

1.38

12.80

1.9

1.7

1.41

1.56

mg/l

0.47

575

4419

Amputation of thigh

258

1636

1.74

12.78

3.2

1.7

2.29

1.51

mg/l

2.77

228

1286

Operations for atrial fibrillation

164

940

2.09

12.77

2.4

1.7

1.86

1.35

mg/l

0.93

127

740

Other spirochaetal diseases

3049

26865

1.17

12.72

1.7

1.8

1.01

1.16

mg/l

1.91

2232

20534

Urethral stricture

487

3513

1.49

12.70

1.7

1.42

1.57

mg/l

0.22

349

2730

Spirochaetal infections, other/unspecified

3041

26796

1.17

12.68

1.7

1.8

1.01

1.15

mg/l

1.89

2223

20493

Bullous disorders

543

4007

1.47

12.67

2.1

1.7

1.56

1.28

mg/l

0.62

426

3077

Volvulus

261

1672

1.74

12.61

1.8

1.7

1.45

1.28

mg/l

0.35

218

1302

Ulcerative colitis (strict definition, all Crohn cases excluded)

1416

11751

1.26

12.56

1.9

1.8

1.07

1.08

mg/l

0.04

1102

8747

Secondary parkinsonism, excluding more controls

218

1330

1.81

12.55

1.9

1.6

1.46

1.54

mg/l

0.11

171

1020

Systemic sclerosis (FG)

245

1557

1.78

12.54

2.1

1.7

1.46

1.10

mg/l

0.53

200

1176

Postpartum haemorrhage

2785

20535

1.18

12.51

1.8

1.7

1.23

0.81

mg/l

7.76

2121

15019

Hepatocellular carcinoma, including Hilmo

248

1570

1.75

12.45

1.9

1.6

2.84

1.34

mg/l

3.78

210

1216

Infective bursitis

258

1652

1.73

12.41

1.9

1.8

1.17

1.39

mg/l

0.89

203

1273

Panniculitis, unspecified

120

624

2.32

12.41

1.9

1.6

0.77

1.21

mg/l

2.82

100

477

Intercostal neuropathy

102

507

2.57

12.35

1.8

1.7

1.02

1.42

mg/l

1.41

393

Hypoparathyroidism

370

2580

1.60

12.35

2.8

1.7

1.45

1.29

mg/l

0.28

287

1974

Secondary polycythaemia

244

1556

1.78

12.35

2.0

1.7

0.96

1.19

mg/l

1.16

183

1200

Allergic purpura

316

2132

1.65

12.32

2.0

1.8

1.01

1.06

mg/l

0.11

240

1580

Respiratory disorders in diseases classified elsewhere

162

937

2.08

12.29

2.8

1.7

1.87

1.19

mg/l

1.53

132

737

Other and unspecified types of non-Hodgkin lymphoma, hilmo

387

2713

1.56

12.27

2.0

1.8

1.87

1.41

mg/l

1.13

318

2099

Status epilepticus

333

2259

1.61

12.24

2.8

1.8

1.50

1.34

mg/l

0.33

270

1732

Benign neoplasm: Rectosigmoid junction

385

2704

1.57

12.19

1.8

1.7

1.34

1.33

mg/l

0.01

308

2121

Explicit fungal Sepsis

387

2.78

12.14

5.9

1.6

2.59

1.39

mg/l

1.91

293

Autonomic disorders

246

1581

1.77

12.12

2.0

1.6

1.85

1.06

mg/l

0.49

182

1210

Lyme disease

3010

26590

1.17

12.09

1.7

1.8

1.01

1.16

mg/l

1.85

2201

20337

Alzheimer’s disease (Atypical or mixed), excluding more controls

663

3986

1.39

12.08

1.5

1.77

1.92

mg/l

0.28

497

3152

Fall involving bed

302

2024

1.65

12.03

2.2

1.8

1.39

mg/l

0.00

245

1577

Medical treatment for female infertility

2311

19961

1.19

11.99

1.8

1.7

0.99

0.80

mg/l

1.68

1786

14685

Retinal haemorrhage

248

1598

1.75

11.96

2.0

1.7

1.29

1.26

mg/l

0.03

199

1241

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

507

3647

1.45

11.96

2.9

2.5

1.66

1.11

mg/l

0.83

355

2545

Other and unspecified mononeuropathies of lower limb

290

1939

1.68

11.93

1.8

1.6

1.15

1.17

mg/l

0.03

217

1471

Necrotizing fasciitis

276

3.18

11.93

2.4

1.5

1.75

1.53

mg/l

0.29

212

Chalazion

1105

9002

1.29

11.89

1.7

1.8

0.91

1.17

mg/l

3.72

819

6791

Implicit parasitic Sepsis

291

3.18

11.88

2.5

1.8

1.36

1.03

mg/l

0.39

226

Non-small cell lung cancer, adenocarcinoma, helper endpoint

542

4035

1.44

11.85

1.7

2.26

1.50

mg/l

1.92

456

3165

Haemangioma and lymphangioma, any site

886

7057

1.33

11.85

2.0

1.8

1.28

1.15

mg/l

0.45

680

5320

Ehlers-Danlos syndrome

157

912

2.08

11.82

2.8

1.7

0.71

0.83

mg/l

0.36

117

659

Congenital malformations of genital organs

956

7632

1.32

11.80

1.8

2.0

0.91

0.96

mg/l

0.30

743

5559

Vitamin B12 deficiency anaemia

939

7506

1.31

11.78

1.8

1.6

1.70

1.37

mg/l

1.13

743

5802

Atopic conjunctivitis

452

3281

1.50

11.74

2.3

1.8

0.79

1.00

mg/l

1.70

339

2423

Pneumonia derived septicemia

326

2229

1.61

11.71

2.3

1.9

2.09

1.33

mg/l

1.68

265

1685

Lactose intolerance, other/unspecified

284

1892

1.67

11.70

1.8

1.46

1.06

mg/l

0.95

205

1393

Thiazolidinediones

1022

8274

1.30

11.67

1.8

1.7

1.51

1.35

mg/l

0.49

823

6386

Alcoholic liver disease

890

7091

1.32

11.67

1.8

2.30

1.25

mg/l

7.62

751

5536

Superficial injury of neck

219

1380

1.80

11.66

2.1

1.8

1.11

1.02

mg/l

0.11

154

1005

Other disorders starting during childhood or adolescence

447

3189

1.48

11.64

3.1

2.7

1.83

1.16

mg/l

0.90

308

2198

Anorexia (incl.atypical)

597

4515

1.41

11.64

2.1

1.8

0.88

1.01

mg/l

0.84

403

3292

Benign neoplasm: Skin of eyelid, including canthus

1484

12477

1.24

11.62

1.6

1.7

1.17

1.27

mg/l

0.60

1117

9622

Pedestrian injured in collision with pedal cycle

321

2201

1.62

11.61

1.9

1.8

1.09

1.12

mg/l

0.07

240

1682

Pilonidal cyst

844

6684

1.33

11.60

1.9

1.8

1.02

0.98

mg/l

0.16

626

4849

Other chondrocalcinosis

141

796

2.13

11.57

1.8

1.7

1.19

1.46

mg/l

0.96

111

636

Hypertrophic scar

542

4064

1.44

11.53

1.9

1.7

0.90

0.98

mg/l

0.31

406

2989

Non-seminoma of testis, including Hilmo

315

2.87

11.51

1.5

2.0

1.66

0.84

mg/l

1.71

219

Flatulence and related conditions

115

604

2.26

11.47

3.2

1.6

0.73

1.04

mg/l

2.11

462

Haemangioma, any site

826

6555

1.34

11.43

2.0

1.8

1.31

1.14

mg/l

0.57

636

4951

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

853

6798

1.33

11.41

1.8

1.7

1.11

1.27

mg/l

0.97

656

5211

Drug-induced polyneuropathy

111

587

2.38

11.39

6.2

1.9

2.19

1.30

mg/l

0.39

471

Injury of other and unspecified intrathoracic organs

589

4472

1.41

11.31

1.7

1.63

1.23

mg/l

1.35

453

3394

Chronic myeloproliferative disease

150

869

2.06

11.29

2.2

1.7

1.38

1.30

mg/l

0.13

117

682

Carcinoma in situ of skin

762

5996

1.35

11.28

1.9

1.7

1.60

1.44

mg/l

0.63

584

4673

Pedestrian injured in transport accident

662

5114

1.38

11.28

1.8

1.18

1.09

mg/l

0.35

486

3847

Conduct disorder

218

1375

1.76

11.26

2.4

2.1

0.84

0.97

mg/l

0.39

158

964

Acne

982

7917

1.30

11.25

2.3

1.9

0.82

0.98

mg/l

1.72

685

5505

Emotional disorders starting during childhood or adolescence

438

3139

1.48

11.23

2.6

2.4

1.52

1.11

mg/l

0.49

270

2118

Other diseases of spinal cord

303

2068

1.63

11.20

2.4

1.7

1.16

1.13

mg/l

0.07

243

1574

Dependence on enabling machines and devices, not elsewhere classified

117

620

2.20

11.12

6.8

2.2

4.60

1.64

mg/l

1.56

104

490

Congenital malformations of the urinary system

575

4365

1.41

11.12

2.1

1.96

1.19

mg/l

1.25

459

3230

Renal tubulo-interstitial disorders in diseases classified elsewhere

112

595

2.30

11.09

3.0

1.6

1.41

1.10

mg/l

0.72

452

Other congenital malformations of skin

406

2930

1.52

11.09

2.0

1.9

1.19

1.13

mg/l

0.08

313

2172

Other orthopaedic follow-up care

533

4005

1.43

11.04

1.8

1.6

0.99

1.06

mg/l

0.28

409

3021

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

676

5255

1.37

11.03

1.8

0.95

0.99

mg/l

0.17

470

3840

Cushing syndrome

139

795

2.11

11.02

2.2

1.7

0.81

1.11

mg/l

1.56

110

607

Social phobias

802

6344

1.33

10.98

2.0

1.8

1.00

mg/l

0.02

557

4509

Papilloedema, unspecified

245

1612

1.72

10.95

2.0

1.8

1.91

1.04

mg/l

0.57

186

1199

Personal history of risk-factors, not elsewhere classified

150

870

2.00

10.95

3.0

1.8

1.89

0.95

mg/l

0.57

115

640

Ulcerative rectosigmoiditis

809

6433

1.33

10.94

1.8

1.7

1.19

1.04

mg/l

0.88

619

4778

Drug-induced osteoporosis

148

865

2.05

10.92

3.9

1.7

1.71

1.13

mg/l

1.10

122

675

Colon adenocarcinoma

998

8104

1.29

10.91

1.7

1.75

1.33

mg/l

3.11

810

6282

Mental and behavioural disorders due to cannabinoids

286

1928

1.62

10.88

2.2

2.0

1.25

0.93

mg/l

0.77

173

1300

Infections of genitourinary tract in pregnancy

957

7763

1.30

10.88

1.7

0.79

0.99

mg/l

2.28

734

5741

Postpartum hemorraghe, all women as controls

2785

24269

1.17

10.88

1.8

1.7

1.23

0.83

mg/l

7.01

2121

17880

Other salmonella infections

421

3058

1.49

10.87

1.9

1.7

1.00

1.11

mg/l

0.49

320

2283

Crohn's disease of large intestine

511

3831

1.44

10.86

1.8

1.09

1.00

mg/l

0.31

370

2839

Inguinal or femoral hernia, bilateral

908

7305

1.30

10.83

1.8

1.22

1.37

mg/l

0.73

700

5731

Personal history of allergy to drugs, medicaments and biological substances

138

790

2.08

10.79

2.0

1.6

1.25

0.98

mg/l

0.17

110

608

Complications of genitourinary prosthetic devices, implants and grafts

261

1745

1.67

10.74

1.9

1.6

1.17

1.10

mg/l

0.21

206

1311

Livedoid vasculitis

251

3.37

10.74

1.9

1.6

0.98

1.47

mg/l

1.19

198

Crohn disease (strict definition, require KELA, min 2 HDR)

625

4828

1.38

10.72

1.8

0.97

0.99

mg/l

0.10

431

3540

Crohn disease (strict definition, require KELA)

632

4889

1.38

10.72

1.8

0.96

0.99

mg/l

0.14

438

3580

Toxic effect of other and unspecified substances

143

824

2.02

10.71

2.1

1.8

0.86

0.98

mg/l

0.36

107

610

Endometriosis ASRM stages 3,4

2412

21201

1.18

10.71

1.7

1.10

1.00

mg/l

0.46

1775

15994

Chronic hepatitis, not elsewhere classified

349

2473

1.56

10.69

2.1

1.7

1.74

1.00

mg/l

3.25

279

1871

Other and unspecified psoriasis

632

4894

1.38

10.65

1.9

1.8

1.46

1.19

mg/l

1.06

482

3751

Malignant neoplasm of breast

4616

27356

1.13

10.65

1.6

1.7

1.16

0.93

mg/l

6.50

3544

20718

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

102

533

2.35

10.65

2.2

1.7

1.82

1.24

mg/l

0.80

431

Malignant neoplasm of breast, HER2-negative, including Hilmo

4719

27790

1.13

10.64

1.6

1.7

1.15

0.92

mg/l

6.54

3631

21033

Malignant neoplasm of breast, including Hilmo

4719

27790

1.13

10.62

1.6

1.7

1.15

0.92

mg/l

6.54

3631

21033

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

108

577

2.30

10.61

2.2

1.8

3.40

1.34

mg/l

0.65

453

Congenital malformations of gallbladder, bile ducts and liver

115

628

2.24

10.61

8.0

2.5

1.76

1.37

mg/l

0.46

493

Other juvenile arthritis

372

2648

1.51

10.60

2.2

2.1

1.11

1.14

mg/l

0.07

280

1859

Malignant neoplasm of breast, HER2-negative

4550

27039

1.13

10.58

1.6

1.7

1.16

0.93

mg/l

6.40

3494

20486

Oesophageal obstruction

315

2182

1.57

10.57

1.8

1.7

1.62

1.31

mg/l

0.98

258

1717

Open wound of abdomen, lower back and pelvis

310

2149

1.59

10.52

2.1

1.9

1.40

1.07

mg/l

0.78

233

1579

Other autoimmune haemolytic anaemias

140

813

2.05

10.49

2.9

1.7

3.10

1.36

mg/l

1.24

118

625

233

1527

1.70

10.40

1.9

1.6

1.05

0.97

mg/l

0.14

169

1132

Alzheimer’s disease (Late onset), excluding more controls

1181

6367

1.26

10.40

1.6

1.69

1.86

mg/l

0.85

920

5004

Malignant neoplasm of other connective and soft tissue, including Hilmo

372

2667

1.51

10.37

2.0

1.6

1.88

1.16

mg/l

1.45

300

2025

Alcohol-induced acute pancreatitis

340

2406

1.55

10.36

1.8

1.44

1.24

mg/l

0.43

262

1864

Carcinoma in situ of skin of trunk

281

1916

1.62

10.36

1.7

1.50

1.49

mg/l

0.02

217

1512

Short Achilles tendon (acquired)

258

1724

1.64

10.36

1.8

1.6

0.91

1.07

mg/l

0.38

216

1284

Childhood allergy (age < 16)

1348

9297

1.23

10.35

2.2

1.46

1.03

mg/l

1.10

880

6233

Unspecified threat to breathing

123

693

2.16

10.31

2.3

2.1

0.85

1.12

mg/l

1.07

515

Malignant melanoma, including Hilmo

1560

13292

1.22

10.31

1.7

1.46

1.20

mg/l

0.93

1206

10194

Congenital aortic valve stenosis

256

3.02

10.30

6.5

3.2

1.57

1.21

mg/l

0.35

194

Manic episode

310

2158

1.58

10.29

2.0

1.7

1.10

1.01

mg/l

0.32

236

1585

Benign neoplasm of meninges

967

7908

1.29

10.27

2.0

1.7

1.39

1.22

mg/l

0.36

752

6065

Implicit parasitic Sepsis

342

2.74

10.27

2.6

1.8

1.29

1.01

mg/l

0.36

265

Pedal cyclist injured in other and unspecified transport accidents

1066

8790

1.27

10.26

1.7

1.8

1.07

1.13

mg/l

0.39

815

6564

Carcinoma in situ of skin of upper limb, including shoulder

236

1564

1.70

10.21

1.7

2.35

1.44

mg/l

0.77

190

1244

Hereditary hypogammaglobulinemia

245

3.33

10.19

2.6

1.7

0.90

1.39

mg/l

0.58

191

Drug-induced systemic lupus erythematosus

470

2.50

10.18

2.9

1.8

1.29

0.91

mg/l

0.75

356

Inflammatory disease of cervix uteri

628

4902

1.37

10.17

1.6

1.7

0.77

1.10

mg/l

5.77

472

3765

Malignant neoplasm of heart, mediastinum and pleura

124

693

2.07

10.15

2.1

1.7

2.00

1.47

mg/l

0.96

538

Infectious mononucleosis

828

6649

1.31

10.14

2.1

1.9

0.92

0.90

mg/l

0.05

559

4671

Motor disorders, excluding more controls

117

597

2.05

10.10

6.7

3.7

1.23

1.69

mg/l

0.53

404

Ulcerative enterocolitis

316

2219

1.57

10.09

2.0

1.7

1.46

0.99

mg/l

1.03

248

1648

Hyperosmolality and hypernatraemia

137

791

1.99

10.08

1.8

1.7

1.67

1.29

mg/l

0.72

108

608

Impetigo

429

3165

1.46

10.06

2.7

2.1

0.87

1.10

mg/l

1.60

329

2296

Idiopathic urticaria

234

1555

1.70

10.06

2.2

1.7

0.77

0.93

mg/l

0.83

190

1155

Other disorders of male genital organs

320

2237

1.54

10.05

1.8

1.9

1.09

1.26

mg/l

0.41

233

1660

Malignant neoplasm of breast, ER-positive, including Hilmo

3420

23701

1.14

10.04

1.6

1.7

1.18

0.96

mg/l

5.31

2633

18059

Malignant neoplasm of ovary

459

3436

1.45

10.03

1.8

1.96

1.10

mg/l

5.25

384

2603

Contact with heat and hot substances

508

3848

1.41

10.03

2.0

1.22

1.12

mg/l

0.34

376

2878

Pulmonary oedema

166

1007

1.84

10.03

3.3

1.7

1.71

1.37

mg/l

0.85

140

798

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

159

953

1.87

10.03

2.1

1.7

1.82

1.37

mg/l

1.08

131

732

Use of levodopa decarboxylase inhibitor

1171

9762

1.25

9.98

1.7

1.34

1.52

mg/l

1.11

922

7624

Xerosis cutis

164

1005

1.89

9.97

2.4

1.7

1.11

1.29

mg/l

0.55

130

780

Lichen sclerosus et atrophicus

989

8133

1.28

9.97

1.7

1.06

1.16

mg/l

0.68

757

6212

Hypersomnia

155

936

1.92

9.96

1.8

0.95

1.08

mg/l

0.28

111

697

Behavioural disorders

214

1386

1.71

9.95

2.4

2.2

0.84

0.99

mg/l

0.48

156

964

Aspergillosis

103

555

2.29

9.95

3.3

1.7

1.58

1.34

mg/l

0.27

446

Herpesviral keratitis and keratoconjunctivitis

417

3076

1.47

9.95

1.8

1.7

1.13

1.19

mg/l

0.14

315

2336

Burns and corrosions confined to eye and internal organs

278

1913

1.61

9.94

1.9

1.8

0.74

1.01

mg/l

1.67

205

1426

Other noninflammatory disorders of cervix uteri

454

3389

1.44

9.93

1.9

1.7

1.02

1.31

mg/l

1.94

340

2618

Malignant neoplasm of corpus uteri, including Hilmo

870

7066

1.30

9.90

1.5

1.7

1.86

1.19

mg/l

3.47

690

5395

Amputation of ankle bones

203

1303

1.74

9.89

2.2

1.7

1.56

1.37

mg/l

0.51

172

1035

Other obstructive and reflux uropathy

409

3001

1.46

9.88

1.8

1.7

1.38

1.10

mg/l

1.19

330

2221

Hypogonadotropic hypogonadism

275

1887

1.61

9.88

2.0

1.9

0.61

1.08

mg/l

6.95

208

1370

Alcohol withdrawal state with delirium

615

4791

1.36

9.87

1.7

1.8

1.35

1.25

mg/l

0.39

491

3723

Mixed disorders of conduct and emotions

224

1465

1.67

9.85

2.0

2.5

0.91

0.93

mg/l

0.07

155

959

Whooping cough

387

2.55

9.84

2.3

1.8

1.19

1.06

mg/l

0.14

283

Anankastic personality disorder

404

2975

1.48

9.83

1.7

0.94

0.96

mg/l

0.06

296

2199

Crohn disease (strict definition, all UC cases excluded)

500

3795

1.42

9.83

1.8

0.97

0.99

mg/l

0.08

346

2793

Primary adrenocortical insufficiency

132

770

2.05

9.82

2.3

1.8

0.76

1.02

mg/l

1.47

596

Foreign body in respiratory tract

487

3681

1.42

9.82

2.0

1.9

0.94

1.17

mg/l

1.37

339

2757

ILD and respiratory illness in diseases classified elsewhere

338

2.77

9.80

2.2

1.7

1.47

1.36

mg/l

0.09

271

Arthropathy in ulcerative colitis

150

905

1.95

9.80

1.8

1.7

1.04

1.07

mg/l

0.06

121

686

Venous complications and haemorrhoids in the puerperium

138

819

2.03

9.80

2.0

1.8

2.18

0.91

mg/l

0.94

106

625

Molar incisor enamel hypoplasia

283

1868

1.57

9.79

6.6

2.9

2.40

1.16

mg/l

1.43

226

1297

Inguinal hernia, bilateral

882

7156

1.29

9.79

1.8

1.23

1.37

mg/l

0.66

681

5619

Assault by unspecified means

217

1422

1.71

9.78

1.8

1.12

0.99

mg/l

0.29

148

1033

Chronic tubulo-interstitial nephritis

359

2586

1.50

9.77

1.7

1.6

1.21

1.05

mg/l

0.67

275

1934

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

758

6076

1.32

9.74

1.9

1.8

1.02

1.17

mg/l

0.97

576

4636

Ehlers-Danlos syndrome

124

714

2.10

9.70

3.0

1.7

0.81

mg/l

0.01

520

Benign neoplasm of eye and adnexa

944

7746

1.28

9.69

1.9

1.8

1.02

1.26

mg/l

2.66

714

5955

Kyphosis

133

772

1.98

9.66

2.0

1.7

1.03

1.26

mg/l

0.81

109

592

Malignant neoplasm of digestive organs

3556

25301

1.13

9.63

1.8

1.7

2.31

1.22

mg/l

23.98

2937

19475

Malignant neoplasm of breast, HER-positive

3337

23405

1.14

9.63

1.6

1.7

1.17

0.97

mg/l

4.73

2564

17833

Ulcerative proctitis

606

4734

1.36

9.60

1.8

1.7

1.03

1.00

mg/l

0.07

471

3500

Contracture of joint

131

759

1.98

9.56

1.6

1.24

1.25

mg/l

0.02

569

Spinal osteochondrosis

118

664

2.06

9.55

1.6

0.92

1.13

mg/l

0.53

486

Other and unspecified vaccines and biological substances

451

2.44

9.53

3.8

1.8

1.04

1.00

mg/l

0.04

346

Hyposplenism

5.78

9.53

5.3

1.8

1.49

1.06

mg/l

0.59

Infection due to other mycobacteria

151

910

1.88

9.52

3.0

1.6

1.72

1.27

mg/l

0.39

124

699

Other retinal artery occlusion

212

1388

1.70

9.50

1.6

1.7

1.16

1.32

mg/l

0.64

161

1090

Previous suicide attempt

119

676

2.07

9.49

2.2

1.9

1.01

0.94

mg/l

0.16

498

Seropositive rheumatoid arthritis, strict definition

1453

12422

1.22

9.49

1.7

1.53

1.17

mg/l

2.94

1181

9496

Other disorders of pigmentation

415

3083

1.46

9.48

1.8

1.19

1.29

mg/l

0.19

314

2348

Complications of labour and delivery

6922

35732

1.10

9.48

1.7

1.04

1.00

mg/l

0.56

5283

26614

Other sexually transmitted chlamydial diseases

640

5031

1.34

9.47

1.8

0.81

0.88

mg/l

0.41

435

3485

Acquired absence of limb

103

558

2.18

9.46

2.0

1.6

1.25

1.30

mg/l

0.08

440

Malignant neoplasm of bronchus and lung, including Hilmo

1838

13327

1.19

9.44

1.7

1.99

1.33

mg/l

4.76

1536

10341

Benign neoplasm: Cerebral meninges

881

7205

1.29

9.43

2.0

1.7

1.42

1.23

mg/l

0.38

686

5520

Diffuse brain injury

311

2186

1.52

9.42

1.7

1.6

1.78

1.26

mg/l

0.85

217

1612

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

541

4187

1.39

9.42

1.7

1.8

1.00

1.19

mg/l

0.99

409

3233

Scar conditions and fibrosis of skin

412

3065

1.46

9.42

2.3

1.7

1.01

1.00

mg/l

0.02

314

2295

Foreign body or object entering through skin

585

4557

1.36

9.41

1.8

1.25

1.08

mg/l

0.35

439

3386

Achalasia of cardia

180

1141

1.78

9.40

1.8

1.7

0.91

1.17

mg/l

1.53

150

883

Defect, injury or illness of neck

362

2.60

9.40

1.6

1.7

0.86

0.94

mg/l

0.14

275

312

2.82

9.34

2.2

1.8

1.53

1.36

mg/l

0.13

251

Graves disease, strict definition

1024

8515

1.26

9.27

2.0

1.7

0.79

0.98

mg/l

3.14

775

6428

Other and unspecified follicular disorders

390

2882

1.47

9.26

2.4

1.7

0.87

1.06

mg/l

1.49

297

2146

Corticotropin deficiency

103

570

2.22

9.25

1.9

1.8

0.79

1.26

mg/l

1.37

452

Erythema multiforme

234

1581

1.65

9.25

1.8

1.7

0.99

1.08

mg/l

0.34

177

1198

Disorders of phosphorus metabolism and phosphatases

277

2.83

9.24

2.4

2.1

1.50

0.88

mg/l

1.01

204

Effects of other external causes

290

2036

1.56

9.22

2.0

0.92

1.07

mg/l

0.48

205

1483

Hyperaldosteronism

277

1938

1.58

9.20

1.8

1.7

0.88

1.17

mg/l

1.65

208

1489

Other specified/unspecified hearing loss

748

6010

1.31

9.20

2.0

1.8

1.43

1.35

mg/l

0.22

575

4632

Thyroiditis, unspecified

172

1091

1.81

9.20

2.2

1.7

0.85

1.01

mg/l

0.64

129

819

Eosinophilia

172

1091

1.81

9.18

2.7

1.9

1.35

1.24

mg/l

0.17

136

833

Guillain-Barre syndrome

166

1042

1.82

9.16

2.0

1.6

1.61

1.16

mg/l

0.58

134

800

Parkinson's disease, including avohilmo

1354

11523

1.22

9.15

1.7

1.38

1.49

mg/l

0.70

1078

8999

Microscopic polyangiitis

389

2.55

9.14

2.3

1.9

2.84

1.36

mg/l

1.22

311

Mature T/NK-cell lymphomas, hilmo

139

835

1.93

9.13

2.5

1.7

1.82

1.30

mg/l

1.56

121

651

Carcinoma in situ of skin of scalp and neck

223

1493

1.66

9.11

1.7

1.39

1.55

mg/l

0.46

184

1195

Other mycoses, not elsewhere classified/unspecified

182

1172

1.78

9.11

3.1

1.7

1.57

1.14

mg/l

0.94

145

889

Viral agents as the cause of diseases classified to other chapters

230

1557

1.66

9.10

2.4

1.9

1.09

1.10

mg/l

0.03

191

1189

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

146

891

1.89

9.04

1.9

0.95

1.08

mg/l

0.33

109

674

Disorders of magnesium metabolism

449

2.34

9.03

1.7

1.70

1.35

mg/l

0.68

359

Other forms of systemic lupus erythematosus

105

589

2.18

9.03

2.1

1.7

1.54

0.94

mg/l

1.23

458

Late syphilis

166

1046

1.81

9.02

1.8

1.6

1.06

1.18

mg/l

0.36

134

818

Injury of nerves at forearm level

146

893

1.90

9.02

2.7

1.6

0.67

1.17

mg/l

4.46

105

662

Personal history of certain other diseases

202

1328

1.70

9.02

2.4

1.7

1.03

0.88

mg/l

0.41

150

964

Problems related to social environment

278

1943

1.56

9.02

1.9

1.7

1.01

1.12

mg/l

0.42

228

1461

Hypoplasia of dental enamel , including avohilmo

264

1763

1.57

9.01

6.6

2.8

2.52

1.17

mg/l

1.46

210

1219

Atrial septal defect, secundum type

267

1849

1.58

9.00

3.0

2.7

1.38

1.36

mg/l

0.02

189

1396

Parkinson's disease, strict definition

1203

10157

1.23

8.95

1.7

1.41

1.51

mg/l

0.48

960

7933

Disorders of porphyrin and bilirubin metabolism

119

686

2.01

8.95

2.3

1.9

1.15

1.12

mg/l

0.05

516

Isolated proteinuria

272

1903

1.57

8.93

1.9

1.8

1.54

1.23

mg/l

0.78

225

1433

Chronic conjunctivitis

298

2123

1.54

8.90

1.9

1.8

1.00

1.21

mg/l

0.63

239

1620

Acquired absence of organs, not elsewhere classified

123

717

1.98

8.90

1.9

1.7

1.62

1.25

mg/l

0.63

560

Other and unspecified injuries of abdomen, lower back and pelvis

159

995

1.82

8.88

2.0

1.7

1.33

1.07

mg/l

0.37

121

731

Other disorders of optic disc

151

937

1.87

8.87

2.1

1.8

2.28

1.14

mg/l

0.44

117

719

Drug-induced headache, not elsewhere classified

394

2.52

8.86

1.9

1.7

0.85

0.75

mg/l

0.17

305

Vertigo of central origin

162

1019

1.81

8.86

1.7

1.6

0.90

1.26

mg/l

1.29

115

785

Puerperal sepsis

1258

10703

1.23

8.85

1.6

1.7

0.93

1.01

mg/l

0.58

947

8155

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

300

2128

1.53

8.85

2.6

2.7

1.72

1.16

mg/l

1.17

235

1562

Central retinal artery occlusion

195

1273

1.70

8.84

1.9

1.6

1.47

mg/l

0.00

162

1010

Fracture of neck

529

4104

1.37

8.82

1.8

1.7

1.37

1.34

mg/l

0.06

400

3152

Mantle cell lymphoma, including Hilmo

131

778

1.92

8.79

2.1

1.6

2.63

1.41

mg/l

0.79

115

591

Benign neoplasm of middle ear and respiratory system

702

5637

1.31

8.78

1.9

1.8

1.26

1.29

mg/l

0.08

563

4332

Injury of intra-abdominal organs

245

1684

1.60

8.78

2.0

1.8

1.99

1.12

mg/l

2.03

183

1270

Other specified disorders of external ear

335

2437

1.49

8.77

1.6

1.7

1.07

1.38

mg/l

1.21

257

1909

Diabetic retinopathy

3368

18993

1.14

8.76

1.8

1.9

1.35

1.29

mg/l

0.37

2675

14947

Acquired coagulation factor deficiency

5.04

8.76

8.3

1.7

1.18

mg/l

0.01

Contact with and exposure to communicable diseases

3228

29036

1.13

8.73

2.0

1.8

0.91

0.99

mg/l

0.71

2196

21260

Sudden idiopathic hearing loss

913

7545

1.27

8.72

1.9

1.7

1.05

1.30

mg/l

2.14

674

5842

Generalized epilepsy

420

3167

1.43

8.71

1.7

2.0

1.33

1.01

mg/l

0.47

312

2349

Benign mammary dysplasia

1372

11768

1.22

8.71

1.7

1.02

1.14

mg/l

0.97

1057

8989

Other acute viral hepatitis

144

887

1.88

8.70

1.7

1.8

1.07

1.11

mg/l

0.09

115

667

Other sexually transmitted chlamydial diseases

954

7901

1.26

8.69

2.0

1.8

0.79

0.95

mg/l

1.72

655

5408

Malignant melanoma

1267

10778

1.22

8.65

1.8

1.7

1.49

1.20

mg/l

0.88

993

8250

Femoral hernia

395

2949

1.44

8.65

1.8

1.7

1.27

1.22

mg/l

0.12

304

2280

Malignant neoplasm of thymus, including Hilmo

240

2.93

8.65

2.0

1.7

1.18

1.08

mg/l

0.14

184

Pedal cyclist injured in transport accident

2168

19173

1.16

8.63

1.8

1.03

1.12

mg/l

1.01

1626

14384

Superficial injuries involving multiple body regions

266

1866

1.57

8.62

1.9

1.8

1.07

1.09

mg/l

0.03

203

1388

Magnesium deficiency

200

3.36

8.61

2.4

1.7

1.34

1.13

mg/l

0.32

159

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

263

2.92

8.60

1.8

1.6

1.32

0.95

mg/l

0.50

207

Congenital malformations of the urinary system

524

4075

1.37

8.60

2.2

2.1

2.02

1.12

mg/l

1.39

419

3007

Polyhydramnios

484

3733

1.39

8.60

1.8

1.7

0.87

0.70

mg/l

1.21

378

2718

Background retinopathy and retinal vascular changes

200

1326

1.68

8.59

1.8

1.7

1.19

1.24

mg/l

0.12

166

1030

Toxic effect of corrosive substances

305

2.63

8.58

1.6

1.9

0.59

1.01

mg/l

1.97

216

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

140

853

1.86

8.58

1.7

1.5

0.96

1.21

mg/l

0.60

113

661

Acquired clawhand, clubhand, clawfoot and clubfoot

305

2.62

8.57

1.7

1.6

0.61

1.00

mg/l

2.34

229

Arthropod-borne viral fevers and viral haemorrhagic fevers

876

7228

1.27

8.56

1.7

1.8

1.14

1.19

mg/l

0.22

683

5510

Pulmonary eosinophilia, not elsewhere classified

129

775

1.94

8.56

2.0

1.6

1.04

1.11

mg/l

0.22

101

609

Benign lipomatous neoplasm of other sites/unspecified

783

6385

1.29

8.55

1.6

1.8

1.27

1.30

mg/l

0.08

616

4929

Loose body in joint

221

1493

1.62

8.53

1.7

0.88

1.28

mg/l

2.06

157

1119

Open wound of hip and thigh

313

2260

1.50

8.51

1.8

1.9

1.11

1.02

mg/l

0.22

247

1651

Pyoderma

190

1250

1.70

8.50

1.9

0.87

1.07

mg/l

1.06

138

961

Personal history of medical treatment

112

647

2.03

8.49

2.7

1.9

1.30

1.10

mg/l

0.35

497

Chronic myeloid leukaemia, including Hilmo

100

559

2.12

8.47

1.9

1.6

1.56

1.01

mg/l

1.22

423

Lower leg

441

2.34

8.47

1.7

2.1

1.27

1.17

mg/l

0.10

339

Benign neoplasm: Pancreas

260

1829

1.58

8.45

2.0

1.6

1.47

1.30

mg/l

0.30

199

1437

Ventricular septal defect, a heart condition

203

1347

1.65

8.41

4.0

3.4

1.42

1.39

mg/l

0.03

152

992

Car occupant injured in noncollision transport accident

350

2582

1.47

8.40

1.9

1.8

1.16

1.06

mg/l

0.29

280

1914

Congenital iodine-deficiency syndrome/hypothyroidism

290

2078

1.53

8.40

1.7

0.99

1.18

mg/l

1.24

226

1574

Other salmonella infections

343

2520

1.47

8.40

2.0

1.7

1.11

1.16

mg/l

0.13

260

1903

Other neurotic disorders

446

3409

1.40

8.36

1.8

1.6

1.43

1.20

mg/l

0.55

323

2602

Serous carcinoma of ovary, including Hilmo

317

2310

1.50

8.36

1.8

2.50

1.13

mg/l

4.73

268

1768

Other specified disorders of kidney and ureter

316

2302

1.50

8.32

2.6

1.8

1.80

1.16

mg/l

2.17

247

1772

Cystic kidney disease

327

2394

1.49

8.31

2.2

1.9

2.58

1.12

mg/l

1.48

267

1816

Paralytic strabismus

636

5089

1.32

8.31

1.8

1.7

1.34

1.31

mg/l

0.07

490

3919

Other meningitis

172

1116

1.75

8.31

1.9

1.7

1.40

1.12

mg/l

0.51

130

835

449

3400

1.38

8.29

1.9

1.6

1.30

1.38

mg/l

0.20

363

2615

Struck by thrown, projected or falling objec

471

3630

1.38

8.29

1.9

1.8

1.12

1.08

mg/l

0.08

341

2700

Other and unspecified iridocyclitis

435

3324

1.41

8.29

1.9

1.7

0.99

1.10

mg/l

0.51

346

2480

Other misadventures during surgical and medical care

232

1603

1.61

8.28

2.2

1.7

1.48

1.14

mg/l

0.69

185

1228

Tracheo-bronchomalasia

241

2.74

8.28

1.9

1.6

0.44

0.56

mg/l

0.75

180

Spondylopathies in diseases classified elsewhere

114

663

1.97

8.27

2.4

1.6

1.27

1.45

mg/l

0.35

532

Alkalosis

129

3.77

8.21

2.8

1.5

1.23

0.90

mg/l

0.48

IgA nephropathy (IgA glomerulonephritis)

231

1596

1.60

8.20

2.8

1.7

1.64

1.11

mg/l

1.68

194

1201

Prurigo nodularis

242

1690

1.59

8.16

2.0

1.7

1.55

1.21

mg/l

0.40

192

1318

Follicular lymphoma, hilmo

378

2838

1.44

8.16

2.0

1.6

1.26

1.37

mg/l

0.30

310

2216

Dermatopolymyositis (FG)

136

834

1.85

8.14

2.2

1.7

1.26

1.18

mg/l

0.16

102

630

Conductive hearing loss, unspecified

763

6239

1.28

8.12

2.2

1.8

1.32

1.20

mg/l

0.43

594

4719

Parkinson's disease

1290

11049

1.21

8.12

1.7

1.39

1.49

mg/l

0.53

1029

8620

Caught, crushed, jammed or pinched in or between objects

473

3660

1.38

8.11

1.8

1.9

0.88

1.07

mg/l

1.71

342

2706

Marfan's syndrome

320

2.55

8.11

2.4

1.7

2.08

0.98

mg/l

1.29

250

Colorectal adenocarcinoma

1665

14484

1.18

8.10

1.6

1.7

1.93

1.29

mg/l

6.70

1355

11246

Complications of the puerperium, not elsewhere classified

443

3413

1.40

8.10

2.5

1.7

1.11

0.76

mg/l

1.89

337

2504

Arteriovenous malformation of peripheral vessels

343

2.53

8.09

3.6

1.8

1.40

0.82

mg/l

0.91

267

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

342

2525

1.46

8.08

2.4

2.3

1.56

1.06

mg/l

0.40

252

1809

Mesothelioma, including Hilmo

117

689

1.92

8.06

1.8

1.6

1.78

1.54

mg/l

0.40

542

Marginal zone B-cell lymphoma, including Hilmo

153

972

1.78

8.03

1.8

1.6

1.59

1.22

mg/l

0.93

120

736

Malignant neoplasm of respiratory system and intrathoracic organs

1776

12933

1.17

8.00

1.7

1.87

1.33

mg/l

5.49

1478

10033

Transient global amnesia

820

6775

1.27

7.98

1.7

1.23

1.34

mg/l

0.28

615

5284

Unspecified event, undetermined intent

250

1761

1.56

7.97

2.4

1.8

0.98

1.07

mg/l

0.27

180

1304

Other and unspecified nail disorders

225

1560

1.61

7.94

2.5

1.7

0.96

1.06

mg/l

0.36

167

1177

Other acquired deformities of musculoskeletal system and connective tissue

432

3320

1.40

7.91

1.9

1.7

0.97

1.11

mg/l

1.02

341

2517

Meningitis

474

3689

1.37

7.88

1.7

1.8

1.11

1.07

mg/l

0.13

360

2772

Pneumococcal septicemia

309

2261

1.48

7.84

2.2

1.9

2.10

1.25

mg/l

1.95

250

1721

Anomalies of pupillary function

221

1530

1.60

7.84

1.8

1.7

1.59

1.00

mg/l

0.46

154

1158

Benign neoplasm of ovary

1673

14677

1.18

7.83

1.7

1.06

1.10

mg/l

0.30

1307

11240

Lesion of sciatic nerve

363

2713

1.42

7.82

1.7

1.48

1.45

mg/l

0.05

297

2105

Monoplegia

158

1021

1.76

7.82

3.7

1.7

1.13

1.17

mg/l

0.06

123

800

Other and unspecified glaucoma

602

4816

1.32

7.82

1.6

1.8

1.77

1.45

mg/l

0.86

467

3753

Systemic sclerosis

245

1732

1.57

7.81

2.1

1.7

1.46

1.02

mg/l

0.70

200

1327

Hypersplenism

265

2.72

7.81

2.9

1.6

1.69

1.00

mg/l

0.87

205

Viral haemorrhagic fevers, not elsewhere classified/unspecified

720

5886

1.29

7.79

1.6

1.8

1.14

1.16

mg/l

0.07

558

4483

Twin gestation

904

7557

1.25

7.79

1.9

1.7

1.03

0.76

mg/l

3.01

709

5628

Ectropion of eyelid

323

2371

1.45

7.75

1.8

1.6

1.98

1.60

mg/l

0.55

257

1855

Perforation of tympanic membrane

902

7533

1.25

7.73

1.8

1.07

1.23

mg/l

1.13

675

5674

Retinal detachment with retinal break

1141

9724

1.22

7.73

2.0

1.8

1.24

1.33

mg/l

0.53

896

7509

Other and unspecified disorders of autonomic nervous system

261

2.76

7.71

2.5

1.8

0.54

0.94

mg/l

2.51

198

Hypermetropia

620

4980

1.31

7.70

2.0

2.1

1.08

1.21

mg/l

0.51

459

3688

Type 1 diabetes, wide definition, subgroup 2

893

0.39

7.69

1.6

2.1

1.30

1.32

mg/l

0.02

679

Pregnancy, childbirth and the puerperium

3076

14525

1.13

7.67

1.6

1.7

1.12

1.21

mg/l

1.00

2301

10695

Acne vulgaris

748

6128

1.27

7.66

2.4

1.9

0.79

0.94

mg/l

1.37

522

4237

Malignant neoplasm of other connective and soft tissue

211

1446

1.60

7.66

2.2

1.6

2.28

1.27

mg/l

1.15

177

1101

Injury of nerves at lower leg level

107

629

1.98

7.66

1.9

1.7

1.39

1.23

mg/l

0.16

490

Osteopathy in diseases classified elsewhere

447

2.22

7.65

3.0

2.1

2.03

1.23

mg/l

0.56

360

Sexual dysfunction

151

967

1.75

7.60

1.9

1.7

0.61

1.15

mg/l

6.53

118

720

Disorder of pancreatic internal secretion, other and/or unspecified

479

2.18

7.60

1.6

1.8

1.11

1.44

mg/l

0.45

374

Congenital malformations of great veins

170

3.19

7.58

6.7

5.0

1.67

2.76

mg/l

0.43

138

Otorrhagia

457

2.21

7.58

2.8

1.9

1.10

1.35

mg/l

0.47

353

Abrasion of teeth

3442

31465

1.12

7.56

1.7

0.96

1.10

mg/l

3.38

2505

24044

Other protozoal intestinal diseases

217

1505

1.59

7.54

1.7

1.8

1.22

1.04

mg/l

0.28

156

1130

Multiple gestation

930

7819

1.24

7.53

1.9

1.7

1.03

0.75

mg/l

3.25

730

5829

Family history of certain disabilities and chronic diseases leading to disablement

481

3769

1.36

7.53

2.0

1.7

0.74

0.96

mg/l

1.94

345

2757

Shoulder region

148

951

1.77

7.52

1.9

1.8

1.40

1.19

mg/l

0.25

110

739

Congenital deformities of feet

368

2785

1.42

7.50

2.1

1.9

1.57

1.01

mg/l

0.67

283

2034

Pyoderma gangrenosum

510

2.12

7.48

2.5

1.7

1.30

1.09

mg/l

0.40

389

Other and unspecified bullous disorders

114

689

1.93

7.48

2.3

1.9

1.73

1.16

mg/l

0.44

537

Presbyopia

630

5113

1.30

7.43

1.8

1.7

0.96

1.03

mg/l

0.14

484

3900

Symptoms and signs involving appearance and behaviour

576

2.02

7.42

2.1

1.6

0.89

1.07

mg/l

0.46

430

Malignant melanoma of skin, including Hilmo

1261

10863

1.20

7.42

1.6

1.7

1.48

1.20

mg/l

0.83

974

8307

Other specified and unspecified retinal disorders

320

2378

1.45

7.40

2.7

1.7

1.14

1.22

mg/l

0.20

250

1823

Disorders of adrenal gland, other and/or unspecified

341

2.45

7.40

1.9

1.8

0.71

0.93

mg/l

0.78

269

Ankylosing hyperostosis [Forestier]

124

762

1.84

7.39

1.8

1.7

1.36

1.39

mg/l

0.02

601

Carrier of infectious disease

247

1765

1.54

7.38

1.9

1.7

1.64

1.07

mg/l

0.57

182

1343

Chronic myeloid leukaemia [CML], BCR/ABL-positive

577

2.01

7.38

1.9

1.7

1.56

1.29

mg/l

0.41

439

Malnutrition

191

1296

1.62

7.37

3.3

2.1

1.61

1.32

mg/l

0.90

152

999

Defects in the complement system

469

2.17

7.37

3.2

2.3

0.93

1.09

mg/l

0.29

352

Myasthenia gravis

169

1124

1.69

7.36

1.8

1.44

1.15

mg/l

0.62

131

865

Hepatocellular carcinoma

167

1095

1.66

7.34

1.7

1.6

3.30

1.42

mg/l

3.20

142

846

Inflammation of lacrimal passages (acute and unspecified)

178

1196

1.66

7.32

2.3

1.7

1.47

1.15

mg/l

0.50

145

930

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

460

2.15

7.32

2.2

1.6

2.25

1.17

mg/l

0.46

360

Other and unspecified acquired haemolytic anaemias

102

602

1.99

7.30

4.7

1.8

2.26

1.40

mg/l

0.46

472

Haemolytic-uraemic syndrome

152

3.47

7.29

4.4

2.1

5.81

0.83

mg/l

0.98

119

Maternal care for known or suspected malpresentation of fetus

1944

12488

1.16

7.29

1.7

0.87

0.76

mg/l

1.23

1440

9065

Burns and corrosions of multiple and unspecified body regions

218

1523

1.57

7.28

2.1

1.9

1.11

1.19

mg/l

0.18

163

1144

Disorders in reading

149

958

1.72

7.28

4.2

2.6

0.86

1.00

mg/l

0.38

100

648

Benign neoplasm: Parathyroid gland

121

750

1.88

7.28

1.7

1.00

1.16

mg/l

0.38

586

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

506

3996

1.33

7.23

2.2

1.7

2.78

1.34

mg/l

6.08

421

3103

Mantle cell lymphoma

481

2.08

7.23

2.3

1.7

1.84

1.37

mg/l

0.42

374

Orthopaedic devices associated with adverse incidents

178

1204

1.66

7.21

1.8

1.6

1.68

1.29

mg/l

0.51

132

956

Congenital deformities of feet

243

1734

1.53

7.20

2.1

2.0

1.47

0.96

mg/l

0.46

181

1273

Other bursitis of elbow

490

2.08

7.19

3.3

1.6

1.44

1.36

mg/l

0.14

379

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

329

2474

1.44

7.16

1.8

1.9

0.81

1.09

mg/l

1.65

248

1843

Injury of nerves and spinal cord at neck level

210

1464

1.58

7.16

1.8

1.50

1.19

mg/l

0.23

160

1127

Family history of malignant neoplasm

1069

9130

1.22

7.15

1.6

1.04

0.96

mg/l

0.44

822

6859

Disorders of eyelid in diseases classified elsewhere

310

2308

1.45

7.13

2.3

1.7

1.01

1.16

mg/l

0.57

228

1734

Foreign body entering into or through eye or natural orifice

713

5873

1.27

7.10

2.0

1.8

1.15

mg/l

0.00

511

4373

Moderate visual impairment, binocular

264

1911

1.49

7.09

1.8

1.7

1.26

1.38

mg/l

0.39

183

1465

Insulin, fast-acting (human)

1335

11588

1.19

7.07

1.8

0.95

1.08

mg/l

1.56

1024

8480

Thyrotoxicosis with toxic multinodular goitre

551

4430

1.32

7.07

1.9

1.7

1.29

1.25

mg/l

0.14

435

3426

Other injuries of lower limb, level unspecified

102

608

1.96

7.07

2.1

1.9

1.11

1.35

mg/l

0.44

473

Malignant neoplasm of corpus uteri

726

6009

1.27

7.02

1.5

1.7

1.97

1.22

mg/l

3.22

583

4587

Fibrosis of liver

446

2.16

7.02

3.0

1.8

1.46

1.30

mg/l

0.21

356

Hypertrophy of (infrapatellar) fat pad

103

613

1.93

7.01

2.2

1.7

0.59

1.07

mg/l

5.24

465

Exposure to other and unspecified man-made environmental factors

169

1137

1.67

6.99

2.5

1.7

0.89

1.12

mg/l

0.79

126

847

Mesothelioma

507

2.01

6.98

1.7

1.6

1.94

1.63

mg/l

0.44

405

Toxic effect of contact with venomous animals

396

3065

1.39

6.98

2.0

1.9

1.10

1.06

mg/l

0.08

286

2307

Intentional self-harm by sharp object

240

1716

1.51

6.97

2.5

1.9

0.79

0.94

mg/l

0.73

166

1219

Malignant neoplasm of thymus

205

2.89

6.96

2.1

1.7

1.29

0.91

mg/l

0.77

159

Other osteochondropathies

655

5368

1.28

6.95

1.8

0.84

1.04

mg/l

2.63

489

4043

Intussusception

204

1421

1.58

6.94

1.7

0.93

1.06

mg/l

0.38

150

1089

Other and unspecified intracranial injuries

269

1962

1.48

6.93

1.8

0.90

1.17

mg/l

1.66

206

1493

Calculus of lower urinary tract

431

3362

1.36

6.93

1.7

1.28

1.51

mg/l

0.82

341

2619

Other lesions of median nerve

251

1814

1.50

6.92

1.6

1.16

1.25

mg/l

0.21

197

1398

IBD (strict) with PSC

104

625

1.92

6.90

2.4

2.1

1.70

0.90

mg/l

1.33

463

Malignant neoplasm of other and ill-defined sites, including Hilmo

138

883

1.73

6.89

1.7

1.6

2.23

1.24

mg/l

1.14

117

680

Toxic effect of ethanol

372

2853

1.39

6.89

1.7

1.9

1.47

1.03

mg/l

1.07

270

2087

Follow-up care involving plastic surgery

371

2851

1.40

6.88

1.7

1.6

0.88

0.92

mg/l

0.20

267

2155

Left side

290

2.60

6.87

1.9

1.8

1.05

1.46

mg/l

0.77

227

Poisoning by medicine, drug-induced

143

934

1.74

6.87

1.9

1.8

0.81

0.97

mg/l

0.62

105

719

Fistulae involving female genital tract

161

1074

1.67

6.86

1.7

2.27

1.19

mg/l

0.69

118

815

Chronic nephritic syndrome

349

2658

1.41

6.85

2.2

1.8

1.76

1.15

mg/l

2.89

294

2041

Cystic kidney disease

295

2195

1.45

6.84

2.2

1.9

2.71

1.12

mg/l

1.43

241

1663

Benign neoplasm: Skin of ear and external auricular canal

344

2613

1.41

6.84

1.7

1.6

1.49

1.26

mg/l

0.52

261

2019

Impaction of intestines

380

2.19

6.84

2.3

1.7

0.79

1.15

mg/l

1.76

303

Colitis, primary sclerosing

143

932

1.73

6.83

2.3

2.0

1.83

0.99

mg/l

2.02

117

694

UC patients in KELA-register (code 208), prior to 1994

397

3082

1.38

6.82

1.9

1.7

1.31

1.11

mg/l

0.77

333

2358

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

216

1532

1.56

6.81

1.9

1.7

0.68

0.65

mg/l

0.16

162

1139

Malignant immunoproliferative diseases

105

638

1.92

6.80

3.0

1.8

2.31

1.36

mg/l

0.53

502

Deficiency of other B group vitamins

192

1326

1.59

6.80

2.0

1.6

1.37

1.20

mg/l

0.31

149

1022

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

385

2982

1.39

6.79

1.7

1.8

0.87

0.78

mg/l

0.46

305

2232

Sequelae of injuries of head

471

3731

1.34

6.78

1.8

1.35

1.13

mg/l

0.48

337

2793

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

546

1.99

6.78

1.7

1.32

1.27

mg/l

0.06

428

Erectile dysfunction, exclusion

185

2.83

6.76

17.8

1.6

1.82

2.27

mg/l

0.31

151

Suppurative otitis media, unspecified

237

1700

1.51

6.76

1.6

1.8

0.92

1.14

mg/l

1.10

171

1246

Other bursal cyst

142

922

1.71

6.74

1.4

1.7

0.86

1.15

mg/l

1.27

102

722

Use of ropinirole

312

2349

1.44

6.74

1.9

1.6

1.34

1.38

mg/l

0.08

246

1838

Assault by blunt object

146

957

1.71

6.74

1.8

1.7

0.97

1.00

mg/l

0.07

106

694

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

591

4813

1.29

6.73

1.7

1.8

1.07

1.20

mg/l

0.58

454

3685

Malignant neoplasm of oral cavity, including Hilmo

377

2904

1.38

6.71

1.6

1.27

mg/l

0.01

291

2227

Dependent personality disorder

209

1480

1.57

6.70

1.8

1.7

1.06

1.11

mg/l

0.13

156

1122

Juvenile arthritis (FINNGEN)

411

3199

1.36

6.70

2.1

1.08

0.99

mg/l

0.29

315

2250

Malignant neoplasm of retroperitoneum and peritoneum

475

2.08

6.70

2.1

1.6

1.73

1.19

mg/l

1.86

374

Anuria and oliguria

399

2.16

6.69

2.4

2.1

1.16

1.39

mg/l

0.51

305

Laparoscopic right hemicolectomy

494

3950

1.33

6.69

1.6

1.7

1.42

1.40

mg/l

0.03

388

3082

Disturbances of smell and taste

382

2957

1.38

6.68

1.9

1.6

1.09

1.16

mg/l

0.16

294

2285

Other disorders of cornea

871

7360

1.23

6.67

1.7

1.8

1.34

1.18

mg/l

0.49

660

5598

Impacted cerumen

861

7264

1.23

6.67

1.9

1.8

1.30

1.38

mg/l

0.28

618

5594

Drug-induced dystonia

189

2.92

6.66

1.5

1.6

0.82

1.02

mg/l

0.32

145

Neovascular glaucoma

351

2682

1.39

6.65

1.8

1.7

1.46

1.27

mg/l

0.66

286

2055

Anomalies of dental arch relationship, including avohilmo

1881

15109

1.15

6.64

2.2

1.9

1.01

1.05

mg/l

0.14

1355

11103

Other endocrine disorders

445

3354

1.34

6.63

3.0

2.6

2.10

1.22

mg/l

0.96

324

2454

Burns classified according to extent of body surface involved

102

617

1.90

6.63

2.2

1.8

1.28

1.44

mg/l

0.23

471

Ulcerative ileocolitis

383

2970

1.38

6.62

2.0

1.7

1.60

0.98

mg/l

1.85

290

2216

Sub-endpoint used in defining T1D endpoints

2790

24964

1.12

6.62

1.9

1.8

1.20

1.24

mg/l

0.24

2137

18636

Unspecified maternal hypertension

137

896

1.75

6.61

1.8

1.6

1.12

0.64

mg/l

2.21

106

655

Contact with other hot fluids

288

2146

1.45

6.59

1.9

2.1

1.02

1.10

mg/l

0.24

211

1584

Late syphilis

130

836

1.76

6.59

1.8

1.7

1.16

1.27

mg/l

0.23

104

659

Malignant neoplasm of liver and intrahepatic bile ducts

216

1525

1.52

6.58

2.1

1.7

2.83

1.31

mg/l

3.26

180

1193

Alcoholic gastritis

135

872

1.72

6.58

2.0

1.7

1.38

1.24

mg/l

0.21

111

683

Other prurigo

119

753

1.81

6.55

1.9

1.6

1.70

1.15

mg/l

0.33

585

Alzheimer’s disease (Early onset)

203

2870

0.67

6.53

1.5

1.7

1.78

1.42

mg/l

0.27

138

2226

Restrictive cardiomyopathy

225

2.74

6.52

5.3

1.9

1.10

1.32

mg/l

0.40

181

Systemic sclerosis, icd10

240

1749

1.51

6.52

2.1

1.7

1.47

1.02

mg/l

0.70

198

1348

Other specific arthropathies, wide

200

1404

1.55

6.51

1.7

1.6

1.09

1.12

mg/l

0.06

151

1054

Encephalopathy

102

620

1.89

6.51

2.0

1.8

2.15

1.37

mg/l

0.80

484

Adult respiratory distress syndrome

127

814

1.76

6.51

3.1

1.7

1.83

1.37

mg/l

0.78

110

638

Assault by other specified means

105

644

1.87

6.48

2.1

1.8

2.60

0.92

mg/l

0.56

477

L02BG Aromatase inhibitors

2919

26657

1.12

6.48

1.6

1.7

1.26

1.18

mg/l

0.90

2265

20561

Folate deficiency anaemia

567

1.93

6.48

2.3

1.6

1.22

1.34

mg/l

0.24

448

Other contact dermatitis

760

6359

1.25

6.48

1.9

1.8

1.00

1.11

mg/l

0.63

548

4816

Haemorrhagic disorder due to circulating anticoagulants

122

773

1.77

6.48

4.9

1.7

2.62

1.48

mg/l

1.43

606

Congenital stenosis of pulmonary valve

395

2.13

6.47

2.8

3.4

1.13

1.07

mg/l

0.07

304

Abnormal reflex

343

2.31

6.47

2.0

1.7

0.67

1.26

mg/l

1.98

274

Premenstrual syndrome

126

808

1.76

6.46

1.6

1.5

0.51

0.76

mg/l

2.44

584

Traumatic ischaemia of muscle

137

897

1.72

6.45

2.9

1.7

1.58

1.17

mg/l

0.40

104

685

Injury of muscle and tendon at wrist and hand level

1225

10653

1.19

6.44

1.9

1.8

0.93

1.18

mg/l

1.86

937

8129

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

177

2.85

6.43

2.0

2.7

1.07

0.92

mg/l

0.18

128

Benign neoplasm: Other and unspecified parts of small intestine

160

1086

1.66

6.43

2.5

1.6

1.02

1.20

mg/l

0.63

137

848

Histrionic personality disorder

322

2.35

6.43

2.0

1.7

0.75

1.04

mg/l

0.92

253

Eclampsia

161

3.13

6.42

2.4

1.8

1.99

0.69

mg/l

1.92

127

Pre-eclampsia superimposed on chronic hypertension

402

2.19

6.42

2.2

1.7

1.12

0.57

mg/l

1.21

292

Vascular syndromes of brain in cerebrovascular disorders

370

2862

1.37

6.41

2.1

1.6

1.30

1.44

mg/l

0.41

291

2222

Contracture of muscle

230

2.58

6.40

1.8

1.6

1.12

1.33

mg/l

0.23

180

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

337

2583

1.40

6.40

2.7

1.7

1.30

1.17

mg/l

0.29

270

1958

Other congenital malformations of nervous system

104

638

1.86

6.39

1.8

2.2

0.82

0.96

mg/l

0.29

452

Medicines for HER+ breast cancer

3702

32421

1.10

6.38

1.6

1.7

1.21

1.13

mg/l

1.06

2862

24902

Drug-induced Cushing's syndrome

4.74

6.38

2.1

1.6

0.59

0.68

mg/l

0.29

Localized skin eruption due to drugs and medicaments

125

807

1.77

6.37

1.8

0.85

1.19

mg/l

0.79

633

Endometroid carcinoma of ovary, including Hilmo

573

1.94

6.37

1.9

1.6

1.56

1.00

mg/l

1.92

445

Glaucoma secondary to other eye disorders

353

2717

1.38

6.36

1.8

1.7

1.47

1.23

mg/l

0.92

287

2089

Arnold-Chiari syndrome

562

1.92

6.36

1.8

2.0

0.80

0.99

mg/l

0.37

394

Burn and corrosion confined to eye and adnexa

228

1650

1.51

6.36

1.9

1.8

0.62

1.02

mg/l

5.49

166

1226

Abnormality of white blood cells, not elsewhere classified

574

1.94

6.36

2.3

1.8

1.44

1.23

mg/l

0.33

443

All dysplastic lesions of the vulva

425

3369

1.35

6.35

1.9

1.7

0.94

0.90

mg/l

0.17

330

2525

Delayed milestone in childhood

127

724

1.71

6.33

5.5

5.8

3.27

1.80

mg/l

0.96

103

508

Benign neoplasm of breast

1160

10087

1.19

6.32

1.7

1.02

1.08

mg/l

0.39

861

7644

Pemphigoid

231

1673

1.49

6.31

1.6

1.7

1.47

1.40

mg/l

0.18

182

1308

Patellar tendinitis

158

1064

1.62

6.31

2.0

1.7

1.16

0.97

mg/l

0.28

112

778

Benign neoplasm of urinary organs

411

3236

1.35

6.31

1.8

1.7

1.65

1.30

mg/l

0.85

319

2506

Other appendicitis

791

6665

1.24

6.30

1.6

1.7

1.22

1.11

mg/l

0.35

607

5055

Other mycoses, not elsewhere classified/unspecified

228

2.67

6.29

5.8

1.9

2.61

1.41

mg/l

0.95

173

Acute drug-induced interstitial lung disorder

476

2.03

6.29

3.6

1.7

1.47

1.32

mg/l

0.17

366

Dislocation, sprain and strain of joints and ligaments of elbow

591

4844

1.28

6.28

1.9

0.84

1.04

mg/l

1.53

445

3558

Benign neoplasm: Parotid gland

696

5801

1.26

6.28

1.7

1.8

1.55

1.26

mg/l

1.02

533

4443

Scleritis

135

889

1.72

6.24

1.9

1.7

0.91

0.95

mg/l

0.10

103

682

Other and unspecified injuries of thorax

179

1246

1.58

6.22

1.9

1.7

1.28

1.13

mg/l

0.29

138

940

Measles

123

795

1.76

6.20

1.7

0.63

0.77

mg/l

0.58

600

Seminoma of testis, including Hilmo

525

1.92

6.20

1.8

1.7

1.28

0.97

mg/l

0.46

374

Male infertility

368

2847

1.36

6.20

2.4

1.9

1.53

0.93

mg/l

0.91

256

1977

Calcaneal spur

114

719

1.77

6.18

1.7

1.5

0.97

1.12

mg/l

0.26

558

Other congenital malformations of circulatory system

249

1841

1.47

6.15

2.4

1.8

1.34

1.14

mg/l

0.37

202

1392

Postpartum hemorraghe, parous women as controls

2785

21679

1.12

6.14

1.8

1.7

1.23

0.82

mg/l

7.45

2121

16191

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

249

2.50

6.13

2.4

1.7

3.01

1.19

mg/l

0.45

194

Other bursitis of knee

128

830

1.71

6.13

3.2

1.7

1.57

1.22

mg/l

0.49

636

Disorders of optic nerve, not elsewhere classified

193

1367

1.55

6.13

1.8

1.7

1.77

1.22

mg/l

0.96

152

1047

Other factor of the environment

133

878

1.71

6.11

2.0

1.7

1.01

1.08

mg/l

0.24

112

666

Autoimmune thyroiditis

196

1395

1.55

6.11

1.8

1.7

0.88

1.00

mg/l

0.36

143

1039

Localized adiposity

358

2.25

6.11

2.2

1.7

1.03

0.96

mg/l

0.09

279

Vascular dementia (subcortical)

255

1880

1.44

6.10

1.7

1.6

1.46

1.56

mg/l

0.23

217

1473

Other superficial mycoses

209

1503

1.52

6.07

2.0

1.8

0.79

1.05

mg/l

1.76

149

1103

Seminoma of testis

439

2.01

6.07

1.9

1.7

1.20

0.96

mg/l

0.30

320

malignant neoplasm of male genital organs

2458

13556

1.13

6.05

1.6

1.8

1.69

1.30

mg/l

3.42

1919

10590

Other protozoal intestinal diseases

144

966

1.66

6.04

1.8

1.9

1.52

1.06

mg/l

0.57

105

731

Hypertension, portal

198

2.76

6.03

3.5

1.7

2.92

1.18

mg/l

1.40

155

Gastrojejunal ulcer

115

731

1.75

6.03

1.8

1.7

1.18

1.27

mg/l

0.14

568

Other specified/unspecified disorders of bone/cartilage

256

1905

1.45

5.99

1.8

1.7

1.27

1.08

mg/l

0.36

193

1456

Other conditions related to polyarteritis nodosa

140

3.14

5.98

1.7

1.6

1.22

1.07

mg/l

0.20

115

Benign neoplasm: salivary glands, exclude unknown (D119)

767

6479

1.23

5.97

1.7

1.52

1.27

mg/l

0.92

587

4962

Use of donepezil

1333

14499

0.86

5.97

1.5

1.7

1.81

1.60

mg/l

0.70

1005

11369

Other intracranial haemorrhages

254

1880

1.44

5.97

2.9

1.6

2.20

1.51

mg/l

1.24

206

1483

Carcinoma in situ of skin of ear and external auricular canal

124

804

1.71

5.97

1.7

2.06

1.53

mg/l

0.51

645

Erectile dysfunction

611

5046

1.26

5.97

11.0

1.7

1.73

1.60

mg/l

0.29

495

3973

Delivery, wide proxy

3497

17113

1.11

5.95

1.7

1.19

1.17

mg/l

0.10

2643

12611

Colitis due to radiation

587

1.86

5.95

2.4

1.7

1.72

1.49

mg/l

0.18

464

Embedded teeth, including avohilmo

856

7288

1.22

5.95

2.0

1.9

1.19

0.98

mg/l

0.98

612

5159

Polycystic kidney disease

247

1833

1.46

5.94

2.2

1.9

2.26

1.09

mg/l

1.52

207

1397

Other disorders of central nervous system

128

843

1.71

5.94

2.0

1.8

0.80

1.20

mg/l

1.77

648

Pleural plaque without asbestos

286

2159

1.41

5.93

1.7

1.6

1.33

1.64

mg/l

1.03

242

1716

Lichen simplex chronicus

310

2375

1.40

5.93

1.7

1.6

1.22

1.14

mg/l

0.22

245

1830

Other nonthrombocytopenic purpura

607

1.86

5.92

1.9

1.47

1.15

mg/l

0.32

478

Eustachian salpingitis and obstruction

746

6290

1.24

5.91

1.7

1.8

0.83

0.88

mg/l

0.28

546

4527

Injury of muscle and tendon at forearm level

179

1258

1.56

5.91

1.6

1.8

1.24

1.06

mg/l

0.48

136

939

Other and unspecified diseases of spleen

268

2.42

5.88

1.5

1.8

1.24

0.90

mg/l

0.38

214

Embolic stroke with flimmer

195

1379

1.51

5.87

2.1

1.6

1.45

1.69

mg/l

0.64

153

1105

Psoriasis (vulgaris), strict definition

304

2326

1.40

5.87

1.7

1.8

1.29

1.05

mg/l

0.44

233

1739

Oral lichen planus, including avohilmo , including avohilmo

601

4983

1.27

5.86

1.6

1.7

0.90

1.11

mg/l

1.48

448

3815

Allergic contact dermatitis due to drugs in contact with skin

216

1576

1.50

5.84

1.9

1.6

0.90

1.13

mg/l

1.11

159

1209

Inguinal of femoral hernia, unilateral

242

1791

1.46

5.84

1.9

1.7

1.17

1.19

mg/l

0.06

183

1384

Inguinal hernia, unilateral

242

1791

1.46

5.84

1.9

1.7

1.17

1.19

mg/l

0.06

183

1384

Femoral hernia, unilateral

242

1791

1.46

5.84

1.9

1.7

1.17

1.19

mg/l

0.06

183

1384

Benign neoplasm: Tongue

255

1907

1.45

5.84

1.9

1.7

1.10

1.17

mg/l

0.17

196

1460

Other disorders of electrolyte and fluid balance, not elsewhere classified

505

1.91

5.83

2.2

1.6

1.20

1.12

mg/l

0.09

391

Use of antiglaucoma preparations and miotics

667

5571

1.25

5.80

1.6

1.8

1.56

1.47

mg/l

0.16

520

4326

Polypectomy (DHB20)

584

4825

1.27

5.80

1.7

1.18

1.23

mg/l

0.09

439

3707

Surgical ablation of atrial fibrillation

357

2.20

5.78

2.9

1.7

1.97

1.34

mg/l

0.67

286

Androgenic alopecia

102

646

1.84

5.77

1.7

1.6

0.95

0.82

mg/l

0.23

486

Specific developmental disorder of motor function

117

731

1.70

5.76

6.7

4.3

1.23

1.61

mg/l

0.47

493

Carcinoma in situ of other and unspecified digestive organs

285

2169

1.41

5.74

2.4

1.7

1.93

1.35

mg/l

0.88

236

1711

Iliotibial band syndrome

109

694

1.76

5.74

1.7

1.6

0.76

1.04

mg/l

1.39

527

Sixth [abducent] nerve palsy

294

2247

1.40

5.73

1.7

1.8

1.49

1.34

mg/l

0.26

231

1726

Acute epiglottitis

144

975

1.63

5.73

2.0

1.7

2.18

1.14

mg/l

0.56

108

758

Congenital malformations of ovaries, fallopian tubes and broad ligaments

568

4699

1.28

5.72

1.7

1.8

0.86

0.82

mg/l

0.15

453

3463

Diastasis of muscle

525

1.89

5.70

1.7

1.6

0.95

1.03

mg/l

0.21

395

Aortic stenosis

4.07

5.70

4.3

4.5

1.73

2.19

mg/l

0.18

Injury of nerves at ankle and foot level

467

1.97

5.70

2.0

1.7

0.85

1.09

mg/l

0.60

359

Retinal breaks without detachment

1448

12855

1.16

5.69

1.7

1.03

1.25

mg/l

2.81

1090

9920

Tooth eruption problems

1324

11374

1.16

5.68

2.3

2.0

1.17

1.01

mg/l

0.75

937

7967

Fasciculation

120

788

1.72

5.67

2.2

1.8

0.75

1.16

mg/l

1.89

602

Unspecified nephritic syndrome

205

1488

1.50

5.65

2.1

1.7

2.04

1.18

mg/l

1.79

164

1148

Intracranial and intraspinal abscess and granuloma

114

740

1.74

5.64

2.0

1.7

1.91

1.28

mg/l

0.93

571

Alopecia areata

256

1927

1.44

5.63

1.8

2.0

1.09

0.98

mg/l

0.23

193

1450

Motor disorders

117

749

1.68

5.62

6.7

4.8

1.23

1.86

mg/l

0.88

512

Striae atrophicae

120

791

1.72

5.61

2.0

1.7

1.20

0.94

mg/l

0.43

598

Lifestyle-related condition

122

807

1.71

5.61

2.0

1.7

1.03

1.09

mg/l

0.18

104

606

Benign neoplasm: Kidney

311

2406

1.39

5.60

1.8

1.7

1.74

1.28

mg/l

0.87

242

1855

Endometroid carcinoma of ovary

381

2.10

5.60

2.0

1.6

1.38

0.94

mg/l

1.10

295

Major anomalies of jaw size

257

1936

1.43

5.60

2.0

1.05

1.07

mg/l

0.02

193

1445

Spinal enthesopathy

198

1406

1.47

5.58

1.5

1.61

1.62

mg/l

0.02

157

1104

Contact with other sharp object(s)

613

5106

1.25

5.57

1.8

1.9

0.87

0.99

mg/l

0.93

443

3729

Glaucoma suspect

3419

31677

1.10

5.57

1.8

1.7

1.24

1.33

mg/l

0.94

2606

24570

Other disorders of prostate

256

1915

1.41

5.55

1.7

1.20

1.62

mg/l

1.90

208

1509

Benign leiomyoma with endometriosis

1485

13240

1.16

5.55

1.6

1.7

1.11

1.13

mg/l

0.04

1090

10140

Embolic stroke

364

2856

1.33

5.54

2.0

1.6

1.61

1.59

mg/l

0.04

288

2220

Parapsoriasis

180

1283

1.54

5.54

2.1

1.8

1.28

1.16

mg/l

0.14

147

969

Other and unspecified injuries of neck

570

1.85

5.53

1.9

1.8

0.79

1.20

mg/l

1.18

425

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

164

2.80

5.53

2.1

1.5

3.04

1.01

mg/l

0.51

128

Other specified and unspecified disorders of eyelid

139

947

1.64

5.51

1.7

1.6

1.06

1.24

mg/l

0.46

114

740

Other abnormal auditory perceptions

120

795

1.71

5.50

1.7

1.8

0.79

1.13

mg/l

1.19

593

Papillary adenocarcinoma of thyroid gland

450

3643

1.30

5.50

2.3

1.8

1.25

1.01

mg/l

0.47

349

2747

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

368

2899

1.33

5.49

2.3

1.6

3.06

1.40

mg/l

5.16

309

2263

Other primary thrombocytopenia

269

2.38

5.48

2.1

2.0

1.44

1.05

mg/l

0.53

208

Tetralogy of Fallot, a congenital heart defect.

217

2.47

5.48

2.6

2.8

1.39

0.98

mg/l

0.60

167

Inflammatory disorders of male genital organs, not elsewhere classified

113

730

1.70

5.48

1.7

1.8

1.61

1.39

mg/l

0.14

554

Use of biperiden

473

3852

1.29

5.48

1.7

1.04

1.07

mg/l

0.14

378

2923

Maze procedure for atrial fibrillation

298

2.29

5.47

2.1

1.7

1.44

1.57

mg/l

0.14

239

Amblyopia ex anopsia

347

2721

1.35

5.46

1.9

2.1

1.28

1.21

mg/l

0.09

247

2008

Reduction defects of lower limb

205

2.54

5.44

1.8

2.3

1.44

0.85

mg/l

1.04

154

Habit and impulse disorders

160

1119

1.57

5.43

2.1

1.8

0.85

0.96

mg/l

0.21

113

796

HSIL lesion of the vulva

175

1253

1.55

5.42

1.8

1.7

0.88

0.93

mg/l

0.21

140

942

Other bacterial agents as the cause of diseases classified to other chapters

123

820

1.68

5.42

4.0

2.0

1.34

1.27

mg/l

0.11

635

Oral lichen planus

249

1883

1.44

5.41

1.7

0.83

1.17

mg/l

2.51

193

1427

Systemic disorders of connective tissue in diseases classified elsewhere

248

2.40

5.41

5.0

1.9

1.23

1.00

mg/l

0.32

187

Tarsal tunnel syndrome

110

718

1.75

5.41

1.7

1.6

1.51

0.99

mg/l

0.44

552

Collapsed vertebra, not elsewhere classified

441

1.94

5.40

2.4

1.7

1.62

1.46

mg/l

0.15

350

Complications peculiar to reattachment and amputation

398

2.01

5.37

2.6

1.6

1.52

1.26

mg/l

0.36

326

Other/unspecified mastoiditis and related conditions

289

2.23

5.37

1.6

1.8

2.01

1.26

mg/l

0.28

225

Atypical mycobacterium lung infection

112

732

1.71

5.35

2.6

1.6

1.33

1.32

mg/l

0.01

578

Bullous pemphigoid

182

1306

1.51

5.35

1.5

1.7

1.31

1.45

mg/l

0.39

141

1035

Disorders of myoneural junction and muscle in diseases classified elsewhere

539

1.88

5.35

2.2

1.6

1.12

0.98

mg/l

0.31

425

Burn and corrosion of head and neck

193

1399

1.49

5.34

1.7

1.9

1.12

1.15

mg/l

0.06

145

1038

Mental retardation, excluding more controls

307

2306

1.36

5.34

2.1

2.2

1.40

1.22

mg/l

0.48

248

1715

Benign neoplasm of major salivary glands

848

7293

1.21

5.34

1.7

1.53

1.29

mg/l

0.93

652

5597

Paraplegia, diplegia of upper limbs

202

1478

1.48

5.33

2.4

1.9

1.46

1.20

mg/l

0.85

164

1125

Polyarteritis nodosa

414

1.98

5.33

2.0

1.8

0.93

1.46

mg/l

1.80

333

Drug-induced obesity

625

1.80

5.33

1.7

1.22

0.89

mg/l

0.97

454

Congenital malformations of the nervous system

207

1519

1.47

5.32

1.9

2.6

0.82

1.17

mg/l

1.23

156

1108

Arthropathy in Crohn disease

107

696

1.75

5.32

1.8

1.6

0.76

0.93

mg/l

0.56

528

Stenosis and insufficiency of lacrimal passages

826

7090

1.21

5.31

1.6

1.8

1.12

1.27

mg/l

0.89

625

5399

Other injuries of spine and trunk, level unspecified

569

1.83

5.30

2.2

1.9

1.00

1.17

mg/l

0.41

444

Pustular psoriasis

431

3495

1.30

5.27

1.7

1.8

1.10

1.08

mg/l

0.05

340

2655

Motorcycle rider injured in other and unspecified transport accidents

494

4048

1.27

5.26

1.9

1.14

0.99

mg/l

0.49

364

2864

Other abnormal findings in urine

146

1012

1.59

5.24

2.0

1.8

1.95

1.34

mg/l

0.73

118

790

Aortic hypoplasia

4.42

5.23

22.9

7.5

2.87

2.60

mg/l

0.06

Aortic stenosis

124

3.13

5.22

4.0

3.8

1.52

1.97

mg/l

0.25

100

Malignant neoplasm of bone and articular cartilage

578

1.80

5.22

3.9

1.8

1.41

1.08

mg/l

0.60

434

Tic and related disorders

105

673

1.70

5.21

3.0

2.6

1.17

0.91

mg/l

0.48

469

Social disorders starting during childhood or adolecense, excluding more controls

382

1.96

5.20

2.2

2.7

0.72

1.04

mg/l

1.02

258

Prophylactic surgery

535

1.86

5.20

1.5

1.6

1.47

0.85

mg/l

0.42

407

Carcinoma in situ of skin of lower limb, including hip

185

1342

1.50

5.19

1.8

1.6

2.62

1.40

mg/l

0.70

136

1056

Other renal tubulo-interstitial diseases

226

1692

1.44

5.15

1.9

1.7

1.27

0.95

mg/l

1.06

172

1265

Benign neoplasm: Hypopharynx

273

2.26

5.15

1.5

2.0

1.21

1.37

mg/l

0.25

216

Injury of nerves and spinal cord at thorax level

316

2.15

5.15

1.9

1.32

1.48

mg/l

0.19

249

Routine general health check-up of defined subpopulation

188

1359

1.48

5.14

2.5

1.5

1.24

0.90

mg/l

0.62

143

1021

Disseminated intravascular coagulation [defibrination syndrome]

190

2.59

5.14

3.5

1.7

5.03

1.03

mg/l

1.47

148

Other hereditary haemolytic anaemias

383

2.03

5.13

5.7

1.8

0.97

1.21

mg/l

0.47

288

Pediculosis, acariasis and other infestations

529

4385

1.26

5.13

2.1

1.8

1.00

1.11

mg/l

0.46

410

3274

Kyphoscoliotic heart disease

3.94

5.11

2.2

1.8

1.24

1.27

mg/l

0.02

Other/unspecified crystal arthropathies

392

2.02

5.11

1.9

1.7

1.33

1.30

mg/l

0.05

305

Transient synovitis

454

1.88

5.10

2.9

1.8

1.06

1.14

mg/l

0.10

330

LSIL lesion of the cervix uteri, vagina or vulva

1422

12712

1.15

5.10

1.7

0.88

0.87

mg/l

0.03

1038

9499

Oral lichen planus and hypothyroidism or thyroxine medication

176

1278

1.52

5.06

1.7

1.6

0.88

1.08

mg/l

0.70

135

986

Malignant neoplasm of breast, ER-negative, including Hilmo

2048

17763

1.12

5.05

1.6

1.7

1.22

1.05

mg/l

1.59

1584

13510

Other disorders of bone density and structure

242

1836

1.42

5.05

2.6

1.8

0.77

1.10

mg/l

2.63

179

1375

Golimumab

329

2601

1.35

5.04

1.8

1.13

0.92

mg/l

0.94

248

1907

Other and unspecified disorders of pigmentation

468

1.90

5.04

2.0

1.7

0.72

1.22

mg/l

2.23

360

Prolapse and hernia of ovary and fallopian tube

306

2363

1.35

5.03

1.6

1.7

1.50

1.64

mg/l

0.24

243

1799

Malignant neoplasm of thyroid gland, including Hilmo

658

5574

1.23

5.03

2.0

1.8

1.12

1.01

mg/l

0.28

502

4160

Other facial nerve disorders

258

1976

1.40

5.02

1.8

1.6

0.80

1.09

mg/l

2.60

191

1475

Hypothyroidism due to medicaments and other exogenous substances

117

787

1.67

5.02

1.9

1.7

1.73

1.13

mg/l

0.83

624

Scabies

407

3292

1.30

5.02

2.1

1.8

0.94

1.03

mg/l

0.37

314

2422

Periodontal disease, other/unspecified

245

1864

1.41

5.01

1.7

0.91

1.14

mg/l

1.40

186

1429

Burn and corrosion of other internal organs

192

2.55

5.01

1.5

1.6

1.28

1.16

mg/l

0.07

149

Erosion and ectropion of cervix uteri

251

1914

1.40

5.01

2.0

1.7

0.93

1.29

mg/l

1.85

183

1467

Malignant neoplasm, without specification of site, including Hilmo

357

2832

1.32

5.00

1.7

1.6

2.26

1.35

mg/l

3.52

284

2200

Injury of nerves at hip and thigh level

241

2.35

5.00

1.8

0.56

1.33

mg/l

2.88

191

Cholesteatoma of external ear

510

1.87

5.00

1.9

1.8

1.08

1.45

mg/l

1.01

407

Abscess of Bartholin gland

276

2141

1.39

5.00

1.8

1.6

0.92

0.84

mg/l

0.30

200

1588

Ulcerative colitis (strict) with PSC

499

1.85

5.00

2.3

2.2

1.80

0.98

mg/l

1.07

370

Myocardial infarction, unclassifiable

1845

14888

1.13

4.98

2.3

1.7

1.52

1.59

mg/l

0.36

1485

11633

Benign neoplasm: Other and unspecified parts of mouth

303

2376

1.36

4.98

1.8

1.7

1.09

1.16

mg/l

0.17

232

1830

Mixed conductive and sensorineural hearing loss

1044

9160

1.17

4.96

1.7

1.29

1.36

mg/l

0.20

813

7099

Other and unspecified acne

137

949

1.59

4.95

2.6

2.0

0.95

0.93

mg/l

0.04

103

680

Other degenerative diseases of the basal ganglia

151

1067

1.55

4.95

1.3

1.7

1.37

1.41

mg/l

0.04

113

846

Abscess of tendon sheath

355

2.01

4.92

2.0

1.6

0.82

1.20

mg/l

1.35

272

Pneumoconiosis due to asbestos and other mineral fibres

151

1056

1.52

4.91

1.6

1.7

1.24

1.68

mg/l

1.34

110

849

Blood alcohol or alcohol intoxication level

221

1660

1.43

4.91

1.9

1.12

1.06

mg/l

0.14

177

1221

Gastrointestinal stromal tumor and sarcoma

101

659

1.72

4.90

1.5

1.7

2.10

1.23

mg/l

0.83

519

Exposure to other and unspecified forces of nature

413

1.97

4.89

1.9

1.87

1.13

mg/l

0.65

319

Carcinoma in situ of colon

172

1247

1.51

4.89

1.8

1.7

2.06

1.34

mg/l

0.64

142

999

Malignant neoplasm of vulva, including Hilmo

128

881

1.61

4.86

1.8

1.6

1.09

1.12

mg/l

0.06

100

686

Toxic liver disease

150

1063

1.55

4.86

2.3

1.7

1.58

1.08

mg/l

0.68

117

806

Endocrine disorders, other/unspecified

185

1358

1.48

4.86

1.7

1.02

1.03

mg/l

0.03

126

1036

Other bullous disorders

244

1865

1.40

4.85

2.1

1.8

1.30

1.18

mg/l

0.15

189

1431

Brain meningioma, including Hilmo

434

3550

1.28

4.85

1.7

1.8

1.56

1.14

mg/l

0.48

339

2693

Other rupture of muscle

372

1.97

4.84

1.8

1.6

1.28

1.18

mg/l

0.12

291

Abscess of external ear

139

973

1.58

4.82

1.9

1.8

1.02

1.10

mg/l

0.23

101

727

Corneal scars and opacities

243

1858

1.40

4.82

2.1

1.7

1.17

1.18

mg/l

0.01

182

1418

Burn and corrosion of trunk

262

2022

1.38

4.82

1.9

1.18

1.15

mg/l

0.07

190

1530

Cutaneous lupus erythematosus

224

1696

1.43

4.81

1.8

1.7

0.96

1.08

mg/l

0.47

187

1290

Diphtheria

3.51

4.81

2.1

1.8

1.06

0.97

mg/l

0.09

Malignant melanoma of skin

914

7964

1.18

4.80

1.6

1.7

1.56

1.19

mg/l

0.83

722

6114

Malignant neoplasm of head and neck

626

5289

1.22

4.80

1.7

1.8

1.38

1.27

mg/l

0.41

477

4106

Other congenital malformations of upper alimentary tract

460

1.89

4.80

2.0

1.7

1.69

1.52

mg/l

0.10

347

Burn and corrosion of hip and lower limb, except ankle and foot

214

1607

1.43

4.79

2.0

1.9

1.83

1.09

mg/l

0.40

147

1189

Other and unspecified primary disorders of muscles

459

1.87

4.78

2.1

2.2

2.42

1.25

mg/l

0.43

364

Malignant neoplasm of anus and anal canal, including Hilmo

113

759

1.65

4.78

2.1

1.6

2.17

1.03

mg/l

0.72

583

Lipomatosis, not elsewhere classified

183

2.59

4.78

1.9

1.6

0.98

0.88

mg/l

0.15

138

Other disorders of peripheral nervous system

399

1.96

4.78

1.8

1.6

0.97

1.25

mg/l

0.58

317

Tetraplegia

460

1.88

4.77

1.9

2.1

1.59

1.35

mg/l

0.20

371

Benign neoplasm: Other/unspecified site

147

1041

1.55

4.77

1.7

1.20

1.11

mg/l

0.17

110

819

Malignant neoplasm of small intestine, including Hilmo

243

1856

1.39

4.77

1.9

1.6

1.41

1.20

mg/l

0.74

191

1435

Contusion of toe(s) with damage to nail

107

711

1.67

4.77

2.0

1.9

0.94

1.04

mg/l

0.23

526

Polymyositis

531

1.81

4.75

2.3

1.7

1.34

1.25

mg/l

0.11

426

Open wound of shoulder and upper arm

182

1334

1.47

4.75

1.8

1.27

1.10

mg/l

0.30

141

993

532

1.81

4.73

2.2

1.6

1.17

0.94

mg/l

0.23

414

Spasmodic torticollis

300

2369

1.35

4.73

1.9

1.7

0.95

1.04

mg/l

0.24

215

1812

Nontoxic single thyroid nodule

655

5583

1.22

4.72

2.1

1.7

0.96

1.10

mg/l

0.79

522

4254

Benign neoplasm: Anus and anal canal

247

1899

1.39

4.71

1.8

1.6

1.23

mg/l

0.01

193

1464

Syphilis

229

1742

1.41

4.71

1.8

1.13

1.14

mg/l

0.02

175

1334

Syphilis

229

1742

1.41

4.71

1.8

1.13

1.14

mg/l

0.02

175

1334

Malignant neoplasm of endocrine gland

617

5231

1.23

4.71

2.1

1.8

1.20

1.04

mg/l

0.42

475

3916

Nontoxic diffuse goitre

290

2279

1.36

4.70

2.0

1.6

1.13

1.07

mg/l

0.15

220

1741

Other specified and unspecified disorders of conjunctiva

651

1.71

4.70

3.8

1.7

2.31

1.27

mg/l

0.38

502

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

318

2.07

4.69

3.8

1.7

0.93

0.90

mg/l

0.10

243

Epileptic seizures related to drugs

169

2.56

4.68

2.1

1.8

1.03

0.91

mg/l

0.12

128

Narcolepsy and cataplexy

406

1.90

4.67

1.9

1.6

1.18

1.28

mg/l

0.12

300

Evidence of alcohol involvement determined by level of intoxication

104

690

1.68

4.67

1.8

1.9

0.97

1.06

mg/l

0.20

511

Retained placenta and membranes, without haemorrhage

1142

10135

1.16

4.67

1.7

1.07

0.91

mg/l

1.15

864

7563

Benign neoplasm: Connective and other soft tissue, unspecified

113

765

1.64

4.66

1.7

1.6

0.92

1.13

mg/l

0.73

602

Gonococcal infection

296

2333

1.35

4.66

1.8

1.9

1.16

1.03

mg/l

0.44

213

1725

Generalized epilepsy, mode (most common among epilepsy diagnosis)

284

2225

1.35

4.66

1.7

2.0

1.51

1.09

mg/l

0.42

208

1660

Benign neoplasm of other and unspecified sites

293

2308

1.35

4.66

1.8

1.7

1.04

1.17

mg/l

0.43

229

1777

Juvenile osteochondrosis

293

2305

1.35

4.63

2.0

1.9

0.91

1.01

mg/l

0.44

218

1669

Personal history of allergy to analgesic agent

411

1.93

4.62

1.7

1.6

1.82

0.94

mg/l

0.30

312

Endometriosis of fallopian tube

503

1.81

4.61

1.6

0.55

0.95

mg/l

2.69

372

Ankylosing spondylitis, strict definition

399

3256

1.29

4.61

1.8

1.01

0.93

mg/l

0.20

296

2383

Rare circulating lymphoid malignancy

288

2.08

4.61

5.1

1.7

2.95

1.32

mg/l

1.13

225

Other bacterial agents as the cause of diseases classified to other chapters

102

679

1.69

4.61

4.5

2.0

1.29

1.28

mg/l

0.01

530

Left hemicolectomy

196

1463

1.44

4.59

2.2

1.7

1.95

1.30

mg/l

2.66

169

1160

Primary biliary cholangitis (PBC)

201

1509

1.44

4.58

2.1

1.8

1.89

1.07

mg/l

2.54

163

1166

Dermatopolymyositis

138

974

1.56

4.58

2.2

1.8

1.26

1.14

mg/l

0.25

103

765

Selective deficiency of immunoglobulin A [IgA]y

293

2.14

4.58

2.0

2.1

1.30

0.83

mg/l

0.87

222

Colitis, primary sclerosing, strict definition

105

703

1.67

4.57

2.4

1.9

1.74

0.96

mg/l

1.25

520

Viral conjunctivitis

352

2840

1.31

4.56

1.8

1.02

0.98

mg/l

0.10

261

2127

Poor fetal growth

1253

11197

1.15

4.56

2.1

1.7

1.14

0.82

mg/l

3.19

929

8148

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

832

7248

1.19

4.56

1.9

1.7

1.03

0.86

mg/l

1.01

614

5394

Sequelae of infectious and parasitic diseases

657

5613

1.21

4.53

1.9

1.7

1.03

1.09

mg/l

0.16

505

4242

Carcinoma in situ of other and unspecified sites

281

2206

1.35

4.53

1.7

1.55

1.49

mg/l

0.10

223

1750

Injury of blood vessels at shoulder and upper arm level

114

3.09

4.52

1.8

1.6

0.99

1.24

mg/l

0.28

Hypoplasia of dental enamel, prenatal , including avohilmo

240

2.20

4.51

11.4

4.7

3.80

2.33

mg/l

0.25

172

Sequelae of intentional self-harm, assault and events of undetermined intent

436

1.87

4.50

2.3

2.1

0.90

0.83

mg/l

0.14

331

Hypothermia

157

1133

1.50

4.50

1.6

1.9

1.77

1.31

mg/l

0.69

121

886

Unspecified visual impairment (binocular)

141

1002

1.54

4.47

1.7

1.9

1.10

1.17

mg/l

0.14

106

769

Sequelae of other and unspecified infectious and parasitic diseases

502

4205

1.25

4.47

1.9

1.7

0.89

0.93

mg/l

0.09

374

3149

Other secondary gout

209

2.39

4.47

2.4

1.6

1.40

1.74

mg/l

0.37

162

Congenital malformations of spine and bony thorax

421

1.88

4.47

3.8

2.7

1.53

0.87

mg/l

0.59

323

Hereditary lymphedema

135

2.90

4.46

2.1

1.9

1.61

0.72

mg/l

0.76

106

Hereditary erythropoietic porphyria

5.79

4.45

2.5

1.8

1.83

1.33

mg/l

—

Viral encephalitis, not elsewhere classified/unspecified

184

1369

1.45

4.45

2.0

1.7

0.83

1.23

mg/l

3.01

145

1044

Unequal limb length (acquired)

487

1.77

4.44

2.2

2.0

0.65

0.92

mg/l

1.46

319

Nonalcoholic steatohepatitis

548

1.76

4.44

2.4

1.7

1.20

1.01

mg/l

0.21

433

Alzheimer’s disease (undefined)

499

0.40

4.43

1.2

1.6

1.10

1.42

mg/l

0.64

395

Deformity of finger(s)

360

1.94

4.43

1.8

1.5

1.57

0.98

mg/l

0.69

270

Macular cyst

242

1873

1.38

4.43

1.6

1.7

1.21

1.28

mg/l

0.15

184

1461

Benign neoplasm of other and unspecified intrathoracic organs

105

709

1.65

4.43

2.5

1.7

1.25

1.20

mg/l

0.06

561

Other secondary coxarthrosis

298

2367

1.34

4.42

1.6

1.7

1.64

1.14

mg/l

1.85

232

1812

Peptic ulcer

576

1.71

4.42

2.3

1.6

1.50

1.20

mg/l

0.44

449

Other disorders of Eustachian tube

266

2086

1.36

4.41

1.9

1.7

0.86

1.09

mg/l

1.48

197

1581

Marginal zone B-cell lymphoma

548

1.75

4.41

1.7

1.32

1.11

mg/l

0.38

430

Malignant neoplasm of breast, HER-negative

1794

16049

1.12

4.41

1.6

1.7

1.23

1.07

mg/l

1.26

1388

12216

Diphtheria

102

3.13

4.40

2.1

1.7

1.01

0.97

mg/l

0.03

Other disorders of choroid

125

871

1.57

4.39

2.4

1.7

1.07

1.30

mg/l

0.69

681

Renal cell carcinoma of kidney

242

1865

1.37

4.38

1.6

1.24

1.35

mg/l

0.27

187

1449

Cyclic neutropenia

129

2.90

4.37

2.1

2.0

0.76

1.07

mg/l

0.42

Chorioretinal scars

217

2.31

4.35

2.7

2.1

0.95

1.32

mg/l

0.61

165

Pustulosis palmaris et plantaris

386

3164

1.29

4.35

1.7

1.8

1.10

1.09

mg/l

0.01

303

2395

Epiphora

199

1505

1.42

4.34

1.7

0.88

1.24

mg/l

2.58

158

1164

Gonococcal infection

313

2506

1.32

4.34

1.8

1.9

1.13

1.01

mg/l

0.41

223

1838

Other disorders of iris and ciliary body

229

1762

1.38

4.33

1.6

1.8

0.94

1.20

mg/l

1.65

171

1334

Perforation of oesophagus

288

2.06

4.33

1.8

1.7

2.19

1.39

mg/l

0.51

228

Crossbite

557

4346

1.22

4.32

3.6

2.2

1.45

1.10

mg/l

0.58

391

3122

Cardiomyopathies, Secondary/extrinsic

377

1.89

4.32

7.0

1.7

1.90

1.44

mg/l

0.35

301

Acute and transient psychotic disorders

1067

9471

1.16

4.31

1.8

1.25

1.02

mg/l

2.04

811

7097

Persistent delusional disorders

667

5737

1.21

4.29

1.8

1.11

1.14

mg/l

0.13

512

4326

Disorder of the sleep-wake schedule

158

1152

1.48

4.28

2.1

0.98

1.21

mg/l

0.65

113

859

Benign neoplasm of bone and articular cartilage

749

6503

1.19

4.26

1.8

1.7

1.02

1.07

mg/l

0.13

571

4874

Rickettsioses

122

2.80

4.26

2.0

1.7

1.27

1.04

mg/l

0.22

102

Chondromalacia

260

2045

1.36

4.26

1.6

1.7

0.90

1.06

mg/l

0.32

191

1564

Valgus deformity, not elsewhere classified

448

1.80

4.26

3.1

1.6

1.42

0.99

mg/l

0.64

334

Family history of other conditions

139

995

1.52

4.26

1.8

1.08

1.02

mg/l

0.07

110

732

Dislocation of lens

121

839

1.55

4.26

1.8

1.6

1.54

1.39

mg/l

0.14

653

Chromosomal abnormalities, not elsewhere classified

186

1390

1.43

4.25

1.9

3.1

1.02

1.30

mg/l

0.63

146

1025

Fourth [trochlear] nerve palsy

200

1519

1.42

4.25

1.8

1.6

1.17

1.18

mg/l

0.02

151

1167

Complications following abortion and ectopic and molar pregnancy

310

2490

1.32

4.25

1.7

1.8

1.26

1.09

mg/l

0.31

226

1922

Noonan syndrome

3.88

4.25

3.2

5.8

0.61

1.84

mg/l

—

Congenital ovarian cysts

444

3705

1.26

4.23

1.7

0.91

0.82

mg/l

0.30

352

2736

Injury of muscle and tendon at ankle and foot level

224

1728

1.39

4.22

1.5

1.7

0.90

1.03

mg/l

0.21

162

1296

Primary open-angle glaucoma

2817

25325

1.09

4.21

1.7

1.50

1.48

mg/l

0.09

2167

19781

Other infective (teno)synovitis

255

2.14

4.21

1.6

1.04

1.11

mg/l

0.05

196

Demyelinating diseases of the central nervous system

814

7121

1.18

4.21

1.7

1.8

0.84

0.95

mg/l

0.97

587

5284

Premature rupture of membranes

2185

14382

1.11

4.20

1.7

0.84

0.80

mg/l

0.23

1572

10478

Other nonscarring hair loss

102

695

1.65

4.20

2.9

1.6

0.95

0.83

mg/l

0.24

527

Failure of sterile precautions during surgical operation

178

2.45

4.19

1.8

1.09

1.14

mg/l

0.05

148

Use of selegiline

357

2907

1.29

4.19

1.8

1.7

1.26

1.44

mg/l

0.82

282

2282

Congenital mitral valve regurgitation

3.08

4.18

6.5

3.4

1.36

1.91

mg/l

0.22

136

932

1.49

4.17

2.5

5.1

1.80

1.76

mg/l

0.03

631

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

106

724

1.61

4.16

2.9

1.8

2.18

1.16

mg/l

0.52

558

Torticollis

142

1021

1.49

4.14

1.9

1.8

0.75

1.05

mg/l

1.37

756

Meningitis, viral

302

2.04

4.14

1.5

1.7

0.59

0.68

mg/l

0.32

222

Varicella [chickenpox]

456

3806

1.25

4.13

2.6

2.2

1.29

1.06

mg/l

0.37

355

2844

Calcification and ossification of muscle

144

2.61

4.13

2.1

1.7

1.31

1.57

mg/l

0.24

113

Other and unspecified disorders of adult personality and behaviour

401

1.88

4.13

2.2

1.6

0.65

0.73

mg/l

0.30

296

Varus deformity, not elsewhere classified

103

701

1.62

4.13

1.4

1.8

0.97

1.28

mg/l

0.74

530

Other benign neoplasms of connective and other soft tissue

868

7633

1.17

4.12

1.7

1.8

1.15

mg/l

0.00

666

5802

Lupus nephritis

258

2.14

4.12

2.1

1.8

2.27

0.79

mg/l

1.25

195

Primary open-angle glaucoma, strict

2298

21183

1.10

4.11

1.8

1.7

1.50

1.46

mg/l

0.15

1750

16572

Intrahepatic Cholestasis of Pregnancy (ICP)

694

6018

1.20

4.11

1.9

1.7

0.94

0.79

mg/l

1.09

514

4435

Malignant neoplasm of bronchus and lung

1484

11136

1.13

4.11

1.6

1.7

1.91

1.34

mg/l

4.61

1243

8651

Malignant neoplasm of small intestine

171

1271

1.44

4.11

1.9

1.6

1.59

1.27

mg/l

0.88

140

974

Motor- or nonmotor-vehicle accident in traffic area

446

1.80

4.11

1.6

1.9

0.66

1.17

mg/l

1.95

335

Other hyperalimentation

223

2.27

4.11

1.7

0.88

1.09

mg/l

0.36

175

Other injuries of upper limb, level unspecified

116

811

1.58

4.10

2.0

1.9

1.30

1.19

mg/l

0.14

604

Carcinoma in situ, bladder

256

2015

1.35

4.10

1.7

1.46

1.50

mg/l

0.06

200

1589

Chronic iridocyclitis

428

3562

1.26

4.09

1.8

1.7

1.64

1.12

mg/l

0.87

324

2679

Brain meningioma

415

3445

1.26

4.08

1.7

1.8

1.59

1.14

mg/l

0.48

325

2615

Diabetes insipidus

608

1.68

4.08

1.9

1.7

1.30

1.06

mg/l

0.41

463

All dysplastic lesions of the cervix uteri, vagina or vulva

3070

28280

1.09

4.06

1.7

0.93

0.90

mg/l

0.24

2272

21044

Contact with other and unspecified heat and hot substances

425

1.82

4.06

1.6

1.8

1.32

1.28

mg/l

0.03

321

L02BA Anti-estrogens

1570

14301

1.12

4.02

1.6

1.7

1.16

1.06

mg/l

0.78

1204

10948

Contact with blunt object, undetermined intent

419

1.83

4.02

1.9

1.7

0.87

0.99

mg/l

0.20

313

Contact urticaria

194

2.30

4.01

1.6

1.7

0.54

0.79

mg/l

1.90

147

Schizophrenia

1450

13145

1.13

4.00

1.8

1.09

1.05

mg/l

0.27

1076

9812

Mild or no visual impairment, binocular

312

1.98

3.99

2.3

1.9

1.18

1.38

mg/l

0.18

237

Neuroendocrine tumor and carcinoma of lung

482

1.76

3.99

1.7

1.6

1.77

0.97

mg/l

1.18

376

Use of rasagiline

216

1675

1.38

3.98

1.9

1.6

1.88

1.36

mg/l

0.85

174

1322

Failed attempted abortion

127

910

1.54

3.98

1.8

1.6

1.03

0.74

mg/l

0.39

674

Congenital malformations of spine and bony thorax

357

1.89

3.97

3.9

2.8

1.63

0.83

mg/l

0.65

267

Abnormality of red blood cells

328

1.96

3.97

1.7

1.9

1.92

1.22

mg/l

0.39

255

Hypertrophy of tongue papillae

125

893

1.54

3.97

1.7

1.15

1.17

mg/l

0.05

690

Malignant neoplasm of cervix uteri, including Hilmo

230

1799

1.37

3.96

2.0

1.7

1.88

1.01

mg/l

1.35

182

1336

Gilbert syndrome

450

1.77

3.96

1.8

1.02

1.14

mg/l

0.19

343

Benign neoplasm: Pituitary gland, craniopharyngeal duct

464

3909

1.24

3.94

1.8

1.7

1.09

1.10

mg/l

0.02

348

2936

Acute hepatitis B

276

2.05

3.94

1.9

1.6

1.15

0.98

mg/l

0.28

217

Contact with lifting and transmission devices, not elsewhere classified

156

1155

1.46

3.93

1.7

1.8

1.48

1.19

mg/l

0.34

114

868

Other congenital malformations, not elsewhere classified

523

1.70

3.91

2.9

2.6

1.79

1.03

mg/l

0.52

383

Other and unspecified injuries of forearm

492

1.73

3.89

2.0

1.9

0.80

1.08

mg/l

0.54

367

Cerebral palsy

146

1070

1.47

3.87

2.9

2.3

3.20

1.06

mg/l

1.37

115

762

Occupational exposure to risk-factors

280

2246

1.32

3.86

1.7

1.11

1.29

mg/l

0.57

220

1733

Pituitary-dependent Cushing's disease

213

2.25

3.86

1.5

1.8

0.78

0.79

mg/l

0.02

170

Benign neoplasm: Other parts of oropharynx

616

1.65

3.86

1.8

1.7

1.87

1.19

mg/l

0.51

489

Other disorders of amino-acid metabolism

269

2.03

3.85

4.9

1.7

10.36

0.99

mg/l

1.31

205

Hyperfunction of pituitary gland

460

3881

1.24

3.85

1.8

1.35

0.96

mg/l

0.73

351

2873

Reduction defects of lower limb

141

2.51

3.84

1.8

2.4

1.37

0.92

mg/l

0.54

103

Acute appendicitis, with complications

1794

16466

1.11

3.82

1.8

1.44

1.17

mg/l

1.71

1376

12686

Dissection of cerebral arteries, nonruptured

487

1.73

3.82

1.7

0.74

1.06

mg/l

0.98

380

Other complications of labour and delivery, not elsewhere classified

1158

9549

1.14

3.80

1.7

1.13

0.74

mg/l

4.14

858

6690

Disorders of brain, other and unspecified

599

1.64

3.80

2.5

1.7

2.39

1.19

mg/l

0.89

463

Contact with other specified venomous animals

441

1.78

3.80

1.8

1.35

1.16

mg/l

0.12

331

Placenta praevia

436

3666

1.24

3.80

1.8

1.7

1.23

0.67

mg/l

2.87

317

2698

Acquired pure red cell aplasia [erythroblastopenia]

256

2.06

3.80

2.7

1.7

0.79

1.40

mg/l

1.61

191

Exposure to smoke, fire and flames

213

1658

1.37

3.77

1.8

1.06

1.17

mg/l

0.28

168

1258

Unspecified multiple injuries

214

2.20

3.76

1.7

1.8

0.82

1.23

mg/l

0.93

159

Malignant neoplasm of thyroid gland

570

4901

1.21

3.76

2.1

1.8

1.20

1.04

mg/l

0.38

443

3678

241

1910

1.34

3.76

1.9

1.7

0.74

0.96

mg/l

1.54

171

1442

Malignant neoplasm of tongue, including Hilmo

211

1640

1.36

3.75

1.5

1.6

1.29

1.23

mg/l

0.11

163

1258

Injury of cranial nerves

386

1.82

3.75

1.7

0.80

1.19

mg/l

1.24

296

Villonodular synovitis (pigmented)

488

1.71

3.75

1.4

1.6

1.36

1.09

mg/l

0.25

363

Chronic hepatitis NAS

127

921

1.51

3.74

1.9

1.7

2.21

1.08

mg/l

2.06

104

712

Systemic sclerosis,strict definition

647

1.63

3.74

2.0

1.7

1.22

0.90

mg/l

0.89

501

Benign neoplasm: Choroid

515

4398

1.22

3.74

2.0

1.8

0.97

1.25

mg/l

2.72

399

3394

Other and unspecified myoneural disorders

252

2.10

3.74

2.0

1.8

1.09

1.32

mg/l

0.29

195

Qualitative platelet defects

252

2.10

3.74

3.3

2.0

2.11

0.95

mg/l

0.68

200

Chylothorax

145

2.58

3.73

3.5

2.8

1.29

1.07

mg/l

0.27

113

Injury of blood vessels at lower leg level

288

1.98

3.73

2.0

1.7

1.74

1.35

mg/l

0.40

227

Melanocytic naevi of upper limb, including shoulder

213

1664

1.37

3.73

2.0

1.7

2.32

1.15

mg/l

0.70

164

1261

Sequelae of burns, corrosions and frostbite

295

1.96

3.72

2.0

1.7

1.25

1.27

mg/l

0.01

222

Thalassaemia

236

2.10

3.72

5.5

2.4

1.17

mg/l

0.00

175

Malignant neoplasm of oral cavity

259

2064

1.32

3.72

1.6

1.42

1.23

mg/l

0.53

197

1589

L02BX Other hormone antagonists and related agents

397

3312

1.25

3.72

1.5

1.7

2.34

1.64

mg/l

1.95

329

2642

Alzheimer’s disease (undefined), excluding more controls

448

0.43

3.71

1.2

1.5

1.10

1.88

mg/l

1.83

345

Granulomatous disorders of skin and subcutaneous tissue

238

1886

1.34

3.71

2.5

1.7

1.18

1.09

mg/l

0.20

181

1417

Secondary parkinsonism

218

1704

1.35

3.71

1.9

1.7

1.46

1.32

mg/l

0.24

171

1322

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

187

2.31

3.71

1.5

1.8

1.66

1.40

mg/l

0.15

157

Viral infections of central nervous system, not elsewhere classified/unspecified

136

997

1.48

3.70

1.7

1.6

0.95

1.08

mg/l

0.40

746

N06DA Anticholinesterases

2573

21775

0.92

3.70

1.5

1.7

1.73

1.57

mg/l

0.93

1951

17171

Use of anticholinesterases

2573

21775

0.92

3.70

1.5

1.7

1.73

1.57

mg/l

0.93

1951

17171

Melanocytic naevi, other sites/unspecified

719

6298

1.18

3.70

2.0

1.8

1.01

1.08

mg/l

0.44

563

4751

Foreign body on external eye

1270

11489

1.13

3.68

1.7

1.9

1.18

1.12

mg/l

0.22

949

8641

Liposarcoma, including Hilmo

604

1.63

3.68

1.8

1.7

1.34

1.13

mg/l

0.50

469

Aphakia

114

802

1.51

3.68

1.6

1.33

1.20

mg/l

0.19

624

Varicella [chickenpox]

395

3297

1.25

3.68

2.5

2.0

1.35

1.02

mg/l

0.51

311

2465

Other vitreous opacities

333

2738

1.28

3.67

1.9

1.7

1.38

1.19

mg/l

0.21

261

2097

Convergence insufficiency and excess

133

974

1.48

3.65

2.3

1.8

0.60

1.04

mg/l

2.81

105

712

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

338

2786

1.27

3.64

2.0

1.7

1.32

1.24

mg/l

0.19

278

2144

Multifocal fibrosclerosis

415

1.79

3.64

1.8

1.6

1.46

1.31

mg/l

0.15

332

Rickettsioses

2.87

3.63

1.8

1.7

1.10

0.98

mg/l

0.10

Malignant neoplasm of bladder

473

3997

1.22

3.63

1.7

1.6

2.02

1.45

mg/l

2.00

404

3150

Benign neoplasm: Larynx

258

2065

1.32

3.63

1.7

0.94

1.30

mg/l

3.11

205

1609

Alzheimer’s disease, strict definition

1768

15848

0.90

3.61

1.6

1.7

1.85

1.60

mg/l

1.46

1356

12475

Iridocyclitis in diseases classified elsewhere

168

1276

1.41

3.61

1.7

1.8

1.28

1.17

mg/l

0.22

126

966

Endometriosis in cutaneous scar

217

2.14

3.59

1.9

1.7

0.71

0.82

mg/l

0.24

155

Assault by sharp object

151

1129

1.43

3.58

1.8

1.83

0.99

mg/l

0.53

115

825

Benign neoplasm: Oesophagus

110

785

1.54

3.55

1.9

1.8

0.99

1.27

mg/l

1.05

622

Lesion of medial popliteal nerve

256

2.04

3.54

1.9

1.7

0.60

1.05

mg/l

2.05

208

Convergent concomitant strabismus

515

4416

1.21

3.53

2.1

1.9

0.98

1.05

mg/l

0.30

404

3228

Pedal cyclist injured in noncollision transport accidents

1010

9055

1.14

3.52

1.8

1.9

1.06

1.11

mg/l

0.36

759

6764

Other specified and unspecified disorders of lens

520

1.66

3.51

1.6

1.11

1.38

mg/l

0.74

406

Disorders of iron metabolism

134

987

1.46

3.51

1.7

1.18

1.03

mg/l

0.25

103

759

Hyphaema and other vascular disorders of iris and ciliary body

166

1262

1.40

3.51

1.6

1.7

1.00

1.25

mg/l

1.21

124

958

Spina bifida

148

2.45

3.49

1.4

2.4

0.66

0.84

mg/l

0.45

111

Exposure to unspecified smoke, fire and flames

628

1.60

3.49

2.1

1.8

1.40

1.46

mg/l

0.06

465

Secondary parkinsonism+Parkinsonism in other disease

221

1745

1.34

3.49

1.9

1.7

1.45

1.32

mg/l

0.21

174

1357

Rheumatoid lung disease

272

1.99

3.49

2.6

1.7

2.51

1.63

mg/l

0.42

219

Combined immunodeficiencies

670

1.57

3.46

2.6

1.8

1.26

1.17

mg/l

0.16

529

Wide developmental disorders, excluding more controls

214

1646

1.33

3.46

1.9

2.3

0.67

1.20

mg/l

2.69

144

1113

Other conjunctival vascular disorders and cysts

201

1574

1.36

3.46

1.7

0.85

1.15

mg/l

2.45

160

1218

Pigmented purpuric dermatosis

690

1.58

3.46

1.8

1.6

1.48

1.31

mg/l

0.19

527

Other congenital malformations of integument

191

2.22

3.46

2.1

1.9

1.80

1.20

mg/l

0.55

156

Other specified and unspecified disorders of choroid

227

2.08

3.45

3.1

1.8

1.25

1.17

mg/l

0.09

180

Arteriovenous malformation of cerebral vessels

103

731

1.55

3.45

1.9

1.6

1.14

1.18

mg/l

0.07

576

Benign neoplasm: Conjunctiva

278

2262

1.30

3.44

1.7

0.84

1.12

mg/l

2.41

196

1727

Recurrent and persistent haematuria

582

1.62

3.44

1.9

1.7

0.83

1.25

mg/l

1.94

448

Torsion of testis

134

982

1.44

3.44

2.2

2.4

1.17

1.13

mg/l

0.04

670

629

1.58

3.44

1.9

1.06

1.04

mg/l

0.04

461

Neuroendocrine tumor and carcinoma of pancreas

381

1.79

3.43

1.9

1.7

1.49

1.08

mg/l

0.91

292

Dementia due to Parkinsons disease, excluding more controls

154

1156

1.40

3.42

1.7

1.6

1.81

1.76

mg/l

0.04

121

900

Mixed specific developmental disorders

150

1033

1.41

3.42

4.4

3.8

1.23

1.45

mg/l

0.30

118

693

Scarlet fever

522

1.64

3.42

1.9

2.0

0.89

0.90

mg/l

0.02

381

Injury of blood vessels at abdomen, lower back and pelvis level

258

2.00

3.42

2.5

1.8

2.56

1.02

mg/l

0.61

195

Dissocial personality disorder

141

1052

1.44

3.42

1.9

1.8

1.55

1.01

mg/l

1.16

107

777

Macular hole

459

3915

1.22

3.41

2.1

1.8

1.03

1.41

mg/l

3.37

351

3058

Hereditary corneal dystrophies

279

2274

1.29

3.41

1.7

1.8

1.38

1.30

mg/l

0.16

204

1756

Other and unspecified corneal deformities and disorders

286

2338

1.29

3.40

1.7

1.33

1.09

mg/l

0.30

217

1773

Malignant neoplasm of rectum, including Hilmo

967

8660

1.14

3.39

1.7

2.01

1.25

mg/l

4.58

791

6696

Respiratory tuberculosis, confirmed

143

1066

1.42

3.39

2.1

1.7

1.29

1.34

mg/l

0.09

110

841

Migraine, unspecified, drug-induced

496

1.69

3.38

2.0

1.7

1.49

0.81

mg/l

0.68

382

Other diseases caused by chlamydiae

150

1135

1.42

3.37

1.9

1.7

1.21

0.76

mg/l

1.17

101

846

Testicular dysfunction, other/unspecified

258

1.96

3.36

1.8

1.7

0.93

1.63

mg/l

0.97

196

Thyrotoxicosis with toxic single thyroid nodule

619

1.60

3.36

2.1

1.7

0.93

1.05

mg/l

0.40

474

Personality and behavioural disorders due to brain disease, damage and dysfunction

131

969

1.46

3.35

1.8

1.25

1.26

mg/l

0.01

103

757

Certain conditions originating in the perinatal period

669

5189

1.17

3.35

2.7

2.4

1.72

1.07

mg/l

1.17

475

3583

Disorders of orbit

385

3242

1.24

3.34

1.9

1.8

1.15

1.14

mg/l

0.02

287

2438

Chorioretinal inflammation

252

2036

1.31

3.34

2.4

1.7

1.12

1.11

mg/l

0.02

197

1545

Melanocytic naevi of other and unspecified parts of face

520

4488

1.20

3.34

2.0

1.7

1.09

1.06

mg/l

0.08

399

3389

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

832

7417

1.16

3.33

1.9

1.7

1.03

0.90

mg/l

0.69

614

5540

Nosocomial condition (hospital)

335

1.82

3.33

2.3

1.7

1.47

1.36

mg/l

0.12

267

Adenocarcinoma and Papillary adenocarcinoma of kidney

642

1.57

3.33

1.6

1.19

1.39

mg/l

0.45

501

149

1062

1.40

3.33

2.9

4.8

2.54

1.70

mg/l

0.58

707

Migraine without aura, drug-induced

113

822

1.51

3.31

2.5

1.7

0.91

0.79

mg/l

0.24

609

Clubfoot

643

1.57

3.31

1.9

2.0

0.91

1.10

mg/l

0.40

482

Tuberculosis, IBD comorbidity

541

4672

1.19

3.31

2.0

1.7

1.60

1.49

mg/l

0.20

424

3629

CR(E)ST syndrome

147

1115

1.43

3.31

2.0

1.6

1.68

1.00

mg/l

0.70

125

874

Motorcycle rider injured in noncollision transport accidents

249

2006

1.30

3.30

1.9

0.94

1.10

mg/l

0.62

192

1432

Myositis ossificans

164

2.25

3.30

1.9

1.7

0.75

1.45

mg/l

1.97

134

Other and unspecified medical devices associated with adverse incidents

347

1.83

3.30

2.2

1.8

1.12

1.40

mg/l

0.54

277

Perioral dermatitis

206

1632

1.35

3.30

2.1

1.7

0.82

0.90

mg/l

0.34

146

1225

Actinomycosis

199

2.08

3.30

1.7

1.54

0.91

mg/l

0.66

156

Respiratory tuberculosis, bacteriologically and histologically confirmed

147

1106

1.41

3.28

2.1

1.7

1.28

1.35

mg/l

0.13

113

869

Senility

438

1.64

3.28

1.5

3.85

1.53

mg/l

0.52

331

Malignant neoplasm of eye and adnexa, including Hilmo

124

911

1.46

3.27

2.0

1.8

1.38

1.16

mg/l

0.44

103

700

Labyrinthitis

186

2.14

3.27

3.9

1.6

1.24

1.04

mg/l

0.25

146

Congenital absence, atresia and stenosis of large intestine

3.01

3.25

5.4

4.9

1.13

0.86

mg/l

0.25

Contact with sharp object, undetermined intent

205

1622

1.34

3.24

1.9

1.8

1.11

1.00

mg/l

0.18

147

1201

106

762

1.51

3.24

1.9

1.7

1.21

1.24

mg/l

0.07

597

Haematosalpinx/Haematoma of broad ligament

103

2.65

3.24

1.9

1.8

0.45

0.75

mg/l

1.23

Horner syndrome

110

798

1.50

3.24

1.8

1.7

3.00

1.19

mg/l

0.52

625

Optic neuritis

393

3330

1.23

3.23

1.8

1.7

0.76

0.95

mg/l

1.73

290

2471

Viral conjunctivitis

194

1528

1.35

3.23

1.9

1.7

0.87

1.00

mg/l

0.44

147

1162

Use of rotigotine

103

741

1.53

3.23

2.2

1.6

0.92

1.31

mg/l

1.85

581

Malignant neoplasm of oesophagus

187

1459

1.35

3.22

1.6

2.17

1.28

mg/l

2.36

159

1123

Other proliferative retinopathy

285

1.89

3.21

1.6

1.8

1.12

1.21

mg/l

0.09

220

Bullous keratopathy

490

1.64

3.21

1.8

1.7

1.61

1.37

mg/l

0.17

396

Maternal care for cervical incompetence

361

3041

1.25

3.21

1.8

1.27

1.00

mg/l

1.04

272

2284

Klinefelter syndrome, karyotype 47 XXY

117

2.51

3.20

1.4

2.9

0.81

0.82

mg/l

0.01

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

169

1307

1.37

3.19

1.5

1.7

1.23

1.12

mg/l

0.28

133

1008

Isolated patent ductus arteriosus

167

2.24

3.19

2.5

1.7

0.54

0.97

mg/l

1.54

110

Disorders of male genital organs in diseases classified elsewhere

338

1.78

3.18

1.9

2.0

0.78

1.47

mg/l

1.89

253

Sequelae of other and unspecified effects of external causes

374

1.77

3.16

2.2

1.7

1.46

1.27

mg/l

0.19

296

Other disorders of binocular vision

122

903

1.46

3.16

1.9

0.96

0.92

mg/l

0.06

662

Other congenital malformations of intestine

542

1.61

3.15

3.0

2.3

0.95

1.13

mg/l

0.38

414

Postdysenteric arthropathy

626

1.56

3.15

1.6

1.7

0.73

1.20

mg/l

2.69

470

Other specified/unspecified deforming dorsopathies

156

1196

1.39

3.14

1.7

1.6

1.05

1.06

mg/l

0.02

111

892

Other superficial injuries of ankle and foot

413

1.71

3.14

1.8

2.5

1.14

1.15

mg/l

0.01

320

Pseudomembranous colitis

560

1.60

3.14

1.7

1.6

1.06

1.07

mg/l

0.01

427

Mucinosis of skin

3.52

3.13

1.6

1.8

0.21

0.75

mg/l

—

Disorders of pituitary gland, other and/or unspecified

391

1.74

3.12

1.4

1.7

0.79

1.19

mg/l

1.31

303

Operations 1 for CAVS

161

2.24

3.11

9.9

3.2

2.22

1.69

mg/l

0.17

134

Increased muscle tone

455

1.67

3.11

1.8

2.0

1.56

1.35

mg/l

0.15

357

Synovial hypertrophy, not elsewhere classified

583

1.57

3.11

1.6

1.7

0.71

1.03

mg/l

1.44

428

Injury of nerves at wrist and hand level

324

2705

1.25

3.11

1.8

1.9

0.95

1.05

mg/l

0.38

236

2042

Tuberculosis

452

3869

1.20

3.10

2.0

1.6

1.36

1.51

mg/l

0.48

361

3001

Psoas tendinitis

272

1.88

3.10

1.6

1.5

0.65

0.94

mg/l

0.91

206

Right side

378

1.77

3.09

2.4

1.8

0.98

1.39

mg/l

1.21

312

Hip and thigh

170

2.23

3.08

2.3

2.7

1.20

1.07

mg/l

0.15

135

Calcific tendinitis

577

1.57

3.08

1.9

1.7

1.00

1.20

mg/l

0.42

442

Other localized connective tissue disorders

174

1362

1.36

3.08

2.3

1.7

0.82

1.10

mg/l

1.95

136

1024

Toxic effect of carbon monoxide

153

1176

1.39

3.07

2.0

1.7

0.90

1.18

mg/l

1.50

118

894

Diseases caused by chlamydiae

138

1047

1.42

3.07

1.9

1.7

1.27

0.73

mg/l

1.37

777

Hereditary nephropathy, not elsewhere classified

185

2.17

3.07

4.5

1.6

0.96

1.22

mg/l

0.49

146

Other acute skin changes due to ultraviolet radiation

285

2353

1.27

3.07

1.8

1.7

1.30

1.12

mg/l

0.44

221

1807

Other and unspecified acute skin changes due to ultraviolet radiation

201

1597

1.33

3.07

1.7

1.6

1.38

1.25

mg/l

0.29

158

1241

Burns and corrosions of multiple body regions

544

1.59

3.07

2.0

1.8

1.20

1.61

mg/l

0.75

423

Certolizumab pegol

169

1319

1.37

3.06

1.9

1.7

1.19

0.99

mg/l

0.65

134

957

LSIL lesion of the cervix uteri

1110

10102

1.13

3.03

1.6

1.7

0.88

0.85

mg/l

0.15

815

7475

Thyrotoxicosis factitia

224

2.04

3.02

1.6

1.8

0.52

1.14

mg/l

2.78

182

Separation of retinal layers (serosa)

348

2933

1.24

3.02

2.3

1.7

1.50

1.11

mg/l

0.59

266

2233

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

694

6163

1.16

3.02

1.9

1.7

0.94

0.83

mg/l

0.60

514

4564

Autoimmune hepatitis

591

1.57

3.00

2.1

1.7

2.22

1.12

mg/l

1.59

457

Drug-induced thyroiditis

165

2.25

2.99

2.0

1.6

1.78

1.09

mg/l

0.58

130

Other congenital malformations of urinary system

322

1.79

2.99

2.4

2.7

1.42

1.10

mg/l

0.32

242

Desensitization to allergens

482

4172

1.19

2.99

1.9

2.0

0.68

0.86

mg/l

2.44

331

2980

Sulfonylureas

2974

22316

1.07

2.98

1.8

1.7

1.50

mg/l

0.02

2383

17305

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

346

1.75

2.98

1.7

1.8

1.02

1.23

mg/l

0.45

263

Other disorders of binocular movement

205

1643

1.32

2.98

2.2

1.9

0.73

1.07

mg/l

2.50

160

1234

Factitial dermatitis

323

1.79

2.97

2.0

1.7

0.78

1.07

mg/l

0.87

259

Melanoma in situ

350

2958

1.23

2.97

2.2

1.7

1.75

1.37

mg/l

0.30

265

2313

Drug-induced hypoglycaemia without coma

134

1015

1.41

2.96

1.8

1.7

1.28

1.20

mg/l

0.09

102

768

Unspecified renal colic

404

1.70

2.96

2.0

1.6

1.07

1.06

mg/l

0.01

312

Perichondritis of external ear

151

1166

1.38

2.96

1.7

1.43

1.24

mg/l

0.29

123

905

Congenital malformations of eye, ear, face and neck

547

4779

1.18

2.96

2.0

2.2

1.13

1.04

mg/l

0.23

398

3498

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

349

1.77

2.95

1.6

1.7

1.04

1.07

mg/l

0.05

286

Malignant neoplasm of prostate, including Hilmo

2406

13379

1.08

2.94

1.6

1.8

1.67

1.30

mg/l

3.17

1874

10511

Fall on and from ladder

604

5319

1.17

2.93

1.9

1.7

1.47

1.32

mg/l

0.45

487

4130

Pityriasis rosea

510

1.60

2.93

2.0

1.8

1.63

1.04

mg/l

0.31

376

Malignant neoplasm of renal pelvis, including Hilmo

614

1.52

2.92

1.7

2.09

1.33

mg/l

1.30

474

Injury of urinary and pelvic organs

170

1333

1.35

2.92

1.9

1.8

1.63

1.18

mg/l

0.83

131

1006

Malignant neoplasm of anus and anal canal

318

1.80

2.91

2.0

1.7

1.20

1.08

mg/l

0.20

253

Atypical virus infections of central nervous system

620

1.54

2.89

1.5

1.7

1.24

1.11

mg/l

0.08

477

Foreign object accidentally left in body during surgical and medical care

211

2.02

2.89

1.7

1.6

2.34

0.85

mg/l

1.03

165

Other adrenocortical overactivity

340

1.73

2.88

2.5

3.1

1.00

1.63

mg/l

0.75

236

Paranoid personality disorder

166

1303

1.36

2.88

1.8

1.7

0.94

1.08

mg/l

0.47

127

980

Other hypertrichosis

226

1.97

2.88

1.9

0.76

0.70

mg/l

0.08

173

Benign neoplasm: Pineal gland

152

2.24

2.86

1.9

1.8

0.64

0.65

mg/l

0.02

112

Myotonic disorders

521

1.58

2.85

1.4

1.9

1.15

1.00

mg/l

0.18

406

Benign neoplasm: Bronchus and lung

108

798

1.46

2.85

1.7

1.30

1.24

mg/l

0.07

633

Relapsing polychondritis

153

2.25

2.85

2.6

1.7

0.49

1.32

mg/l

1.84

124

Effects of other deprivation

167

2.16

2.85

1.7

1.9

0.72

1.10

mg/l

0.70

120

Non-seminoma of testis

136

2.23

2.84

1.3

1.6

2.45

0.67

mg/l

1.52

conjunctival degenerations and deposits

179

1420

1.34

2.84

1.8

1.6

0.72

1.22

mg/l

6.44

142

1114

Drug-induced fever

118

2.51

2.84

2.0

1.7

0.95

1.05

mg/l

0.11

Benign neoplasm: Tonsil

107

792

1.46

2.84

1.7

1.8

0.87

1.18

mg/l

1.26

635

Panhypopituitarism

152

1182

1.37

2.83

1.9

1.70

1.28

mg/l

0.46

114

902

Acute mastoiditis

571

1.55

2.83

1.9

1.8

0.70

1.17

mg/l

1.74

440

Meckel's diverticulum

383

1.69

2.83

1.8

0.92

1.15

mg/l

0.37

301

Isolated proteinuria with specified morphological lesion

103

759

1.47

2.82

2.1

1.8

1.82

1.14

mg/l

0.57

588

Pemphigus

432

1.65

2.82

2.5

1.8

3.51

1.21

mg/l

0.87

344

Malignant neoplasm of prostate

2301

12881

1.08

2.82

1.6

1.8

1.71

1.31

mg/l

3.19

1800

10139

Tuberculosis, wide

554

4857

1.17

2.81

2.0

1.7

1.58

1.49

mg/l

0.16

435

3775

Social disorders starting during childhood or adolescence

454

1.60

2.80

2.2

2.9

0.72

1.14

mg/l

0.94

301

Laparoscopic left hemicolectomy

146

1133

1.38

2.80

1.9

1.7

1.76

1.27

mg/l

0.86

121

889

Granulosa cell carcinoma of ovary

258

1.87

2.80

1.8

1.7

1.11

0.89

mg/l

0.39

206

Other acquired deformities of ankle and foot

514

1.58

2.80

1.6

1.10

1.02

mg/l

0.08

379

Other diseases caused by chlamydiae

114

856

1.45

2.79

2.1

1.7

1.45

0.78

mg/l

1.51

659

Other zoonotic bacterial diseases, not elsewhere classified

274

1.84

2.79

3.3

2.0

1.20

1.04

mg/l

0.24

219

Malignant cancer of tonsil and base of tongue, including Hilmo

186

1484

1.32

2.78

1.7

1.6

1.51

1.20

mg/l

0.90

147

1138

Exposure to uncontrolled fire, not in building or structure

139

2.27

2.78

2.0

2.2

1.50

1.09

mg/l

0.23

111

Assault by other and unspecified firearm discharge

104

2.54

2.78

2.9

1.8

1.60

0.88

mg/l

0.51

Phakomatoses, not elsewhere classified

101

743

1.47

2.77

1.9

2.3

1.07

0.97

mg/l

0.15

562

Other drug-induced secondary parkinsonism

626

1.52

2.77

2.0

1.7

0.91

1.31

mg/l

1.73

499

Injury of nerves at shoulder and upper arm level

719

1.48

2.75

2.0

1.7

0.75

1.17

mg/l

2.57

546

Mental and behavioural disorders due to hallucinogens

321

1.74

2.74

1.7

1.6

1.00

0.86

mg/l

0.21

234

Syndactyly

197

1.97

2.74

3.3

2.0

1.08

0.74

mg/l

0.77

144

Open wounds involving multiple body regions

252

1.87

2.73

2.1

1.8

0.95

1.28

mg/l

0.48

205

Other lack of coordination

144

1119

1.37

2.72

2.0

1.8

0.75

1.16

mg/l

3.38

106

859

Diabetic retinopathy, strict definition

1551

12712

1.10

2.71

1.9

2.0

1.22

1.27

mg/l

0.23

1217

9984

Myotonic dystrophy (Steinert)

199

1.99

2.71

1.5

1.9

1.04

1.08

mg/l

0.05

161

Respiratory tuberculosis, confirmed and not-confirmed

388

3323

1.20

2.71

2.0

1.6

1.33

1.44

mg/l

0.30

302

2578

Contact with sharp glass

333

2825

1.22

2.70

1.8

1.9

0.73

0.99

mg/l

3.25

227

2050

Intermittent heterotropia

484

4217

1.18

2.70

2.5

2.2

1.09

1.16

mg/l

0.19

353

3065

Urticaria due to cold and heat

578

1.54

2.70

2.3

1.6

0.95

0.80

mg/l

0.35

434

Respiratory tuberculosis

388

3324

1.20

2.70

2.0

1.6

1.33

1.44

mg/l

0.30

302

2579

Vascular dementia

660

5651

1.15

2.69

1.6

1.45

1.67

mg/l

1.30

544

4431

Other zoonotic bacterial diseases, not elsewhere classified

2.88

2.69

1.6

1.40

1.13

mg/l

0.20

Chronic mastoiditis

207

1680

1.29

2.69

1.6

1.7

1.30

1.35

mg/l

0.10

154

1297

Disorders of parathyroid gland, other and/or unspecified

472

1.61

2.68

1.8

1.6

2.24

1.13

mg/l

0.43

380

Disorders of other and unspecified cranial nerves

315

1.74

2.68

2.1

1.6

0.84

1.47

mg/l

1.27

250

Other and unspecified mental retardation

125

946

1.39

2.66

2.2

4.0

1.56

1.69

mg/l

0.14

103

717

Short stature, not elsewhere classified

155

1121

1.34

2.66

5.3

4.2

2.30

1.42

mg/l

0.50

116

770

Drug-induced aplastic anaemia

2.54

2.66

1.9

1.7

1.74

1.14

mg/l

0.55

Certain zoonotic bacterial diseases

253

2100

1.26

2.66

1.9

1.7

1.10

1.13

mg/l

0.09

207

1595

Dementia in Alzheimer disease

1179

10858

0.90

2.65

1.5

1.6

1.95

1.67

mg/l

0.91

888

8511

Hereditary lymphedema

107

2.52

2.65

2.0

1.74

0.69

mg/l

0.67

Oher contracture of tendon (sheath)

184

1.99

2.65

1.6

0.77

1.20

mg/l

1.33

148

Mental retardation

307

2572

1.23

2.65

2.1

2.8

1.40

1.27

mg/l

0.33

248

1900

Malignant neoplasm of vulva

580

1.53

2.64

1.9

1.6

1.24

1.12

mg/l

0.27

451

Abnormal findings in cerebrospinal fluid

201

1.98

2.64

1.9

1.8

0.70

0.85

mg/l

0.21

159

Moderate visual impairment, monocular

278

1.80

2.64

1.7

0.87

0.98

mg/l

0.28

216

Other and unspecified nonscarring hair loss

515

1.57

2.64

2.0

1.7

0.94

0.78

mg/l

0.25

381

Helminthiases

146

1141

1.36

2.63

2.8

1.8

1.25

1.15

mg/l

0.17

104

874

Maternal care for known or suspected disproportion

408

3534

1.20

2.62

1.6

1.7

0.72

0.67

mg/l

0.17

300

2639

Neuromyelitis optica

187

2.04

2.62

1.9

0.68

0.92

mg/l

0.69

146

Organ-limited amyloidosis

261

1.80

2.62

2.0

1.6

1.91

1.47

mg/l

0.38

202

Allergic colitis

160

1257

1.33

2.62

2.1

3.5

1.17

1.42

mg/l

0.37

116

858

Migraine with aura, drug-induced

102

762

1.45

2.61

1.8

1.7

0.88

0.89

mg/l

0.02

586

Unspecified abortion

452

3945

1.19

2.61

2.0

1.7

0.94

0.87

mg/l

0.18

337

3026

Generalized epilepsy, strict definition

194

1569

1.30

2.61

1.7

2.1

1.76

1.17

mg/l

0.39

140

1162

Melanocytic naevi of lower limb, including hip

386

3331

1.20

2.60

2.3

1.7

1.03

1.05

mg/l

0.05

281

2533

Undescended testicle

466

1.55

2.60

3.2

4.5

1.70

1.83

mg/l

0.10

337

Bilateral cryptorchidism (undescended testicles)

2.48

2.59

2.6

6.3

1.48

2.07

mg/l

0.21

Lagophthalmos

106

795

1.43

2.59

1.6

1.22

1.26

mg/l

0.08

630

Palindromic rheumatism

657

1.48

2.59

1.9

1.5

0.78

1.16

mg/l

1.86

501

Acne varioliformis

165

2.10

2.59

1.8

1.7

1.18

0.98

mg/l

0.22

136

Cholera

106

2.38

2.59

1.8

1.5

1.47

1.04

mg/l

0.33

Behçet disease

195

1.99

2.58

2.5

1.7

1.20

0.87

mg/l

0.21

148

Effects of heat and light

456

1.58

2.58

2.2

1.7

1.58

1.42

mg/l

0.14

353

Carcinoma in situ of skin, other sites/unspecified

113

856

1.42

2.58

1.9

1.7

1.49

1.47

mg/l

0.03

680

Other and unspecified disease of Bartholin gland

248

2065

1.26

2.58

1.7

1.8

1.11

mg/l

0.02

173

1594

Other congenital malformations of intestine

736

1.45

2.58

2.8

2.2

0.96

1.10

mg/l

0.38

561

Burn and corrosion of ankle and foot

121

926

1.40

2.58

1.8

1.11

1.39

mg/l

0.64

705

Asymmetry of jaw

129

996

1.38

2.57

1.9

0.77

0.88

mg/l

0.38

739

Polyglandular dysfunction

166

2.11

2.57

3.1

1.7

1.28

1.24

mg/l

0.03

127

Benign neoplasm: Nasopharynx

558

1.53

2.57

1.7

1.8

1.00

1.28

mg/l

0.89

433

Chronic myeloid leukaemia

272

1.79

2.56

2.0

1.7

1.40

1.05

mg/l

0.47

207

Haemorrhagic and haematological disorders of fetus and newborn

109

777

1.40

2.56

6.5

5.6

1.33

1.88

mg/l

0.87

552

L02BB Anti-androgens

648

5777

1.15

2.56

1.6

1.7

2.27

1.71

mg/l

1.65

519

4583

Drug-induced tremor

418

1.62

2.55

1.9

0.99

1.30

mg/l

0.74

338

Acquired keratosis [keratoderma] palmaris et plantaris

289

1.77

2.55

2.0

1.6

0.92

1.20

mg/l

0.49

231

Other infestations

145

1140

1.36

2.55

1.6

1.8

1.11

1.14

mg/l

0.05

121

891

Other demyelinating diseases of the central nervous system

340

2912

1.22

2.54

1.6

1.8

0.88

0.91

mg/l

0.07

223

2163

Superficial frostbite

442

1.59

2.54

1.9

1.8

0.62

1.23

mg/l

3.13

330

Ulcer of oesophagus, drug-induced

272

1.77

2.53

1.6

1.7

1.98

1.50

mg/l

0.25

215

Juvenile rheumatoid arthirtis

187

1511

1.30

2.53

1.9

1.8

1.04

0.96

mg/l

0.17

153

1090

Cardiovascular disorders originating in the perinatal period

155

2.01

2.53

4.3

6.8

1.31

2.59

mg/l

0.85

121

Sequelae of malnutrition and other nutritional deficiencies

129

2.22

2.52

2.0

1.9

1.32

1.66

mg/l

0.32

110

Myopia

1149

10566

1.11

2.51

2.0

1.9

0.98

1.03

mg/l

0.25

830

7736

Exophthalmic conditions

705

1.45

2.51

1.8

1.7

1.50

1.17

mg/l

0.37

549

Atrioventricular septal defect

250

1.82

2.51

4.3

3.3

1.44

1.43

mg/l

0.00

195

Retinoschisis and retinal cysts

185

1497

1.30

2.50

1.6

1.02

1.25

mg/l

0.79

139

1185

Disorder of thyroid, unspecified

118

905

1.40

2.50

1.8

1.6

1.07

1.02

mg/l

0.08

703

Other infiltrative disorders of skin and subcutaneous tissue

306

1.73

2.50

2.4

1.8

1.35

1.19

mg/l

0.16

238

Other and unspecified thalassaemias

2.48

2.50

4.2

3.4

0.90

1.12

mg/l

0.21

Frostbite

687

1.45

2.50

1.9

1.8

1.14

1.30

mg/l

0.23

513

188

1.95

2.50

2.3

1.7

1.20

0.63

mg/l

0.71

143

Dementia in other diseases classified elsewhere

341

2918

1.21

2.49

1.8

1.7

1.49

1.46

mg/l

0.04

255

2281

Drug-induced myopathy

174

2.02

2.49

2.2

1.7

3.63

1.26

mg/l

0.63

143

Erythrasma

122

2.24

2.49

1.3

1.9

1.17

1.10

mg/l

0.06

107

Congenital lactase deficiency

167

2.06

2.49

2.2

1.6

5.03

0.90

mg/l

0.51

126

Open bite

446

3896

1.18

2.49

2.3

2.1

0.83

0.99

mg/l

1.08

326

2813

Common variable immunodeficiency

421

1.61

2.48

1.9

1.8

1.01

0.97

mg/l

0.06

320

Any dementia, excluding more controls

3023

19731

1.07

2.48

1.6

1.63

1.58

mg/l

0.23

2372

15478

Unspecified severe protein-energy malnutrition

101

2.40

2.48

3.1

2.0

1.52

0.85

mg/l

1.40

Subarachnoid haemorrhage

838

7598

1.13

2.48

1.8

1.6

1.59

1.31

mg/l

1.18

674

5862

Atlantoaxial subluxation

403

1.61

2.47

1.8

1.6

1.31

1.25

mg/l

0.10

312

Actinomycosis

242

1.81

2.47

1.7

1.52

0.87

mg/l

0.72

193

Other specified/unspecified disorders of middle ear and mastoid

176

2.05

2.47

1.5

1.7

1.82

1.18

mg/l

0.32

142

Mitochondrial myopathy

276

1.78

2.46

2.1

1.9

3.28

0.87

mg/l

0.45

214

Diseases caused by chlamydiae

104

788

1.43

2.45

2.0

1.7

1.54

0.75

mg/l

1.73

603

Lesion of femoral nerve

514

1.54

2.43

1.8

1.6

1.44

0.99

mg/l

0.69

406

Cholera

2.79

2.43

1.6

1.19

1.04

mg/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

472

1.56

2.43

1.4

1.7

1.37

1.12

mg/l

0.36

376

Unspecified parasitic disease

505

1.54

2.43

2.1

1.7

1.21

mg/l

0.00

393

Labour and delivery complicated by fetal stress [distress]

2497

15448

1.07

2.43

1.7

0.82

0.74

mg/l

1.31

1838

11069

Cholinergic urticaria

316

1.70

2.42

1.8

1.6

0.77

1.05

mg/l

0.47

242

Disorders of amino-acid transport

2.42

3.5

1.5

8.53

0.71

mg/l

0.65

Other congenital musculoskeletal deformities

221

1.85

2.41

2.7

2.5

0.99

0.72

mg/l

0.55

157

Universal erythroderma, KELA reimbursement

120

927

1.38

2.41

1.6

1.7

1.34

1.20

mg/l

0.18

713

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

308

1.70

2.41

2.7

1.8

1.75

1.07

mg/l

0.75

240

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

2.76

2.41

3.9

2.2

1.08

0.70

mg/l

—

Disorders of visual cortex

4.51

2.40

3.4

4.1

0.57

0.89

mg/l

—

Tic disorders

732

1.42

2.40

3.0

2.8

1.08

1.07

mg/l

0.01

508

Benign neoplasm: Appendix

720

1.44

2.40

1.9

1.7

1.27

1.24

mg/l

0.05

558

Unspecified hairloss

2.74

2.39

2.2

1.5

1.52

0.98

mg/l

0.58

Burn and corrosion of wrist and hand

311

2655

1.21

2.39

1.8

1.9

0.93

1.10

mg/l

0.75

232

1955

Alcohol induced polyneuropathy

617

1.47

2.37

1.9

1.6

1.62

1.42

mg/l

0.16

492

Necrobiosis lipoidica, not elsewhere classified

392

1.62

2.37

2.4

1.6

0.84

0.77

mg/l

0.14

291

Nightmares

154

2.05

2.37

1.9

1.6

0.78

0.71

mg/l

0.14

113

Toxic erythema

103

2.33

2.37

1.7

1.6

0.58

0.88

mg/l

0.77

Dacryoadenitis

517

1.52

2.36

2.5

1.7

0.71

1.13

mg/l

2.02

407

Hyperprolactinaemia

322

2765

1.21

2.36

1.8

1.7

0.92

0.88

mg/l

0.09

244

2060

Other disorders of thyroid

121

940

1.38

2.36

1.8

1.7

1.14

1.07

mg/l

0.10

716

Mental retardation, wide definition

323

2749

1.21

2.36

2.1

2.7

1.43

1.26

mg/l

0.43

258

2035

MS-disease / Multiple Sclerosis

667

6004

1.14

2.35

1.7

1.8

0.81

0.91

mg/l

0.79

483

4448

Tic and related disorders

105

796

1.40

2.35

3.0

2.8

1.17

1.06

mg/l

0.16

545

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

359

1.63

2.35

3.3

1.8

2.09

1.24

mg/l

0.44

273

Epidural haemorrhage

496

1.50

2.34

1.6

1.7

1.45

1.32

mg/l

0.15

378

Hyperkinetic disorders (excl. ADHD)

137

1064

1.33

2.34

2.4

3.1

1.45

1.31

mg/l

0.10

736

Other and unspecified atrophic disorders of skin

305

1.70

2.30

2.9

1.7

1.42

1.13

mg/l

0.43

248

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

468

1.54

2.30

3.0

1.8

1.90

1.17

mg/l

0.44

352

Osteosarcoma, including Hilmo

216

1.83

2.30

7.2

1.9

2.07

1.31

mg/l

0.57

163

Hypersensitivity pneumonitis due to organic dust

138

1094

1.34

2.30

2.0

1.7

1.14

1.26

mg/l

0.26

111

856

Malignant neoplasm of base of tongue, including Hilmo

501

1.51

2.30

1.6

1.7

1.64

1.24

mg/l

0.58

391

Inhalation and ingestion of other objects causing obstruction of respiratory tract

368

1.61

2.30

2.0

1.9

2.66

1.25

mg/l

0.35

298

Apocrine sweat disorders, other sweat gland disorders

273

1.75

2.30

2.0

1.7

0.88

0.93

mg/l

0.10

221

LSIL lesion of the vulva

271

2305

1.23

2.30

2.0

1.7

0.95

0.81

mg/l

0.51

205

1732

Amoebiasis

536

1.50

2.29

1.6

2.0

0.71

1.49

mg/l

1.24

418

Secondary malignant neoplasm of respiratory and digestive organs

122

949

1.36

2.29

1.6

2.27

1.27

mg/l

2.11

104

736

Benign neoplasm: Skin of lower limb, including hip

235

1971

1.25

2.28

1.9

1.7

1.12

1.10

mg/l

0.04

181

1504

Malignant neoplasm, without specification of site

211

1742

1.25

2.28

1.7

1.6

2.24

1.35

mg/l

2.36

165

1356

Contact with other hot metals

127

996

1.35

2.28

2.1

1.9

1.44

1.31

mg/l

0.16

760

Thyrotropin deficiency

101

771

1.41

2.27

1.7

0.61

1.08

mg/l

2.30

583

Malignant neoplasm of lip, including Hilmo

541

1.47

2.27

1.5

1.6

1.33

1.28

mg/l

0.07

435

Toxic encephalopathy

127

2.17

2.27

1.6

1.7

5.85

1.23

mg/l

0.89

105

Postinfectious hypothyroidism

388

1.61

2.27

1.7

1.6

1.29

1.06

mg/l

0.20

311

Cysts of oral region, not elsewhere classified

485

4295

1.16

2.26

2.0

1.8

1.20

1.15

mg/l

0.14

371

3247

Malignant neoplasm of gum, including Hilmo

562

1.48

2.26

1.7

1.6

1.22

1.16

mg/l

0.07

430

Delivery

4101

20731

1.05

2.26

1.7

1.14

mg/l

0.02

3133

15356

Chronic suppurative otitis media

532

4732

1.15

2.25

2.5

1.8

1.14

1.31

mg/l

0.65

393

3541

Benign neoplasm: Orbit, unspecified

413

1.58

2.25

2.4

1.8

1.40

1.20

mg/l

0.16

319

Telogen effluvium

128

2.19

2.25

6.5

1.7

1.30

0.74

mg/l

0.54

Shigellosis

453

1.54

2.25

2.2

1.8

1.03

1.14

mg/l

0.14

341

Cysticercosis

7.84

2.25

2.4

1.5

0.33

0.69

mg/l

—

Blindness, monocular

572

1.47

2.24

2.2

1.7

1.87

1.36

mg/l

0.33

442

LeFortI or BSSO operation

366

3186

1.19

2.24

1.5

1.7

0.68

0.88

mg/l

1.94

260

2343

Malignant neoplasm of cervix uteri

135

1071

1.34

2.24

1.7

1.6

2.47

0.88

mg/l

1.57

106

786

Sequelae of poisoning by drugs, medicaments and biological substances

2.36

2.23

1.7

2.0

0.48

0.85

mg/l

1.95

Certain zoonotic bacterial diseases

157

1268

1.31

2.23

1.7

1.12

1.20

mg/l

0.16

130

964

Secondary systemic amyloidosis

180

1.92

2.23

2.0

1.5

5.57

1.14

mg/l

0.71

139

Enduring personality changes

250

1.75

2.22

1.9

1.8

0.73

0.84

mg/l

0.27

189

Urethral discharge

2.56

2.22

1.9

1.7

1.18

1.59

mg/l

—

Other assisted single delivery

162

1316

1.30

2.22

1.8

1.04

0.68

mg/l

0.61

107

971

Other deformity of hallux (acquired)

488

1.51

2.22

1.7

1.34

1.17

mg/l

0.20

364

Benign neoplasm: Skin of lip

115

896

1.37

2.21

1.6

1.7

1.23

1.24

mg/l

0.01

695

Congenital deformities of hip

147

1176

1.31

2.21

2.3

2.5

1.35

1.11

mg/l

0.26

106

847

Benign neoplasm: Skin of scalp and neck

208

1730

1.26

2.20

1.5

1.8

1.61

1.19

mg/l

0.73

158

1325

Benign neoplasm: Endocrine pancreas

416

1.57

2.19

1.6

1.8

2.26

1.41

mg/l

0.56

326

Congenital malformations of uterus and cervix

198

1644

1.27

2.19

1.8

1.7

0.81

mg/l

0.00

156

1206

Other abnormal immunological findings in serum

172

1406

1.29

2.18

2.3

1.8

1.11

1.08

mg/l

0.05

129

1043

Sleepwalking [somnambulism]

189

1.88

2.18

2.8

2.2

0.64

0.76

mg/l

0.36

133

Benign neoplasm: Floor of mouth

220

1.80

2.18

1.7

1.05

1.23

mg/l

0.25

175

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

121

2.15

2.17

1.5

1.6

0.94

1.35

mg/l

0.32

Severe visual impairment, monocular

593

1.45

2.17

1.8

1.7

1.16

1.28

mg/l

0.18

460

Vitreous prolapse

159

1.98

2.16

1.7

1.45

1.09

mg/l

0.16

125

Nystagmus and other irregular eye movements

120

942

1.35

2.16

2.0

2.3

1.39

1.16

mg/l

0.30

722

Pedestrian injured in other and unspecified transport accidents

107

829

1.38

2.16

1.8

1.7

1.08

1.11

mg/l

0.03

636

Primary amenorrhea

491

1.50

2.16

2.3

2.1

0.75

0.77

mg/l

0.03

336

Hydrocephalus

585

5250

1.14

2.16

1.8

1.7

1.64

1.37

mg/l

0.69

459

4040

Other acantholytic disorders

167

1.96

2.16

4.8

1.7

0.84

1.38

mg/l

1.17

137

Malignant neoplasm of oesophagus, including Hilmo

253

2141

1.22

2.16

1.6

2.05

1.30

mg/l

2.40

211

1661

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

516

1.48

2.16

1.3

1.6

0.93

1.16

mg/l

0.60

390

Other obstructed labour

686

6219

1.13

2.15

1.6

1.7

0.86

0.88

mg/l

0.11

510

4652

Pseudopolyposis of colon

174

1.91

2.15

1.5

1.7

0.75

0.83

mg/l

0.14

142

Coarctation of the aorta

645

1.42

2.13

6.7

3.2

2.48

1.20

mg/l

1.52

484

Relapsing fevers

136

2.03

2.13

2.3

2.0

1.28

0.91

mg/l

0.38

113

Monosomies and deletions from the autosomes, not elsewhere classified

151

1.97

2.13

3.0

5.6

1.35

2.40

mg/l

0.37

117

Pectus excavatum

251

1.70

2.12

1.6

2.3

1.46

1.17

mg/l

0.18

171

Cachexia

259

1.68

2.12

1.5

1.68

1.30

mg/l

0.53

204

Guttate psoriasis

127

1009

1.34

2.11

1.7

1.18

1.00

mg/l

0.28

757

Congenital malformations of breast

166

1359

1.29

2.10

1.8

1.7

0.86

0.78

mg/l

0.25

127

991

Other fibroblastic disorders

230

1.76

2.09

1.6

1.5

0.82

1.13

mg/l

0.69

182

Other mosquito-borne viral fevers

146

2.03

2.09

1.4

1.7

1.25

1.20

mg/l

0.04

120

Disorders of purine and pyrimidine metabolism

335

1.61

2.09

3.3

1.7

1.51

1.37

mg/l

0.17

258

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

383

1.55

2.09

1.7

2.02

1.40

mg/l

0.63

296

Crushing injury of lower leg

161

1.95

2.08

1.8

1.7

0.86

1.06

mg/l

0.33

134

Donors of organs and tissues

122

964

1.34

2.08

2.0

1.6

0.99

0.96

mg/l

0.07

707

Malignant neoplasm of other and unspecified parts of mouth

327

1.61

2.08

1.2

1.6

0.88

1.17

mg/l

0.55

246

Bacterial meningitis

288

2479

1.21

2.08

1.6

1.7

1.03

1.11

mg/l

0.29

218

1883

Pectus excavatum

301

1.62

2.08

1.6

2.7

1.32

1.13

mg/l

0.13

206

Severe visual impairment, binocular

286

1.65

2.07

1.7

1.30

1.44

mg/l

0.17

228

Juvenile Open Angle Glaucoma

387

1.57

2.07

1.9

1.7

0.79

0.96

mg/l

0.37

296

Postpartum haemorrhage due to retained placenta

1253

11681

1.09

2.06

1.8

1.7

1.38

0.82

mg/l

5.30

976

8708

Congenital deformities of hip

164

1340

1.28

2.06

2.2

2.4

1.35

1.11

mg/l

0.28

115

967

Other and unspecified neuropathies

247

1.71

2.05

1.8

1.9

1.36

1.54

mg/l

0.15

193

Scarlet fever

402

1.53

2.05

1.9

1.8

0.70

0.91

mg/l

0.41

291

HSIL lesion of the cervix uteri, vagina or vulva

1983

18759

1.07

2.05

1.7

0.97

0.88

mg/l

0.57

1479

13993

Open wound of thorax

127

1011

1.32

2.04

1.9

1.8

1.22

1.13

mg/l

0.25

102

761

Lymphangioma, anys site

514

1.47

2.04

3.0

2.3

2.01

1.18

mg/l

0.38

394

Vascular dementia (multiple infarctions)

663

0.65

2.04

2.2

1.6

1.15

1.44

mg/l

0.80

526

Primary angle-closure glaucoma

342

2983

1.18

2.04

1.6

1.28

1.40

mg/l

0.30

270

2321

Helminthiases

334

2911

1.19

2.03

2.2

1.9

1.03

1.09

mg/l

0.20

239

2172

Other effects of reduced temperature

147

1.99

2.03

1.8

0.76

1.22

mg/l

0.63

110

Occlusion and stenosis of arteries, not leading to stroke

734

1.37

2.03

1.6

1.41

1.49

mg/l

0.08

581

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

116

914

1.34

2.02

1.6

1.8

0.74

1.21

mg/l

2.24

660

Anisometropia and aniseikonia

256

2189

1.21

2.01

2.1

1.8

1.21

1.17

mg/l

0.06

186

1654

Infections of breast associated with childbirth

339

2964

1.18

2.00

1.8

1.7

1.15

0.82

mg/l

1.17

253

2170

Graves ophthalmopathy, strict

196

1642

1.25

2.00

2.0

1.7

0.92

0.99

mg/l

0.16

143

1261

Carcinoma in situ of other and unspecified genital organs

169

1398

1.28

2.00

1.6

1.7

0.77

0.95

mg/l

1.15

132

1057

Malignant neoplasm of tongue

145

1175

1.29

2.00

1.5

1.7

1.51

1.09

mg/l

1.05

110

901

Disorders of glossopharyngeal nerve

118

2.13

1.99

3.6

1.8

0.97

1.39

mg/l

0.42

Malignant neoplasm of floor of mouth, including Hilmo

481

1.48

1.99

1.8

1.7

1.68

1.12

mg/l

0.70

372

Alzheimer disease

2394

18433

0.94

1.98

1.6

1.7

1.78

1.59

mg/l

1.11

1839

14525

Placental disorders

691

1.40

1.98

2.1

1.7

1.10

0.69

mg/l

0.84

498

All dysplastic lesions of the cervix uteri

2637

24945

1.06

1.97

1.7

0.93

0.88

mg/l

0.41

1945

18510

Carcinoma in situ of oral cavity, oesophagus and stomach

340

1.58

1.97

1.7

1.35

1.56

mg/l

0.21

264

Muscle wasting and atrophy, not elsewhere classified

339

1.57

1.96

1.9

1.7

1.24

1.47

mg/l

0.35

270

Crohn's disease (strict) with PSC

111

2.14

1.96

3.4

1.9

0.61

0.70

mg/l

0.17

Femoral hernia, bilateral

195

1.81

1.96

2.0

1.8

0.81

1.16

mg/l

1.16

162

Motor neuron disease (with DMD)

133

1066

1.30

1.96

1.8

1.6

1.28

1.38

mg/l

0.19

106

820

Glaucoma-related operations

438

3896

1.16

1.96

1.6

1.7

1.31

1.45

mg/l

0.44

331

3029

Other and unspecified papulosquamous disorders

374

1.55

1.95

2.2

1.9

1.54

1.24

mg/l

0.33

291

Other and unspecified cicatricial alopecia

189

1.86

1.95

1.5

1.8

0.67

0.92

mg/l

0.93

152

Neuroendocrine tumor and carcinoma of stomach

275

1.65

1.94

1.4

1.8

1.47

1.17

mg/l

0.16

217

Schizotypal disorder

201

1690

1.24

1.94

2.0

1.7

1.99

0.94

mg/l

0.63

141

1253

Other operation for atrial fibrillation

326

1.61

1.94

2.1

1.7

2.22

1.56

mg/l

0.32

256

Exposure to ignition of highly flammable material

267

1.66

1.94

1.6

1.8

0.85

1.33

mg/l

0.97

207

Disorders of lacrimal system and orbit in diseases classified elsewhere

212

1793

1.23

1.93

2.0

1.7

0.88

1.03

mg/l

0.48

155

1365

Colorectal neuroendocrine tumor and carcinoma

113

895

1.34

1.93

1.8

1.6

0.86

0.92

mg/l

0.15

660

Benign neoplasm: Skin of upper limb, including shoulder

167

1382

1.27

1.93

1.9

1.7

1.01

1.14

mg/l

0.45

132

1061

Other congenital malformations of limb(s)

475

1.47

1.93

3.2

2.6

1.30

0.79

mg/l

0.67

335

Benign neoplasm: Central nervous system, other parts/unspecified

236

1.72

1.93

1.8

2.1

0.83

1.37

mg/l

1.11

194

Accessory breast

470

1.49

1.92

1.7

1.6

0.91

0.71

mg/l

0.35

347

Autism spe, excluding more controls

155

1264

1.26

1.92

2.0

2.1

0.66

1.03

mg/l

2.12

848

Lumbosacral root disorders, not elsewhere classified

100

782

1.36

1.90

1.8

1.7

1.34

1.27

mg/l

0.05

623

Other congenital malformations of tongue, mouth and pharynx

126

1002

1.30

1.90

4.0

3.0

2.06

1.32

mg/l

0.40

705

Protein-energy malnutrition of moderate and mild degree

564

1.43

1.89

4.2

2.0

1.76

1.41

mg/l

0.57

426

Evidence of alcohol involvement determined by blood alcohol level

127

1023

1.31

1.89

1.9

1.7

1.20

1.12

mg/l

0.10

104

764

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

117

930

1.32

1.88

1.8

1.6

3.06

1.19

mg/l

3.15

106

736

Benign neoplasm: Skin of trunk

344

3024

1.17

1.88

2.1

1.7

0.92

1.18

mg/l

1.58

255

2299

Cutis laxa senilis

550

1.44

1.88

1.5

1.7

0.73

1.03

mg/l

1.09

447

Adrenogenital disorders

269

1.64

1.88

1.8

0.85

1.45

mg/l

0.89

209

Maxillary hypoplasia

213

1.74

1.87

1.8

2.3

0.71

0.85

mg/l

0.14

157

Acute alcohol intoxication ICD-9

251

2153

1.20

1.87

1.6

1.7

1.18

1.27

mg/l

0.23

196

1680

Exfoliative dermatitis

669

1.38

1.87

2.2

1.7

1.93

1.46

mg/l

0.56

524

Hereditary spherocytosis

158

1.87

1.86

2.0

2.3

1.13

0.79

mg/l

0.39

121

Bradycardia, unspecified, drug-induced

142

1.91

1.86

1.6

1.9

2.17

1.60

mg/l

0.33

116

Other porphyria

106

2.15

1.86

1.8

1.5

1.27

0.88

mg/l

0.19

Thalassaemia trait

2.69

1.85

1.9

3.0

2.21

0.69

mg/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

104

820

1.34

1.85

1.6

1.7

1.09

1.34

mg/l

0.71

651

Unspecified contracted kidney

353

1.55

1.85

2.7

1.8

1.56

1.46

mg/l

0.12

276

Other and unspecified hypertrophic disorders of skin

447

1.48

1.84

1.7

1.6

0.96

0.98

mg/l

0.02

340

Injury of heart

128

1.99

1.84

1.5

1.6

0.99

1.21

mg/l

0.26

104

Schizoid personality disorder

147

1207

1.28

1.84

1.6

1.8

0.92

1.12

mg/l

0.83

119

925

Pterygium

216

1835

1.22

1.84

1.7

1.6

1.84

1.38

mg/l

0.46

167

1443

Abnormal findings in peritoneal fluid saliva

230

1.70

1.84

1.3

1.8

2.79

1.07

mg/l

0.71

190

Other melanin hyperpigmentation

175

1462

1.25

1.84

1.8

1.6

1.09

1.31

mg/l

0.33

133

1125

Undescended testis, unilateral

366

1.50

1.84

3.3

4.3

1.76

1.51

mg/l

0.20

258

Contact with nonpowered hand tool

335

2943

1.17

1.84

1.8

1.02

1.22

mg/l

0.70

262

2197

Need for immunization against single bacterial diseases

143

1.90

1.83

3.1

4.5

1.71

3.14

mg/l

0.45

116

Nail dystrophy

414

1.50

1.82

2.5

1.9

1.04

1.08

mg/l

0.06

315

Malignant cancer of tonsil and base of tongue

147

1207

1.27

1.82

1.6

1.7

1.59

1.18

mg/l

1.03

116

926

Ankyloglossia

114

904

1.31

1.82

4.1

3.4

1.37

mg/l

0.00

621

Other specified/unspecified disorders of ear

183

1.79

1.82

1.9

1.8

0.97

0.88

mg/l

0.12

132

Family history of mental and behavioural disorders

121

2.00

1.81

2.0

1.6

0.98

0.83

mg/l

0.21

Benign neoplasm: Vagina

115

924

1.32

1.81

1.4

1.6

0.93

0.96

mg/l

0.04

708

Other fusion of spine

107

2.12

1.81

1.5

0.76

1.04

mg/l

0.63

Labour and delivery complicated by umbilical cord complications

445

3988

1.15

1.81

1.6

1.8

0.80

0.84

mg/l

0.17

330

2953

Carcinoma in situ of endometrium

332

1.58

1.80

1.6

0.73

0.98

mg/l

0.90

257

Ankylosis of joint

278

1.59

1.80

1.5

0.72

1.20

mg/l

1.70

210

Other specified acquired deformities of limbs

288

1.60

1.80

1.7

2.1

1.64

0.94

mg/l

0.52

216

Drug-induced gout

247

1.65

1.79

1.6

1.10

1.70

mg/l

1.32

192

Other mosquito-borne viral fevers

475

1.46

1.79

1.7

1.8

0.83

1.12

mg/l

0.73

367

Other specified and unspecified strabismus

100

789

1.34

1.79

1.9

2.1

2.00

1.42

mg/l

0.22

590

Procedures for purposes other than remedying health state

213

1817

1.22

1.78

1.6

1.00

0.91

mg/l

0.28

154

1364

Hirsutism, drug-induced

131

2.01

1.78

2.0

1.7

0.59

0.76

mg/l

0.31

104

Tularaemia

109

870

1.33

1.78

1.7

1.12

1.26

mg/l

0.24

665

Postpartum haemorrhage due to anatomy

1040

9693

1.09

1.78

1.8

1.7

1.13

0.92

mg/l

1.44

789

7149

Defect, injury or illness of face

100

2.14

1.78

1.9

2.0

0.40

0.85

mg/l

3.20

Seronegative juvenile rheumatoid arthritis

150

1238

1.26

1.77

2.1

2.2

1.14

0.85

mg/l

0.67

113

884

Chromomycosis and phaeomycotic abscess

266

1.64

1.77

1.7

1.9

0.86

0.95

mg/l

0.13

202

Galactorrhea

739

1.36

1.77

2.1

1.6

0.70

0.79

mg/l

0.28

538

Ovarian dysfunction, other/unspecified

426

1.49

1.77

2.5

1.8

1.18

0.84

mg/l

0.31

309

Hydatidiform mole

129

1052

1.30

1.77

1.4

1.6

0.77

0.78

mg/l

0.03

103

794

HSIL lesion of the vagina

127

1035

1.30

1.77

1.7

0.97

0.91

mg/l

0.17

102

791

Alzheimer’s disease (Late onset)

1643

14633

0.93

1.77

1.6

1.79

1.65

mg/l

0.80

1268

11508

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

605

1.39

1.76

3.9

1.7

1.62

1.13

mg/l

0.78

443

Embedded and impacted teeth

2517

19830

1.06

1.75

2.0

1.9

1.00

0.98

mg/l

0.06

1793

13946

Amoebiasis

340

1.53

1.75

1.6

1.9

0.86

1.14

mg/l

0.44

262

Tick-borne viral encephalitis

317

1.56

1.72

1.4

1.6

0.98

1.18

mg/l

0.30

253

Aggressive periodontitis

175

1474

1.24

1.72

1.7

1.50

1.17

mg/l

0.35

130

1131

Generalized pustular psoriasis

269

1.64

1.72

2.2

2.4

1.70

1.39

mg/l

0.19

219

Mental and behavioural disorders due to cocaine

101

2.10

1.72

2.3

1.7

1.38

0.78

mg/l

0.70

Hereditary motor and sensory neuropathy

565

1.40

1.72

1.5

1.8

0.71

1.22

mg/l

2.79

442

Other nutritional anaemias

589

1.38

1.71

2.2

1.8

1.91

1.42

mg/l

0.47

452

Cytomegaloviral hepatitis

171

1.80

1.70

2.0

1.7

1.12

0.83

mg/l

0.24

139

Acute poliomyelitis

108

867

1.32

1.70

1.5

1.7

1.33

1.21

mg/l

0.10

660

Pemphigus vulgaris

140

1.91

1.70

3.4

1.9

5.36

1.35

mg/l

0.48

114

Other congenital malformations of male genital organs

314

1.52

1.70

2.6

5.2

1.24

1.96

mg/l

0.69

223

Glaucoma secondary to eye inflammation

548

1.40

1.70

2.0

1.8

1.20

1.30

mg/l

0.18

422

Melanoma in situ of lower limb, including hip

446

1.46

1.70

3.9

1.7

4.63

1.03

mg/l

0.54

362

Vertical strabismus

276

2411

1.18

1.69

1.8

1.23

1.26

mg/l

0.04

212

1828

Liver disorders in diseases classified elsewhere

187

1.76

1.69

2.5

1.6

1.63

0.78

mg/l

0.73

153

Congenital malformations of lung

147

1.86

1.69

2.4

2.6

2.29

1.14

mg/l

0.28

118

Diaper [napkin] dermatitis

2.13

1.69

1.5

3.4

1.43

1.39

mg/l

0.02

Non-small cell lung cancer, squamous

280

2437

1.17

1.68

1.5

1.6

1.26

1.38

mg/l

0.41

237

1899

Degenerative diseases of the nervous system

2747

21060

0.95

1.68

1.6

1.7

1.73

1.56

mg/l

1.12

2122

16597

Onycholysis

429

1.46

1.67

1.9

1.74

0.98

mg/l

0.47

327

Motor neuron disease

126

1025

1.27

1.67

1.7

1.6

1.27

1.39

mg/l

0.23

103

790

Primary ovarian failure

176

1489

1.24

1.67

1.9

1.8

0.80

0.78

mg/l

0.07

129

1113

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

285

1.58

1.67

3.6

1.7

1.45

1.32

mg/l

0.13

220

Gender identity disorders

838

0.72

1.67

1.6

1.9

0.47

0.83

mg/l

2.81

557

Malignant neoplasm of lip

366

1.48

1.67

1.5

1.6

1.31

1.43

mg/l

0.13

288

Foreign body granuloma of skin and subcutaneous tissue

220

1.67

1.66

1.7

1.51

1.10

mg/l

0.28

171

Benign neoplasm of other and unspecified female genital organs

361

3218

1.16

1.65

1.6

1.8

0.91

1.05

mg/l

0.67

269

2449

Glaucoma, exfoliation

837

7752

1.10

1.65

1.5

1.7

1.63

1.55

mg/l

0.18

671

6037

Alzheimer disease, including avohilmo

2830

20778

0.95

1.65

1.6

1.7

1.71

1.57

mg/l

0.90

2167

16379

Other specified and unspecified disorders of iris and ciliary body

253

1.62

1.65

1.4

2.0

0.57

0.91

mg/l

1.23

196

Pityriasis lichenoides chronica

262

1.61

1.65

1.9

2.1

1.12

1.51

mg/l

0.37

205

Foreign body in ear

154

1286

1.25

1.65

1.6

2.1

0.85

1.11

mg/l

1.34

110

960

Other specified transport accidents

361

1.49

1.64

1.6

2.3

1.21

0.92

mg/l

0.27

273

Henoch-Schönlein purpura nephritis (HSPN)

237

1.64

2.1

1.8

0.84

1.39

mg/l

0.74

188

Other and unspecified disorders of binocular movement

371

1.49

1.64

2.4

2.2

1.13

1.29

mg/l

0.17

281

Chronic suppurative otitis media, including avohilmo

632

5791

1.11

1.63

2.4

1.9

1.09

1.27

mg/l

0.87

466

4320

Anorexia

128

1052

1.28

1.63

2.3

1.8

1.65

1.07

mg/l

0.66

778

Typhoid and paratyphoid fevers

440

1.45

1.63

2.0

1.7

0.83

1.06

mg/l

0.50

350

Abscess of mediastinum

103

2.05

1.63

4.8

2.3

1.41

1.15

mg/l

0.32

Combined immunodeficiency, unspecified

2.43

1.62

2.2

2.4

1.26

1.16

mg/l

—

Intentional self-harm by hanging, strangulation and suffocation

390

0.60

1.62

3.6

1.9

0.77

1.41

mg/l

0.97

303

Enteropathogenic Escherichia coli infection

214

1.68

1.62

1.5

2.0

1.23

1.01

mg/l

0.34

169

Acquired atrophy of ovary and fallopian tube

173

1.75

1.61

2.0

1.8

1.62

0.95

mg/l

0.90

125

Relapsing fevers

110

1.96

1.61

2.6

2.0

1.31

0.98

mg/l

0.24

Other congenital malformations of female genitalia

615

1.37

1.61

1.7

1.9

0.71

0.76

mg/l

0.11

438

Reduction defects of upper limb

173

1.74

1.60

2.2

3.1

2.04

1.89

mg/l

0.04

139

Bicornuate uterus

503

1.42

1.60

1.8

1.7

0.66

0.68

mg/l

0.08

367

Other corneal oedema

502

1.41

1.59

1.9

1.7

1.33

1.29

mg/l

0.06

401

Acute myringitis

441

1.43

1.59

3.5

2.0

1.16

1.08

mg/l

0.09

335

Normotensive glaucoma

673

6198

1.11

1.59

1.6

1.8

1.55

1.46

mg/l

0.20

509

4819

Melanoma in situ of other and unspecified parts of face

778

1.32

1.58

1.9

1.6

1.23

1.38

mg/l

0.27

621

Malignant neoplasm of larynx, including Hilmo

123

1005

1.27

1.58

1.7

1.11

1.42

mg/l

1.08

783

Idiopathic hypercalciuria

383

1.48

1.57

1.8

1.7

1.50

1.11

mg/l

0.22

295

Aortic arch syndrome [Takayasu]

136

1.90

1.57

2.6

1.6

0.76

1.13

mg/l

0.65

103

Chronic constrictive pericarditis

167

1.77

1.57

1.7

1.8

1.25

1.70

mg/l

0.54

137

Unspecified protein-energy malnutrition

357

1.49

1.56

2.4

1.7

1.64

1.16

mg/l

0.75

285

Hypertensive encephalopathy

257

1.60

1.56

2.1

1.7

0.96

1.46

mg/l

1.14

210

Acute otitis externa, noninfective

135

1121

1.26

1.56

1.7

0.96

1.19

mg/l

1.10

111

848

Vitamin A deficiency

281

1.55

1.56

2.1

1.8

1.03

1.28

mg/l

0.37

227

Accidental poisoning by and exposure to other gases and vapours

332

1.51

1.55

2.1

1.7

1.28

1.31

mg/l

0.03

259

Osteomalacia

584

1.37

1.55

1.9

1.7

0.75

1.12

mg/l

1.21

453

Malignant neoplasm of nasal cavity and sinuses

365

1.47

1.54

1.6

1.7

2.11

1.08

mg/l

1.06

274

Hyperchylomicronaemia

112

1.94

1.54

3.1

1.4

3.74

1.14

mg/l

0.80

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

2.34

1.54

2.0

3.5

3.84

2.41

mg/l

—

Neonatal jaundice from other and unspecified causes

602

1.34

1.54

7.5

6.4

1.27

2.14

mg/l

1.28

436

Carcinoma in situ of vulva

595

1.37

1.54

1.6

1.7

0.78

0.87

mg/l

0.25

449

Chromophobe cell carcinoma of kidney

307

1.52

1.54

1.6

1.7

1.25

1.08

mg/l

0.23

242

Tuberculosis of other organs

157

1322

1.23

1.54

1.9

1.6

2.52

1.31

mg/l

1.06

125

1030

Other congenital malformations of tongue, mouth and pharynx

762

1.30

1.54

4.8

3.2

2.61

1.36

mg/l

0.52

531

Distal bite

263

2286

1.17

1.54

2.6

2.5

0.92

1.08

mg/l

0.46

188

1616

Injury of blood vessels at neck level

249

1.60

1.54

1.6

1.5

1.70

1.19

mg/l

0.24

193

Malignant neoplasm of bone and articular cartilage of limbs

257

1.58

1.53

4.1

1.8

2.07

1.36

mg/l

0.57

190

Overjet

171

1440

1.22

1.53

3.0

2.9

0.98

1.19

mg/l

0.35

125

1024

Secondary sideroblastic anaemia due to drugs and toxins

2.65

1.53

1.6

1.90

0.98

mg/l

1.55

Acute nephritic syndrome

166

1408

1.23

1.52

2.3

1.8

1.67

1.21

mg/l

0.96

136

1073

Benign neoplasm: Long bones of lower limb

272

2395

1.17

1.52

1.9

1.8

1.03

1.01

mg/l

0.06

208

1774

Congenital malformations of lung

176

1.72

1.51

2.3

2.5

2.18

1.08

mg/l

0.29

138

Onychogryphosis

152

1.78

1.51

1.9

1.7

0.93

1.09

mg/l

0.17

121

Disorders of puberty, other/unspecified

207

1.63

1.51

1.7

3.6

1.24

1.45

mg/l

0.16

143

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

3.28

1.51

1.8

2.4

2.35

1.73

mg/l

—

Reduction defects of upper limb

152

1.77

1.51

2.3

3.2

2.04

1.95

mg/l

0.02

124

Mental and behavioural disorders associated with the puerperium

800

1.31

1.51

2.0

1.6

1.01

0.74

mg/l

0.78

583

Vascular dementia (undefined)

252

2174

1.17

1.51

1.6

1.37

1.62

mg/l

0.99

201

1697

Other specified/unspecified nutritional deficiencies

454

1.41

1.51

1.7

1.6

0.75

1.22

mg/l

1.93

350

Birth trauma

332

1.48

1.50

2.5

3.0

2.46

1.06

mg/l

0.38

240

Divergent concomitant strabismus

651

6005

1.11

1.50

1.8

1.9

1.09

1.07

mg/l

0.07

487

4469

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

801

1.30

1.49

2.0

1.5

1.01

0.75

mg/l

0.73

590

Squamous cell neoplasms and carcinoma of cervix

403

1.44

1.49

1.5

1.7

1.44

0.93

mg/l

0.61

303

Congenital malformations of breast

149

1256

1.24

1.49

1.9

1.7

0.89

0.76

mg/l

0.43

116

917

Adenocarcinoma and papillary adenocarcinoma of stomach

123

1489

0.81

1.49

1.5

1.6

2.19

1.30

mg/l

2.47

104

1142

Tularaemia

158

1339

1.23

1.48

1.6

1.7

1.01

1.15

mg/l

0.31

134

1017

Mandibular retrognathia

537

4898

1.11

1.48

2.0

0.82

0.96

mg/l

0.65

392

3589

Optic atrophy

137

1146

1.25

1.48

2.0

1.8

1.34

1.21

mg/l

0.22

872

Benign lipomatous neoplasm of of intra-abdominal organs

202

1.66

1.48

1.9

1.8

0.66

1.19

mg/l

1.53

166

Carcinoma in situ of breast

406

1.45

1.48

1.4

1.6

0.60

0.86

mg/l

1.06

328

Disorders of globe

188

1614

1.20

1.47

1.6

1.7

1.24

1.26

mg/l

0.06

147

1246

Sunburn

130

1.86

1.47

1.8

1.6

1.24

0.80

mg/l

0.32

103

Sequelae of other accidents

119

981

1.26

1.47

1.7

1.48

1.19

mg/l

0.51

769

Vascular dementia (mixed)

122

1006

1.26

1.47

1.6

1.57

1.52

mg/l

0.09

103

805

Xanthelasma of eyelid

589

1.36

1.47

1.8

1.6

0.92

1.17

mg/l

0.73

471

Benign neoplasm: Spinal cord

118

975

1.27

1.47

1.6

1.7

1.03

1.17

mg/l

0.27

741

Congenital musculoskeletal deformities of head, face, spine and chest

782

1.30

1.46

1.9

2.6

0.94

0.99

mg/l

0.09

556

Central nervous system disorder causing precocious puberty

153

1.75

1.46

2.0

3.5

8.24

1.46

mg/l

0.52

100

Cyst of Bartholin Gland

338

3028

1.15

1.46

1.7

1.8

0.79

0.88

mg/l

0.51

267

2271

Type1 diabetes, definitions combined, early onset

425

4675

0.89

1.46

2.1

2.3

1.12

0.97

mg/l

0.22

291

3221

Secondary lactase deficiency

2.18

1.45

2.4

1.4

10.18

0.77

mg/l

—

Other, unspecified and serous retinal detachments

237

2074

1.18

1.45

2.8

1.7

1.42

1.23

mg/l

0.21

184

1603

Optic atrophy

144

1213

1.24

1.45

2.0

1.9

1.34

1.24

mg/l

0.18

104

922

Acanthosis nigricans

211

1.62

1.44

1.6

1.8

0.63

1.04

mg/l

1.11

158

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

139

1165

1.24

1.43

2.7

1.6

3.29

1.35

mg/l

2.29

121

897

Traction detachment of retina

519

1.37

1.43

1.7

1.9

1.33

1.18

mg/l

0.13

403

Other disorders affecting eyelid function

609

1.34

1.43

1.6

1.7

0.77

1.11

mg/l

1.39

465

Acrodermatitis continua

123

1.86

1.43

1.4

1.7

0.77

0.98

mg/l

0.31

Toxic effect of organic solvents

236

1.57

1.42

1.6

1.9

0.80

1.22

mg/l

0.70

176

Small cell lung cancer, helper endpoint

110

1338

0.80

1.42

1.5

1.7

1.66

1.58

mg/l

0.16

1060

Pyogenic granuloma

141

1188

1.24

1.41

1.7

1.14

1.17

mg/l

0.08

108

903

Hydrocephalus in other diseases

382

1.44

1.41

2.1

1.8

1.12

1.28

mg/l

0.13

304

Maxillary prognathism

303

1.49

1.41

2.4

2.6

0.53

1.15

mg/l

1.26

219

Bilateral sagittal split ramus osteotomy operation

294

2618

1.16

1.41

1.6

1.7

0.70

0.88

mg/l

1.42

211

1923

Idiopathic peripheral autonomic neuropathy

229

1.59

1.41

1.8

1.7

1.47

0.85

mg/l

0.72

182

Malignant neoplasm of other and unspecified parts of tongue

104

851

1.28

1.40

1.6

1.7

1.37

1.01

mg/l

0.74

658

Malignant neoplasm of adrenal gland

254

1.55

1.40

2.7

1.9

1.18

0.89

mg/l

0.44

193

Ectopic testis

218

1.56

1.40

3.0

5.3

1.37

2.05

mg/l

0.42

160

Superficial injury of ankle and foot, unspecified

339

1.47

1.40

1.8

1.9

0.84

0.86

mg/l

0.03

255

Respiratory and cardiovascular disorders specific to the perinatal period

127

941

1.24

1.40

3.7

5.2

1.47

1.92

mg/l

0.64

654

Carcinoma in situ, other/unspecified

2.37

1.39

1.6

1.7

2.76

1.66

mg/l

0.22

Cervical root disorders

443

1.40

1.39

1.6

1.8

1.97

1.25

mg/l

0.56

353

Toxic effect of other gases, fumes and vapours

347

1.45

1.39

2.4

1.7

1.13

1.19

mg/l

0.05

273

Viral infections of central nervous system, not elsewhere classified/unspecified

782

1.29

1.38

1.7

1.6

1.00

1.02

mg/l

0.05

582

Other and unspecified hydrocephalus

145

1228

1.23

1.38

2.0

1.8

2.10

1.21

mg/l

0.71

116

958

Reiter disease

383

1.43

1.38

1.8

0.76

1.33

mg/l

1.57

302

Toxoplasmosis

375

1.44

1.38

2.0

1.8

0.99

1.12

mg/l

0.21

297

Malignant neoplasm of larynx

750

1.28

1.38

1.7

1.16

1.41

mg/l

0.69

592

Unspecified transport accident

271

1.51

1.38

1.9

1.8

1.08

0.92

mg/l

0.21

212

Other transepidermal elimination disorders

3.75

1.37

2.4

1.8

1.38

1.99

mg/l

—

Malignant neoplasm of adrenal gland, including Hilmo

417

1.40

1.37

2.5

1.8

1.33

0.92

mg/l

0.99

314

118

0.39

1.37

13.6

7.8

0.91

2.92

mg/l

—

Otorrhoea

173

1.68

1.36

2.6

1.67

1.56

mg/l

0.04

135

Injury of blood vessels at wrist and hand level

454

1.39

1.36

1.8

1.7

0.65

1.19

mg/l

3.54

354

Maternal care for (suspected) damage to fetus from alcohol

249

1.57

1.36

1.9

1.7

0.77

0.71

mg/l

0.07

181

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

231

1.57

1.36

1.8

1.6

1.12

0.83

mg/l

0.38

188

Small plaque parapsoriasis

165

1.69

1.35

2.0

1.7

0.68

1.16

mg/l

1.33

137

Liposarcoma

428

1.39

1.34

1.9

1.6

1.32

1.13

mg/l

0.31

338

282

1.50

1.34

1.6

1.8

0.89

0.88

mg/l

0.01

218

Leiomyosarcoma, including Hilmo

588

1.33

1.9

1.6

1.92

0.99

mg/l

1.63

452

Hypothyroidism, autoimmune, DX-based

275

1.52

1.32

1.7

2.0

0.69

1.18

mg/l

0.70

197

Other dermatomyositis

317

1.47

1.32

1.7

1.29

1.14

mg/l

0.19

250

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

777

1.28

1.32

2.0

1.7

0.95

1.04

mg/l

0.16

599

Hereditary sideroblastic anaemia

189

1.60

1.32

6.1

1.6

1.27

1.21

mg/l

0.05

154

Other or unspecified common variable immunodeficiency

233

1.57

1.32

1.7

1.8

0.75

0.64

mg/l

0.18

175

Oral leukoplakia, including avohilmo

219

1924

1.18

1.32

1.6

1.7

1.13

1.17

mg/l

0.10

162

1476

Intentional self-harm by smoke, fire and flames

110

1.85

1.31

1.9

1.6

0.93

1.25

mg/l

0.31

Other abortion

635

1.32

1.31

2.1

1.9

1.28

0.87

mg/l

0.56

482

Diabetic maculopathy

1075

9564

1.08

1.31

1.9

2.0

1.28

1.30

mg/l

0.06

853

7502

Leiomyosarcoma

430

1.39

1.31

1.9

1.7

2.18

1.02

mg/l

1.53

336

Tuberculosis of other organs, strict

172

1483

1.20

1.30

1.9

1.6

2.35

1.33

mg/l

0.94

137

1157

Endovascular or surgical operations to intracerebral aneurysms

484

4440

1.11

1.30

1.8

1.7

1.19

1.22

mg/l

0.09

392

3410

Deep bite

897

7375

1.08

1.30

2.3

2.1

1.01

1.12

mg/l

0.41

648

5354

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

2.06

1.30

2.1

1.7

1.76

0.93

mg/l

—

Colour vision deficiencies

231

1.53

1.30

1.3

1.9

1.05

1.33

mg/l

0.26

175

Malignant neoplasm of tonsil

104

859

1.26

1.30

1.7

1.48

1.14

mg/l

0.69

660

Other and unspecified pemphigus

208

1.59

1.30

1.8

1.7

3.05

1.14

mg/l

0.76

162

Trichomoniasis

664

1.31

1.29

1.7

1.6

0.73

0.97

mg/l

1.00

505

Deep bite that required surgery

107

889

1.26

1.29

1.6

1.7

0.72

0.84

mg/l

0.37

664

Bus occupant injured in other and unspecified transport accidents

441

1.38

1.28

1.8

1.38

0.97

mg/l

0.63

342

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

104

863

1.27

1.28

1.5

1.7

0.67

0.77

mg/l

0.42

624

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

424

1.39

1.28

1.9

1.8

0.75

1.13

mg/l

1.69

316

Burn and corrosion of shoulder and upper limb, except wrist and hand

163

1404

1.20

1.28

2.0

1.09

1.18

mg/l

0.15

134

1046

Findings of drugs and other substances, not normally found in blood

250

1.51

1.28

1.8

0.87

1.17

mg/l

0.54

194

Maxillary retrognathism

135

1144

1.22

1.28

1.9

2.3

0.67

1.20

mg/l

1.56

817

Pediculosis and phthiriasis

415

1.39

1.27

2.4

1.9

0.70

1.08

mg/l

1.38

307

Changes in corneal membranes

193

1.61

1.27

1.6

1.8

0.65

1.02

mg/l

1.01

151

Malignant neoplasm of other and ill-defined digestive organs

448

1.36

1.27

2.0

1.7

4.39

1.26

mg/l

2.70

351

Vaginal lichen planus

347

1.44

1.27

1.7

1.8

0.77

0.90

mg/l

0.35

271

Abnormal findings on diagnostic imaging of breast

122

1030

1.24

1.26

2.0

1.6

0.81

0.99

mg/l

0.83

795

Disorders of puberty, all

116

969

1.24

1.26

2.4

3.0

2.41

1.07

mg/l

0.54

635

Complicated migraine, drug-induced

2.12

1.25

2.1

1.8

1.01

1.24

mg/l

0.13

Wrist or foot drop (acquired)

3.15

1.25

1.4

1.6

1.40

1.59

mg/l

—

Melanocytic naevi of scalp and neck

195

1707

1.18

1.25

1.9

1.7

1.33

1.04

mg/l

0.50

151

1280

Other degenerative disorders of eyelid and periocular area

194

1.61

1.25

1.7

1.6

0.68

1.14

mg/l

1.28

151

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS